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ABSTRACT 
This thesis investigated neutrophil extracellular traps (NETs) in the pathogenesis of 
periodontal diseases, including chronic periodontitis, experimental gingivitis and Papillon 
Lefèvre syndrome (PLS).  In vitro assays investigated the interactions between periodontal 
bacteria and peripheral neutrophils isolated by discontinuous Percoll gradients, and 
demonstrated differential NET release in response to bacteria.  Interestingly, NETs entrapped 
all periodontal bacteria assayed to some extent; however bacterial growth and survival were 
not impeded.  A longitudinal intervention clinical study of chronic periodontitis patients and 
matched healthy controls revealed no differences in peripheral NET production; however 
NET production by patients decreased following non-surgical treatment.  Furthermore, a 
subset of patients displayed impeded NET degradation by plasma that was restored following 
disease treatment; this may be the result of increased circulating immunoglobulins and free 
light chains (FLCs) pre-treatment.  Peripheral NET production did not change throughout the 
experimental gingivitis model study; however NET release was impeded in PLS patients 
relative to healthy controls.  Additional in vitro studies demonstrated that cigarette smoking 
had an inhibitory effect on NET release.  Collectively, this thesis indicates that NETs 
contribute to innate immunity, however, given that periodontitis pathogenesis is characterised 
by aberrant neutrophil responses, NETs may also be involved in the progression of the 
disease.    
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1.1 Neutrophilic polymorphonuclear leukocytes (PMNLs) 
Neutrophilic polymorphonuclear leukocytes (PMNLs), otherwise known as neutrophils, are 
recognised for playing a critical role in both the innate and acquired (humoral) immune 
response.  The name PMNLs derives from the cells’ multi-lobed nucleus (Figure 1.1), which 
distinguishes the neutrophil from other granulocytes, such as eosinophils, basophils and mast 
cells (Kobayashi et al., 2009).  The innate immune system is characterised by a rapid, though 
poorly specific response to infection, which does not require previous exposure to 
microorganisms to be effective. This process is facilitated by pattern recognition receptors 
(PRR) on the PMNL membrane that recognise highly conserved pathogen-associated 
molecular patterns (PAMPs) from foreign species or “non-self”.  In contrast, the acquired 
(humoral) immune system specifically targets previously encountered pathogens and thus 
results in a delayed, but highly targeted and effective response (Kumar & Sharma 2010).  In 
addition to the neutrophil’s direct effector functions, such as phagocytosis and NETosis (see 
1.1.4), they are able to modulate the activity of acquired immune cells by releasing signalling 
molecules, such as cytokines and by expressing humoral pattern recognition molecules 
(PRMs).  Collectively, the diverse functions of neutrophils make them indispensable to both 
the cellular and humoral arms of the acquired immune response (Jaillon et al., 2013).    
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Figure 1.1: Microanatomy of the human neutrophil 
(a) Schematic of neutrophil activation and the subsequent sequencing cascade in response to 
a microbe. (b) Transmission electron microscopy image of a neutrophil that has phagocytosed 
a microbe (red arrows indicate the microbe, phagosome, granules and nuclei) (Kobayashi et 
al., 2009).  
 
 Neutrophil origin, maturation and longevity 1.1.1
Neutrophil production initiates in the bone marrow, with an estimated two thirds of 
haematopoiesis being assigned to the formation of myeloblasts (cells which are committed to 
becoming granulocytes).  In a healthy individual, neutrophil production is maintained at a 
consistent level, with an estimated 1-2 x 10
11 
neutrophils being generated per day (Savil et 
al., 1989).  However, neutrophil release significantly increases up to 10 fold (Furze & Rankin 
2008) during periods of infection and inflammation, and the transient increase in circulating 
neutrophils accommodates the heightened demands placed upon the immune system (Metcalf 
et al., 1991).  Whilst neutrophils were previously considered to be short-lived cells equipped 
with an estimated half-life of 8 hours in humans, a recent study demonstrated that neutrophils 
have a much longer circulatory lifespan of approximately 5.4 days (Pillay et al., 2010).  
Precise adjustments of neutrophil levels are regulated by apoptosis pathways within the 
tissues, whereby increased neutrophil apoptosis signals a reduction in the number of stem 
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cells assigned to myeloblast formation within bone marrow (Michlewska et al., 2009).  
Apoptotic neutrophils, along with the particles they have engulfed, are efficiently cleared by 
macrophages and dendritic cells, which recognise death signals on the neutrophil surface in 
the form of phosphatidylserine groups (Michlewska et al., 2009, Hochreiter-
Hufford & Ravichandran 2013).   
 
 The neutrophil extravasation cascade 1.1.2
Once released into the circulatory system, neutrophils resolutely survey for invading 
microorganisms.  If pathogens are encountered the neutrophil transitions from a circulating 
non-activated cell, crosses the vascular endothelium and traverses the tissues for in situ 
eradication of the invading pathogen (Figure 1.2).   This occurs as a result of the infection 
triggering the release of bacterial virulence factors, for example lipopolysaccharide (LPS) and 
N-formyl-methionyl-leucyl-phenylalanine (fMLP), as well as host derived inflammatory 
mediators such as interleukin-8 (IL-8) and macrophage inflammatory protein-1 alpha (MIP-1 
alpha). The release of vascular peptides, such as histamine and complement (e.g. C5a and 
C3a) cause vasodilation within the capillary beds; this reduces flow rate and releases 
neutrophils from mid-stream flow, enabling neutrophil contact with the vascular endothelium 
(Muller et al., 2013).  The concomitant activation of the endothelium causes endothelial cells 
to up-regulate their expression of cell adhesion molecules (CAMs) on their luminal surfaces.  
Heightened expression of selectins (e.g. P- and E-selecins), a family of glycoproteins with an 
extracellular lectin-like domain, facilitates the adhesion between the endothelium and 
circulating leukocytes.  Selectins bind to their corresponding ligand, causing the neutrophils 
to intermittently adhere to the vascular endothelium, which represents the initial stage of the 
cells’ migration into the tissues.  This transient adhesion causes the neutrophil to roll along 
the endothelium in the same direction as the vessel’s blood flow, a process also referred to as 
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“leukocyte tethering”.  This further slows the cell and the contact with the endothelium 
induces neutrophil activation.  Activation is postulated to be a synergistic process, instigated 
by a combination of several pro-inflammatory cytokines, (e.g. tumour necrosis factors-α 
[TNFα] and IL-1) and contact with the activated endothelial cells.  The expression of 
immunoglobulin-superfamily cell adhesion molecules, such as platelet endothelial cell 
adhesion molecule-1 (PECAM-1), are also thought to facilitate transmigration (Christofidou-
Solomidou et al., 1997).  Neutrophil diapedesis through the endothelium is believed to occur 
either between endothelial cells (paracellularly) or via a single endothelial cell 
(transcellularly) (Wagner et al., 2000).   
 
 
Figure 1.2: Neutrophil extravasation cascade 
Tissue infection triggers the release of cytokines and bacterial virulence factors that activate 
the vascular endothelium.  This causes the expression of cell adhesion molecules (CAMs), 
such as selectins and integrins, which bind to their corresponding ligand on the neutrophil 
and cause the cells to roll along the endothelium.  Interaction with the endothelium induces 
neutrophil activation and subsequent adhesion, which results in neutrophil transmigration.  
Once the endothelium and basement membrane is traversed, neutrophils follow a chemotactic 
gradient, e.g. complement or bacterial components that emanate from the infected tissue. 
(Image produced by P. White). 
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 Chemotaxis 1.1.3
Chemotaxis describes the directional movement of neutrophils in response to a chemotactic 
gradient, enabling the cells to migrate through the infected tissues.  Once leaving the 
bloodstream and entering the tissue, neutrophils no longer rely on chemokines produced by 
the endothelium, but follow a new chemotactic gradient emanating from the site of infection.  
It is hypothesised that this occurs as a result of a hierarchy of chemotactic molecules that 
overrides the endothelial chemoattractants (Kim & Haynes 2012).  Chemoattactants can be 
categorised into endogenous factors, such as platelet activating factor (PAF), complement 
components (e.g. C5a) and cytokines/chemokines (e.g. IL-8); or exogenous factors, which 
include bacterial components such as fMLP and endotoxins (e.g. LPS).  Chemoattractants 
provide a chemical hierarchy due to differences in concentrations and potencies, which 
orchestrate the recruitment of neutrophils towards the site of infection.  Typically neutrophils 
are the first immune cells to arrive at the site of infection and are present in abundance 
(Swirski et al., 2013).  Neutrophil activation triggers a downstream signalling cascade 
leading to the activation of their cytoskeleton to facilitate cell movement (Samanta et al., 
1990).  The highly sequential migration of cells occurs by polymerisation of F-actin, which 
brings about cytoskeletal changes and the protrusion of pseudopods in the direction of the 
gradient enabling the motile behaviour seen in neutrophil chemotaxis (Andrew & Insall 
2007).  The chemotactic gradient also activates neutrophils via the complementary neutrophil 
receptors of the transmembrane G-protein-coupled receptor (GPCR) family.   
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 Neutrophil killing 1.1.4
In order to fulfil their primary role of eliminating invading pathogens, neutrophils rely on the 
release of granule proteins and the generation of ROS.  Research suggests that a combination 
of both granule proteins and oxidase activity are required for the most efficient microbial 
killing.  This is evidenced in knockout (KO) mice deficient in either ROS or neutrophil 
proteases (e.g. neutrophil elastase [NE]), in which both strains of mice were susceptible to 
infection compared with wild type (WT) mice (Papayannopoulos et al., 2010).  
 
1.1.4.1 Neutrophil cytoplasmic granules 
One of the neutrophils’ defining features is their granules, which are organelles assigned to 
housing a variety of antimicrobial molecules and deploying them into either the phagosome 
or extracellularly via secretory vesicles.  Dependent upon their contents and the time at which 
they are produced during haematopoeisis, granules are subdivided into 3 principal types (as 
described below); however there is significant overlap between granule content (Faurschou & 
Borregaard 2003).  
 
Peroxide positive granules (azurophilic) were named on the basis of their uptake of the dye 
“azure A”; they are the largest of the three granules and the first to be produced in the cell.  
Azurophilic granules contain multiple proteins and peptides that function to aid the neutrophil 
in eliminating microbes.  Myeloperoxidase (MPO), NE, cathepsin G (CG) and proteinase 3 
(PR3) are all contained in azurophilic granules (Faurschou & Borregaard 2003).  Azurophilic 
granules also provide a rich source of defensins, which are cationic peptides that possess the 
ability to kill a wide variety of microbes (Ganz et al., 1985).   
Peroxide-negative granules can be categorised into “specific” and “gelatinase” granules 
(Kjeldsen et al., 1992).  There are significant differences between the granule content; 
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whereas the specific granules are a reservoir of proteins targeted to microbial killing, 
gelatinase granules are involved in other neutrophilic processes.   
 
Specific granules provide a rich source of lactoferrin, which upon release, has the ability to 
sequester bacterial iron and bind to the bacterial membranes.  This enables lactoferrin to elicit 
antimicrobial activity against a range of both Gram-positive and Gram-negative bacteria by 
causing membrane disruption and subsequent cell death (Yamauchi et al., 1993).   
 
Gelatinase-containing granules facilitate neutrophil extravasation, providing the enzymes 
necessary to digest the extracellular matrix.  Typically, gelatinase granules are assigned based 
on these granules lacking lactoferrin, whereas many lactoferrin-containing specific granules 
will also contain gelatinase.  Both specific and gelatinase granules contain flavocytochrome 
b558, which is a heterodimer membrane component of nicotinamide adenine dinucleotide 
phosphate (NADPH)-oxidase and composed of cytochrome P-22
phox 
and GP-91
phox
 subunits 
(Yu et al., 1999, Borregaard & Cowland 1997).  
 
1.1.4.2 Neutrophil oxidative killing 
The generation of ROS via the NADPH-oxidase pathway is critical to the neutrophil’s ability 
to kill invading pathogens.  The significance of this process is exemplified in chronic 
granulomatous disease (CGD) patients, in whom a mutation in any of the four genes 
encoding the NADPH-oxidase complex proteins causes impaired ROS generation and thus 
defective microbial killing (Bianchi et al., 2011).  Oxidative killing relies on the assembly of 
the NADPH-oxidase, resulting in the non-mitochondrial generation of ROS and increased 
oxygen uptake via the “respiratory burst”.  Flavocytochrome b558 plays a pivotal role in 
sequentially transporting electrons from NADPH-oxidase, residing in the neutrophil 
cytoplasm, across the phagosome membrane.  In order for electron transfer to occur, 
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NADPH-oxidase needs to bind with an assembled form of flavocytochrome b558.  Following 
neutrophil stimulation, second messengers such as protein kinase C (PKC), activate the 
assembly of the cytosolic oxidase components, P-47
phox
, P-67
phox
 and P40
phox
, which 
translocate
 
to join flavocytochrome b558 on the phagosome membrane and activate the 
subsequent electron transfer within the completely assembled oxidase complex.  Electron 
transfer results in molecular oxygen being reduced to form superoxide (O2 ̇-), which is 
pumped into the vacuole where it is believed to produce active forms of pro-active enzymes.  
The O2 ̇- is then converted to hydrogen peroxide (H2O2), either spontaneously or following 
superoxide dismutase-2 (SOD-2) enzyme activity.  Finally, catalysed by MPO, H2O2 
combines with chloride ions (Cl
-
) to form HOCl (Robinson 2008, Chapple 1996) (Figure 1.3).  
HOCl plays a vital role in bacterial killing; despite not being well characterised, HOCl has 
been suggested to elicit its bactericidal activity by chlorinating bacteria (Chapman et al., 
2002).  In addition to killing bacteria directly, the generation of ROS via the NADPH-oxidase 
cascade also activates granule proteins.  This involves an elevation in pH and potassium ions 
(K
+
) to compensate for the charge difference created by the movement of electrons into the 
vacuole.  Increased K
+ 
causes the cationic contents of the granules to lose their charge 
interaction with negatively charged proteoglycans and triggers the release of granule proteins 
(Reeves et al., 2002). 
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Figure 1.3: NADPH-oxidase pathway for the generation of ROS   
Neutrophil activation stimulates the assembly of the NADPH-oxidase complex.  This results 
in molecular oxygen being reduced to superoxide (O2 ̇-), which is subsequently converted to 
hydrogen peroxide (H2O2), either spontaneously or catalysed by superoxide dismutase (SOD-
2).  Finally, catalysed by myeloperoxidase (MPO), H2O2 combines with chloride ions (Cl
-
) to 
produce hypochlorous acid (HOCl) (Chapple 1996). 
 
 
1.1.4.3 Intracellular killing: phagocytosis 
Phagocytosis is the intracellular microbicidal mechanism of neutrophils thought to represent 
“safe” killing through containment of cytotoxic molecules within a membrane bound 
phagosome.  Neutrophils are equipped to recognise unopsonised pathogens, as well as 
opsonised pathogens.  Phagocytosis of opsonised pathogens, either with immunoglobulins or 
complement components, relies primarily on Fc-gamma receptors (FcγR) or integrins, 
respectively (Nordenfelt & Tapper 2011).  Neutrophils are also capable of recognising 
pathogens directly by their expression of Toll-like receptors (TLR), which are type-1 
transmembrane PRRs that have the capacity to recognise invading microbes.  For example, 
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TLR2 allows the neutrophil to detect peptidoglycans of Gram-positive bacteria and TLR4 
detects LPS present from Gram-negative bacteria (Takeuchi et al., 1999).  Following 
recognition of invading pathogens by neutrophils, the microorganism is internalised into the 
neutrophil phagocytic vacuole, and the maturation of the phagosome follows.  This is 
characterised by the activation of NADPH-oxidase and the fusion of granules within the 
phagosome, thus delivering proteins derived from azurophilic granules into the phagosome, 
which destroy the engulfed pathogen (Nunes et al., 2013).  Following bacterial phagocytosis, 
neutrophils undergo apoptosis to prevent the release of cytotoxic substances derived from 
necrosing phagocytic neutrophils, such as oxygen radicals, which are reported to cause 
collateral tissue host damage and further propagate the immune response into a chronic state 
(Henson & Johnston 1987). 
 
1.1.4.4 Extracellular killing: degranulation  
In addition to the granule contents being released into the phagosome, neutrophil activation 
can also trigger the extracellular expulsion of granule proteins.  The initial step in exocytosis 
is the acquisition of granules from the neutrophil cytoplasm to the plasma membrane.  
Following translocation, the granules tether along the cell membrane surface, which promotes 
granule fusion with the target membrane and the release of the granule contents.  The process 
relies on elevations of intracellular calcium ions (Ca
2+
) and the hydrolysis of adenosine 
triphosphate (ATP) and guanosine triphosphate (GTP) (Lacy et al., 2006). 
 
1.1.4.5 Extracellular killing: Neutrophil extracellular traps (NETs) 
A relatively novel neutrophil-mediated defence mechanism, termed neutrophil extracellular 
traps (NETs), was recently reported (Brinkmann et al., 2004).  NETs are highly conserved 
extracellular mesh-like structures of decondensed nuclear chromatin (Figure 1.4).  The DNA 
backbone is associated with antimicrobial peptides (AMPs) derived from the azurophilic, 
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specific and gelatinase granules.  The DNA component is essential for extracellular fibres to 
maintain their structure. Indeed analysis of the nuclear and granular NET components 
revealed that deoxyribonuclease (DNase) treatment, which degrades DNA, resulted in NET 
digestion, whilst protease treatment did not (Brinkmann et al., 2004).  NETs are believed to 
function by containing and subsequently destroying pathogenic microbes following their 
immobilisation within the “DNA” traps, thus preventing bacterial dissemination into 
underlying tissues.   
 
 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4: Photomicrograph illustrating fluorescence microscopy of NETs   
Image captured by fluorescence microscopy (x10 magnification) using a Sytox green stain for 
DNA on 50nM phorbol 12-myristate 13-acetate (PMA)-stimulated neutrophils (10
5
) after 4 
hours.  Red arrows indicate neutrophils and white arrows show NET strands, scale bar 
represents 100µm. (Image produced by P. White).   
 
 
NETs are only released by mature neutrophils, endowed with the molecular equipment to 
trigger receptor signalling and the subsequent enzyme activation necessary for NET extrusion 
(Martinelli et al., 2004).  Live image microscopy by Fuchs et al., (2007) demonstrated that 
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NETs are produced during a unique and active form of programmed cell death (termed 
NETosis), which is distinct from apoptosis and necrosis.  A range of stains were employed to 
unravel the sequential events of NET formation and data indicated that neutrophils treated 
with phorbol 12-myristate 13-acetate (PMA), a commonly utilised stimulus for in vitro NET 
production, exhibited nuclear DNA decondensation and subsequent release into  the 
cytoplasm following plasma membrane rupture, leading to chromatin and granular protein 
expulsion (Figure 1.5).  This process was in agreement with previous findings by Brinkmann 
et al., (2004), who demonstrated that NET formation was indeed distinct from necrosis as 
lactate dehydrogenase (a marker of cell necrosis) was not simultaneously released with 
NETs.  NETs have also been shown to be released by viable neutrophils in response to 
priming with granulocyte-macrophage colony-stimulating factors (GM-CSF) and subsequent 
stimulation with LPS or complement (C5a), a process referred to as vital NET release.  This 
requires a much shorter stimulation period of as little as 15 mins.  Interestingly, polymerase-
chain reaction (PCR) analysis demonstrated that the extracellular DNA sequences in vital 
NET release were derived from mitochondrial DNA, rather than nuclear DNA.  
Mitochondrial NETs are distinct from nuclear DNA derived NETs, as they lack nuclear 
proteins, such as lamin B and nuclear matrix protein-45 (Yousefi et al., 2009).  It is therefore 
possible that nuclear and mitochondrial NETs have different extracellular effects. 
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Figure 1.5: Confocal immunofluorescensce images of NET release 
(a) 180 min incubation period without stimulation: neutrophil chromatin and granules are 
distinctly separate.  (b) 60 min incubation period with 20nM phorbol 12-myristate 13-acetate 
(PMA) stimulation: neutrophils flatten to show clear nuclei and granules.  (c) 120 min 
incubation period with 20nM PMA: co-localisation of nuclei and granules (arrows show 
intense yellow staining at nuclear borders).  (d) 180 min incubation period with 20nM PMA: 
some cells are releasing NETs.  Immunofluorescence stains: Red (histone-DNA), green 
(neutrophil elastase), yellow (co-localisation of chromatin and NE).  Scale bar represents 
10μm (Fuchs et al., 2007).   
 
 
1.2 The process of NET release 
The initial step in the production of NETs by activated and NETosing neutrophils is the 
generation of ROS via the NADPH-oxidase complex.  As previously described, this results in 
the production of H2O2, which is catalysed by MPO to produce HOCl.  Subsequent to the 
production of ROS, arginine and methylarginine residues are citrullined by peptidyl arginine 
deiminase 4 (PAD4), causing the nuclear chromatin to decondense (Wang et al., 2009).  
Chromatin decondensation promotes the formation of vesicles between the inner and outer 
nuclear membranes, and neutrophil granule proteins are released and co-localise with the 
chromatin (Figure 1.6).  Nuclear membrane integrity is lost and this enables the DNA to 
combine with AMPs.  Indeed, proteins such as elastase and MPO have all been found to 
associate with the NET complex.  Subsequently, the decondensed DNA, now decorated with 
AMPs, occupies the intracellular cytoplasmic space before rupturing the neutrophil cell 
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membrane.  Active expulsion of the NET web-like structure requires the activation of the 
neutrophil actin cytoskeleton and microtubular systems (Neeli et al., 2009).  Finally, the 
DNA/histone complex is released into the extracellular space.   
 
 
 
 
 
 
 
 
 
 
Figure 1.6: Schematic representation of the steps involved in nuclear NET release     
(Adapted from Brinkmann & Zychlinsky 2007). 
 
 Requirements for NET release 1.2.1
The role of the NADPH-oxidase was confirmed by Fuchs et al., (2007), who demonstrated 
that neutrophils subjected to PMA, alongside diphenylene iodonium (DPI) treatment (an 
NADPH-oxidase inhibitor), produced fewer NETs.  Subsequent findings from patients with 
CGD showed these individuals also lacked the ability to produce NETs.  However the 
phagocytosis of glucose oxidase (GO) coated latex spherules, which circumvents the 
mutation by producing a H2O2 generating system (Baehner et al., 1970), restored NET 
production.  Recent findings by Bianchi et al., (2011) have confirmed the importance of 
NETs in the immune response in CGD patients suffering from pulmonary aspergillosis, 
where the restoration of NET formation using gene therapy was correlated with the 
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eradication of the Aspergillus infection.  These results lend further support for the importance 
of NADPH-oxidase activity in NET production and immune defence.  NET release is also 
reported to require PAD4, an enzyme which converts arginine and methylarginine residues to 
citrulline.  Hypercitrullination of condensed nuclear chromatin causes chromatin 
decondensation/unfolding, which is crucial for extracellular NET formation and subsequent 
NET extrusion (Wang et al., 2009).  Mice deficient in PAD4 do not citrullinate histones, 
which subsequently results in no unfolding of the nuclear chromatin and an inability to 
produce NETs.  Abrogated NET production in these mice has been associated with a 
susceptibility to bacterial infections (Li et al., 2010).  It has also been reported that azurophil-
derived NE necessitates chromatin decondensation prior to NET extrusion.  Papayannopoulos 
et al., (2010) demonstrated that NE inhibitors caused attenuated NET release, as a result of 
inhibited nuclear decondensation.  NE has been proposed to play a key role in determining 
whether neutrophils are assigned to phagocytosis or NETosis in response to invading 
pathogens.  It has been suggested that the acquisition of NE to the phagosome concomitantly 
sequesters NE from the nucleus, which inhibits chromatin decondensation and NET release 
(Branzk et al., 2014).  Use of additional specific inhibitors revealed that MPO and other 
serine proteases, including CG and PR3, were not essential for NET release.  Active 
expulsion of the NET web-like structure also relies on the actions of the neutrophil actin 
cytoskeleton and microtubular systems.  Inhibition of either of these mechanisms, for 
example with cytochalasin D and nocodazole, considerably reduced NET formation in 
response to LPS from 30% to 5% (Neeli et al., 2009).  Whilst it is believed that the actin 
cytoskeleton is essential for signal transmission involved in histone deamination (Neeli et al., 
2009), microtubules have been suggested to transport other components that are vital for NET 
release, such as NE and PAD4 (Cooper et al., 2013).  Furthermore, intracellular calcium has 
been found to play a role in NET release.  In response to PMA, neutrophils pre-treated with 
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2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA; which chelates 
intracellular calcium) exhibited significantly reduced NET production.  Notably, NET 
production was not inhibited to the same extent in response to bacterial stimulation of NETs, 
thus the exact contribution of calcium to this process is difficult to delineate (Parker et al., 
2012).  These requirements for NET release further support the contention that their 
expulsion involves a highly sequential and orchestrated series of events. 
 
 Stimuli that induce NET release 1.2.2
Neutrophils release NETs in response to multiple stimuli including bacteria and their 
components, viruses, fungi and protozoa/parasites (Table 1.1).  Interestingly, host derived 
components, such as cytokines and activated platelets, can also potentiate NET production.   
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Table 1.1: All previously reported NET stimuli 
 
Bacterial Parasites/protozoa and fungi 
Streptococcus pneumonia
1
 Candida albicans
18
 
Staphyloccus aureus
2
 Aspergillus funigatus
19
 
Shigella flexneri
3
 Cryptococcus gattii
20
 
Escherichia coli
4
 
Mycobacterium tuberculosis
5
 
Leishmania amazonensis
21
, chagasi
21
,
 
donovani
15
, 
major
15
 
Listeria monocytogenes
6
 Eimeria bovis
22
 
Klebsiella pneumonia
7
 Plasmodium falciparum
23
 
Mannheimia haemolytica
8
  
Serratia marcescens
9
 
Viruses 
Yersinia pseudotuberculosis
10
 
Porphyromonas gingivalis
11
 Influenza A
24
 
HIV-1
25
 
Feline leukaemia virus
26 
 
Bacteria-derived components Host/Inflammatory mediators 
Glucose oxidase
12
 Platelets & platelet activating factor (PAF)
27
 
Lipopolysaccharide (LPS)
13
 Nitric oxide
28
 
fMLP
14
 Antibodies
29
 
Lipophosphoglycan
15
 TNF-α30 
Leukotoxin GH (S. aureus)
16
 IL-1β30, 830  
Panton-Valentine leukocidin (S. aureus)
16 
Streptococcal surface enolase
17
 
GM-CSF+C5a, LPS
31 
LL-37
32
 
Adhesive protein invasin (Y. enterocolitica)
10
  
 
Non-physiological 
 Phorbol 12-myristate 13-acetate (PMA)
13
 
 Hypochlorous acid (HOCl)
33
 
 Statins
34 
 
  
  
 
References: (1) Beiter et al., 2006. (2) Pilsczek et al., 2010. (3) Brinkmann et al., 2004. (4) 
Grinberg et al., 2008. (5) Ramos-Kichik et al., 2009. (6) Munafo et al., 2009. (7) 
Papayannopoulos et al., 2010. (8) Aulik et al., 2010. (9) González-Juarbe et al., 2015. (10) 
Gillenius & Urban 2015. (11) Delbosc et al., 2011. (12) Yost et al., 2009. (13) Fuchs et al., 
2007. (14) Neeli et al., 2009. (15) Gabriel et al., 2010). (16) Malachowa et al., 2013. (17) 
Mori et al., 2012. (18) Byrd et al., 2013. (19) Urban et al., 2006. (20) Springer et al., 2010. 
(21) Guimarães-Costa et al., 2009. (22) Behrendt et al., 2010. (23) Baker et al., 2008. (24) 
Narasaraju et al., 2011. (25) Saitoh et al., 2012. (26) Wardini et al., 2010. (27) Clark et al., 
2007. (28) Patel et al., 2010. (29) Short et al., 2014. (30) Keshari et al., 2012. (31) Yousefi et 
al., 2009. (32) Neumann et al., 2014. (33) Palmer et al., 2012. (34) Chow et al., 2010.  
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1.2.2.1 Ex vivo stimuli 
PMA is structurally and functionally analogous to diacylglycerol (DAG), an intracellular 
second-messenger lipid and an agonist for PKC.  PMA exposure triggers NET production as 
it bypasses neutrophil surface receptors and the activation of phagocytosis.  Fuchs et al., 
(2007) reported that in vitro stimulation neutrophils with PMA caused one third of cells to 
release NETs.  HOCl is also known to be required for NET release in vivo and using relevant 
concentrations of sodium hypochlorite as a stimulus can replicate this in ex vivo assays.  
HOCl is usually produced by activated neutrophils following NADPH-oxidase assembly.  
This is followed by the production of H2O2, which is converted to HOCl by the enzymatic 
activity of MPO.  HOCl as an ex vivo stimulant negates the requirement for receptor-ligand 
binding and the activation of the NADPH-oxidase, and has been reported to produce NETs in 
as little as 30 mins (Palmer et al., 2012). 
 
1.2.2.2 Bacteria-derived stimuli  
Live bacteria, such as Staphylococcus aureus (S. aureus) (Fuchs et al., 2007) and Shigella 
flexneri (S. flexneri) (Brinkmann et al., 2004), which are Gram-positive and Gram-negative 
bacteria, respectively, have been found to stimulate NET production.  As previously 
mentioned (section 1.2.1), bacteria-induced NET production is dependent upon the activation 
of NADPH-oxidase as DPI treatment (an NADPH-oxidase inhibitor) attenuates NET 
production.  Intriguingly, it has been reported that NETs can be produced in an oxidant-
independent manner in as little as 10 mins in response to S. aureus.  Unlike the typical 4 hour 
release that results in nuclear DNA NETs, this rapid mechanism is thought to also involve the 
expulsion of intact secretory vesicles without nuclear and plasma membrane fusion.  The 
authors hypothesise that this rapid NET release may be critical to contain bacterial infections 
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and the mechanism is dependent on vesicular exocytosis, rather than activation of NADPH-
oxidase (Pilsczek et al., 2010).   
 
LPS is a key component of Gram-negative bacterial cell walls, where it maintains the 
structural integrity, stability and negative charge of the bacteria.  LPS does not have the 
capacity to directly induce neutrophils to release NETs, however, there is growing evidence 
that LPS can activate platelets, which subsequently initiates NET release.  TLR4 has recently 
been reported to be present on platelets, which is indicative of platelets having the capacity to 
recognise and respond to LPS from Gram-negative bacteria (Andonegui et al., 2005).  TLR4 
positive platelets have also been found to sequester in infectious tissues as a result of 
bacterial LPS release.  Activation of platelet TLR4 receptors by LPS causes binding of 
platelets to neutrophils, which has been found to trigger NET release and is believed to 
enable the ensnaring of invading microbes (Clark et al., 2007).  
 
Streptococcus pneumoniae (S. pneumoniae) is reported to associate with plasmin(ogen), an 
enzyme that may facilitate bacterial dissemination via increased proteolytic activity.  S. 
pyogenes, and other group A streptococcal species (GAS), possess a plasmin(ogen) receptor, 
known as streptococcal surface enolase (Bergmann et al., 2001).  Streptococcal surface 
enolase expressed by S. pneumoniae was found to stimulate NET release by human 
peripheral blood neutrophils (PBN).  However, the mechanisms pertaining to the production 
of surface enolase-mediated NET release remains to be elucidated (Mori et al., 2012). 
 
1.2.2.3 Protozoan/parasitic and fungal-derived stimuli 
Neutrophils also produce NETs in response to a range of protozoan parasites, including 
Apicomplexan and Trypanosomatid species (Behrendt et al., 2010, Guimarães-Costa et al., 
2009, respectively).  These parasites are intracellular, however the putative function of NET 
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release in this context is to prevent the dissemination and invasion of protozoa into other 
cells.  Fungi also possess the requisite signals to trigger NET release, including Aspergillus 
fumigatus (A. fumigatus) (Urban et al., 2006) and Candida albicans (C. albicans) (Byrd et 
al., 2013).  C. albicans can be found in both cellular and hyphal forms.  Similar to protozoan 
parasites, NET activation by the cellular form is limited to when C. albicans is emerging 
from cells to invade other cells.  Hyphal forms are extracellular and are likely to be too large 
to phagocytose; thus NETs may represent a critical extracellular defence mechanism (Branzk 
et al., 2014).  Interestingly, C. albicans’ β-glucan, a pathogen associated molecule pattern 
(PAMP), can also stimulate for NET release.  β-glucan is present in the cell walls of fungi 
and enables neutrophils to recognise the invading fungus.  In the presence of fibronectin, an 
extracellular matrix glycoprotein, β-glucan reportedly stimulated neutrophils to release NETs 
in as little as 30 mins (Byrd et al., 2013).  The authors postulate that neutrophil activation and 
downstream NET release is likely due to fibronectin binding with integrins, which causes an 
oxidant-independent mechanism via homotypic aggregration.  
 
1.2.2.4 Host-derived NET stimuli 
Host-derived inflammatory mediators involved in neutrophil recruitment and activation have 
recently been reported to induce NET production.  Systemic inflammatory response 
syndrome (SIRS) is a disease characterised by a dysregulated inflammatory response to non-
infectious insults, such as surgery and trauma (Drifte et al., 2013, Nystrom et al., 1998).  
SIRS patients are known to have high circulating levels of cytokines, including IL-8, IL-1β 
and TNFα and reported to release elevated levels of NETs.  This knowledge prompted the 
investigation into the contribution of circulating cytokines to NET release, which revealed 
that the addition of SIRS patients’ plasma to healthy neutrophils resulted in NET production.  
The neutralisation of patient plasma cytokines prior to incubation with neutrophils 
22 
 
normalised NET release, confirming the contribution of cytokines to NET production 
(Keshari et al., 2012).   
 
Another known stimulus for NETs is LL-37, a member of the cathelicidin family.  
Cathelicidins are AMPs that bind to cholesterol deficient membranes to elicit antibacterial 
(Gennaro & Zanetti 2000), antiviral (Takiguchi et al., 2014) and antifungal (Lopez-Garcia et 
al., 2005) activity.  Neutrophil production of LL-37 is considerably increased when the cell 
is challenged with an infectious agent.  Ex vivo experiments with PBNs have shown that 
physiologically relevant concentrations of LL-37 can cause the production of NETs.  It was 
found that LL-37 could trigger NET release directly, but also confer increased NET 
production in response to S. aureus.  Subsequent immunostaining studies suggested that LL-
37 translocates to the nucleus, which then ruptures the nuclear membrane and facilitates the 
extrusion of nuclear chromatin-derived NETs (Neumann et al., 2014).  
 
1.3 Microbial virulence factors used to bypass NET effects 
Bacteria are known to possess virulence factors that enable them to evade host-defence 
mechanisms, thereby increasing the likelihood of bacterial survival and dissemination.  Some 
bacterial evasion strategies are believed to target the NET response with the aim of escaping 
this form of extracellular entrapment and killing.   
 
 Formation of a bacterial capsule 1.3.1
The expression of a bacterial capsule comprising a layer of polysaccharides can mimic the 
host’s sialic acids.  This allows bacteria to conceal their antigenic molecules, which would 
otherwise be recognised by the host’s immune cells and trigger innate and acquired immune 
responses (Moxon & Kroll 1990).  Capsule expression has recently been shown to allow the 
fungal pathogen, Cryptococcus neoformans (C. neoformans), to evade NET production.  It 
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was discovered that compared with a mutant strain, the WT capsular fungus inhibited 
neutrophil ROS production in PMA-stimulated neutrophils.  Considering NET production is 
largely ROS-dependent, dampened ROS responses may be responsible for the attenuated 
NET production observed (Rocha et al., 2015).  In addition, Wartha et al., (2007) observed 
that S. pneumonia trapped in NET structures were resistant to killing compared with the non-
capsulated serotype of the same organism.  The evasion mechanism appears to be the result 
of a polysaccharide capsule and the incorporation of a positive surface charge, which repels 
the positively charged AMPs within the NETs.  Conversely, some bacteria do not attempt to 
prevent recognition by immune cells, but rely on exaggerated responses to bring about pro-
inflammatory activity.  Lauth et al., (2009) demonstrated that GAS express a crucial 
virulence factor, M1 protein, which causes the production of excessive NETs relative to M1 
KOs.  Subsequent to increased NET production, M1 also promoted GAS survival by 
conferring a resistance to AMPs and thus inhibiting NET-mediated killing.  
 
 Bacterial surface charge modifications 1.3.2
Bacterial surface charge modifications can also facilitate bacterial survival in the host.  By 
altering their usual anionic (negative) surface charge, bacteria are thought to bypass specific 
innate responses (Ernst et al., 1999).  AMPs harbour positive cations, which allow them to 
electrostatically bind to bacterial surfaces.  NETs provide a high local concentration of AMPs 
in the extracellular milieu, however if the bacterial surface charge is altered, the AMPs can be 
repelled rendering NETs ineffective.  Surface modifications employed by the Gram-negative 
bacteria, S. flexneri, allow it to escape neutrophil killing. S. flexneri were found to utilise their 
negatively charged surface to bind AMPs derived from neutrophil degranulation.  This 
enhanced bacterial adherence resulted in hyper-invasion into epithelial cells and the authors 
postulated that S. flexneri rely on its adherence to AMPs to disseminate into epithelial cells 
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and escape neutrophil killing.  However this appears to be counter-intuitive, as whilst the 
bacteria may be conferred with enhanced invasion capabilities allowing dissemination into 
epithelial tissues, they would also surely be susceptible to AMP killing (Eilers et al., 2010).   
 
 Deoxyribonucleases (DNases) 1.3.3
One virulence strategy that appears to be specifically directed at NET structures involves the 
release of bacterial DNases.  DNases target the DNA backbone of NETs, thus disassembling 
the network of AMPs.  DNase production by Gram-negative bacteria, and to a lesser extent, 
Gram-positive bacteria, has been recognised for many years (Porschen & Sandra 1974), but 
has lacked a logical explanation.  However, the discovery of NETs provides a rationale for 
bacterial DNase release and it seems logical to hypothesise that invading bacteria may 
promote their survival by degrading NETs.  A recent study in mice revealed that treatment 
with human recombinant deoxyribonuclease (rhDNase) results in decreased NET-derived 
antimicrobial activity.  Notably, rhDNase treatment during polymicrobial sepsis facilitates 
sepsis progression, increased murine mortality and perturbed neutrophil function.  Increased 
neutrophil infiltration was also observed in the lungs and liver of mice treated with rhDNase, 
and was associated with severe tissue damage.  It is possible that the increased neutrophil 
recruitment is a compensation strategy for attenuated NET bactericidal activity.  These 
findings suggest that NETs play a pivotal role in the elimination of bacteria in vivo (Meng et 
al., 2012).  Similar findings have been observed in mono-microbial infections with S. aureus.  
Berends et al., (2010) investigated the ability of NETs to kill a WT S. aureus strain and a 
nuclease deficient mutant strain.  The nuclease deficient strain of S. aureus was susceptible to 
entrapment and killing by NETs, while the WT organism exhibited resistance. 
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1.4 The role of NETs in the immune response  
NETs may be fundamental to containing sizeable pathogens in a plaque biofilm, which may 
be too large to remove by phagocytosis, such as fungal hyphae (Branzk et al., 2014).  The 
nuclear chromatin backbone is negatively charged and it is likely that the charge interactions 
between NETs and the pathogens’ cell surface cause microbial immobilisation (Figure 1.7).  
Indeed, NETs have been found to trap a significant majority of microorganisms, including 
Gram-positive and Gram-negative bacteria (Brinkmann et al., 2004). 
 
 
Figure 1.7: NETs associated with bacteria 
Scanning electron micrographs illustrating (a) Staphylococcus aureus (Gram-positive), (b) 
Salmonella typhimurium (Gram-negative) and (c) Shigella flexneri (Gram-negative) 
interaction with NET structures.  Neutrophils were primed with 100ng of IL-8 for 40 mins 
prior to infection.  (Scale bar represents 500nm) (Adapted from Brinkmann et al., 2004).  
 
 
 
NET-associated proteases, such as NE, can elicit bactericidal activity against Gram-positive 
and Gram-negative bacteria by degrading bacterial virulence factors (Brinkman et al., 2004).   
MPO is also reported to be involved in NET-mediated microbial killing.   In a recent study 
where S. aureus were incubated with NETs, the growth of colonies following incubation 
indicated that NETs did not affect bacterial viability.  However the addition of H2O2, which 
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functions as a substrate for MPO in the generation of HOCl, led to the killing of the bacteria.   
It is possible that in inflamed tissues, there is a continued recruitment of neutrophils, which 
provides a source of H2O2 to enable the production of HOCl by NET-bound MPO, resulting 
in a lethal environment in the extracellular space (Parker et al., 2012).   
 
As well as acting as a trigger for NET release, the presence of NET-bound LL-37 has been 
strongly correlated with NET antimicrobial activity (Kaplan & Radic 2012).  This fortuitous 
association inferred that a high local concentration of LL-37 in the extracellular milieu may 
have bactericidal properties.  However, earlier studies by Weiner et al., (2003) showed that 
the interaction between LL-37 with DNA resulted in LL-37 losing its antimicrobial activity 
against Pseudomonas spp bacteria.  This considered; a recent publication by Neumann et al., 
(2014) sought to characterise the exact contribution of NET-bound LL-37 to bacterial killing.  
The authors found that LL-37 is a cationic molecule that can bind to extracellular DNA and 
prevent the action of bacteria-derived nucleases.  Virulent nucleases released by invading 
bacteria, such as S. aureus and S. pneumoniae, allow them to degrade NETs and thus evade 
this immune killing mechanism.  Subsequently the association of LL-37 with NET-DNA is 
postulated to promote NET longevity during their encounter with nuclease-producing 
bacterial species (Neumann et al., 2014).   
 
Histones are also proposed to elicit antimicrobial properties against Gram-positive and Gram-
negative bacteria, including S. flexneri and S. aureus respectively (Brinkmann et al., 2004).  
Antibody neutralisation of histones, both NET-bound and purified histones, causes increased 
bacterial viability, indicating that histones do participate in NET-mediated killing.  However, 
it is likely that histone antimicrobial activity is pathogen specific, as C. albicans, in both 
fungal and hyphal forms, appears to demonstrate resistance to histone treatment and remains 
viable (Urban et al., 2006).   
27 
 
In addition to fighting bacterial pathogens, NETs are equipped to defend against viral 
challenge.  The role of NETs in viral infections is less well understood than in bacterial 
infections, however recent findings by Jenne et al., (2013) demonstrated that NETs are 
produced following the systemic administration of poxvirus in a mouse model.  This is 
believed to be the result of the concurrent recruitment of neutrophils and platelets, as already 
alluded to, platelets are capable of activating NET release.  The importance of extracellular 
DNA was evident following DNase degradation, which led to increased viral survival and 
dissemination.  Supporting the contribution of NETs to the host’s response to viral infections, 
NET release is also believed to be important in human immunodeficiency virus (HIV)-1 
infection.  The interactions of the NET-bound components, MPO and α-defensin, have been 
reported to inactivate HIV-1 (Saitoh et al., 2012). 
A further consideration is the participation of NETs in facilitating the acquired immune 
response.  NET production may provide a link between the innate and acquired immune 
responses.  NETs can directly prime helper T-cells (CD4
+
) and cytotoxic T-cells (CD8
+
), 
which has been shown to elevate T-cell responses by decreasing their activation threshold.  
NET-mediated activation of T-cells resulted in increased cytokine release, proliferation and 
surface marker expression.  Collectively, the presence of NETs can bridge the gap between 
the innate and acquired immune systems, providing for a more efficient activation of specific 
immune responses (Tillack et al., 2012).  NETs can also interact with the classical pathway of 
the host’s complement system.  The classical pathway plays a key role in the humoral branch 
of the immune response, and involves opsonising foreign microorganisms to facilitate the 
lysis of the target pathogen.  Binding of C1q to NET DNA initiates the activation of the 
classical pathway (Leffler et al., 2012).   
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1.5 NET degradation and removal 
Following the discovery of NETs in 2004, investigations into NET removal have only been 
performed recently.  Whilst it is appreciated that the appropriate removal of NETs is essential 
for tissue homeostasis, the time scale and processes involved in this are not yet fully 
understood.   In 2010 it was reported NETs produced in vitro are stable for over 90 hours.  
However NET treatment with human sera results in the degradation of extracellular NET-
DNA.  The authors deduced that it was the acquisition of serum-derived DNase 1 that was 
responsible for deconstructing the NETs, as specifically chelating calcium impeded NET 
degradation (Hakkim et al., 2010) (Figure 1.8).  NET degradation by DNase 1 is believed to 
represent the initial stage in NET clearance, which facilitates their subsequent removal by 
macrophages.  Following disassembly, NET histones and DNA are opsonised by complement 
component C1q, which causes phagocytosis of NET debris by macrophages.  It is postulated 
that NETs are then degraded in the lysosomal compartment of the macrophage; however the 
specific nucleases involved in this process remain elusive.  Key to this process is that NET 
clearance resembles a mechanism similar to that of apoptosis, whereby macrophages appear 
non-phlogistic and do not release pro-inflammatory cytokines (Farrera & Fadeel 2013).   
 
 Host-derived DNase  1.5.1
DNases may also be necessary to maintain a normal tissue homeostasis, such as in 
fertilisation, where NETs are produced by “sperm-activated neutrophils”, which may entrap 
and immobilise spermatozoa.  Artificial insemination of spermatozoa alongside seminal 
plasma was found to increase the chance of fertilisation, which is believed to be due to the 
presence of DNase in the seminal plasma preventing NET entrapment and facilitating 
motility of the spermatozoa (Alghamdi et al., 2005).  The importance of host DNase 
production is also evident in cystic fibrosis (CF) (see section 1.6.3), where it has been 
proposed that not only are NETs detrimental to the host, evidenced by the fact that NET 
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production is positively correlated with impaired obstructive lung function (Marcos et al., 
2010), but DNase may have utility in CF treatment.  The administration of DNase as an 
adjuvant therapy alongside current anti-proteases facilitates NET degradation and thus the 
removal of potentially immunogenic structures (Papayannopoulos et al., 2011).  
 
 
Figure 1.8: NET degradation by DNase 1 
(a) NETs were incubated with healthy DNase-containing serum (10%) for 6 hours in the 
presence of G-actin.  NET degradation was inhibited in a concentration-dependent matter 
following treatment with G-actin, a specific DNase 1 inhibitor.  (b) Neutrophils were 
stimulated to produce NETs and were subsequently incubated with 10% serum for 0, 3 or 6 
hours.  The cells were fixed and immunostained for histones (red), DNA (blue) and MPO 
(green). There were considerably fewer NETs following incubation with serum.  Scale bar 
represents 10µm (Hakkim et al., 2010).  
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1.6 NETs and autoimmune processes 
In contrast to the proposed beneficial anti-infectious role of NETs, excess NET formation has 
been associated with deleterious effects in a range of pathologies.  Whilst the extracellular 
DNA and high localised concentrations of AMPs function to remove invading pathogens, 
they concomitantly provide a source of cytotoxicity; therefore perturbed NET release or 
delayed NET clearance may initiate undesirable immune processes. 
 
 Rheumatoid arthritis (RA) 1.6.1
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease that causes 
inflammation of joints, causing pain, swelling and restricted movement.  Neutrophils play an 
active role in RA, by processes such as the release of cytokines and interacting with other 
immune cells.  RA patient neutrophils exhibit hyperactivity in terms of ROS generation and 
have elevated concentrations of granule proteins in the synovial fluid, which have been linked 
to collateral tissue damage (Wright et al., 2014).  RA patients are known to release 
autoantibodies, namely rheumatoid factor (RF) and anti-citrullinated protein antibodies 
(ACPA).  RA patients also exhibit higher levels of circulating pro-inflammatory cytokines, 
including TNFα (Wright et al., 2014).  Neutrophils from RA patients reportedly have a 
greater propensity to produce NETs compared with healthy controls.  Notably, patient 
derived RF, ACPAs and higher levels of pro-inflammatory cytokines reportedly stimulate 
healthy neutrophils to release NETs.  RA patients are therefore susceptible to excessive NET 
production in both circulating and RA synovial fluid neutrophils (Khandpur et al., 2013).  As 
previously discussed (section 1.2.1), NETs are dependent on the enzymatic actions of PAD4 
(Wang et al., 2009), which is essential for NET release, as NETs have been found to harbour 
citrullinated proteins in their extracellular structures.   Interestingly, ACPAs react with 
citrullinated histone H4, indicating that NETs may provide a source of autoantigenic histones 
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that enhance ACPA formation (Pratesi et al., 2014).  This may bring about a vicious cycle 
characterised by increased NETs and subsequent increased ACPA levels.  The authors also 
demonstrated that elevated levels of NETs were associated with more severe clinical 
endpoints, such as increased joint destruction.  Moreover, there is significant interest in the 
association between RA and periodontitis, with NET production in periodontal tissues 
serving as a plausible mechanism for ACPA generation following a break in immune 
tolerance to citrullinated proteins released by neutrophils (dePablo et al., 2009).  In addition 
the periodontal pathogen, P. gingivalis, possesses a unique PAD enzyme that functions 
similarly to that of the mammalian isoform (Wegner et al., 2010).  P. gingivalis PAD (PPAD) 
may citrullinate P. gingivalis proteins in a form of molecular mimicry or may citrullinate host 
proteins, thus generating ACPAs.  
   
 Systemic lupus erythematosus (SLE) 1.6.2
Systemic lupus erythematosus (SLE) is an autoimmune disease caused by a loss of tolerance 
to self-antigens that results in autoantibody production against nuclear antigens including 
double-stranded DNA (dsDNA) and histones.  Neutrophils are understood to play a 
predominant role in disease mechanisms that contribute to the pathogenesis of SLE (Yu & Su 
2013).  In addition to exaggerated neutrophil activation, SLE neutrophils reportedly display 
abnormal phagocytosis, increased aggregation and elevated apoptosis (Abramson et al., 1983; 
Courtney et al., 1999). Anti-neutrophil cytoplasmic antibodies (ANCAs) are present in 25%-
56% of SLE patients (Fauzi et al., 2004) and NETs may therefore perpetuate SLE, as they 
contain multiple neutrophil-derived granular proteins that act as immunogens.  Notably, it has 
recently been reported that NET clearance by sera is impeded in a subset of SLE patients.  To 
establish the mechanisms preventing NET disassembly by DNase 1, Hakkim et al., (2010) 
identified two processes that resulted in reduced NET removal.  In one group of “poor 
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degraders”, DNase 1 inhibitors were believed to be responsible.  However, some individuals 
exhibited elevated levels of anti-NET antibodies, which were thought to provide a physical 
barrier that blocked enzymatic NET degradation by host DNases.  Abrogated NET clearance 
in some SLE patients was also confirmed by Leffler et al., (2012) in a different patient 
cohort.  However Leffler et al., (2012) found that DNase 1 treatment could augment NET 
degradation in all “poorly degrading” patients, indicating the absence of DNase inhibitors.  
Conversely, it was found that NETs could bind C1q, a component of the classical 
complement pathway.  Whilst the deposition of C1q is believed to facilitate NET 
phagocytosis by macrophages (Farrera & Fadeel 2013), Leffler et al., (2012) proposed that 
C1q may concomitantly provide a physical barrier preventing enzymatic disassembly by 
DNase 1.  The delayed removal of NETs may provide a source of citrullinated autoantigens 
in the extracellular space, such as nuclear chromatin and AMPs, which may indeed promote 
anti-dsDNA titres and therefore contribute to SLE pathogenesis (Khandpur et al., 2013). 
 
 Cystic fibrosis (CF)  1.6.3
Cystic fibrosis (CF) is an autosomal recessive disease caused by a mutation in the cystic 
fibrosis transmembrane conductance regulator (CFTR) gene, which is associated with 
mucocilary dysfunction characterised by excess amounts of abnormal mucus.  Despite an 
excessive inflammatory response, patients are unable to effectively eradicate bacteria inhaled 
into the lungs, such as Pseudomonas aeruginosa (Gifford & Chalmers et al., 2014, Lyczak et 
al., 2002).  The neutrophil is the predominant immune cell in CF; however whilst their 
recruitment facilitates defence against the bacterial challenge, neutrophil accumulation and 
their compromised clearance concomitantly fuels the inflammatory response associated with 
disease progression.  In addition, CF neutrophils are believed to be less responsive to anti-
inflammatory signals released by IL-10, which perpetuates the inflammatory response (Petit-
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Bertron et al., 2008).  Following this, the excessive production and accumulation of NETs in 
CF patients is reported to exacerbate disease development.  Recent findings have identified a 
specific chemokine receptor, CXCR2, believed to facilitate NADPH-oxidase independent 
NET release in CF patients.  This was confirmed by CXCR2 inhibitors that negated NET 
production and may represent a therapeutic target in CF patients, as interestingly, inhibited 
NET production was not reported to affect antimicrobial defence (Marcos et al., 2010).  It is 
likely that exaggerated NET production in CF produces NET-bacteria complexes, which if 
not removed efficiently, provide a source of autoantigens that trigger further inflammatory 
episodes.  As previously discussed (1.5.1), DNase inhalation therapy has been found to 
improve lung function in CF by digesting NET structures within the mucous (Saffarzadeh et 
al., 2013). 
 
1.7 Periodontitis 
Periodontitis is the most prevalent chronic inflammatory disease of humans, and severe 
periodontitis represents the sixth most common disease worldwide (Kassebaum et al., 2014).  
In the UK, 45% of all adults have periodontitis, defined by periodontal pockets measuring 
≥4mm (Adult Dental Health Survey 2009, White et al., 2012).  Periodontitis is believed to be 
the leading cause of tooth loss worldwide, but also impacts upon speech, function, nutrition 
and quality of life.  Moreover, periodontitis has far reaching consequences for general health 
contributing to elevations in the systemic inflammatory burden, which is associated with 
increased risk of age-related conditions including cerebrovascular accident (CVA) (Grau et 
al., 2004), atherosclerosis (Pinho et al., 2013) and RA (Smit et al., 2012).  It is well 
recognised that periodontitis is the result of a bacterially evoked inflammatory response in 
susceptible individuals, which leads to tissue destruction and disease progression (Figure 
1.9). This results in periodontal pocket formation, gingival bleeding and alveolar bone 
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destruction (Bascones-Martínez et al., 2009).  Periodontitis and gingivitis represent two 
inflammatory processes affecting the tissues surrounding the teeth (the periodontium), in 
response to bacterial accumulation in the form of a plaque biofilm.   
 
 
 
 
 
 
 
Figure 1.9: Clinical symptoms of chronic periodontitis 
Image from a 50 year old female patient with chronic periodontitis illustrating inflammation, 
calculus formation and recession with drifting of upper left central incisor due to bone loss 
(courtesy of Professor I. Chapple). 
 
Gingivitis is a reversible inflammatory condition limited to the gingival tissues and unlike 
periodontitis; the inflammatory response does not ultimately result in connective tissue 
attachment loss and alveolar bone destruction.  Periodontitis is believed to be preceded by 
gingivitis. Progression to periodontitis arises when inflammation is not limited to the gingiva 
but spreads to the deeper periodontal tissues, causing a deep gingival crevice (known as the 
periodontal pocket) between the tooth and lining epithelial surface (Kinane 2001).  However, 
the transition from gingivitis to periodontitis only arises in susceptible individuals, which 
may be as a result of exposure to a variety of risk factors, e.g. smoking, plaque accumulation, 
diabetes or genetic predisposition (section 1.7.3).  Notably according to Lӧe et al., (1986) 
approximately 10% of the population is completely resistant to the disease.   
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 Role of the microbial biofilm in periodontitis 1.7.1
Periodontitis is initiated by the accumulation of bacterial plaque at, and below, the gingival 
margin (Figure 1.10).  Indeed it has been estimated that ~500 oral bacterial species and ~1200 
predominant phylotypes exist (Paster & Dewhirst 2009, Dewhirst et al., 2010).  Of these 
bacterial species, 5 major bacterial complexes (red, orange, yellow, green and purple) have 
been identified by Socransky et al., (1988).  The clustering and ordination analysis allowed 
Socransky to assign microbial species to a colour complex dependent upon the strength of 
association with each other and the clinical staging of periodontitis (Figure 1.11).  For 
example, bacteria assigned to orange and red complexes denote late stage colonisers 
associated with the subgingival plaque.  Bacteria have also been categorised according to 
their location in relation to the gingival margin: supragingival or subgingival.  Whereas the 
supragingival plaque contains facultative species (such as Streptococcus species), the 
subgingival plaque is dominated by a Gram-negative anaerobic motile microbiota (Loesche et 
al., 1982).  The role of bacteria in periodontitis has historically been encapsulated in two 
different hypotheses, describing how microflora may contribute to the host response and 
disease pathogenesis. The “non-specific hypothesis” (Loesche 1976) proposes that the entire 
microbial flora contribute to the disease and once a threshold quantity is reached, 
periodontitis will occur.  Alternatively, the “specific hypothesis” (Theilade 1986) proposes 
that the presence of particular pathogenic bacterial species is necessary for the diseased state 
(Loesche & Grossman 2001).  A third model was introduced by Marsh (1994), the 
“ecological hypothesis”, which encompasses both previous hypotheses. This model proposes 
that an inflammatory response is initiated as a direct result of the accumulation of a 
pathogenic subgingival microbiota, which triggers a shift away from microbial homeostasis, 
encouraging the growth of proteolytic and anaerobic bacterial species.  The colonisation of 
multiple bacteria in the generation of a mature plaque biofilm is a highly organised sequential 
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process.  The biofilm is orchestrated to maximise adherence, communication, survival and 
the accumulation of other bacterial species.  Oxygen levels, environmental exposures and 
competing commensal bacteria will all determine microbial growth and govern the locality of 
where each bacterial species will thrive (Feng & Weinberg 2006).  The biofilm encloses the 
bacterial community and protects it from mechanical and chemical disruption; however a 
synergistic and antagonistic relationship exists between bacteria (Koll-Klais et al., 2005).  
Development of the plaque biofilm is initiated by deposition of salivary components, such as 
glycoproteins (termed the acquired pellicle), onto the tooth surface prior to deposition of 
early colonising bacteria.  The acquired pellicle provides receptors on the tooth surface for 
microorganisms to adhere to; routinely Streptococci species are the first to adhere, 
representing 60-90% of the initial colonisers (Nyvad & Kilian 1987).  Subsequent to initial 
colonisation, secondary colonisers adhere via co-adhesion and co-aggregation, increasing the 
biofilm size and complexity.  Particular bacterial species appear to play a more dynamic role. 
For example Fusobacterium nucleatum (F. nucleatum), a Gram-negative anaerobe that is 
present in periodontally diseased sites,  is not generally classified as an early or late coloniser, 
but is a quorum sensing organism believed to facilitate biofilm formation (Kolenbrander et 
al., 2009, 2010).  A health promoting biofilm is essential for periodontal health, as bacteria 
exist symbiotically with each other and the host.  However, if the biofilm is allowed to 
mature and is not frequently disrupted, then pathogenic species emerge. Dysbiosis results in 
susceptible individuals and the host-microbial equilibrium is lost, which can result in the 
onset of disease (Hajishengallis 2014). 
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Figure 1.10: Sequential bacterial colonisation which results in the formation of a plaque 
biofilm 
The acquired pellicle (yellow), containing receptors (green), is deposited onto the tooth 
surface.  Early colonisers (blue) bind to their complementary receptors (black lines), followed 
by the adherence of secondary colonisers.  Sequential binding enables co-aggregation 
between different species, which bridges the gap between bacteria.  F. nucleatum (pink) 
bridges early and late colonisers, allowing interaction between the two groups.  Co-
aggregation is represented by complementary shapes, for example the top left depicts 
adhesion (red and white, with stem) and it’s receptor (red, no stem) (Kolenbrander et al., 
2002).  
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Figure 1.11: Periodontal bacteria assigned to the Socransky colour complexes    
Diagrammatic representation indicates the relationships between specific bacterial species 
within the colour complexes.  The complexes also provide a possible sequence of 
colonisation in the biofilm and the associations with the clinical parameters of periodontitis.  
The bacteria listed above represent the panel of bacterial species employed in this thesis 
(adapted from Socransky et al., 1998). 
 
 The contribution of the immune response to host periodontal tissue damage 1.7.2
Periodontitis occurs as a result of dysbiosis, which involves an increase in harmful 
periodontal bacteria that become established in the host (Hajishengallis 2014) (Figure 1.12).  
However, the microbial biofilm thrives by exploiting the host response, in particular the 
neutrophil-mediated inflammatory response in susceptible individuals.   This fuels a vicious 
cycle of bacterial accumulation, inflammation and subsequent tissue destruction.  The acute 
inflammatory response is initially protective, providing the recruitment of neutrophils, the 
activation of innate neutrophil-derived defence mechanisms and the activation of the acquired 
cellular and humoral immune response.  However in periodontitis, the neutrophil response is 
reputed to unintentionally contribute to the progression of periodontitis causing collateral 
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tissue damage, which perpetuates the inflammation leading to chronicity and providing 
nutrients for pathogenic bacteria like P. gingivalis to survive and proliferate (Scott & Krauss 
2012).  A common hypothesis for the involvement of the host in periodontitis pathogenesis is 
that neutrophils exhibit hyperactivity and hyper-reactivity in response to the biofilm.  This 
exaggerated immune response is exemplified in the systemic neutrophils derived from 
chronic periodontitis patients. PBNs are reportedly hyper-reactive in response to a microbial 
challenge, but also hyperactive in the absence of an exogenous stimulus (Matthews et al., 
2007a, 2007b).  In addition, excessive proteolytic activity has been observed in periodontitis 
patients, which normalised following successful treatment.  This is thought to be partly 
attributed to the increased intensity of protease-activated receptor-2 (PAR2) expression in 
chronic periodontitis.  PAR2 is a receptor present on multiple cells, including neutrophils, and 
is involved in the initiation of an inflammatory response via interactions with bacterial 
proteases (Lourbakos et al., 1998).    Increased PAR2 expression can promote the production 
of cytokines and proteolytic enzymes, such as IL-6, IL-8 and matrix metalloproteinase 
(MMP)-9 (Holzhausen et al., 2006).  MMPs are a family of proteolytic enzymes that function 
to degrade extracellular matrix molecules during physiological and pathophysiological tissue 
remodeling.  However these proteolytic agents are also thought to be key proteinases 
involved in periodontal tissue destruction.  Periodontal bacteria, including F. nucleatum and 
P. gingivalis, trigger the extracellular release of MMPs.  MMP release is regulated by 
endogenous inhibitors, such as the tissue inhibitors of metalloproteinases (TIMPs), however 
neutrophils do not produce this inhibitor de novo (Masure et al., 1991) and it is thought this 
inhibitory mechanism is overwhelmed in periodontitis (Romanelli et al., 1999).  The elevated 
release of MMPs facilitates tissue degradation, which is likely to be exacerbated by the 
heightened recruitment of neutrophils in periodontitis.  Other neutrophil serine proteases also 
associated with tissue degradation include NE and CG.  NE can contribute to tissue 
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destruction by degrading molecules such as collagen and fibronectin and has been positively 
correlated with periodontal attachment loss (Armitage et al., 1996).  Interestingly, CG can 
activate MMP-8 (Ding et al., 2005) and has been found to be higher in periodontitis patients 
(Tervahartiala et al., 1996).  It has been proposed that the elevated release of NE is the result 
of a genetic polymorphism that leads to neutrophils with an intrinsically elevated function.  
For example neutrophils from individuals with a (131 H/H) polymorphism of the Fcγ-
receptor are associated with more severe periodontitis.  These individuals also overexpress 
degranulation markers, CD63 and CD66b, resulting in increased NE release when challenged 
with an infectious agent (Nicu et al., 2007). 
 
Periodontitis is also associated with increased levels of cytokines, as a result of plaque 
bacteria initiating the recruitment of neutrophils.  As already discussed, chemokines 
orchestrate the directional movement of neutrophils to the infected periodontal tissues (see 
section 1.1.3).  Chemokines have been suggested to be involved in bone resorption, as they 
play a role in maintaining the equilibrium between osteoblastogenesis (bone formation) and 
osteoclastogenesis (bone resorption) (Silva et al., 2007), a loss of which may associate with 
alveolar bone resorption in periodontitis.  Chemokines have been reported to be involved in 
multiple steps of the signalling cascade resulting in osteoclastogenesis.  For example CXCR4 
expressed on osteoclast precursor cells is involved in their chemotaxis and differentiation into 
osteoclasts (Wright et al., 2005).  Furthermore, chemokines can indirectly modulate 
osteoclastogenesis by possessing ligands that can increase MMP-9 activity, which in turn 
facilitates tissue destruction and bone resorption (Grassi et al., 2004).  Cytokines are also 
deemed partly responsible for promoting bone resorption in periodontitis.  This is evident in 
periodontitis patients, in whom IL-1β was found to be elevated at sites of recent bone and 
attachment loss (Lee et al., 1995).   
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Figure 1.12: The pathogenic model of periodontitis 
In susceptible individuals, the equilibrium between commensal and periodontal bacteria is 
lost; giving rise to polymicrobial dysbiosis.  This triggers activation of immune cells, for 
example by toll-like receptors (TLRs), pattern recognition receptors (PRRs) and complement.  
This triggers an inflammatory response, in which neutrophils are the predominant immune 
cell.  Whilst aiming to contain the bacteria attempting to colonise the epithelium, neutrophil 
immune responses concurrently cause tissue damage.  This provides nutrients which bacteria 
utilise to proliferate, which promotes further dysbiosis (adapted from Hajishengallis 2014). 
 
 
 
However, it is noteworthy that whilst neutrophil hyperactivity likely exacerbates periodontal 
tissue destruction, impaired neutrophil activity can also increase disease severity.  Multiple 
diseases characterised by a deficient immune response are also correlated with severe 
periodontitis.  For example Papillon Lefèvre syndrome (PLS) is an autosomal recessive 
disease in which a mutation in the cathepsin C gene (CTSC) results in a failure to encode 
lysosomal cysteine protease, cathepsin C.  Disease is characterised by palmoplantar 
hyperkeratosis (abnormal thickening of the skin on the palms of the hands and soles of the 
feet), significant pre-pubertal periodontal attachment loss, alveolar bone destruction, and the 
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subsequent loss of primary and permanent dentition (Singh et al., 2011).  CTSC is essential 
for post-translational trimming of serine proteases, e.g. granule-associated neutrophil serine 
proteases (NSP) including NE, CG, PR3 and the recently described neutrophil serine protease 
4 (Perera et al., 2013). CTSC removes N-terminal amino acids that block the active site of the 
proteases and is thus necessary for activation of these proteases.  These proteases are stored 
as active enzymes in neutrophil granules, and localise to primary granules (azurophilic) 
(Figure 1.13).  NET production has recently been found to be impeded in a female PLS 
patient (homozygous missense mutation in the CTSC gene) and the authors report that this is 
due to decreased NE, which necessitates NET release (Sorensen et al., 2014).  As ROS is not 
inhibited in PLS patients, it is unlikely that reduced NET production is due to aberrant 
NADPH-oxidase production (as in CGD).  Whilst CGD patients also fail to generate NETs, 
there are contradictory findings as to whether these individuals suffer from rapidly 
progressing periodontitis (Budeneli et al., 2001, Cohen et al., 1985).  Notably, the mild 
immunodeficiency in PLS patients indicates that NET formation is not a major antimicrobial 
defence mechanism, however the exact process that leads to such aggressive periodontitis 
with clinically severe inflammation in PLS remains elusive.  Furthermore, patients with 
cyclic neutropenia who have considerably fewer neutrophil numbers are susceptible to severe 
periodontitis (Matarasso et al., 2009).   
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Figure 1.13: Clinical signs and symptoms in a PLS case study 
Intraoral periapical radiograph (a) and clinical photograph (b) from a 4 year old male with 
PLS. The images show generalised gingival recession and severe periodontal destruction, 
indicated by the yellow arrows (courtesy of Professor I. Chapple).   
 
 
The importance of the host response is also evident in KO mice deficient in the chemokine, 
CXCR2.  Upon infection with P. gingivalis, CXCR2 KO mice had elevated periodontal bone 
destruction compared with WT mice (Jeffrey et al., 2007).  Interestingly, as previously 
discussed (1.6.3) CXCR2 is also postulated to be required for NET release in an NADPH-
oxidase independent mechanism (Marcos et al., 2010). Collectively these results highlight 
that both a hyperactive and deficient neutrophil response are associated with increased 
disease.  It is therefore likely that a homeostatic imbalance in the immune response 
contributes to the initiation and development of disease in susceptible individuals.   
 
 Risk factors for periodontitis 1.7.3
Substantial epidemiological data exists which have identified the risk factors contributing to 
the initiation and progression of periodontal disease.  These include poor oral hygiene 
(Kakudate et al., 2008), smoking (Bergstrom et al., 2000), obesity (Gocke et al., 2014), 
   
a b 
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poorly controlled diabetes (Demmer et al., 2012), genetic predisposition (Divaris et al., 
2013), stress (MousaviJazi et al., 2013) and osteoporosis (Esfahanian et al., 2012).  The 
understanding that periodontitis only affects a proportion of the population who exhibit 
atypical susceptibility has fuelled further research to understand the importance of specific 
risk factors.   Cigarette smoking is considered to be a major risk factor in the development of 
periodontitis (Grossi et al., 1994, 1995).  Tobacco smoking causes the inhalation of over 
4000 toxins and is associated with many diseases, including cardiovascular disease (Burns 
1991, Ambrose et al., 2004). Ragghianti et al., (2004) reported an association between 
smoking and the clinical manifestations of periodontitis (Table 1.2).  Worthy of note is that 
numerous studies have shown that smoking is positively correlated with poor oral hygiene; 
however even after adjustment for oral hygiene as a cofactor, smoking still appears to be a 
primary independent risk factor (Tonetti et al., 1998).  There is also a body of evidence 
suggesting that smoking adversely affects treatment responses, indeed considerably more 
smokers require additional treatment after the initial periodontal therapy (Delima et al., 
2010).  These findings are supported by individuals who showed improved treatment 
outcomes following smoking cessation.  A possible explanation for the increased prevalence 
of periodontitis amongst smokers is that smoking was found to select for specific periodontal 
bacteria, including P. gingivalis, Treponema denticola (T. denticola) and Tannerella 
forsythia (T. forsythia) (Zambon et al., 1996).  These are all bacterial species assigned to the 
red Sokransky complexes and are associated with severe disease.  Smoking has also been 
found to adversely affect neutrophil function, indeed nicotine has been shown to promote 
neutrophil degranulation, which can cause an exaggerated response to the invading bacteria 
and induce local tissue damage (Soder et al., 1999). 
 
It has been reported that smoking can affect neutrophil total, extracellular and superoxide 
ROS production (Matthews et al., 2011, 2012).  High concentrations of cigarette smoke 
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extract (CSE) resulted in increased ROS production; however pre-treatment of neutrophils 
with lower concentrations of CSE had an inhibitory effect on subsequent ROS production in 
response to FcγR and TLR stimulation.  In periodontitis, reduced ROS production in smokers 
may impede the elimination of periodontal bacteria; however in heavy smokers increased 
ROS production may facilitate oxidative stress and tissue damage.  Intriguingly, neither 
nicotine nor cotinine were deemed responsible for the observed effects, as these did not 
directly alter ROS production.  Notably, CSE was not found to be cytotoxic towards 
neutrophils, but did have an inhibitory effect on apoptosis.  It is possible that transient 
exposure to cigarette smoke components may perturb the neutrophil response to bacterial 
infection if ROS species are not being generated accordingly.  However in the absence of an 
exogenous stimulus, such as a bacterial biofilm, smokers may elicit excessive background 
ROS production, which could associate with collateral tissue damage.  Abnormal neutrophil 
responses may therefore represent a crucial link between smoking and periodontitis. 
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Table 1.2: Effect of smoking status on periodontal health 
Mean pocket depth (mm) and clinical attachment loss (mm) were measured in 380 
periodontitis patients in Brazil.  Smoking status (self-reported smoking habits: current smoker 
or non-smoker) was significantly correlated with disease severity (ANOVA and Tukey test: 
p≤0.05).  Data expressed ± standard deviation (SD) (adapted from Ragghianti et al., 2004). 
 
Age (years) 
Pocket depth (mm) Clinical attachment loss (mm) 
Non-smoker Smoker Non-smoker Smoker 
20-29 2.56 ± 0.54 2.80 ± 0.63 2.63 ± 0.57 2.91 ± 0.65 
30-39 2.64 ± 0.51 3.09 ± 0.74 2.87 ± 0.58 2.52 ± 0.95 
40-49 2.85 ± 0.72 3.02 ± 0.62 3.29 ± 0.81 3.81 ± 1.33 
≥50 2.81± 0.69 3.37 ± 0.86 3.59 ± 1.02 4.25 ± 0.96 
 
 
1.8 The role of NETs in periodontitis 
Currently there is a paucity of literature investigating the role of NETs in the pathogenesis of 
periodontitis.  As already discussed, chronic periodontitis patients elicit hyperactivity and 
hyper-reactivity in terms of ROS release (Matthews et al., 2007a, 2007b) (section 1.7.2).  
This may represent a constitutive mechanism, in which increased baseline ROS production is 
involved in the onset of disease.  Conversely, this could be a reactive mechanism as a result 
of a pathogenic biofilm and the development of periodontitis.  It is possible that, given NET 
release is reliant on ROS generation; periodontitis may associate with exaggerated NET 
production. Recent evidence from our group suggests that neutrophil hyperactivity/hyper-
reactivity may result from an altered intracellular ratio of reduced glutathione (GSH) to 
oxidised glutathione (GSSG), as well as defective GSH synthesis in periodontal patient 
neutrophils (Grant et al., 2010, Dias et al., 2013).  Perturbed antioxidant functioning in 
chronic periodontitis may thus affect NADPH-oxidase dependent NET release.  High 
concentrations of NET-associated cytotoxic components in the tissues may provide a source 
of autoantigens.  This could be exacerbated if NETs are produced in excess or are not cleared 
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efficiently, which may result in further periodontal tissue damage.  Vitkov et al., (2009) 
employed microscopy to visualise NETs, which appeared abundant in gingival pocket 
epithelium, the gingival exudate and in the gingival crevicular fluid (GCF) of chronic 
periodontitis patients (Vitkov et al., 2010) (Figure 1.14).  The authors postulated that during 
the bacteria’s attempt to migrate and adhere to the gingival surface, they encounter NETs 
which shield the epithelium and prevent adhesion.  Interestingly, the bacterial counts in the 
purulent GCF exudate were relatively inconsistent, which led to the theory that if 
phagocytosis is overwhelmed, for example due to large numbers of colonising bacteria, NETs 
may compensate for the increased demand on the immune system by providing an additional 
neutrophil-defence mechanism. Further observations, such as the lack of neutrophils 
containing engulfed bacteria and the large quantities of NETs in the GCF suggest NETosis is 
the predominant defence mechanism employed by neutrophils in the GCF at periodontally 
diseased sites (Vitkov et al., 2010).  Worthy of note is that this research did not include 
healthy matched controls and that NETs were not quantified in the periodontal tissues.  
Indeed it would be interesting to compare GCF and periodontal tissue samples from 
periodontitis patients and matched controls to determine if any disparity exists in NET 
formation and accumulation.  Preliminary findings presented in Cooper et al., (2013) 
employed confocal microscopy and immunofluorescence staining to identify increased levels 
of NET-like structures in inflamed gingival tissues, compared with healthy control tissues 
(Figure 1.15).  Supporting the theory of increased NETosis in periodontitis is that a range of 
molecules that are elevated in periodontitis, such as nitric oxide and interferon-α (IFNα), can 
also stimulate for NET release (Reher et al., 2007, Wright et al., 2008). 
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Figure 1.14: NET entrapment of periodontal bacteria 
Scanning electron micrographs illustrating: (a1) Crevicular exudate containing bacteria 
(white arrowheads), contrast with (a), which has received DNase treatment (degrading NETs) 
and shows no entrapped bacteria. (b) Crevicular exudate with multiple large NETs entrapping 
bacteria (white arrowheads). (c) Pocket epithelium with entrapped bacteria, (e) denotes 
epithelium surface.  (d) enlarged version of (c), showing NET fibres (small white 
arrowheads).  Scale bar represents 5μm (a1, b, c), 1μm (a, d) (Vitkov et al., 2009).  
  
A1 
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Figure 1.15: NETs in human gingival tissues 
Confocal microscopy where DNA is stained red and MPO is stained green in gingival tissues 
in health and disease.  Considerably more NET-like structures were observed in gingivitis 
compared with health (Cooper et al., 2013, courtesy of Dr Yousefi University of Berne, 
Switzerland).  
 
The timely removal of NETs may represent an important mechanism in periodontitis.  As 
previously mentioned, the removal of NETs in SLE patients is impeded, compared with 
healthy controls (see section 1.6.2) and the delayed removal of NETs provides a high 
concentration of NET-associated molecules that may drive the autoimmune response. Indeed, 
de Pablo et al., 2013) reported an increased prevalence of ACPAs and raised ACPA titres 
within the serum of non-RA patients with periodontitis, relative to non-periodontitis controls 
(see section 1.6.1). 
Conversely, decreased levels of NETs in periodontitis may enhance patient susceptibility to 
increased periodontal bacterial colonisation.  DNases released by bacteria can degrade the 
DNA backbone, which disassembles the NET structure (see 1.3.3).  This is thought to enable 
invading bacteria to circumvent NET defences and allow bacterial dissemination into the 
surrounding tissues (Berends et al., 2010).  Notably, several periodontal bacteria, including P. 
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gingivalis and F. nucleatum, have been found to express membrane-bound and secreted 
DNases (Palmer et al., 2012).  DNase release will enable bacterial infiltration and their 
establishment within the biofilm.    NET production has also been reported to be reduced in 
older (over 50 years) periodontitis patients compared with younger patients (under 50) in 
response to HOCl.  This implies the neutrophil responses in periodontitis may deteriorate 
with age, which may be associated with periodontitis being an age related disease (Grossi et 
al., 1995), however in this cohort (n=19 pairs) no differences in NET production were 
observed between periodontitis patients and their healthy controls (Hazeldine et al., 2014).  
Reduced levels of NETs have been associated with increased susceptibility to infections, for 
example in neonates (Yost et al., 2009) and CGD (Bianchi et al., 2011).  It is possible that 
decreased NETs in periodontitis would impair the elimination of pathogenic species; 
facilitating persistent dysbiosis.  This would likely result in further neutrophil recruitment and 
activation, such as extracellular degranulation, which may result in further tissue damage.  
 
1.9 Neutrophil isolation and ex vivo handling 
To characterise neutrophils in periodontitis, as well as other inflammatory diseases, cells are 
often isolated from the peripheral blood of volunteers and investigated ex vivo.  Indeed there 
are neutrophil-like cells, such as the HL60 human promyelocytic cell line, which can be 
employed within the laboratory to circumvent problems of inter-individual variations 
between neutrophil donors (Martin et al., 1990).  Nevertheless, these immortalised cell lines 
do not fully reflect primary neutrophils in their behaviour or in their intricate biological 
functions (Hallett 1990). In addition, despite 99% of murine genes having an equivalent 
human counterpart, murine disease models also do not fully replicate the human situation.  
Exemplifying the limitations of such murine models is the fact that while human neutrophils 
represent 50-70% of circulating PBNs, mouse neutrophils make up only 10-25% of cells 
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(Doeing et al., 2003).  Isolation from human blood requires an efficient, aseptic and 
reproducible method to obtain non-activated and viable cells.  A further consideration is the 
effect of the isolation and purification method on neutrophil behaviour; in particular 
neutrophils may become activated as a result of ex vivo manipulation (Oh et al., 2008).  
Therefore, research investigating neutrophil function needs to consider whether ex vivo 
purification techniques influence neutrophil activation status.  Methods of neutrophil 
isolation from whole blood can differ between research groups, creating potential phenotypic 
differences in neutrophils even if retrieved from the same volunteer.   
 
 Neutrophil isolation: density gradient materials  1.9.1
There are currently several materials employed for the isolation and purification of 
neutrophils from whole blood; including Percoll™ (GE Healthcare), Dextran (Sigma) and 
Histopaque™ (Sigma).  Neutrophil isolation aims to provide an appropriate separation range 
at a high purity from other blood cells, whilst at the same time, not stimulating or activating 
the cells.   
 
1. Percoll is comprised of colloidal silica and coated with non-dialyzable 
polyvinylpyrrolidone (PVP), and is used in conjunction with NaCl and water to 
produce a gradient to isolate neutrophils by differences in density.   
2. An alternative density gradient material is Histopaque, which is a polysucrose and 
sodium diatrizoate solution that also enables the isolation of neutrophils at a density 
gradient interface.   
3. A third method involves layering the blood on Dextran, which results in the 
sedimentation of a neutrophil layer above the aggregated erythrocytes.  The neutrophil 
layer is then collected by aspiration and centrifuged on layered Percoll gradients to 
isolate the neutrophils further. 
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1.10 Aims of this study 
Background: The pathogenic biofilm that initiates periodontitis has previously been 
characterised with respect to the sequence of microbial colonisation and associations with 
disease manifestations (Socransky et al., 1998).  However, the interactions between 
periodontal bacteria and NET release are less well understood.  Specifically, whether 
bacterial species stimulate for increased or decreased NET release, and whether NETs have 
the capacity to entrap and kill periodontal microbes remains to be elucidated.   
Aim 1: To investigate the interactions between NETs and a range of periodontal bacteria.   
 
Background: NET release represents a novel neutrophilic defence mechanism; however the 
exact role of NETs in the pathogenesis of periodontitis remains unclear.  Periodontitis is 
driven by a dysfunctional inflammatory response towards a pathogenic biofilm, in which the 
neutrophil is a key effector cell and patients’ neutrophils are hyperactive and hyper-reactive 
in terms of ROS production (Matthews et al., 2007a, 2007b).  It is likely that NETs are also 
employed by the neutrophil in periodontitis pathogenesis, and given that NETs are largely 
dependent on ROS generation (Fuchs et al., 2007), it is possible that NET release is also 
perturbed in periodontitis.   
Aim 2: To investigate NET production by PBNs from periodontitis patients and in patients 
with PLS in comparison with healthy control groups. 
 
Background: The importance of NET clearance has recently received substantial attention in 
studies of disease pathogenesis, such as in CF and SLE.  As with periodontitis, both CF and 
SLE are characterised by a dysfunctional host immune response.  NET clearance is reportedly 
impeded in SLE patients (Hakkim et al., 2010); however the clearance of NETs in 
periodontitis has not been studied.  Therefore, the ability of periodontitis patients to degrade 
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NETs and the nature of the mechanisms involved is of interest.  An accumulation of NETs in 
certain tissues has been associated with disease severity via autoimmune mechanisms, for 
example in RA (Khandpur et al., 2013).  Indeed our own group have reported significantly 
elevated levels of autoantibodies to NET-related antigens in the serum of periodontitis 
patients (dePablo et al., 2013).   
Aim 3: To investigate NET degradation by periodontitis patients’ plasma and the effect of 
NETs on neutrophil function. 
 
Background: Cigarette smoking is a major risk factor in the development of periodontitis 
(Grossi et al., 1995), and it has previously been reported that smoking has a range of effects 
upon neutrophil ROS production (Matthews et al,. 2011, 2012).   
Aim 4: To determine the impact of CSE upon NET production, neutrophil chemotaxis and 
the expression of key genes involved in neutrophil activation. 
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2.1 MATERIALS  
 
 GENERAL BUFFERS 2.1.1
 
 
2.1.1.1 Phosphate Buffered Saline (PBS) 
A 1L bottle of PBS was prepared by adding 7.75g NaCl (Sigma S9625), 0.2g KH2PO4 
(Sigma P5379) and 1.5g K2HPO4 (Sigma P8281) to 1L of sterile distilled water.  This was 
autoclaved (121°C for 15 mins) and stored at 4°C for up to 1 month prior to use. 
 
2.1.1.2 PBS supplemented with glucose and cations (gPBS) 
A 1L bottle of gPBS was prepared by adding 1.8g glucose (Sigma G8270), 0.15g CaCl2 
(BDH 10070), 1.5ml 1M MgCl2 (BDH 22093) to 1L of PBS.  This solution was made up in 
order with each component mixed before adding the next.  This was stored at 4°C for up to 1 
month prior to use. 
 
2.1.1.3 Blocking buffer: 1% bovine serum albumin (BSA) 
A 1L bottle of BSA was produced by adding 10g BSA (Sigma A2153) to 1L of PBS.  The 
resulting solution was filter-sterilised (pore size 0.22 µm), added to 25ml universal containers 
and frozen at -20°C until needed.   
 
2.1.1.4 4-(2-Hydroxyethyl) piperazine-1-ethanesulfonic acid, N-(2-Hydroxyethyl) 
piperazine-N′-(2-ethanesulfonic acid) (HEPES) buffer 
HEPES (0.1M) (Sigma H3375) was prepared by adding 2.38g HEPES to 100ml of distilled 
water.  This was adjusted to a pH of 7.5 (Beckman 40 pH meter, pH adjusted with HCl or 
NaOH) and stored at 4°C prior to use.   
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2.1.1.5 0.9% saline solution 
A 1L bottle of 0.9% saline solution was prepared by adding 9g of NaCl (Sigma S9625) to 1L 
of distilled water and autoclaving (121°C for 15 mins). 
 
 NEUTROPHIL PREPARATION AND ASSAYS 2.1.2
 
2.1.2.1.1 Preparation of Percoll gradients 
Percoll densities composed of 1.13g/ml Percoll, distilled water and 1.5M NaCl (Sigma 
S9625) were prepared according to Table 2.1.   
 
 
Table 2.1: Preparation of Percoll density gradients 
 
Density 1.079 1.098 
Percoll 19.708ml 24.823ml 
Water 11.792ml 6.677ml 
NaCl (1.5M) 3.5ml 3.5ml 
 
2.1.2.1.2 Lysis Buffer  
A 1L bottle of lysis buffer was prepared by adding 8.3g NH4Cl (A9434 Sigma), 1g KHCO3 
(Sigma P9144), 0.04g Na2 EDTA 2H2O (E5134 Sigma) and 2.5g BSA (Sigma A2153) to 1L 
of sterile distilled water.  This was stored at 4°C for up to 1 month prior to use. 
 
2.1.2.1.3 Preparation of Dextran and Percoll gradients 
Dextran-isolation of neutrophils involves layering the blood onto Dextran (see 2.2.1.1.4), 
which results in the sedimentation of a neutrophil layer above the aggregated erythrocytes.  
The neutrophil layer is then collected with a Pasteur pipette and centrifuged on layered 
Percoll gradients to separate the neutrophils further. 
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2.1.2.1.4 2% Dextran 
A 2% Dextran solution was prepared by adding 1g Dextran (Sigma 31392) to 50ml of 0.9% 
NaCl (saline). This was mixed by vortexing prior to being syringe-filter sterilised (pore size 
0.22µm). 
 
2.1.2.1.5 90% isotonic stock Percoll 
Percoll for use in the preparation of 80% and 56% gradients (see Table 2.2) was prepared by 
combining 5ml of 9% NaCl with 45ml of Percoll (17-0891-01 GE Healthcare).   
 
 
Table 2.2: Preparation of Percoll density gradients following Dextran sedimentation 
 
Density 80% 56% 
90% Percoll 40ml 28ml 
0.9% NaCl (saline) 10ml 22ml 
 
 
2.1.2.1.6 Luminol  
A 30mM stock solution was prepared by dissolving 0.5g luminol (Sigma A8511) in 94.05ml 
of 1mM NaOH.  The stock solution was foil-wrapped and stored for up to 6 months at 4°C 
prior to use.  The working solution was prepared on the day by diluting 1ml of stock solution 
with 9ml of PBS and the pH adjusted to 7.3 (Beckman 40 pH meter, pH adjusted with HCl or 
NaOH). 
 
2.1.2.1.7 Isoluminol 
A 30mM stock solution was prepared by dissolving 0.5g isoluminol (Sigma A8264) in 
94.05ml of 1mM NaOH.  The stock solution was foil-wrapped and stored for up to 6 months 
at 4°C.  The working solution was prepared on the day by diluting 1ml of stock solution with 
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9ml PBS and the pH adjusted to 7.3 (Beckman 40 pH meter, pH adjusted with HCl or 
NaOH). 
 
2.1.2.1.8 Lucigenin 
A 1mg/ml stock solution of Lucigenin was prepared by dissolving 0.005g lucigenin (Sigma 
B49203) in 5ml of PBS.  The stock solution was foil-wrapped and stored for up to 6 months 
at 4°C prior to use.  The working solution was made up on the day prior to use by diluting 1:3 
with PBS. 
 
2.1.2.2 Micrococcal nuclease (MNase) 
MNase (Worthington 4789) was diluted to a 13.3U/ml working solution and stored at -20°C 
in 1ml aliquots.  MNase was used at a final concentration of 1U/ml in 15µl aliquots unless 
otherwise stated. 
 
2.1.2.3 Sytox green 
Sytox green (Invitrogen S7020) was diluted 1:500 in RPMI (Roswell Park Memorial 
Institute)-1640 (Sigma R7509) to obtain a 10µM working solution.  This solution was foil 
wrapped and stored at -20°C in 1ml aliquots. 
 
2.1.2.4 Fluorescein-5-isothiocyanate (FITC) 
FITC (isomer I, Invitrogen F-1906) was diluted to a working concentration of 6mg/ml in 
1.5ml Eppendorfs, which were foil wrapped and stored at -20°C prior to use.  When needed, 
FITC was defrosted at room temperature and used at a final concentration of 0.3mg/ml by 
adding 50µl to 1ml of bacterial suspension in a 1.5ml Eppendorf.   
 
59 
 
2.1.2.5 Cytochalasin B 
Cytochalasin B (Sigma C6762), which blocks phagocytosis (Densen & Mandell 1978), was 
used at a final concentration of 10µg/ml by adding 166.5µl cytochalasin B (2mg/ml stock in 
DMSO, Sigma D8418) to 4.833ml of PBS.  This was stored at -20°C. 
 
 BACTERIAL CULTURE 2.1.3
 
2.1.3.1 Bacterial stimuli 
A panel of 19 bacteria (see Tables 2.5 & 2.6), plus opsonised S. aureus, was employed to 
stimulate neutrophils via TLR and FcγR, respectively.  Bacterial stocks were provided by Dr. 
Mike Milward, originally obtained from the Forsyth Institute (Boston, US) or purchased from 
the American Type Culture Collection (ATCC).   
 
2.1.3.2 Blood agar plates 
Pre-prepared blood agar plates (Base no. 2 with 7% horse blood) were purchased from Oxoid 
(PB0114).  Plates were stored at 4C and allowed to equilibrate to room temperature for an 
hour prior to use.  All plates were used before the manufacturer’s expiry date.   
 
2.1.3.3 Fastidious plates 
P. gingivalis (strain W83) was cultured on pre-prepared anaerobic 20% blood agar plates 
(Wilkins Chalgren) purchased from Oxoid (PB0112).  This is a medium enriched with 
neomycin that is specific for the growth of fastidious anaerobes.  Plates were stored at 4C 
and allowed to equilibrate to room temperature for an hour prior to use.  All plates were used 
before the manufacturer’s expiry date.   
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2.1.3.4 Tryptone soya agar (TSA) plates 
S. aureus was cultured on tryptone soya agar (TSA) plates.  Plates were made according to 
the manufacturer’s instructions by adding 40g TSA (Oxoid CM0131) to 1L of distilled water.  
This was autoclaved (121°C for 15 mins) and cooled to 50°C, prior to pouring the agar into 
Petri dishes (Sterilin 101VR20).  Plates were inverted and incubated at room temperature to 
solidify.  Plates were subsequently stored at 4C until needed, at which point they were 
equilibrated to room temperature for an hour prior to use. 
 
2.1.3.5 Brain heart infusion (BHI) broth 
BHI broth was made according to the manufacturer’s instructions (Oxoid CM1135); 37g 
dehydrated culture medium were dissolved in 1L of distilled water.  The BHI broth was 
mixed, autoclaved (121°C for 15 mins) and stored at 4°C until needed. 
 
2.1.3.6 Fastidious anaerobe broth 
Fastidious anaerobe broth was used to culture P. gingivalis.  This dehydrated medium 
enriched with vitamin K, haemin and L-cysteine was purchased from Lab M (LAB071).  
Fastidious anaerobe broth was made according to the manufacturer’s instructions by adding 
29.7g to 1L of distilled water.  This mixture was autoclaved (121°C for 15 mins) and stored 
at 4°C until needed. 
 
2.1.3.7 Typtone soya broth (TSB) 
TSB (Oxoid CM0876) was made by adding 30g of dehydrated culture medium to 1L of 
distilled water.  This was mixed, autoclaved (121°C for 15 mins) and stored at 4°C until 
needed.    
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2.1.3.8 Crystal violet 
Crystal violet solution was prepared by adding 2g crystal violet (Sigma C0775) to 20ml of 
95% ethanol (Sigma E7023).  0.8g ammonium oxalate (Sigma A8545) was dissolved in 80ml 
of distilled water to produce 1% ammonium oxalate.  The crystal violet solution was mixed 
with 1% ammonium oxalate in a 1:1 dilution and allowed to stand at room temperature for 
several days prior to use. 
 
2.1.3.9 Carbon fuchsin 
A 1ml stock of carbol fuchsin solution (BDH 351874U) was mixed with 9ml of distilled 
water and kept at room temperature. 
 
2.1.3.10 Glutaraldehyde in sodium cacodylate buffer 
A 100ml of 0.1M sodium cacodylate buffer were prepared by adding 4.28g sodium 
cacodylate trihydrate (Sigma CO250) to 100ml of distilled water, and adjusted to pH 7.4 
(Beckman 40 pH meter, pH adjusted with HCl or NaOH).  2.5% glutaraldehyde was made by 
combining 7.5ml of sodium cacodylate buffer, 6ml of distilled water and 1.5ml of 
glutaraldehyde solution (Sigma G5882). 
 
 CIGARETTE SMOKING REAGENTS 2.1.4
 
2.1.4.1 Nicotine 
Liquid nicotine was purchased (Sigma N3876) and diluted to final concentrations of 1µg/ml, 
5µg/ml and 10µg/ml in PBS (section 2.2.4.1.1) and stored at -20°C.   
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2.1.4.2 Cotinine 
Cotinine was purchased from Sigma (C5923) and used at the same final concentrations as 
nicotine (see 2.2.4.1.1); 1µg/ml, 5µg/ml and 10µg/ml in PBS and stored at -20°C.  Cotinine is 
the principal stable metabolite of nicotine and it has been demonstrated that 70-80% of 
absorbed nicotine is subsequently metabolised to produce cotinine (Yuki et al., 2013, 
Hukkanen et al., 2005).  Concentrations in the saliva of smokers are reportedly 0.23 ± 0.17 
µg/ml, ranging from 0.003µg/ml to 0.733µg/ml (Etter & Perneger 2001).   
 
2.1.4.3 Thiocyanate (SCN-) 
Thiocyanate (SCN-) levels are significantly elevated in the plasma of smokers, as it in an end 
product of detoxification of hydrogen cyanide, which is inhaled in cigarette smoke.  SCN- is 
present in the plasma of smokers at levels of 131.4  30.8µM (Morgan et al., 2011).  SCN- 
functions as a substrate for neutrophil derived MPO in the generation of hypothiocyanous 
acid (HOSCN-).  Sodium thiocyanate was purchased from Sigma (251410) and diluted to 
final concentrations of 50µM, 100µM and 150µM in PBS and stored at -20°C. 
 
 PCR STUDIES 2.1.5
 
2.1.5.1 The synthesis of complementary DNA (cDNA) 
Ribonucleic acid (RNA) was reverse transcribed to produce cDNA from pooled RNA using a 
cDNA synthesis kit (Tetro Bioline 65042) (Table 2.3).  
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Table 2.3: Components and quantities used for cDNA synthesis 
All components were provided in the cDNA synthesis kit (Tetro Bioline 65042).  
Abbreviations: Oligo-dT (oligonucleotide deoxy-thymine) dNTP mix (deoxynucleotide mix), 
RT (reverse transcriptase), RNase (ribonuclease), DEPC (diethylpyrocarbonate). 
 
 
cDNA Kit components 1 x Eppendorf 
Pooled RNA (0.5-0.6µg) 8µl 
Oligo-dT primer mix 1µl 
dNTP mix 10mM total 1µl 
5x RT Buffer 4µl 
RNase inhibitor (10u/µl) 1µl 
Reverse transcriptase (200u/µl) 1µl 
DEPC-treated water 4µl 
 
 
2.1.5.2 Design and validation of PCR primers 
Housekeeping and target gene primer sequences were selected from the literature (Table 2.4) 
and purchased from Invitrogen, UK.   
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Table 2.4: Primers employed to quantify gene expression in CSE and SCN- treated 
neutrophils using real time PCR  
Abbreviations: YWHAZ (tyrosine 3/tryptophan, 5-monooxygenase activation protein, zeta 
polypeptide); GAPDH (glyceraldehyde-3-phosphate dehydrogenase); RPL13 (ribosomal 
protein L13); HPRT1 (hypoxanthine phosphoribosyltransferase 1); NFĸB epsilon (nuclear 
factor kappa B); HSP40 (heat shock protein 40); IL-8 (interleukin-8).  Efficiency refers to the 
amplification of the targer molecule, where an efficiency of 2.0 is considered 100% efficient 
and means the target molecule doubles every PCR cycle (LightCycler®).   
 
 
Gene Primer sequence (5’-3’) 
Amplicon 
size (bp) 
Efficiency 
Housekeeping genes 
YWHAZ 
 
(f) ACTTTTGGTACATTGTGGCTTCAA 
(r) CCGCCAGGACAAACCAGTAT 
 
94 1.93 
GAPDH 
 
(f) CTCCTGTTCGACAGTCAG 
(r) GCCCAATACGACCAAATC 
 
111 1.83 
RPL13 
 
(f) CCTGGAGGAGAAGAGGAAAGAGA 
(r) TTGAGGACCTCTGTGTATTTGTCAA 
 
126 1.86 
HPRT1 
 
(f) GACCAGTCAACAGGGGACAT 
(r) AACACTTCGTGGGGTCCTTTTC 
 
195 1.97 
Target genes 
NFĸB 
epsilon 
 
(f) GTGAAGCCTGTTTGCCTCTC 
(r) AGGGTCCTCAACAGCAAGAA 
 
172 2.07 
HSP40 
 
(f) TACAGGAGCACTGTGGAAACG 
(r) AGGTCTGAGCACTGGACTGG 
 
192 1.83 
IL-8 
 
(f) TAGCAAAATTGAGGCCAAGG 
(r) GGACTTGTGGATCCTGGCTA 
 
204 1.75 
P-47
phox
 
 
(f) ACCCAGCCAGCACTATGTGT 
(r) AGTAGCCTGTGACGTCGTCT 
 
767 1.89 
P-67
phox
 
 
(f) CGAGGGAACCAGCTGATAGA 
(r) CATGGGAACACTGAGCTTCA 
 
726 1.78 
GP-91
phox
 
 
(f) GCTGTTCAATGCTTGTGGCT 
(r) TCTCCTCATCATGGTGCACA 
 
403 1.93 
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 CELL CULTURE 2.1.6
 
2.1.6.1 Culture of an oral epithelium cell line 
A human oral epithelium cell line (OEC), H400, was kindly donated by Dr S. Prime from 
University of Bristol, UK.  The cell line was derived from a squamous cell carcimona of the 
alveolar process from a 55 year old female.  The carcinoma was at stage 2, node negative, 
moderately differentiated and measured 20-40mm in size.  Prime et al., (1990) demonstrated 
close similarities to gingival epithelium and therefore H400s represent a suitable cell line for 
use as a model system. 
 
2.1.6.2 Supplemented Dulbecco’s Modified Eagle’s Medium:nutrient mixture F-12 
(DMEM/F-12) 
 
DMEM/F-12 (Invitrogen 21331-020 500ml) is a commonly used medium for the growth of 
human endothelial cells, which is a 1:1 solution of DMEM and Ham’s F-12.  The media was 
supplemented with heat-inactivated foetal calf serum (FCS, 10% v/v), L-glutamine (2% v/v, 
Sigma G7513) and 10mg/ml hydrocortisone (0.005% v/v, Sigma H0888).  Supplemented 
growth media was stored at 4°C prior to use. 
 
2.1.6.3 Trypsin Ethylenediaminetetraacetic Acid (T-EDTA) 
T-EDTA (Invitrogen R-001-100), comprising 0.0025% trypsin and 0.01% EDTA, was used 
to release adherent cells to produce a cell suspension.  This solution was divided and frozen 
at -20°C in 4ml aliquots until needed. 
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2.2 METHODS 
 
 ISOLATION OF NEUTROPHILS FROM PERIPHERAL BLOOD 2.2.1
 
2.2.1.1 Percoll components 
 
2.2.1.1.1 Preparation of Percoll gradients 
PMNLs were isolated from whole blood using discontinuous Percoll gradients (17-0891-01 
GE Healthcare).  The discontinuous gradients were generated by carefully layering 8ml of 
1.079 density gradient over 8ml of 1.098 (see 2.1.2.1.1) in a 25ml centrifuge tube (Fisher 
Scientific). 
 
2.2.1.1.2 Neutrophil isolation with Percoll 
Blood was collected in 6ml lithium heparin vacutainers (Greiner Bio-One) and inverted to 
ensure the mixing of the anticoagulant.  Post-collection, 6ml of blood were layered over the 
Percoll density gradients and centrifuged (Hettich Universal 320R) for 8 mins at 150 relative 
centrifugal force (rcf), followed by 10 mins at 1200rcf (both with a ramp and brake of 1 and 
at 4°C).  Plasma, monocytes, lymphocytes and density gradient material were aspirated off 
and discarded, allowing for the transfer of the neutrophil layer to 30ml of lysis buffer (see 
2.1.2.1.2) in a 50ml centrifuge tube (Fisher Scientific), which was then made up to a total 
volume of 50ml with lysis buffer.  Following gentle inversion, the centrifuge tube was 
incubated for 15 mins at room temperature to lyse any remaining erythrocytes.  Subsequently, 
the tube was centrifuged for 6 mins at 500rcf (4°C) to pellet the neutrophils.  The supernatant 
was aspirated off, whilst the pellet was re-suspended in 2ml of lysis buffer and incubated for 
5 mins at room temperature, prior to centrifugation for 6 mins at 500rcf (4°C).  The 
supernatant was again aspirated off and the neutrophil pellet washed in 2ml of PBS, followed 
by re-centrifugation (6 mins at 500rcf, 4°C).  The supernatant was discarded, cells re-
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suspended in 2ml of PBS (see 2.1.1.1) and counted by light microscopy (Leitz Laborlux s) 
(2.2.1.1.5). 
 
2.2.1.1.3 Isolation of neutrophils by Histopaque gradients 
H1077 (Sigma) density Histopaque (3ml) were layered over H1119 (Sigma) (3ml) in a 15ml 
tube (Fisher Scientific).  6ml of blood were carefully layered over the gradients using a 
Pasteur pipette, prior to centrifugation (Hettich Universal 320R) for 50 mins at 800rcf (at 
4°C).  Plasma, monocytes, lymphocytes and density gradient material were aspirated and 
discarded, allowing for the retrieval of the neutrophil layer from the H1077/H1119 interface.  
Neutrophils were transferred to 5ml of Dulbecco’s PBS (Sigma D8537) in a fresh 15ml 
centrifuge tube and centrifuged for 6 mins at 400rcf, followed by manual aspiration of the 
supernatant.  The neutrophil pellet was re-suspended in 10ml of Dulbecco’s PBS, prior to re-
centrifugation for 6 mins at 400rcf (4°C).  The supernatant was again aspirated off and cells 
re-suspended in 1ml of Dulbecco’s PBS prior to erythrocyte lysis, where 5ml of distilled ice 
cold water were added, followed by the immediate addition of 2ml 4x PBS after 30 secs.  
Neutrophils were then centrifuged for 8 mins at 450rcf (4°C), finally re-suspended in 2ml 
Dulbecco’s PBS and cells were counted by light microscopy (Leitz Laborlux s) (2.2.1.1.5). 
 
2.2.1.1.4 Isolation of neutrophils using Dextran 
Blood (approximately 6ml) was added to a 50ml tube containing 1ml of 2% Dextran (see 
2.1.2.1.3); this was incubated for 40 mins at room temperature to sediment erythrocytes.  
Post-incubation, the neutrophil “buffy coat” was collected from the blood and carefully 
layered over the Percoll density gradients using a Pasteur pipette (2.1.2.1.4).  This was 
centrifuged (Hettich Universal 320R) for 20 mins at 220rcf (4°C) and post-incubation the 
neutrophils were added to a falcon tube (Fisher Scientific) containing 5ml PBS.  This was re-
centrifuged (10 mins at 250rcf, 4°C) and the supernatant discarded.  The cells were then re-
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suspended in 5ml of RPMI-1640 (Sigma R7509) and counted by light microscopy (Leitz 
Laborlux s) (2.2.1.1.5).  
 
2.2.1.1.5 Neutrophil cell counting 
Cells (10µl of isolated cell suspension) were counted using a haemocytometer (Neubauer, 
Reichert) on a light microscope at x20 magnification (Leitz Laborlux s).  The central area of 
the haemocytometer (1mm
2
) is sub-divided into 25 smaller squares (0.04mm
2
). Cells were 
counted in 9 of the 0.04mm
2 
squares and calculations were subsequently performed according 
to the equation below, where 25 refers to the number of squares, 1x10
4 
denotes the 
haemocytometer dimensions and 9 is the number of squares counted. 
 
(Cell count x 25 x 1x10
4
) = number of cells/ml stock cell suspension 
    9 
 
2.2.1.2 NEUTROPHIL VIABILITY AND METABOLIC ACTIVITY 
 
2.2.1.2.1 Confirmation of neutrophil isolation by cytospin 
Neutrophils were re-suspended in PBS (see 2.1.1.1) at 2x10
6
 cells/ml, added to a cytospin 
funnel and centrifuged for 5 mins at 300rcf (Shandon cytospin).  The resultant smears on 
glass slides were allowed to air dry for 20 mins.  Neutrophils were stained with Diff-Quick, 
which is a Romanowski stain, in which slides are submerged in a methanol fixative, followed by 
staining with eosin and methylene blue.  Slides were then rinsed in distilled water and allowed to 
air dry, this was followed by visualisation and differential cell counts using light microscopy 
(x20 magnification) (Leitz Laborlux s).  The nuclei of neutrophils stain a dark blue, whilst the 
cytoplasms appear pink. 
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2.2.1.2.2 Confirmation of neutrophil isolation by flow cytometry 
Flow cytometry was employed to determine the isolation and purity of neutrophils.  Percoll-
isolated cells were diluted to 1x10
6 
in 100µl of PBS (see 2.1.1.1) and combined with 1µl of 
CD66b with an anti-human phycoerythrin tag (eBioscience, clone G10F5) and incubated for 
30 mins on ice.  Erythrocytes were lysed by adding 50µl of whole blood to 450µl OptiLyse C 
(Beckman Coulter A11895) and 500µl of PBS, and incubated for 30 mins on ice.  To serve as 
a negative control, whole blood was also assayed.  Post-incubation, whole blood or isolated 
cells were transferred to a flow cytometry tube and analysed (300 secs or 50,000 parts) on a 
Cytomics FC 500 flow cytometer (Beckman Coulter, CXP software, FL3 wavelength). 
 
2.2.1.2.3 Trypan blue exclusion 
Cell viability was confirmed by trypan blue dye (Sigma T8154) exclusion staining using a 1:1 
dilution of cells with trypan blue.  Cells were visualised with a haemocytometer (Neubauer, 
Reichert) and light microscopy (x20 magnification) (Leitz Laborlux s).  Tyrpan blue is not 
absorbed by viable cells, however if the neutrophil cell membrane is damaged, the dye will 
be absorbed and stain the cell blue.  A calculation was employed to determine the percentage 
of viable cells: number of viable cells/ total number of cells x 100. 
 
2.2.1.2.4 Quantification of neutrophil caspase-3 and 7 activity 
Neutrophil apoptosis was measured by quantifying caspase-3 and 7 activities using the 
Caspase-Glo® 3/7 assay (Promega G8091).  Following isolation, 1x10
5 
neutrophils were re-
suspended in 100µl of gPBS (see 2.1.1.2).  50µl of Caspase-Glo® 3/7 substrate, containing a 
tetrapeptide sequence (DEVD), were added to each well.  Caspase activity results in the 
cleavage of the caspase-substrate to release aminoluciferin generating light, which was 
measured by chemiluminescence (Berthold Tristar
2
 LB942, MikroWin2000) for 10 mins. The 
light production is directly proportional to apoptotic activity.    
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2.2.1.2.5 Quantification of neutrophil adenosine triphosphate (ATP) activity 
The amount of ATP released by neutrophils is indicative of the metabolic activity and 
therefore proportional to the number of viable cells (Crouch et al., 1993).  ATP was measured 
using CellTiter-Glo® (Promega G7570), which utilises the luminescence produced by 
luciferase in the presence of ATP.  Following isolation, 1x10
5 
neutrophils were re-suspended 
in 100µl of gPBS (see 2.1.1.2).  50µl of CellTiter-Glo® were added to each well.  ATP 
production is proportional to light production, which was measured by chemiluminescence 
(Berthold Tristar
2
 LB942, MikroWin2000) for 10 mins. 
 
 NEUTROPHIL ACTIVATION 2.2.2
 
2.2.2.1 Stimuli employed to activate neutrophils 
Neutrophils were stimulated using a range of stimuli.  Phorbol 12-myristate 13-acetate 
(PMA) targets NET production via the activation of PKC.  Previous findings (Palmer 2010), 
demonstrated that double the concentration of PMA is required for NET release (50nM) 
compared with what is needed to stimulate ROS production (25nM) by neutrophils.  HOCl is 
usually produced from H2O2, in a reaction catalysed by MPO.  HOCl stimulation therefore 
avoids the requirement for receptor-ligand binding and the activation of NADPH-oxidase, 
and thus avoids the upstream signalling of the NET production pathway (Palmer et al., 2012).  
Gram-positive and -negative bacteria activate neutrophils via TLR-2 and -4 and were 
employed as a stimulus for ROS (2.2.3.2) and NET (2.2.3.3) release.   In addition, ROS and 
NETs were produced in response to stimulation with opsonised S. aureus (2.2.2.2.5), which 
activates neutrophils via FcγR. 
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2.2.2.2 Determination of the concentration of HOCl 
Sodium hypochlorite was purchased from Sigma (425044), which contains 10-15% available 
chlorine.  The concentration of hypochlorite ions (OCl-) was determined previously (Palmer 
et al., 2012) by measuring the optical density of solutions at pH 12 (OD290nm, extinction 
coefficient of 350M/cm).  HOCl used in experimentation had approximately the same pH and 
acid dissociation constant (pKa) of 7.5.  Therefore it was assumed that 50% of the solution 
existed as HOCl and 50% as OCl-.  HOCl was used at a final concentration of 0.75mM for all 
neutrophil assays. 
 
2.2.2.2.1 Culture of periodontal bacteria 
Bacterial suspensions (2.1.3.1) in cryotubes containing tryptone soya broth (TSB, Oxoid 
CM0876) and 10% dimethyl sulfoxide (DMSO, Sigma D8418) were stored at -80°C.  When 
required, they were resuscitated by defrosting at room temperature.  Inocula were established 
by pipetting 100µl of bacterial suspension onto agar plates (sections 2.1.3.2, 2.1.3.3 & 
2.1.3.4) and spread with disposable pre-sterilised loops.  Plates were loosely wrapped in 
Clingfilm to prevent desiccation of agar following prolonged incubation, inverted and 
incubated in the appropriate chamber (Tables 2.5 & 2.6) for at least 3 days.  Cultures were 
grown planktonically by inoculating a single representative colony into the appropriate 
growth broth (sections 2.1.3.5, 2.1.3.6 & 2.1.3.7). 
 
2.2.2.2.2 Determination of bacterial growth 
Bacterial cell suspensions were measured spectrophotometrically (Jenway 6300) at an optical 
density of 600nm (OD600nm).  Non-inoculated media was used to calibrate the 
spectrophotometer.  The OD600nm values used to estimate bacterial numbers were calculated 
by the Forsyth Institute (Boston) and have been previously reported by Roberts et al., (2005).  
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2.2.2.2.3 Heat-killing of bacteria 
Following planktonic growth in broth, the bacterial suspension was centrifuged (Harrier 
18/80, 15 mins, 1800rcf, 4°C).  The supernatant was discarded and the bacterial pellet re-
suspended in sterile PBS (see 2.1.1.1), this step was repeated a total of 3 times to wash the 
bacteria.  The bacterial concentration was determined by spectrophotometry (section 
2.2.2.2.2) and then diluted to the desired bacterial concentration in PBS (2.1.1.1).  The 
bacteria were heat-killed by incubating at 80°C for 30 mins (microbiology oven, LTE OP30). 
 
2.2.2.2.4 Comparison of live and heat-killed bacteria 
Experiments were conducted to compare live and heat-killed bacterial stimuli.  A panel of 4 
bacteria was cultured on agar plates (2.1.3.2, 2.1.3.4), followed by inoculation of broth 
(2.1.3.5, 2.1.3.7), and incubation for a further 48 hours.  Once turbid due to bacterial growth, 
the bacteria were subjected to 3 PBS (2.1.1.1) wash steps as described above.  Each bacterial 
species suspension was divided into 2 tubes and bacterial concentrations determined by 
spectrophotometry (section 2.2.2.2.2).  All bacteria were diluted to 5x10
7
 (multiplicity of 
infection [MOI] of 500) and whilst 1 tube of each species was placed in an oven 
(microbiology oven, LTE OP30) at 80°C for heat-killing, the second tube was maintained at 
4°C.  Neutrophil ROS and NET production was determined following stimulation with live 
or dead bacteria in parallel. 
 
2.2.2.2.5 Opsonisation of S. aureus 
S. aureus (ATCC 9144) was grown on TSA plates (2.1.3.4) prior to planktonic growth in 
TSB (2.1.3.7).  Following a 48 hour growth in the aerobic chamber (Swallow), the bacteria 
were pelleted by centrifugation (Harrier 18/80, 15 mins, 1800rcf, 4°C).  The supernatant was 
discarded and the pellet re-suspended in sterile PBS (see 2.1.1.1); this was repeated a total of 
3 times to remove any remaining broth.  Bacterial concentration was determined by 
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spectrophotometry and diluted as necessary for subsequent assays (2.2.2.2.2).  Bacteria were 
heat-killed by incubating at 80°C for 30 mins (2.2.2.2.3) prior to opsonisation with Vigam 
liquid (5mg/ml IgG, Bio Products Laboratory), which was used at 33µl per ml of bacterial 
suspension (Bergstrom & Åsman 1993).  This mixture was agitated (Luckham R11/TW, 
speed 2) overnight at room temperature to enable thorough opsonisation of the bacteria.  
Following this, the bacteria were subjected to 2 wash steps in PBS (2.1.1.1) and stored at -
20°C until needed. 
 
2.2.2.2.6 Gram-stain protocol 
To identify bacterial species, colonies were visualised microscopically to determine their 
colour, size and morphology.  Gram-stains were also utilised to determine whether the 
bacteria were Gram-positive or Gram-negative.  Gram-staining differentiates positive and 
negative bacteria by detecting peptidoglycan, which whilst present as a thick outer layer in 
Gram-positive cell walls, is thinner and surrounded by an outer lipid membrane in Gram-
negative species.  These characteristic cell wall properties enable species distinction between 
Gram-positive bacteria (appear purple or blue) and Gram-negative bacteria (appear red or 
pink) (McClelland 2001).  A drop of saline was deposited onto a microscope slide, prior to 
the addition of a bacterial colony sample, forming an emulsion, which was heat fixed using a 
Bunsen burner.  Crystal violet (see 2.1.3.8) was added to the slide for 30 secs, rinsed with 
water, followed by the addition of Lugol’s iodine (Sigma L6146) for a further 30 secs prior to 
rinsing with distilled water.  Acetone was then added and immediately rinsed with water; 
finally the slide was flooded with carbol fuchsin (see 2.1.3.9) for 30 secs and rinsed with 
distilled water.  The slide was blotted dry and visualised under oil immersion microscopy at 
x100 magnification (Leitz Dialux 22) and digital images captured (Nikon Coolpix 1990).  
Images were subsequently analysed in Fiji Is Just ImageJ (Fiji) (http://fiji.sc/Fiji). 
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Table 2.5: Characterisation of periodontal bacterial species 
The Socransky complex indicates the colour complex the bacteria are assigned to (Socransky 
et al., 1998). Abbreviations: ATCC (American type culture collection) 
 
Bacteria Strain ATCC number 
Socransky 
complex 
Gram-stain 
Actinomyces viscosus (naeslundii 
genospecies 2) 
43146 Blue Positive 
Aggregatibacter 
actinomycetemcomitans serotype b 
43718 White Negative 
Propionybacterium acnes 11827 White Positive 
Selenomonas noxia 43541 White Negative 
Veillonella parvula 10790 Purple Negative 
Streptococcus sanguinis 10556 Yellow Positive 
Streptococcus oralis 35037 Yellow Positive 
Streptococcus intermedius 27335 Yellow Positive 
Streptococcus anginosus 33397 Yellow Positive 
Streptococcus gordonii 10558 Yellow Positive 
Capnocytophagia gingivalis 33624(27) Green Negative 
Aggregatibacter 
actinomycetemcomitans serotype a 
29523 Green Negative 
Capnocytophaga sputigena 33612(4) Green Negative 
Streptococcus constellatus 27823(M32b) Orange Positive 
Camylobacter rectus 33238(371) Orange Negative 
Campylobacter showae 51146 Orange Negative 
Fusobacterium nucleatum sp. 
Nucleatum 
25586 Orange Negative 
Fusobacterium nucleatum sp. 
Polymorphum 
10953 Orange Negative 
Porphyromonas gingivalis W83 Red Negative 
Staphyloccus aureus (opsonised) 9144 N/A Positive 
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Table 2.6: Culture conditions of periodontal bacterial species 
Abbreviations: BHI (brain heart infusion), TSA (tryptone soya agar), TSB (tryptone soya 
broth).  Bacteria were incubated at 37°C in an aerobic incubator (Swallow), a 5% CO2 
incubator (Napco 6500) or under anaerobic conditions (Don Whitley Scientific, Modular 
Atmosphere Controlled System, CAL-3200).   
 
Bacteria Strain Culture medium 
Growing 
conditions 
Bacteria per ml 
if OD600nm =1 
Actinomyces viscosus (naeslundii 
genospecies 2) 
Plate: Blood 
Broth: BHI 
Anaerobic 8.3x10
8
 
Aggregatibacter 
actinomycetemcomitans serotype b 
Plate: Blood 
Broth: BHI 
Anaerobic 6.8x10
9
 
Propionybacterium acnes 
Plate: Blood 
Broth: BHI 
Anaerobic 1.69x10
9
 
Selenomonas noxia 
Plate: Blood 
Broth: BHI 
Anaerobic 1.69x10
9
 
Veillonella parvula 
Plate: Blood 
Broth: BHI 
Anaerobic 6.8x10
9
 
Streptococcus sanguinis 
Plate: Blood 
Broth: BHI 
5% CO2 1.69x10
9
 
Streptococcus oralis 
Plate: Blood 
Broth: BHI 
5% CO2 1.69x10
9
 
Streptococcus intermedius 
Plate: Blood 
Broth: BHI 
5% CO2 1.69x10
9
 
Streptococcus anginosus 
Plate: Blood 
Broth: BHI 
5% CO2 1.69x10
9
 
Streptococcus gordonii 
Plate: Blood 
Broth: BHI 
5% CO2 1.69x10
9
 
Capnocytophagia gingivalis 
Plate: Blood 
Broth: BHI 
Anaerobic 1.62x10
9
 
Aggregatibacter 
actinomycetemcomitans serotype a 
Plate: Blood 
Broth: BHI 
Anaerobic 6.8x10
9
 
Capnocytophaga sputigena 
Plate: Blood 
Broth: BHI 
Anaerobic 1.62x10
9
 
Streptococcus constellatus 
Plate: Blood 
Broth: BHI 
5% CO2 1.69x10
9
 
Camylobacter rectus 
Plate: Blood 
Broth: BHI 
Anaerobic 6.8x10
9
 
Campylobacter showae 
Plate: Blood 
Broth: BHI 
Anaerobic 6.8x10
9
 
Fusobacterium nucleatum sp. 
Nucleatum 
Plate: Blood 
Broth: BHI 
Anaerobic 1.62x10
9
 
Fusobacterium nucleatum sp. 
Polymorphum 
Plate: Blood 
Broth: BHI 
Anaerobic 1.62x10
9
 
Porphyromonas gingivalis 
Plate: Fastidious blood 
with neomycin 
Broth: Fastidious 
Anaerobic 1.69x10
9
 
Staphyloccus aureus (opsonised) 
Plate: TSA 
Broth: TSB 
Aerobic 1.69x10
9
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2.2.2.3 Modulators of neutrophil activation 
To further characterise the activation of neutrophils, specific components of the neutrophil 
activation cascade were targeted (Table 2.7) to determine their effect on ROS (2.2.3.2) and 
NET (2.2.3.3) release in response to a range of stimuli.  All modulating agents were added to 
wells in 50µl aliquots prior to the addition of 1x10
5
 neutrophils (2.2.1.1.2), incubated for 30 
mins (Galaxy S, 37°C, 5% CO2) and subsequently stimulated.  Neutrophil total ROS and 
NET production with and without the addition of modulating agents was quantified in 
response to a panel of bacterial species (1x10
8
, MOI of 1000) and PMA (50nM).   
 
Table 2.7: Modulators of neutrophil activation 
Abbreviations: TLR (toll like receptors), NADPH-oxidase (nicotinamide adenine 
dinucleotide phosphate-oxidase), H2O2 (hydrogen peroxide), HOCl (hypochlorous acid). 
 
 
Modulating agent Concentration Neutrophil activation cascade target 
OxPAPC (Invivogen tlrl-
oxp1) 
Working: 
120µg/ml 
Final: 30µg/ml 
Interacts with bacterial lipids, which 
prevents bacterial signalling and blocks 
TLR2 and TLR4 activation. 
Chloroquine (Invivogen 
tlrl-chq) 
Working: 400µM 
Final: 100µM 
Inhibits endosomal TLRs 3, 7 and 9 by 
preventing endosomal acidification. 
Diphenyleneiodonium 
chloride (DPI) (Sigma 
D2926) 
Working: 100µM 
Final: 25µM 
Inhibitor of flavoenzymes such as 
neutrophil NADPH-oxidase. 
N-acetyl-cysteine (NAC) 
(Sigma A7250) 
Working: 40mM 
Final: 10mM 
Glutathione peroxidase precursor 
substrate, causing the removal of H2O2. 
Taurine (Sigma T0625) 
Working: 400mM 
Final: 100mM 
Scavenges HOCl by reacting with it to 
produce taurine chloramine. 
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 NEUTROPHIL ASSAYS 2.2.3
 
2.2.3.1 Treatment of neutrophil assay plastic-ware 
All plastic-ware was coated with filter-sterilised 1% BSA (2.1.1.3) and incubated at 4°C 
overnight, as the addition of BSA “blocks” assay plates to prevent neutrophil adhesion and 
inadvertent activation (Palmer 2010, Steinckwich et al., 2007).  Following incubation, un-
adhered BSA was removed by washing 5 times in PBS (2.1.1.1) with a plate washer (assay 
plates, BioTek ELx50) or using a Pasteur pipette (coverslips).  
 
2.2.3.2 Chemiluminescence protocol for ROS assay 
Neutrophils (1x10
5 in 100μl gPBS, 2.1.1.2) were added to a white flat bottom non-treated 96-
well plate (Costar 3912) previously coated with 200μl filter-sterilised 1% BSA (2.2.3.1). To 
measure total ROS, 30µl luminol (2.1.2.1.6) was added, and to identify extracellular radical 
generation 60µl of isoluminol (2.1.2.1.7) and 15µl of 1.5 units of horseradish peroxidase 
(HRP, Sigma P8415) were added.  To selectively measure superoxide production, 30µl of 
lucigenin (2.1.2.1.8) was added.  The plate was placed in the luminometer (Berthold Tristar
2
 
LB942) and after a 30 mins, selected wells were stimulated with PMA (25nM), bacteria 
(1x10
8
, MOI of 1000, see section 2.2.2) or opsonised S. aureus (5 x 10
7
, MOI of 500, see 
section 2.2.2.2.5).  Light output was read for a further 120 mins. All readings were expressed 
as relative light units (RLUs) and read at 37°C in MikroWin2000. 
 
2.2.3.3 Quantification of NET-DNA 
Neutrophils (1x10
5
 in 175µl RPMI-1640, Sigma R7509) were added to a white flat bottom 
non-treated 96-well plate (Costar 3912) previously coated with 200μl filter-sterilised 1% 
BSA (2.2.3.1).  After a 30 min incubation period (Galaxy S, 37°C, 5% CO2), selected wells 
were stimulated with either PMA (50nM), heat-killed bacteria (1x10
8
, MOI of 1000) or 
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opsonised S. aureus (5x10
7
, MOI of 500) (see 2.2.2), and incubated for 4 hours (Galaxy S, 
37°C, 5% CO2).  Post-incubation, 15μl of 1U/ml micrococcal nuclease (MNase, Worthington, 
2.1.2.2) were added to each well and incubated at room temperature for 15 mins, prior to 
centrifugation (Hettich Universal 320R, 10 mins at 1800rcf).  Subsequently, 150μl of the 
supernatant were transferred to a black flat bottom non-treated 96-well plate (Costar 3915), 
with the addition of 15μl of 10μM Sytox green (Invitrogen S7020, 2.1.2.3) to quantify free 
DNA within the supernatant.  Fluorescence was read in arbitrary fluorescence units (AFU) 
using a fluorometer (Twinkle LB970, Berthold Technologies; MikroWin2000, excitation 
filter F485, emission filter F535, lamp energy 2000) 10 times at 37°C.  Bacteria-derived 
DNA was also quantified in a neutrophil-free 96-well plate and these values were subtracted 
from the final NET quantification readings. 
 
2.2.3.4 Quantification of NET-bound components 
Quantifying neutrophil granule components associated with NETs is a DNA-independent 
measure of NET production.  Neutrophils (1x10
6
 in 800µl RPMI-1640, Sigma R7509) were 
added to a clear non-treated 24-well plate (Costar 3526) previously coated with 200μl filter-
sterilised 1% BSA (2.2.3.1).  After a 30 min incubation period (Galaxy S, 37°C, 5% CO2), 
selected wells were stimulated with PMA (50nM), heat-killed bacteria (1x10
8
, MOI of 1000) 
or opsonised S. aureus (5x10
7
, MOI of 500) (see 2.2.2).  The plate was incubated for 4 hours 
(Galaxy S, 37°C, 5% CO2).  Post incubation, the supernatant was gently aspirated and the 
NETs were subjected to 2 x 1ml wash steps with RPMI-1640.  This approach removes non 
NET-bound components concurrently released during neutrophil activation.  75µl of 1U/ml 
MNase (2.1.2.2) were added to the well and incubated at room temperature for 15 mins, 
followed by centrifugation (Hettich Universal 320R, 10 mins at 1800rcf).  The supernatants 
were then transferred to fresh cryotubes and stored at -20°C.  To quantify NE, MPO or CG, 
79 
 
the samples were defrosted at room temperature and centrifuged (Geneflow micro, 10 mins at 
1800rcf). 
   
2.2.3.4.1 Neutrophil elastase (NE) 
NET-bound NE was quantified by adding 100µl of sample to a clear non-treated 96-well 
plate (Costar 3370) in duplicate.  100µl of 0.5mM N-Methoxysuccinyl-Ala-Ala-Pro-Val p-
nitroanilide (Sigma M4765) was added to each well and the plate was covered and incubated 
for 2 hours (Galaxy S, 37°C, 5% CO2).  Post incubation, the optical density was determined 
at 405nm (OD405nm) (ELx800, Bio-Tek Instruments Inc. Gen 5 1.11) (Figure 2.1).  A standard 
curve was generated by serially diluting a human NE standard solution (Caymann chemical 
601014).   
 
2.2.3.4.2 Myeloperoxidase (MPO) 
NET-bound MPO was quantified by adding 50µl of sample to a clear non-treated 96-well 
plate (Costar 3370) in duplicate.  50µl of 3,3’,5,5’-Tetramethylbenzidine (TMB) substrate 
(Cayman chemical 400074) was added to each well and the plate covered and incubated for 
20 mins at room temperature.  Post-incubation, 50µl of 1M sodium phosphate was added to 
stop the reaction.  The optical density was immediately read at 450nm (OD450nm) (ELx800, 
Bio-Tek Instruments Inc. Gen 5 1.11).  A standard curve was generated by serially diluting 
the MPO standard derived from human leukocytes (Sigma M6908). 
 
2.2.3.4.3 Cathepsin G (CG) 
NET-bound CG was quantified by adding 50µl of sample to a clear non-treated 96-well plate 
(Costar 3370) in duplicate.  50µl of 1mM N-Succinyl-Ala-Ala-Pro-Phe p-nitroanilide (Sigma 
S7388) in 0.1M HEPES (see 2.1.1.4) was added to each well and the plate covered and 
incubated for 2 hours (Galaxy S, 37°C, 5% CO2).  Post incubation, the absorbance was read 
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at 405nm (OD405nm) (ELx800, Bio-Tek Instruments Inc. Gen 5 1.11).  A standard curve was 
generated by serially diluting CG from human leukocytes (Sigma 4428).   
 
 
Figure 2.1: Diagrammatic representation of the quantification of NET-bound NE   
PMA-activated neutrophils are incubated for 4 hours (37°C, 5% CO2) to produce NETs 
(green strands) and allow for NE release (purple triangles).  Following multiple wash steps 
and freeze storage, NET-bound NE is quantified in the supernatants by the addition of 0.5mM 
N-Methoxysuccinyl-Ala-Ala-Pro-Val p-nitroanilide substrate (Sigma M4765, orange 
chevrons) and incubated for 2 hours.  The optical density is read at 405nm (OD405nm).  
Schematic based on Cayman Chemical kit (601010).  Abbreviations: NE (neutrophil 
elastase); PMA (phorbol 12-myristate 13-acetate); MNase (micrococcal nuclease). 
 
 
2.2.3.5 NET entrapment of bacteria 
Neutrophils (1x10
5
 in 175µl RPMI-1640, Sigma R7509) were added to a black flat bottom 
non-treated 96-well plate (Costar 3915) previously coated with 200µl filter-sterilised 1% 
BSA (2.2.3.1).  After a 30 min incubation period (Galaxy S, 37°C, 5% CO2), selected wells 
were stimulated with 25μl of 0.75mM HOCl (Palmer et al., 2012) and incubated for 3 hours 
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(Galaxy S, 37°C, 5% CO2).  Bacteria were measured by spectroscopy (section 2.2.2.2.2) and 
diluted to 1x10
7 
per 50µl
 
(MOI of 100) prior to incubation with 0.3mg/ml fluorescein-5-
isothiocyanate (FITC isomer I, Invitrogen F-1906) (see 0) with continuous agitation 
(Luckham R11/TW, speed 2) for 30 mins on ice.  The bacteria were centrifuged (Geneflow 
micro, 10 mins at 5000rpm) to precipitate FITC-stained live bacteria, which were then re-
suspended in 1ml PBS (see 2.1.1.1) and added to the NETs suspensions in 50µl aliquots and 
incubated for 1 hour (Napco 6500, 37°C, 5% CO2).  Post-incubation, the supernatant was 
carefully aspirated and replaced with 200µl fresh, pre-warmed (20°C) PBS (2.1.1.1).  This 
washing procedure was repeated to ensure bacteria not actively bound within NETs were 
removed.  Fluorescence was read in AFU on a fluorometer (2.2.3.3). 
 
2.2.3.6 NET killing of bacteria 
Neutrophils (1x10
5
 in 440µl RPMI-1640, Sigma R7509) were added to a clear non-treated 
24-well plate (Costar 3526) previously coated with 500µl filter-sterilised 1% BSA (2.2.3.1).  
After a 30 min incubation period (Galaxy S, 37°C, 5% CO2), selected wells were stimulated 
with 60μl of 0.75mM HOCl (section 2.2.2.2, Palmer et al., 2012) and incubated for 3 hours 
(Galaxy S, 37°C, 5% CO2).  Post-incubation, the supernatant was carefully removed from 
each well and replaced with fresh 500µl RPMI-1640 with or without 10µg/ml cytochalasin B 
(to prevent phagocytosis, see 2.1.2.5) or 100U/ml MNase (2.1.2.2) and incubated for 15 mins 
at room temperature.  Live bacteria were added to each well at 1x10
7
 in 50µl aliquots (MOI 
of 100), determined by OD measurements (2.2.2.2.2).  The plate was centrifuged (10 mins at 
700rcf) and incubated for 1 hour (Napco 6500, 37°C, 5% CO2).  Post-incubation, selected 
wells were subjected to MNase digestion (100U/ml, 2.1.2.2) for 15 mins at room temperature, 
to degrade NETs.  The well contents were aliquoted, diluted in broth and 50µl of this 
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suspension, sub-cultured onto blood agar plates and incubated for 24 hours in the appropriate 
atmospheric incubator for subsequent colony counting.     
 
2.2.3.7 NET fluorescence visualisation 
Neutrophils (1x10
5
 in 260μl RPMI-1640, Sigma R7509) were added to a clear non-treated 24-
well plate (Costar 3526) previously coated with 300μl filter-sterilised 1% BSA (2.2.3.1).  
After a 30 min incubation period (Galaxy S, 37°C, 5% CO2), selected wells were stimulated 
with PMA (50nM) and the plate covered and incubated for 4 hours (Galaxy S, 37°C, 5% 
CO2). Post-incubation, 30μl of 10μM Sytox green (Invitrogen S7020, 2.1.2.3) were added to 
each well. NETs were visualised with an epi-fluorescence microscope (Nikon Eclipse TE300) 
with excitation and emission fluorescence filters of 472nm and 520nm, respectively. Images 
were captured with a QImaging camera (Retiga 2000R) in Micro-Manager and analysed in 
Fiji. 
 
2.2.3.8 Scanning electron microscopy (SEM) of NETs 
Round 11mm glass coverslips were sterilised in 0.2M HCl, followed by 2 wash steps in 
distilled water.  After which, coverslips were coated in 100µl filter-sterilised 1% BSA and 
stored at 4°C overnight (2.2.3.1).  Neutrophils (1x10
5 
in 100µl) were seeded onto the 
coverslips, and after a 30 min period (Napco 6500, 37°C, 5% CO2) stimulated with either 
50nM PMA or 1x10
7 
previously cultured live bacteria (MOI of 100) (section 2.2.2.2.1).  After 
4 hours of incubation (Napco 6500, 37°C, 5% CO2), samples were fixed in 2.5% 
glutaraldehyde in 0.1M sodium cacodylate buffer (pH 7.3) (see 2.1.3.10) for 30 mins at room 
temperature.  The samples were dehydrated through a graded ethanol (Sigma E7023) series 
diluted in distilled water (20%, 30%, 40%, 50%, 60%, 70%, 90%, 100% x2 for 10 mins 
each). Samples were then dried with hexamethyldisilazane (HMDS, Sigma 440191), which 
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was allowed to evaporate in a fume hood overnight.  Dried samples were mounted onto 
25mm aluminium stubs (G3024 Agar Scientific) with carbon conductive tabs and coated in 
gold for 90 secs (Denton Vacuum Desk II). The samples were analysed using a Zeiss EVO 
MA10 scanning electron microscope at an accelerating voltage of 5 kilovolts (kV).  Images 
were captured in SmartSEM software and analysed in Fiji. 
 
 CIGARETTE SMOKING AND NEUTROPHIL RESPONSES 2.2.4
 
2.2.4.1 Extraction and preparation of cigarette smoke extract (CSE)  
To mimic the in vivo inhalation of cigarette constituents, cigarettes were attached to 
automatic smoking apparatus and lit (Matthews et al., 2011, Figure 2.2).  The cigarette smoke 
extract (CSE) was collected by drawing the smoke through a cigarette filter and bubbled 
through 30ml of PBS (see 2.1.1.1) (pH 7.4, 37°C) via a peristaltic pump.  The cigarettes 
employed (Superkings Black) were commercially available filter cigarettes (10mg tar, 0.9mg 
nicotine, 10mg CO) and measured 100mm in length, including a 30mm filter.  The CSE was 
collected over a 5 min period and stopped after 65mm of the cigarette had burnt.  Three 
cigarettes were consumed for every 30ml PBS, and this process was repeated 10 times to 
produce 300ml of pooled CSE.  This was divided into 1ml aliquots and stored under liquid 
nitrogen until needed; the resultant extract represented 100% CSE.  For use in neutrophil 
assays, CSE was defrosted at room temperature and used immediately (Matthews et al., 2011, 
2012).   
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Figure 2.2: Schematic representation showing the collection of CSE   
Cigarettes were burnt until 65mm were consumed (5 mins) and the smoke was drawn through 
PBS by a peristaltic pump to collect 100% CSE (image produced by P. White). 
 
 
 
2.2.4.1.1 Estimation of CSE concentration 
The concentration of CSE was determined based on the assumption that all available nicotine 
was collected during 65mm burning to produce the 100% CSE solution (Matthews et al., 
2011).  The stored CSE aliquots would thus constitute an estimated 83.6µg/ml of nicotine 
(Matthews et al., 2011).  Reported levels of nicotine in saliva and GCF after smoking one 
cigarette are 1.82 ± 0.61μg/ml and 5.96 ± 0.77µg/ml respectively (mean ± SE) (Ryder et al., 
1998).  100% CSE was diluted with PBS to final concentrations of 1%, 5% and 10%, which 
is equivalent to 0.84µg/ml, 4.2µg/ml and 8.4µg/ml of nicotine (2.1.4.1), respectively.   
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2.2.4.2 Cigarette components 
In addition to looking at the impact of CSE on neutrophil activity, specific cigarette 
constituents were also assayed, including nicotine (section 2.1.4.1), cotinine (section 2.1.4.2) 
and thiocyanate (SCN-) (section 2.1.4.3). 
 
2.2.4.2.1 Impact of CSE and CSE components on NET production 
The impact of CSE and CSE components on NET production was determined by quantifying 
NET-DNA (section 2.2.3.3).  In brief, neutrophils were exposed to CSE (1%, 5% or 10%), 
nicotine (1µg/ml, 5µg/ml or 10µg/ml), cotinine (1µg/ml, 5µg/ml or 10µg/ml) or SCN- 
(50µM, 100µM or 150µM) priming, followed by subsequent stimulation with PMA (50nM) 
or HOCl (0.75mM).  Alternatively, neutrophils did not receive priming, but were stimulated 
with CSE or CSE components.  Both primed and stimulated neutrophils were incubated for 4 
hours prior to quantification of NET-DNA with Sytox green (2.2.3.3).  
 
2.2.4.2.2 NET visualisation of CSE and CSE component-treated neutrophils 
NETs were also visualised in response to CSE (1%, 5% or 10%), nicotine (1µg/ml, 5µg/ml or 
10µg/ml), cotinine (1µg/ml, 5µg/ml or 10µg/ml) or SCN- (50µM, 100µM or 150µM).  NET-
DNA was visualised by fluorescence microscopy by staining extracellular DNA with Sytox 
green 4 hours post-stimulation (see 2.2.3.7). 
 
2.2.4.2.3 Neutrophil Chemotaxis assay 
To determine the effect of CSE on neutrophil chemotaxis, cells were incubated with PBS 
(2.1.1.1) or CSE (1%, 5% or 10%) (2.2.4.1.1) for 30 mins, prior to washing by centrifugation 
(6 mins at 500rcf) and re-suspending in RPMI-1640 (Sigma R7509).  To visualise and 
quantify neutrophil chemotaxis (speed, velocity, and resultant vector length) in response to 
chemoattractants, an assay was developed in house (Roberts et al., 2015) using the Insall 
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chamber (Muinonen-Martin et al., 2010, Figure 2.3).  Isolated neutrophils were diluted to 
1x10
6
/ml in RPMI-1640 (Sigma R7509), plus 1.5µl of 7.5% BSA (Sigma A2153, 2.1.1.3) per 
ml of cell suspension.  Coverslips (square 22ml, VWR international) were washed by 
submerging in 0.2M HCl, followed by 2 wash steps in distilled water.  After air drying 
(approximately 30 mins), 400µl of 7.5% filter-sterilised BSA (2.1.1.3) was added to each 
coverslip and this was incubated at room temperature for 20 mins to facilitate neutrophil 
adhesion.  During this time, the Insall chamber was washed 3 times in RPMI-1640.  Post-
incubation, the coverslip was inverted onto the washed chamber, ensuring the 
chemoattractant loading bays were still exposed.  Excess fluid was aspirated from the 
chamber with filter paper to create a seal between the coverslip and chamber.  80µl of the 
chemoattractant was pipetted into the loading bay, which included RPMI-1640 (negative 
control), 10nM N-Formyl-Met-Leu-Phe (fMLP, Sigma F3506) or 200ng/ml IL-8 (Sigma, 
SRP3098).  Neutrophil migration was visualised by microscopy (x20 magnification) (Zeiss 
Primovert, Carl Zeiss Imaging Thornwood) and time-lapse images captured every 30 secs for 
40 frames over 20 mins (Q Imaging Retiga 2000R).     
  
87 
 
 
 
 
 
 
 
 
 
Figure 2.3: Photograph of Insall chemotaxis chamber 
To visualise neutrophil chemotaxis, neutrophils on a coverslip were placed over the Insall 
chamber, as shown by the white dotted square in Figure (a).  The yellow arrows indicate the 
addition of the chemoattractant via the loading bays.  Figure (b) shows a magnified image of 
the area visualised by time-lapse microscopy, indicated by the blue square.  Neutrophil 
chemotaxis in response to the chemoattractant is recorded every 30 secs for 40 frames (20 
mins), typical migration towards the chemoattractant is illustrated by the green arrows.  Scale 
bar represents 1mm (image produced by P. White). 
  
 
2.2.4.2.4 Neutrophil chemotaxis analysis 
The 40 time-lapse images produced for each condition were processed with Q pro-imaging 
software, followed by analysis in Fiji.  The movement of 15 mobile cells (selection of cells 
validated by Helen Roberts) was tracked through each frame with a manual tracking plug-in 
(MtrackJ).  The quantitative data generated was used to calculate neutrophil speed, velocity 
and chemotactic index, see Table 2.8 for definitions.  
  
 
a b 
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Table 2.8: Neutrophil chemotaxis measurements 
 
Chemotaxis 
measure 
Description 
Speed 
Average speed of neutrophil movement in any direction over 40 frames (20 
mins). 
Velocity Average speed of neutrophil directional movement over 40 frames. 
Chemotactic 
index 
Measure of directional accuracy of neutrophil chemotaxis calculated by the 
angle of cell movement along the Y-axis (Andrew & Insall 2007). 
 
 
2.2.4.3 Gene expression of CSE and SCN- treated neutrophils 
Quantitative real time polymerase chain reaction (RT-PCR) was employed to compare the 
expression profile of neutrophil gene transcripts in response to CSE and SCN- treatment. 
 
2.2.4.3.1 Storage of neutrophils for subsequent RNA isolation 
Following isolation (2.2.1.1.2), neutrophils were re-suspended at 1x10
6 
in 1ml of RPMI-1640 
(Sigma R7509) in a 1.5ml Eppendorf.  Cells were incubated (Galaxy S, 37°C, 5% CO2) with 
CSE (1%, 5% or 10%, see 2.2.4.1) or SCN- (50µM, 100µM or 150µM, see 2.1.4.3) for 4 
hours, then centrifuged for 6 mins at 500rcf, after which the supernatant was carefully 
removed and discarded.  1ml of Tri-reagent (Sigma T9424) was added to each Eppendorf, the 
pellet re-suspended by pipetting and the sample frozen at -20°C until needed. 
 
2.2.4.3.2 Isolation of RNA 
RNA was isolated from neutrophils using a Qiagen RNeasy Minikit (74104) according to the 
manufacturer’s instructions.  Neutrophils previously stored in tri-reagent were defrosted and 
200µl of chloroform (Sigma 34854) added to each Eppendorf prior to mixing and 
centrifugation (Eppendorf 5415D) for 15 mins at 800rcf.  Following centrifugation, 450µl 
(clear section) from each tube were transferred to a fresh 1.5ml Eppendorf, followed by the 
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addition of 450µl 70% ethanol (Sigma E7023).  The mixture was gently combined by 
pipetting, before being transferred to a spin column assembly and centrifuged (30 secs at 
3500rcf).  The collection tube was emptied to discard the flow through fluid.  700µl of wash 
buffer were added to the spin column to wash the membrane, this was then centrifuged (30 
secs at 3500rcf).  The collection tube contents were discarded and 500µl of RPE buffer 
(provided in kit and prepared by adding 44ml 100% ethanol prior to use) were added to the 
spin column.  This was centrifuged for 30 secs at 3500rcf, this step was repeated, however 
with a centrifugation step of 2 mins at 3500rcf to dry the membrane and to ensure that all the 
ethanol was removed.  The flow through fluid and collection tube were discarded and the spin 
column membrane was placed in a fresh Eppendorf.  50µl RNase free water was added and 
this was centrifuged for 1 min at 3500rcf.  This results in the RNA being eluted from the 
membrane into the Eppendorf collection tube.  The spin column was discarded and the 
samples were stored at -80°C until needed. 
 
2.2.4.3.3 Quantification of RNA 
The amount and purity of neutrophil RNA isolated was determined by measuring the optical 
density and the ratio of absorbance at 260/280nm (OD260/280nm).  Pure RNA has a 260/280nm 
absorbance of 2.1, thus a value between 1.8-2.0nm is considered to be pure (Sambrook et al., 
1989; Manchester 1996).  RNA samples were diluted in RNase free water (2µl sample plus 
68µl diluent).  Based on the amount of RNA in each sample, samples were equally pooled 
across the treatment conditions (n=10 biological repeats).  
 
2.2.4.3.4 The synthesis of complementary DNA (cDNA) 
RNA was reverse transcribed to produce complementary DNA (cDNA) from pooled RNA 
with a cDNA synthesis kit (Tetro Bioline 65042).  Pooled RNA samples were defrosted, 
gently mixed and kept on ice until needed.  The primer mix was made up in an RNase free 
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reaction tube as described in section 2.1.5.1.   Samples were heated to 45°C for 40 mins and 
the reaction terminated by incubating the samples for 5 mins at 85°C (Eppendorf 
Mastercycler Gradient).  Samples were made up to a final volume of 500µl with RNase free 
water and the sample was transferred to a Microcon® tube (Millipore 42410).  This was 
centrifuged for 2 mins at 100rcf, prior to inverting the column into a new tube to collect 
approximately 50µl of clean cDNA.  This was centrifuged for 1 min at 3500rcf and the 
cDNA samples were stored at -20°C until needed for real time PCR. 
 
2.2.4.3.5 Quantitative real time PCR analysis 
A white 96-well multi-well plate (LightCycler® 480, 04729692001) was prepared by 
combining 2µl of cDNA (2.2.4.3.4), 10µl LightCycler® 480 SYBR green PCR mix 
(04707516001), 0.5µM of forward and reverse primers and RNase-free water to give a final 
volume of 20µl per well.  The plate was covered and centrifuged (3 mins at 1500rcf) and 
PCR was performed by placing the plate in the Roche LightCycler® 480 PCR system.  All 
samples were amplified in duplicate and 2 “no-template” controls per primer pair were 
included in every run (Table 2.9 and Figure 2.4).  Gene expression levels were measured by 
following the manufacturer’s instructions from crossing point (Cp) values by fit points 
methods programmed on the LightCycler® 480 software (Roche diagnostics version 1.5). 
 
2.2.4.3.6 Validation of PCR primers and assays 
Preliminary experiments were used to determine the PCR amplification and efficiency for 
each primer pair (see 2.1.5.2) for reference genes and target genes), to indicate the amount of 
amplicon being amplified each cycle.  An efficiency of 2.0 is considered 100% efficient, and 
means the target molecule doubles every PCR cycle (LightCycler®).  Pooled cDNA was 
serially diluted (1, 1:1, 1:10, 1:100, 1:1000) with RNase free water using the LightCycler® 
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480 software.  Melt curves were also produced for each primer to ensure primers were only 
amplifying a single amplicon, which is the housekeeper or target gene (Figure 2.5).  
 
2.2.4.3.7 Analysis of gene expression levels 
Target gene expression was determined using LightCycler® 480 software by calculating 
fold-changes in gene expression as a ratio of a housekeeping gene.  The most appropriate 
housekeeper was determined by analysis with the statistical algorithm “BestKeeper” (Pfaffl et 
al., 2004).  The BestKeeper program index was created using the geometric mean of each 
candidate gene’s Cp values. The variation of the housekeeping gene is calculated according 
to the Cp values, standard deviation (SD) and coefficient of variance.  Reference genes with a 
SD of >1 are considered inconsistent, whilst the lowest SD is considered the most stable 
(Piehler et al., 2010, Radonic et al., 2004).  Based on these results, the YWHAZ housekeeper 
was considered the most consistent and subsequently used as a reference to quantify the 
expression of the genes of interest. 
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 Temperature Time Cycles 
Pre-incubation 98°C 5 mins 1 
Denaturation 98°C 20 secs 
60 Annealing 60°C 20 secs 
Extension 72°C 30 secs 
Melting 98°C - 1 
Cooling 4°C Hold 1 
 
 
 
 
 
 
 
 
 
 
 
 
+9 
 
 
 
Table 2.9 and Figure 2.4: PCR cycling protocol 
Amplification of the neutrophil housekeepering and target genes was performed according to 
the temperatures and times outlined in the graph and table.  Graph shows the representative 
cycling conditions for reference gene, YWHAZ.     
  
 
Denaturation of DNA at 98°C Primers anneal at 60°C and extend 
at 72°C.  Green indicates the point 
at which the product is quantified. 
Product melts at 98°C 
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Figure 2.5: Amplification curve, efficiency standard curve and melt curve for the 
YWHAZ assay 
(a) Representative amplification curve of serially diluted reference gene YWHAZ, including 
2 no-template controls.  This enabled the generation of a YWHAZ standard efficiency curve 
by the LightCycler® 480 software, (b), which is indicative of the amount of amplicon being 
amplified each cycle.  An efficiency of 2.0 is considered 100% efficient.  (c) YWHAZ melt 
curve was assessed to ensure primers are only amplifying a single amplicon (i.e. the product 
of interest), as shown by the single peak.  Amplification curves, standard efficiency curves 
and melt curves were produced for all references and targets genes.   
 
 
 
 
(a) 
(b) 
(c) 
Error: 0.0158, Efficiency: 1.93, Slope: -3.5 
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 NET DEGRADATION AND THE EFFECT OF DELAYED NET REMOVAL 2.2.5
 
2.2.5.1 NET degradation with plasma 
Neutrophils were isolated (2.2.1.1.2) and stimulated for NET production in a 96-well plate 
(Corning) (section 2.2.3.3).  Following NET release, previously isolated plasma samples 
(section 2.2.6.2.3) were defrosted and diluted to 10% in PBS (2.1.1.1).  Plasma was added to 
wells in 50µl aliquots and incubated for 3 hours (Galaxy S, 37°C, 5% CO2).  Selected wells 
containing NETs were treated with 1U/ml MNase (2.1.2.2) for 15 mins to act as a positive 
control for NET degradation, and were considered “100% NET degradation” (Hakkim et al., 
2010).  After 3 hours incubation, the plate was centrifuged (Hettich Universal 320R, 10 mins 
at 1800rcf).  Next, 150μl of the supernatant were transferred to a a black flat bottom non-
treated 96-well plate (Costar 3915), with the addition of 15μl of 10μM Sytox green 
(Invitrogen S7020) to quantify any free DNA within the supernatant.  Controls included the 
addition of 1U/ml Mnase to the plasma sample prior to incubation with NETs.  Fluorescence 
was read in AFU on a fluorometer (2.2.3.3). 
 
2.2.5.2 Quantification of immunoglobulin G (IgG), free light chains (FLCs), and cystatin 
C 
Plasma samples (500µl aliquots, 2.2.6.2.3) from chronic periodontitis patients and healthy 
controls were processed for the quantification of IgG subclasses (1-4), FLCs and cystatin C.  
All plasma samples were analysed by The Binding Site Group Ltd (Birmingham, UK).  IgG 
subclasses were quantified using the SPAPLUS® analyser and the reference ranges used for 
IgG subclasses were: IgG1: 3.824-9.286g/L, IgG2: 2.418-7.003g/L, IgG3: 0.218-1.761g/L, 
IgG4 0.039-0.864 (Schauer et al., 2003).  Samples were analysed for FLC kappa and FLC 
lambda on the SPAPLUS® turbidimeter (Freelite, The Binding Site Group Ltd, Bradwell et 
al., 2001).  The reference ranges employed for FLC analyses were: FLC kappa: 3.3-
19.4mg/L, FLC lambda: 5.71-26.3mg/L, FLC kappa/lambda ratio: 0.26-1.65, summated FLC: 
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9.01-45.7 (Katzmann et al., 2002).  Plasma cystatin C levels were quantified using the 
SPAPLUS® assay, the reference range was 0.51-0.98 mg/L (Finney et al., 2000). 
 
2.2.5.3 Collection of NET supernatants 
Isolated neutrophils (1x10
5
, 2.2.1.1.2) were stimulated to produce NETs using 0.75mM HOCl 
in a clear non-treated 24-well plate (Costar 3526) (section 2.2.3.3).  Following a 4-hour 
incubation (Galaxy S, 37°C, 5% CO2), the supernatant was gently aspirated and the NETs 
washed by adding 1ml of pre-warmed (20°C) RPMI-1640 (Sigma R7509). This process 
removes components that are not NET bound and also any remaining HOCl (Appendix III).  
NETs were digested by adding 75µl MNase (1U/ml, 2.1.2.2) and the plate was incubated for 
15 mins at room temperature.  Post incubation, the plate was centrifuged (Hettich Universal 
320R, 10 mins at 1800rcf).  The supernatants were then transferred to fresh 2mL cryotubes 
and frozen under liquid nitrogen prior to storage at -80°C.  Preliminary experiments revealed 
that snap freezing produced NET supernatants most representative of fresh NETs, compared 
with -20°C, -80°C and slow freezing (1°/min, Mr Frosty
TM
) (Appendix VI).  
 
2.2.5.4 NET supernatant concentration 
To determine the concentration of NET supernatants, the amount of DNA in each pooled 
sample (from 5 volunteers) were quantified fluorometrically with Sytox green (2.2.3.3).  50µl 
of 25%, 50% or 100% of NET supernatants were added to a black flat bottom non-treated 96-
well plate (Costar 3915), 125µl of RPMI-1640 (Sigma R7509) added, plus 15µl of 10μM 
Sytox green.  A standard curve was produced by serially diluting calf thymus DNA (Sigma 
D4522).  Fluorescence was read in AFU using a fluorometer (2.2.3.3).  To determine whether 
NET supernatants stimulate neutrophil responses, pooled samples were employed as total 
ROS stimuli (2.2.3.2), NET stimuli (2.2.3.3) and chemoattractants (2.2.4.2.3). 
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2.2.5.5 NET supernatants effects on oral epithelial cells (OECs)   
To determine whether NET supernatants affect the growth of OECs, H400s were cultured 
(see section 2.1.6) in a 96-well plate and incubated with NET supernatants (25%, 50%, 
100%, 2.2.5.3).  At 4 and 24 hours, the impact of NET supernatants on H400 cell apoptosis, 
metabolic activity and necrosis was determined by quantifying caspase activity (see 
2.2.1.2.4), ATP activity (see section 2.2.1.2.5) and lactase dehydrogenase (LDH) release (see 
2.2.5.7). 
 
2.2.5.5.1 H400 oral epithelial cell storage and recovery 
Preservation of H400 oral epithelial cells for future use was achieved by storing cells at -
80°C.  Cells in supplemented Dulbecco’s Modified Eagle’s Medium:nutrient mixture F-12 
(DMEM/F-12) were divided into 1ml cryotubes containing 1x10
6
 cells in 20% (v/v) heat 
inactivated FCS (Labtech) and 10% (v/v) DMSO (Sigma D8418) (see 2.1.6.2).  When 
required, cell suspensions were rapidly defrosted in a water bath (37°C) and transferred to 
9ml of pre-warmed (37
o
C) DMEM/F-12 and gently mixed.  This mix was centrifuged (10 
mins at 150rcf) and the supernatant removed prior to the pellet being re-suspended in 10ml of 
fresh warmed (37
o
C) DMEM/F-12.  This was then transferred to a sterile cell 75cm2 culture 
flask (Thermo Scientific) and incubated for 3-4 days (Galaxy S, 37°C, 5% CO2).  Cell growth 
was observed microscopically (Leitz Laborlux s), after which the media was removed and 
replaced with 10ml of fresh pre-warmed (37
o
C) DMEM/F-12.  The flask was re-incubated 
(Galaxy S, 37°C, 5% CO2) for an additional 2-3 days and cells were passaged when the 
monolayer was nearing confluence with a neutral pH.  This was indicated by the phenol red 
present in DMEM/F-12, where if the cells are left too long and the nutrients in the media are 
exhausted, the media solution will turn yellow due to increased acidity (The Merck Index 
1996).  
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2.2.5.5.2 Cell passage 
H400 oral epithelial cells were passaged when they reached 90-100% confluence.  This 
process dissociates the monolayer of adherent cells to produce a cell suspension for re-
seeding into a new flask.  Growth media was removed and the adherent cells were washed 
with pre-warmed (37
o
C) Dulbecco’s PBS (Invitrogen 14190).  This was then removed and 
4ml of T-EDTA added (see 2.1.6.3), and the flask then incubated for 10 mins (Galaxy S, 
37°C, 5% CO2).  Microscopy was employed to confirm cells were released from the 
monolayer.  The resultant single cell suspension was transferred to a universal container with 
4ml of pre-warmed (37
o
C) DMEM/F-12, in order to terminate the action of T-EDTA.  The 
cells were centrifuged (IEC Centra CL2, 10 mins at 150rcf) and the supernatant removed.  
Pelleted cells were re-suspended in 5ml of pre-warmed (37
o
C) DMEM/F-12, counted with a 
haemocytometer (Neubauer, Reichert) (2.2.5.5.3) and seeded accordingly in a sterile flask 
(75cm
2
, Thermo Scientific).  All experiments were undertaken between 4 and 10 passages. 
 
2.2.5.5.3 Determination of cell concentrations and viability 
Trypsinised cells were counted under a light microscope at x20 magnification (Leitz 
Laborlux s) on each of the 4 quadrants of a haemocytometer (Neubauer, Reichert).  This 
count was divided by 4 to yield a cell count of 1x10
4 
per ml of cell suspension.  This stock of 
cells was diluted appropriately in DMEM/F-12 (2.1.6.2).  Cell viability was confirmed by 
trypan blue exclusion (Sigma T8154, 2.2.1.2.3).  Tyrpan blue is not absorbed by viable cells, 
however if the neutrophil cell membrane is damaged, the dye will be absorbed and stain the 
cell blue.  A calculation was employed to determine the percentage of viable cells: number of 
viable cells/ total number of cells x 100.  Preliminary experiments compared trypsinised cells 
and in situ cell counts (Appendix VII), and based on these results all subsequent experiments 
relied on trypsinised cell counts. 
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2.2.5.6 Culture of H400 oral epithelial cells in a 96-well format 
To determine the effect of NETs on H400 oral epithelial cell growth, cultures were 
maintained in a white walled tissue culture grade 96-well plate with clear bottoms (Costar 
3610).  Following cell passage, 1x10
4 
cells in 100µl of DMEM/F-12 (2.1.6.2) were seeded 
into each well of a 96-well plate.  Cells were cultured until 90% confluent prior to addition of 
NET supernatants (25%, 50% and 100%) in 50µl aliquots (2.2.5.3).  Treatment with 0.1% 
triton (Sigma T8787) was also employed to act as a positive control for cell death. 
 
2.2.5.7 Determination of H400 oral epithelial cell lactate dehydrogenase release 
The CytoTox-ONE
TM 
(Promega G7890) homogenous membrane integrity assay was 
employed to determine H400 cell viability, by fluorometrically quantifying lactate 
dehydrogenase (LDH), which is released when cell membrane integrity is lost. Cell culture 
supernatants (50µl) were transferred to a black flat bottom non-treated 96-well plate (Costar 
3915) and an equal volume of CytoTOx-ONE reagent was added.  The plate was covered and 
incubated at room temperature for 10 mins.  25µl of stop solution (kit reagent) was added to 
each well and the fluorescence was read at an excitation of 560nm and an emission of 590nm 
(Berthold Tristar
2
 LB942, ICE). 
 
 NEUTROPHIL RESPONSES IN PERIODONTAL HEALTH AND DISEASE 2.2.6
 
2.2.6.1 NEUTROPHIL RESPONSES IN GINGIVITIS 
 
2.2.6.2 21-day gingivitis model 
An experimental model of gingivitis in 10 systemically and periodontally healthy 
undergraduate dental students from the University of Birmingham was employed (Loe et al., 
1965).  Ethical approval was obtained from South Birmingham Research Ethics Committee 
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(2004/074) and all volunteers gave informed consent.  A split mouth model was used, in 
which volunteers were required to wear a soft vinyl mouth guard that covers the maxillary 
left 4-6 teeth (the right side was used in left handed individuals) during brushing for 21 days 
(Table 2.10).  This prevents mechanical or chemical cleaning of these teeth, allowing for the 
accumulation of plaque and the development of inflammatory responses characteristic of 
gingivitis.  The maxillary right 4-6 teeth were used as control teeth, as these teeth were 
subjected to normal oral hygiene, comprised of brushing twice a day.  All volunteers were 
non-smokers (for at least 5 years), had not been prescribed antibiotics or anti-inflammatories 
in the past 3-months and were not diabetic or pregnant.  Volunteers also refrained from using 
mouth wash and chewing gum for the entirety of the study period.  
 
2.2.6.2.1 Clinical measures of gingival inflammation 
Plaque accumulation was determined using the Quigley & Hein, Turesky & Lobene modified 
(1982) plaque index (PI; Quigley & Hein 1962, Turesky et al., 1970, Lobene et al., 1982).  
Gingival inflammation was measured using the Löe (1967) gingival index (GI; Löe 1967) 
and the volume of GCF was also measured using a pre-calibrated Periotron 8000
TM 
(Chapple 
et al., 1999).  GCF was collected over a 30 sec period by inserting Periopaper strips 
(OraFlow) into the mesio-buccal gingival crevices of test and control sites.  Clinical 
parameters were measured immediately prior to blood collection for neutrophil assays.  All 
volunteers were assessed and indices performed at days 0, 7, 14 and 21 of plaque 
accumulation (Table 2.10).  At day 21 all plaque was removed by prophylaxis and volunteers 
recommenced normal brushing prior to final assessment at day 35 (designated as return to 
health).  All clinical parameters were measured immediately prior to blood collection for 
neutrophil assays by a single experienced examiner. 
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2.2.6.2.2 Plaque sampling 
Plaque samples were collected from the palatal test and control teeth at each time point 
outlined in Table 2.10, using a size 30 finger spreader (25mm, Claudius Ash).  Plaque was re-
suspended in 200µl PBS (2.1.1.1) and vortexed until the plaque was homogenised and 
samples were stored at -20°C within 1 hour of collection.  Collection of plaque at each time 
point was from different teeth to ensure plaque accumulation was assessed after 0, 7, 14 and 
21 days of build-up, and final samples were obtained at day 35 (return to health).   
 
2.2.6.2.3 Collection of plasma  
Plasma was isolated from blood collected into 6ml lithium heparin anticoagulant tubes by 
centrifuging for 30 mins at 1000rcf (4°C).  Following centrifugation, plasma was transferred 
to cryotubes in 500µl aliquots and stored at -80°C. 
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Table 2.10: Outline of the 21-day gingivitis model study 
Pink background denotes the 21-day study period and ticks indicate the time points at which 
clinical indices and bloods were collected.  Abbreviations: GCF (gingival crevicular fluid). 
 
Time 
(Days) 
Gingivitis model study design 
Measurement 
of gingivitis 
and plaque & 
GCF collection 
Blood collection 
for 
plasma/neutrophil 
assays 
-14 
Volunteers were introduced to the 
study and those who consented 
were assessed, their teeth 
professionally cleaned and 
impressions taken for the 
construction of an occlusal guard. 
  
0 
Volunteers were fitted with a guard 
to commence 21 days of no 
brushing of the maxillary left 4-6 
teeth. 
  
7 
Volunteers were examined and 
clinical indices measured. 
  
14 
Volunteers were examined and 
clinical indices measured. 
  
21 
Volunteers no longer have to wear 
the mouth guard and their teeth are 
professionally cleaned. 
  
35 
Volunteers were examined to 
ensure they have returned to 
gingival health. 
  
 
 
 
2.2.6.2.4 Plaque as a neutrophil stimulus 
The ability of plaque to stimulate neutrophils for ROS (2.2.3.2) and NET production (2.2.3.3) 
was assayed. Preliminary experiments sought to determine the concentrations of plaque 
required to evoke ROS and NET production; plaque was initially derived from a healthy 
volunteer who had not brushed for 24 hours.  Preliminary experiments were conducted to 
determine the concentration of plaque required to stimulate neutrophils, and based on these 
resutls all further assays employed plaque as a neutrophil stimulus at 25% in 25µl aliquots.  
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Plaque was pooled across the 10 volunteers at each time point, providing 1 control and 1 test 
plaque suspension at days 0, 7, 14, 21 and 35. 
 
2.2.6.2.5 Characterisation of plaque samples 
Pooled plaque samples were characterised in order to normalise ROS and NET production in 
response to a plaque stimulus.  Endotoxin, DNA and protein content were quantified for 
pooled plaque sample at each time-point. 
 
2.2.6.2.5.1 Quantification of endotoxin 
Gram-negative bacterial endotoxins present within plaque were characterised using the 
Pierce® Kit Limulus Amebocyte Lysate (LAL) Chromogenic Endotoxin Quantitation Kit 
(88282).  A clear non-treated 24-well plate (Costar 3526) was equilibrated to 37°C for 10 
mins, followed by the addition of 25µl of 50% plaque sample.  A standard curve was 
produced by serially diluting an Escherichia coli endotoxin standard (011:B4, provided in 
kit).  The plate was covered and incubated for 5 mins (Galaxy S, 37°C, 5% CO2).  50µl LAL 
reagent were added to each well, the plate was again covered and incubated for 10 mins 
(Galaxy S, 37°C, 5% CO2).  Post-incubation, 100µl of substrate solution was added to each 
well, this was then incubated for a further 6 mins (Galaxy S, 37°C, 5% CO2).  Finally, 50µl 
of stop reagent (25% acetic acid) were added to each well.  The optical density was read on a 
plate reader at 405nm (OD405nm) (ELx800, Bio-Tek Instruments Inc. Gen 5 1.11).  Plaque 
samples and standards were assayed in duplicate. 
 
2.2.6.2.5.2 Quantification of DNA 
The amount of plaque DNA within plaque samples was quantified fluorometrically with 
Sytox green.  25µl of 50% plaque samples was added to a black flat bottom non-treated 96-
well plate (Costar 3915).  125µl of RPMI-1640 (Sigma R7509) was added, plus 15µl of 
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10μM Sytox green (2.1.2.3).  A standard curve was produced by serially diluting calf thymus 
DNA (D4522).  Fluorescence was read in AFU on a fluorometer (2.2.3.3). 
 
2.2.6.2.5.3 Quantification of protein 
Plaque protein content was measured using a Pierce™ bicinchoninic acid (BCA) Protein 
Assay Kit (23227), which enables colorimetric detection of total protein content.  25µl of a 
50% plaque sample were added to a clear non-treated 96-well plate (Costar 3370), followed 
by the addition of 200µl working reagent.  A standard curve was produced by serially 
diluting BSA (Sigma A2153, 2.1.1.3).  The plate was covered and incubated for 30 mins 
(Galaxy S, 37°C, 5% CO2).  Post-incubation the plate was cooled at room temperature for 5 
mins and the optical density read at 562nm (OD562nm) on a plate reader (ELx800, Bio-Tek 
Instruments Inc. Gen 5 1.11)   
 
2.2.6.3 NEUTROPHIL RESPONSES IN CHRONIC PERIODONTITIS 
 
2.2.6.3.1 Chronic periodontitis clinical study volunteers 
NET production (2.2.3.3) by neutrophils derived from the peripheral blood of chronic 
periodontitis patients pre- and post-treatment was investigated.  All volunteers provided 
written informed consent, and ethical approval for the study was obtained from the West 
Midlands Research Ethics Committee (10/H1208/48).  Chronic periodontitis was defined by a 
minimum of 2 non-adjacent sites per quadrant with probing pocket depth >4mm, which bled 
upon probing and displayed radiographic bone loss >30% of the root length, as defined by the 
European Federation of Periodontology (Tonetti & Claffey 2005).  All patients were non-
smokers (for at least 5 years), had not been prescribed antibiotics or anti-inflammatories in 
the past 3-months and were not diabetic or pregnant.  The study group age ranged from 33 to 
63, however age was accounted for by recruiting age and gender-matched healthy controls.  
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The patients received tailored oral hygiene instruction and non-surgical periodontal treatment 
that involved scaling and root surface debridement of periodontal pockets >4mm.  The 
periodontally healthy control group showed no interproximal attachment loss, no probing 
pocket depths >3mm and whole mouth bleeding scores were <10%.  These volunteers were 
also subjected to the same exclusion criteria as the chronic periodontitis patients.  All NET 
assays were carried out on patients and their healthy counterpart in parallel on the same day.  
Plasma (2.2.6.2.3) and neutrophils (2.2.1.1.2) were isolated from peripheral venous blood 
pre-treatment and 3 months post-therapy.   
 
2.2.6.3.2 Clinical measures of gingival inflammation 
To determine the severity of periodontitis and the response to treatment, several parameters 
were measured.  These included clinical attachment loss (CAL) probing pocket depth (PDD) 
and bleeding on probing (BOP).  CAL was calculated by summation of periodontal pocket 
depth and gingival recession measurements in accordance with Haffajee & Socransky (1986).   
In addition, Plaque accumulation was determined using the Quigley & Hein, Turesky & 
Lobene modified (1982) PI (Quigley & Hein 1962, Turesky et al., 1970, Lobene et al., 1982).  
Gingival inflammation was measured using the Löe (1967) GI (Löe 1967) and the volume of 
GCF was also measured using a pre-calibrated Periotron 8000
TM
 (Chapple et al., 1999).  All 
clinical parameters were measured immediately prior to blood collection for neutrophil 
assays by a single experienced examiner, who also confirmed periodontal health in the 
healthy controls. 
 
 
 
 
 
 
105 
 
2.2.6.4 NEUTROPHIL RESPONSES IN PAPILLON LEFÈVRE SYNDROME (PLS) 
 
2.2.6.4.1 PLS study volunteers  
PLS patients ranging from 9-14 years old (n=3 males, n=2 females) were enrolled into the 
study by the University of Birmingham Dental School following a specialised clinic at the 
Birmingham Children’s Hospital.  All volunteers provided written informed consent, and 
ethical approval for the study was obtained from the West Midlands Research Ethics 
Committee (14/WM/1175).  Prior to the study, all volunteers had been genotyped, assessed 
for comorbidities and their dermatological and periodontal health was determined by 
Birmingham Children’s Hospital.  Plasma (2.2.6.2.3) and neutrophils (2.2.1.1.2) from the 
peripheral blood of patients and healthy gender-matched controls were isolated in parallel for 
subsequent NET assays (2.2.3.3).  Healthy volunteers were periodontally and systemically 
healthy, non-smokers (for at least 5 years), had not been prescribed antibiotics or anti-
inflammatories in the past 3-months and were not diabetic or pregnant.   
 
2.2.6.4.2 Quantification of NE and LL-37 in plasma samples 
Commercially available sandwich ELISA kits were employed to quantify NE (eBioscience 
BMS269) and LL-37 (Hycult biotech HK321) in PLS patient and control plasma samples 
(2.2.6.2.3).  To analyse the previously stored (-80°C) patient and control plasma samples, 
samples were defrosted, centrifuged (6 mins at 500rcf to pellet any cell debris), and the 
supernatants transferred to a fresh cryotube.  All reagents were provided in the kit were 
equilibrated to room temperature and diluted according to the manufacturer’s instructions 
prior to use. 
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2.2.6.4.2.1 Quantification of NE 
Samples were diluted 1:100 with sample diluent (provided in kit) and 100µl added to each 
well (samples assayed in duplicate).  The standard (human NE) was serially diluted from 
10ng/ml to achieve a suitable standard dilution range and also added to the plate in 100µl 
aliquots.  The plate was covered and incubated at room temperature for 1 hour on a shaker 
(Luckham R11/TW, speed 2).  Post incubation, wells were washed 4 times by emptying 
wells, adding 400µl wash buffer (incubate for 15 secs at room temperature) followed by 
aspiration.  150µl of HRP was added to each well and the plate covered and incubated at 
room temperature for 1 hour on a shaker (Luckham R11/TW, speed 2).  The wells were again 
washed 4 times (as before with 400µl wash buffer), followed by the addition of 200µl TMB 
substrate and incubation at room temperature in the dark for 20 mins.  The reaction was 
subsequently stopped by the addition of 50µl of stop solution (2M HCl) and the absorbance 
read at 450nm (OD450nm) (ELx800, Bio-Tek Instruments Inc. Gen 5 1.11).  The standard 
curve was used to determine sample concentrations and expressed in ng/ml. 
 
2.2.6.4.2.2 Quantification of LL-37 
Samples were diluted 1:20 with sample diluent (provided in kit) and 100µl added to each well 
(samples assayed in duplicate).  The standard (human LL-37) was serially diluted from 
100ng/ml to achieve a suitable standard dilution range and also added to the plate in 100µl 
aliquots.  The plate was covered and incubated at room temperature for 1 hour on a shaker 
(Luckham R11/TW, speed 2).  Post incubation, wells were washed 4 times by emptying 
wells, adding 400µl wash buffer (incubate for 15 secs at room temperature) followed by 
aspiration.  100µl of biotinylated tracer antibody was added to each well and the plate 
covered and incubated at room temperature for 1 hour on a shaker (Luckham R11/TW, speed 
2).  The wells were again washed 4 times (as before with 400µl wash buffer), followed by the 
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addition of 100µl of streptavidin peroxidase and incubation at room temperature for 1 hour 
on a shaker (Luckham R11/TW, speed 2).  The 4 wash steps were repeated, prior to the 
addition of 100µl of TMB solution and incubation at room temperature in the dark for 30 
mins.  The reaction was subsequently stopped by the addition of 100µl of stop solution (2% 
oxalic acid) and the absorbance read at 450nm (OD450nm) (ELx800, Bio-Tek Instruments Inc. 
Gen 5 1.11).  The standard curve was used to determine sample concentrations and expressed 
in ng/ml. 
 
 STATISTICAL ANALYSIS 2.2.7
Unless otherwise stated, all statistical analyses were performed in GraphPad Prism 5 software 
package.  The distribution of data, and thus whether data was considered parametric or non-
parametric, was determined by Kolmogorov-Smirnov tests.  Statistical tests employed for the 
purpose of this study were at a significance of 0.05.  The level of significance is indicated as 
follows: *, **, *** and **** denotes <0.05, <0.01, <0.001 and <0.0001 respectively, ns means 
the results are >0.05 and therefore not significant.   
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 NEUTROPHIL ISOLATION TECHNIQUES AND THEIR CHAPTER 3:
EFFECTS UPON EX VIVO NEUTROPHIL BEHAVIOUR 
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3.1 Introduction 
This chapter reports on the preparation technique of neutrophils upon ex vivo neutrophil 
behaviour using a variety of assays to determine neutrophil function and viability.  Isolation 
aims to separate neutrophils from other blood cells, whilst at the same time not causing 
inadvertent cell activation, which may affect subsequent ex vivo neutrophil analysis (1.9).  
There are a number of neutrophil isolation methods reported in the literature, including use of 
different density gradient materials, such as Percoll, Histopaque and Dextran sedimentation 
followed by Percoll centrifugation (2.2.1).  This work aims to determine whether the method 
of isolation affects ex vivo neutrophil activation levels and to identify the most appropriate 
technique prior to application of a range of ex vivo neutrophil assays used in this thesis.  
Initially, neutrophils were isolated from healthy volunteers (University of Birmingham Ethics 
Reference ERN_13-0325) using Percoll or Histopaque density centrifugation.  Subsequent 
experiments compared cell isolation by Percoll density centrifugation and Dextran 
sedimentation (Dextran neutrophils were kindly isolated by Dr Adam Usher, University of 
Birmingham).  Comparisons between isolation techniques were performed in parallel from 
the same individual.    
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3.2 Comparisons between isolation techniques 
It is worthy of note that Percoll-Histopaque comparisons were undertaken at a different time 
and in a different research laboratory to the Percoll-Dextran comparisons.  Therefore 
differences in blood donors, laboratory equipment and the neutrophil stimuli employed only 
allow for these direct comparisons, and not comparisons between Dextran and Histopaque 
isolation procedures. 
 
 Cell yield: Percoll vs Histopaque 3.2.1
Following neutrophil isolation from whole blood, cells were counted to ensure the 
appropriate numbers of re-suspended cells were employed in subsequent assays (2.2.1.1.5), 
and also to provide relative yields following Percoll, Histopaque or Dextran isolation 
procedures (Figure 3.1).  Comparisons between Percoll and Histopaque demonstrated that 
across 10 paired isolations neutrophil yield was significantly higher for the Percoll gradient 
isolation procedure (Mann-Whitney **p=0.0014, n=10) (Figure 3.1a).   
 
 Cell yield: Percoll vs Dextran 3.2.2
Across 5 paired isolations with Percoll or Dextran isolation gradients, there was no 
significant difference in the cell yield isolated per ml of blood.  Percoll and Dextran isolation 
approaches resulted in a mean cell yield of 8.9x10
6 
and 9.7x10
6
, respectively (Mann-Whitney 
p=0.467, n=5) (Figure 3.1b). 
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Figure 3.1: The effect of neutrophil preparation techniques on cell numbers 
Cell yield (per ml of blood) was compared between (a) Percoll- and Histopaque-isolated 
neutrophils (n=10 in triplicate), and (b) Percoll- and Dextran- isolated neutrophils (n=5 in 
triplicate).  Statistical significance calculated using Mann-Whitney tests (**p<0.01, ns=not 
significant) n=10 in triplicate.  Data expressed as mean ± SEM (n=5 in triplicate).   
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 Total peak ROS production: Percoll vs Histopaque isolation procedures 3.2.3
Subsequent to isolation, Percoll and Histopaque separated neutrophils were assessed for ROS 
generation (total ROS was measured with luminol, section 2.2.3.2) (Figure 3.2).  Histopaque-
isolated neutrophils demonstrated higher peak ROS production in response to PBS 
(unstimulated control); however this did not reach statistical significance.  Percoll-isolated 
cells stimulated with opsonised S. aureus (5x10
7 
and MOI of 500) produced significantly 
more ROS compared with Histopaque-isolated neutrophils (2 way ANOVA and Bonferroni 
post-hoc tests ***p<0.001, n=10), however there was no significant difference in total ROS 
production between F. nucleatum poly-stimulated (1x10
8 
and MOI of 1000) Histopaque- and 
Percoll-isolated neutrophils (Figure 3.2a).   
 
 Total peak ROS production: Percoll vs Dextran isolation procedures 3.2.4
Following isolation, both Percoll and Dextran separated neutrophils were assessed for ROS 
generation (total ROS measured with luminol) in response to PBS (unstimulated control), F. 
nucleatum poly (1x10
8 
and MOI of 1000) or PMA (25nM).  There was no significant 
difference in ROS generation by untreated cells (PBS) or cells stimulated with F. nucleatum 
poly or PMA between Percoll and Dextran isolated neutrophils (2way ANOVA p=0.0762, 
n=5) (Figure 3.2b). 
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Figure 3.2: The effect of neutrophil preparation technique on peak total ROS 
production 
Total ROS production (quantified with luminol) was compared between (a) Percoll- and 
Histopaque-isolated neutrophils in response to F. nucleatum poly (1x10
8
,
 
MOI of 1000) and 
opsonised S. aureus (5x10
7
,
 
MOI of 500) (n=10 in triplicate), or (b) Percoll- and Dextran- 
isolated neutrophils in response to F. nucleatum poly (1x10
8
,
 
MOI of 1000) and PMA (25nM) 
(n=5 in triplicate).  Statistical significance calculated using 2way ANOVA and Bonferroni 
post-tests (***p<0.001, ns=not significant).  Data expressed as the peak RLU (relative light 
units) and mean ± SEM. 
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 Total ROS production over stimulation period: Percoll vs Histopaque isolation 3.2.5
procedures 
Consistent with the total peak ROS results, ROS production expressed as “area under the 
curve” over a 175 min time-course revealed that Histopaque-isolated cells produced 
marginally higher levels of ROS in response to PBS (unstimulated control), compared with 
Percoll, implying greater background activation of the isolated neutrophils (Figure 3.3a).  No 
differences were observed between Percoll and Histopaque cells in response to F. nucleatum 
poly (1x10
8 
and MOI of 1000) (Figure 3.3b), however higher levels of total ROS were 
produced following opsonised S. aureus stimulation (5x10
7 
and MOI of 500) in Percoll-
isolated cells (Figure 3.3c).  Following stimulation at 30 mins, levels of total ROS 
considerably increased in both F. nucleatum poly and opsonised S. aureus-stimulated cells at 
approximately 60 mins, and peaked at approximately 80 mins. 
 
 Total ROS production over stimulation period: Percoll vs Dextran isolation 3.2.6
procedures 
Consistent with the total peak ROS results, time-course ROS production expressed as “area 
under the curve” over 250 mins revealed no observable differences in ROS production 
between Percoll and Dextran cells in response to PBS (unstimulated control) (Figure 3.4a), F. 
nucleatum poly (1x10
8 
and MOI of 1000) (Figure 3.4b) and PMA (25nM) (Figure 3.4c).  
Following stimulation at 30 mins, ROS production in response to F. nucleatum poly and 
PMA steadily increased at approximately 125 mins. 
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Figure 3.3: Neutrophil isolation time-course analysis of ROS production  
Time-course total ROS production over 175 mins by cells isolated with Percoll (green) or 
Histopaque (purple).  (a) ROS production by cells treated with PBS (unstimulated), (b) F. 
nucleatum poly (1x10
8
,
 
MOI of 1000) or (c) opsonised S. aureus (5x10
7
,
 
MOI of 500).  Data 
presented as mean RLU (relative light units) (n=10 in triplicate). 
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Figure 3.4: Neutrophil isolation time-course analysis of ROS production  
Time-course total ROS production over 250 mins by cells isolated with Percoll (green) or 
Dextran (blue).  (a) ROS production by cells treated with PBS (unstimulated), (b) F. 
nucleatum poly (1x10
8
,
 
MOI of 1000) or (c) PMA (25nM).  Data presented as mean RLU 
(relative light units) (n=5 in triplicate). 
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 NET production: Percoll vs Histopaque isolation procedures 3.2.7
NET production (NET-DNA quantified with Sytox green, section 2.2.3.3) was considerably 
higher in Percoll-isolated unstimulated cells (PBS); however this did not reach statistical 
significance.  Neutrophils stimulated with F. nucleatum poly (1x10
8 
and MOI of 1000) or 
opsonised S. aureus (5x10
7 
and MOI of 500) also exhibited increased NET release when 
isolated with Percoll (2way ANOVA and Bonferroni post-tests ***p<0.001 and *p<0.05 for 
F. nucleatum poly and opsonised S. aureus, respectively, n=10) (Figure 3.5a). 
 
 NET production: Percoll vs Dextran isolation procedures 3.2.8
Dextran-prepared neutrophils produced significantly fewer NETs in response to stimulation 
with PMA (50nM) and HOCl (0.75mM) relative to cells isolated with Percoll gradients 
(2way ANOVA and Bonferroni post-tests **p<0.01 and ***p<0.001, for PMA and HOCl, 
respectively, n=5).  Higher NET release in unstimulated Percoll-isolated cells was also 
observed, however this difference was not statistically significant (Figure 3.5b).     
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Figure 3.5: The effect of neutrophil preparation techniques on subsequent NET 
production 
NET production (quantified with Sytox green) was compared between (a) Percoll- and 
Histopaque-isolated neutrophils in response to F. nucleatum poly (1x10
8
,
 
MOI of 1000) and 
opsonised S. aureus (5x10
7
,
 
MOI of 500) (n=10 in triplicate), or (b) Percoll- and Dextran- 
isolated neutrophils in response to PMA (50nM) and HOCl (0.75mM) (n=5 in triplicate). 
Statistical significance calculated using 2way ANOVA and Bonferroni post-tests (*p<0.05, 
**p<0.01, ***p<0.001).  Data expressed as AFU (arbitrary fluorescence units) and mean ± 
SEM. 
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 Metabolic activity: Percoll vs Histopaque 3.2.9
To investigate neutrophil metabolic activity, ATP production by isolated neutrophils was 
measured at 30 min intervals over a 60 min period (section 2.2.1.2.5).  ATP generation was 
initially higher in Histopaque-isolated neutrophils compared with Percoll-isolated neutrophils 
(2way ANOVA and Bonferroni post-tests *p<0.05, n=10).  However over the 60 min period, 
ATP production by Histopaque-isolated neutrophils decreased.  The metabolic activity of 
Percoll-isolated neutrophils was lower at the onset of the ROS assay and despite also 
decreasing with time, the reduction in ATP activity did not reach the level of that of 
Histopaque-isolated neutrophils. Therefore the difference between Percoll- and Histopaque-
isolated cell activity at 30 and 60 mins was not statistically significantly different (Figure 
3.6a). 
 
 Metabolic activity: Percoll vs Dextran 3.2.10
ATP production by isolated neutrophils was measured at 30 min intervals over a 60 min 
period.  ATP generation was significantly higher in Dextran-isolated neutrophils compared 
with Percoll-isolated cells at all 3 time-points assayed (2way ANOVA and Bonferroni post-
tests ***p<0.001, ***p<0.001 and **p<0.01 at time-points 0, 30 and 60 mins, respectively, 
n=5).  The metabolic activity of both Percoll and Dextran-isolated cells remained relatively 
consistent over the 60 min period (Figure 3.6b). 
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Figure 3.6: The effect of the neutrophil preparation technique on neutrophil metabolic 
activity 
ATP production (indicative of metabolic activity) was compared between (a) Percoll- and 
Histopaque-isolated neutrophils (n=10 in triplicate) and (b) Percoll- and Dextran- isolated 
neutrophils (n=5 in triplicate) following isolation.  Statistical significance calculated using 
2way ANOVA and Bonferroni post-tests (*p<0.05, **p<0.01, ***p<0.001).  Data expressed 
as RLU (relative light units) and mean ± SEM. 
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 Caspase activity: Percoll vs Histopaque 3.2.11
To investigate the effect of neutrophil preparation methods upon apoptosis, caspase-3 and -7 
activity was assayed in isolated neutrophils at 30 min intervals over a 60 min period (section 
2.2.1.2.4).  Caspase activity was initially higher in Histopaque-isolated neutrophils compared 
with Percoll-isolated neutrophils (0mins, 2way ANOVA and Bonferroni post-tests *p<0.05, 
n=10).  Over the 60 min period, caspase activity in Histopaque-isolated neutrophils gradually 
decreased.  The apoptotic activity of Percoll-isolated neutrophils remained consistent over the 
60 min measurement period.  There was no significant difference in caspase-3 and -7 activity 
between Percoll and Histopaque isolated cells at 30 or 60 mins (Figure 3.7a). 
 
 Caspase activity: Percoll vs Dextran 3.2.12
Caspase activity in Percoll and Dextran isolated neutrophils was measured at 30 min intervals 
over a 60 min period.  Caspase-3 and -7 production was marginally higher at each time-point 
(0, 30 and 60 mins) in cells isolated by Dextran sedimentation, however this difference was 
not statistically significant (2way ANOVA p=0.0855, n=5) (Figure 3.7b). 
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Figure 3.7: The effect of the neutrophil preparation technique on caspase activity 
Caspase-3 and -7 activity (indicative of apoptotic activity) was compared between (a) 
Percoll- and Histopaque-isolated neutrophils (n=10 in triplicate) and (b) Percoll- and 
Dextran- isolated neutrophils (n=5 in triplicate) following isolation.  Statistical significance 
calculated using 2way ANOVA and Bonferroni post-tests (*p<0.05, ns=not significant).  
Data expressed as RLU (relative light units) and mean ± SEM. 
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3.3 Efficiency of neutrophil preparation using Percoll 
 
 Validation of chosen neutrophil preparation technique using Percoll gradients 3.3.1
The isolation and purity of neutrophils obtained from peripheral venous blood by 
discontinuous Percoll gradients was determined by nuclear morphological analysis using a 
cytospin technique, and the expression of the CD66 surface marker (Carlos et al., 1994) by 
fluorescence microscopy and flow cytometry. 
 
3.3.1.1 Cytospin of Percoll-isolated neutrophils  
Representative cytospins from 3 separate experiments demonstrated that Percoll-isolated 
neutrophils display the characteristic multi-lobed nuclei of neutrophils stained blue (indicated 
by yellow arrows), whilst the cytoplasm stained pink, following staining with Diff-Quick 
(Figure 3.8).   
 
3.3.1.2 CD66 staining of neutrophil preparations 
Neutrophil isolation using Percoll gradients was confirmed by staining for surface marker 
activation antigen, CD66, which is specific to granulocytes (Carlos et al., 1994).  
Fluorescence microscopy demonstrated that the cells isolated by Percoll density gradient 
centrifugation expressed the surface marker CD66 (Figure 3.9).   
 
 
  
124 
 
 
Figure 3.8: Cytospin of Percoll-isolated neutrophils 
Following neutrophil isolation using a Percoll gradient, cells were stained with Diff-Quick 
and visualised using light microscopy (x10 magnification).  Multi-lobed nuclei characteristic 
of neutrophils stained dark blue and the cytoplasms stained pink.  Representative image from 
3 separate experiments is shown.  Scale bar represents 100µm.  
 
 
   
Figure 3.9: Fluorescence microscopy of surface marker CD66 
Following neutrophil isolation, cells were stained for CD66 expression and visualised using 
fluorescence microscopy (x10 magnification). The expression of CD66 on neutrophils was 
indicated by the red staining. Representative image from 3 separate experiments is shown.  
Scale bar represents 100µm.  
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3.3.1.3 Flow cytometric identification of neutrophils. 
Flow cytometry was employed to determine the isolation efficiency and purity of neutrophils 
in Percoll-derived cell suspensions (section 2.2.1.2.2).  Neutrophils were quantified in whole 
peripheral blood prior to isolation by measuring their auto-fluorescence in the blood sample, 
which indicated that neutrophils represent 40.21% of the cells (representative results from 2 
separate isolations) (Figure 3.10a).  Following isolation with Percoll gradients, levels of the 
surface marker CD66b was quantified.  Flow cytometry data indicated that Percoll gradients 
resulted in a cell suspension comprising 97.3% neutrophils (Figure 3.10b).  Representative 
results from 2 separate isolations.   
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a) Flow cytometric analysis of whole blood 
 
 
b) Flow cytometric analysis of Percoll-isolated neutrophils 
 
Figure 3.10: Flow cytometric characterisation of neutrophils 
(a) Flow cytometry analysis of unstained whole blood (relies on autofluorescence of cells) 
demonstrated that prior to any neutrophil preparation, whole blood contains 40.21% 
neutrophils.  (b) The enumeration of CD66b on Percoll-isolated neutrophils demonstrated that 
the isolation of neutrophils from whole blood resulted in a cell suspension containing 97.3% 
neutrophils.  The gating identifies the neutrophil population.  Representative results from 2 
separate isolations.  Abbreviations: FS Lin (forward scatter linear), SS Lin (side scatter 
linear). 
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3.4 Discussion 
The aim of this work was to determine the most suitable method for peripheral blood 
neutrophil isolation by comparing Percoll isolation with two additional neutrophil isolation 
approaches with respect to ex vivo neutrophil responses.  Parameters investigated included 
cell yield, ROS release (luminol chemiluminescence), NET production (quantification of 
NET-DNA with Sytox green), apoptotic activity (caspase-3 and -7 production) and metabolic 
status (ATP production).  Overall, results revealed that there were indeed differences in 
cellular responses generated following the various neutrophil isolation techniques. 
The numbers of neutrophils obtained from the same individual were significantly higher 
when a Percoll gradient was used for purification (section 3.2.1, 3.2.2).  This is consistent 
with the findings of Grisham (1985), who reported that the use of two discontinuous Percoll 
gradients produced a higher cell yield than Histopaque gradients.  However no difference in 
cell yield was observed between Percoll and Dextran gradient isolated neutrophils.  Whilst 
recent in vivo analyses have demonstrated neutrophil longevity within the blood stream of 5.4 
days (Pillay et al., 2010), neutrophils are terminally differentiated cells, meaning they cannot 
be passaged in tissue culture without undergoing apoptosis (Gottlieb et al., 1995).  Therefore, 
despite the fact that this difference in yield is corrected for in subsequent neutrophil assays, 
yield is an important variable as the number of cells attainable from a limited amount of 
venous blood governs the number of subsequent experiments that can be conducted.   
 
To determine whether the isolation method activated neutrophils, baseline ROS production 
over a 30 min period was measured (section 3.2.3, 3.2.4).  At this point, cells were 
unstimulated and the method of neutrophil isolation represented the only variable between 
these cells.  Although no statistical difference in ROS production was measured between 
Percoll and Histopaque-isolated cells, there was a general trend towards higher ROS 
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production in neutrophils isolated with Histopaque.  It is possible that the Histopaque 
isolation method activates the neutrophils, resulting in inadvertent ROS production 
immediately after isolation.  ROS release is known to be a causative agent in neutrophil 
death, as co-incubation of neutrophils with glutathione, which scavenges H2O2 and other 
ROS, has been found to decrease neutrophil death (Yamamoto et al., 2002).  These findings 
infer that upon exposure to a threshold level of ROS, as a result of activation, neutrophils will 
enter into apoptosis (Scheel-Toellner et al., 2004).  Conversely, high levels of ROS can also 
inhibit caspase activity, suggesting that caspase-independent pathways may be involved in 
ROS-dependent cell death (Fadeel et al., 1998).  However it is noteworthy that apoptosing 
neutrophils are still capable of producing substantial amounts of ROS in response to 
exogenous stimulation (Xu et al., 2009), thus baseline ROS may be derived from a 
combination of activated and/or apoptosing neutrophils.   
 
Caspase activity was determined by quantifying effector caspases-3 and -7 over a 60 min 
period post-isolation (section 3.2.11, 3.2.12).  Caspase activity was higher in Histopaque-
isolated cells immediately following isolation; however less caspase activity was evident over 
time.  In response to stimulation, Percoll-isolated cells produced higher levels of ROS than 
Histopaque-isolated cells.  This could be due to the Histopaque-prepared cells being less 
responsive to exogenous stimulation, or the possibility that initially apoptotic neutrophils are 
no longer viable and thus less ROS is produced in response to stimulation.  No differences 
were observed between Percoll and Dextran isolation with respect to baseline total ROS 
release, as well as in response to stimulation.  Furthermore, no significant differences were 
found between Percoll and Dextran isolation techniques with regard to neutrophil apoptosis, 
which lends further support for the association of caspase activity with ROS production. 
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Percoll, Histopaque and Dextan-purified neutrophils were also compared in terms of their 
ability to produce NETs (3.2.7, 3.2.8).  Percoll-isolated neutrophils were found to produce 
consistently more NETs following stimulation with F. nucleatum poly and opsonised S. 
aureus.  This was also observed following Dextran isolation, with Percoll-isolated cells 
producing significantly higher levels of NETs in response to PMA and HOCl.  Collectively, 
these findings suggest that Percoll isolated neutrophils are more sensitive to NET production 
following stimulation.  The differences between Percoll and Histopaque cell NET production 
may be explained by the total ROS results being lower in Histopaque isolated cells following 
stimulation, as ROS is known to be vital for NET release (Kirchner et al., 2011, Nishinaka et 
al., 2011); in support of this is treatment of neutrophils with NADPH-oxidase inhibitor (DPI), 
which abolishes NET release.  Whilst it is recognised that NADPH-oxidase independent 
NETs may occur, and could therefore provide an explanation for the reduced NET release in 
Dextran cells (as decreased ROS was not observed in these cells), this seems unlikely as 
NADPH-oxidase independent NET release is reported in response to specific stimuli such as 
uric acid (Arai et al., 2014) and soluble immune complexes (Chen et al., 2012).  It is also a 
possibility that a higher proportion of Histopaque- and Dextran-isolated neutrophils are no 
longer viable 3 hours following isolation, which is the time at which NETs are quantified and 
may explain the lower number of NETs quantified.   
 
Consistent with the hypothesis that Histopaque isolation causes activation of neutrophils, 
ATP quantification (indicative of metabolic activity) revealed that Histopaque isolated cells 
were metabolically active initially, however less ATP was produced over time, indicating 
either that negative internal feedback mechanisms switch neutrophils to a less active state, or 
potentially that apoptosis was indeed being induced (Scheel-Toellner et al 2004) (section 
3.2.9).  Metabolic activity was significantly higher in Dextran-isolated cells at each time 
points, relative to Percoll cells (section 3.2.10).  Physiologically relevant concentrations of 
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ATP are correlated with a concentration dependent delay in neutrophil apoptosis (Vaughan et 
al., 2007).  Although NETosis is distinct from apoptosis (Fuchs et al., 2007); it is possible 
that increases in ATP may also be associated with delayed or decreased NET release, which 
was observed in both Histopaque- and Dextran-prepared cells.  To the best of my knowledge, 
the effect of neutrophil isolation technique upon NET responses has not previously been 
investigated.   
 
A further consideration is that neutrophils isolated with Percoll were subjected to multiple 
centrifugation and wash steps, whereas isolation with Histopaque and Dextran required less 
handling and transfers between tubes; suggesting Histopaque and Dextran neutrophils should 
be less activated.  All three gradient protocols take approximately 90 mins, and following 
several reports demonstrating that delays prior to isolation can trigger neutrophil activation 
(Ferrante & Thong 1980, Maqbool et al., 2011), isolation was started immediately following 
blood collection.  Thus with regard to neutrophils’ relatively short life span, no gradient is 
superior in terms of isolation time.  Whilst erythrocyte lysis produces a cleaner cell 
suspension, it has been reported that repeated or extended lysis can damage neutrophils 
(Nauseef et al., 2007).  Dextran isolation did not employ a lysis step, however the Histopaque 
protocol relied on a 30 sec erythrocyte lysis with distilled water, as initial experiments 
demonstrated erythrocyte contamination. This is distinct from Percoll-isolated neutrophils, 
which are subjected to an ammonium chloride (NH4Cl) lysis.  Although it has been suggested 
that distilled water-induced erythrocyte lysis causes less neutrophil activation, the ROS 
results in this particular study indicate this may not be the case under these particular assay 
conditions.  This is also supported by Vuorte et al., (2001), who reported that neither 
hypotonic shock with distilled water or NH4Cl lysis influenced neutrophil integrity or 
activation.  In addition the choice of anticoagulant blood collection tube may also influence 
neutrophil isolation and effector functions.  All blood for the current study was collected in 
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lithium heparin tubes, acting as an anticoagulant by activating anti-thrombin.  However, 
another commonly used collection tube is ethylenediamine tetraacetic acid (EDTA), which 
chelates free calcium ions.  Calcium ions play a vital role in the activation of the neutrophil 
respiratory burst, and are the likely explanation for reports demonstrating reduced 
Histopaque-isolated neutrophil ROS release from blood collected into EDTA tubes, 
compared with heparin (Freitas et al., 2008). 
Visualisation of Percoll-isolated neutrophils by cytospin identified neutrophils in the cell 
suspension, evidenced by the characteristic multi-lobed nuclei observed that stained dark blue 
(section 3.3.1.1).  Fluorescence microscopy of the neutrophil surface marker CD66 also 
confirmed the isolation of neutrophils (section 3.3.1.2).  To determine the purity of Percoll-
isolated cells, neutrophil marker CD66b was quantified by flow cytometry; this demonstrated 
that the cell suspension contained 97.3% neutrophils (section 3.3.1.3), which is in line with 
other reports that obtain >95% purity following the isolation of human neutrophils (Kirchner 
et al., 2011, Maqbool et al., 2011).  The remaining 2.7% of cells are likely to include 
eosinophils and monoculear cells (Dorward et al., 2013).  In addition, neutrophils were 
quantified in lysed whole peripheral blood prior to Percoll-isolation by measuring the auto-
fluorescence in the blood sample, which demonstrated that neutrophils comprised 40.21% of 
whole blood prior to isolation.  Optimisation of the Percoll-isolation protocol and meticulous 
technique can reduce the number of contaminating mononuclear cells in the neutrophil cell 
suspension.  However it is noteworthy that density gradient centrifugation techniques cannot 
prevent the complete exclusion of contaminating cells, for example, it is reported that in 
blood derived from individuals with atopic conditions, such as asthma, eosinophils may 
represent 5-10% of the granulocyte population isolated (Dorward et al., 2013).   
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In conclusion, when analysing the impact of isolation technique on neutrophil cell yield, 
function and activation, Percoll appears to be the most appropriate method, evidenced by the 
lower metabolic activation and higher NET release by Percoll-isolated cells.  Percoll was 
subsequently selected as the isolation technique for all ex vivo neutrophil assays in this thesis. 
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 INTERACTIONS BETWEEN PERIODONTAL CHAPTER 4:
BACTERIA AND PERIPHERAL BLOOD NEUTROPHILS 
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4.1 Introduction 
Given that NET release is reported to be predominantly ROS dependent (Fuchs et al., 2007), 
various neutrophil responses to heat-killed periodontal bacteria were investigated 
(Appendices I, IV), including total, extracellular and superoxide ROS production (section 
2.2.3.2).  NET production was determined by quantifying the amount of DNA released 
(2.2.3.3) alongside the NET-bound components, neutrophil elastase (NE), myeloperoxidase 
(MPO) and cathepsin G (CG) (2.2.3.4, Appendix III).  The ability of NETs to entrap bacteria 
was also qualitatively determined by visualising interactions using SEM (2.2.3.8), and by 
quantifying the number of viable bacteria entrapped within NET structures (2.2.3.5, 2.2.3.6, 
Appendix II).  All neutrophils were from periodontally and systemically healthy volunteers 
(University of Birmingham Ethics Reference ERN_13-0325) and neutrophil assays employed 
a panel of bacteria associated with periodontitis.  For clinical relevance, data are presented by 
grouping periodontal bacteria according to the Socransky complexes (Socransky et al., 1998).    
The ROS-dependent activation and signalling cascades for NET release in response to heat-
killed periodontal bacteria were also investigated by determining the effects of modulators of 
neutrophil activation (2.2.2.3).  
 
4.2 Neutrophil ROS release in response to periodontal bacteria  
ROS production in response to a panel of 19 heat-killed periodontal bacteria (1x10
8
 and MOI 
of 1000) was determined using enhanced chemiluminescence (2.2.3.2).  ROS release 
following exposure to PBS (unstimulated negative control), PMA (25nM, positive control) 
and opsonised S. aureus (5x10
7
 and MOI of 500, positive control) was also quantified.  
Neutrophils were stimulated after being equilibrate for a 30 min baseline period and then 
ROS measured over the subsequent 100 mins.  Total neutrophil ROS release was determined 
using luminol chemiluminescence. Opsonised S.aureus induced significantly higher ROS 
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production than the PBS control (Kruskal-Wallis and Dunn’s multiple comparison post-tests 
***p<0.001, n=5).  Certain periodontal bacteria elicited higher total ROS production, which 
was statistically significant for P. acnes, S. anginosus and C. rectus (Kruskal-Wallis and 
Dunn’s multiple comparison post-tests **p<0.01, **p<0.01, *p<0.05, respectively, n=5) 
(Figure 4.1a).   
Neutrophil extracellular ROS production was subsequently analysed by isoluminol 
chemiluminescence.  PMA induced significantly higher ROS production than PBS treatment 
(Kruskal-Wallis and Dunn’s multiple comparison post-tests **p<0.01, n=5).  S. gordonii also 
elicited significantly higher total ROS production (Kruskal-Wallis and Dunn’s multiple 
comparison post-tests *p<0.05, n=5) (Figure 4.1b).   
Neutrophil superoxide production was measured with lucigenin.  PMA and opsonised S. 
aureus did not induce significantly higher superoxide production relative to the PBS control.  
However, some periodontal bacterial species elicited higher superoxide production, which 
was statistically significant for S. anginosus, C. suptigena, and F. nucleatum nuc (Kruskal-
Wallis and Dunn’s multiple comparison post-tests **p<0.01, *p<0.05, *p<0.05, respectively, 
n=5) (Figure 4.1c). 
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a) Neutrophil total ROS production 
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b) Neutrophil extracellular ROS production 
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c) Neutrophil superoxide production 
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Figure 4.1: Neutrophil ROS production in response to periodontal bacteria  
Neutrophil (a) total ROS, (b) extracellular ROS and (c) superoxide production were 
quantified in response to a panel of periodontal bacteria (1x10
8
 and MOI of 1000) using 
luminol, isoluminol and lucigenin enhanced chemiluminescence, respectively.  ROS release 
in response to PBS (unstimulated negative control), PMA (25nM, positive control) and 
opsonised S. aureus (5x10
7
 and MOI of 500, positive control) was also quantified.  Statistical 
significance calculated using Kruskal-Wallis and Dunn’s multiple comparison post-tests 
(*p<0.05, **p<0.01, ***p<0.001).  Data presented as RLU (relative light units) and expressed 
as mean ± SEM (n=5 in triplicate).     
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 Time-course of neutrophil ROS production in response to periodontal bacteria  4.2.1
The time-course of ROS production was analysed following stimulation with heat-killed 
periodontal bacteria, as previously described.  Consistent with the data expressed as total 
peak ROS production, time-course ROS production expressed as “area under the curve” 
demonstrated that total ROS production (luminol) was highest in response to opsonised S. 
aureus (5x10
7
 and MOI of 500), followed by S. anginosus (1x10
8
 and MOI of 1000).  
Notably, the increase in total ROS following stimulation with opsonised S. aureus was more 
rapid than following bacterial stimulation, as illustrated by the sharp increase in ROS levels 
following stimulation.  Total ROS release following opsonised S. aureus-stimulation peaked 
at approximately 20 mins post stimulation, which was followed by a steady decrease in total 
ROS production (Figure 4.2a).  Extracellular ROS production measured using isoluminol 
demonstrated that PMA (25nM) stimulation induced the highest ROS signal.  The steep time-
course curve in response to PMA suggests a rapid neutrophil response to PMA.  PMA-
induced extracellular ROS release peaked approximately 20 mins post stimulation, followed 
by a steady decrease in total ROS.   S. gordonii (1x10
8
 and MOI of 1000) also produced 
elevated levels of extracellular ROS in comparison with other periodontal bacteria (Figure 
4.2b).  The quantification of superoxide production (lucigenin) in response to periodontal 
bacteria demonstrated that F. nucleatum nuc (1x10
8
 and MOI of 1000) generated the highest 
levels of superoxide, relative to other periodontal bacteria.  F. nucleatum nuc-induced 
superoxide release peaked approximately 30 mins post-stimulation, followed by a steady 
decrease in total ROS.  PMA and opsonised S. aureus did not generate detectable elevations 
in superoxide production (Figure 4.2c).   
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Figure 4.2: Time-course of neutrophil ROS production in response to periodontal 
bacteria 
Time-course for ROS production assayed over 130 mins by neutrophils stimulated with PMA 
(25nM), opsonised S. aureus (5x10
7
 and MOI of 500) or periodontal bacteria (1x10
8
 and MOI 
of 1000).  (a) Total ROS production (luminol), (b) extracellular ROS production (isoluminol), 
(c) superoxide production (lucigenin). Data presented as mean RLU (relative light units) (n=5 
in triplicate).     
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4.3 Quantification of NET production in response to periodontal bacteria exposure 
NET production in response to a panel of 19 heat-killed periodontal bacteria (1x10
8
 and MOI 
of 1000) was determined by quantifying NET-DNA (2.2.3.3) and NET bound components 
(2.2.3.4).  NET release following exposure to PBS (unstimulated negative control), PMA 
(50nM, positive control) and opsonised S. aureus (5x10
7
 and MOI of 500, positive control) 
was also quantified.  Neutrophils were stimulated after being equilibrate for a 30 min baseline 
period and then NET production measured after a 4 hour incubation period.  NET-DNA 
measured with Sytox green demonstrated that PMA stimulated significantly higher NET 
production compared with PBS (Kruskal-Wallis and Dunn’s multiple comparison post-tests 
*p<0.05, n=5).  Certain periodontal bacteria elicited higher NET-DNA production and this 
was statistically significant compared with PBS for P. acnes, V. parvula, and S. gordonii 
(Kruskal-Wallis and Dunn’s multiple comparison post-tests *p<0.05, *p<0.05, *p<0.05, 
respectively, n=5) (Figure 4.3a).   
 
NET-bound NE was quantified colorimetrically (2.2.3.4.1) and demonstrated that certain 
periodontal bacteria elicited higher NET-bound NE production relative to PBS, however this 
was not statistically significant.  Similarly, stimulation with PMA and opsonised S. aureus 
(positive controls) stimulation did not reach statistical significance (Kruskal-Wallis p>0.05, 
n=3) (Figure 4.3b).   
 
NET-bound MPO was quantified colorimetrically (2.2.3.4.2) and demonstrated that PMA 
stimulated significantly higher NET-bound MPO production (Kruskal-Wallis and Dunn’s 
multiple comparison post-tests *p<0.05, n=3).  Certain periodontal bacterial species elicited 
higher NET-bound MPO production relative to PBS; however this did not reach statistical 
significance (Kruskal-Wallis and Dunn’s multiple comparison post-tests p>0.05, n=3) 
(Figure 4.3c). 
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NET-bound CG was quantified colorimetrically (2.2.3.4.3) and demonstrated that opsonised 
S. aureus stimulated for significantly higher NET-bound CG production (Kruskal-Wallis and 
Dunn’s multiple comparison post-tests *p<0.05, n=3).  Certain periodontal bacterial species 
elicited higher NET-bound CG production, which was statistically significant for A. viscosus 
and C. gingivalis (Kruskal-Wallis and Dunn’s multiple comparison post-tests *p<0.05 for 
both, n=3) (Figure 4.3d). 
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b) NET-bound neutrophil elastase 
N
E
 m
U
/m
l
P
B
S
P
M
A
op
so
ni
se
d 
S
. a
ur
eu
s
A
. v
is
co
su
s
A
. a
ct
in
om
yc
et
em
co
m
ita
ns
 b
P
. a
cn
es
S
el
. n
ox
ia
V
. p
ar
vu
la
S
. s
an
gu
in
is
S
. o
ra
lis
S
. i
nt
er
m
ed
iu
s
S
. a
ng
in
os
us
S
. g
or
do
ni
i
C
.g
in
gi
va
lis
A
. a
ct
in
om
yc
et
em
co
m
ita
ns
 a
C
. s
pu
tig
en
a
S
. c
on
st
el
la
tu
s
C
. r
ec
tu
s
C
. s
ho
w
ae
F.
 n
uc
le
at
um
 n
uc
F.
 n
uc
le
at
um
 p
ol
P
. g
in
gi
va
lis
0
20
40
60
80 ns
 
 
 
 
c) NET-bound myeloperoxidase 
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d) NET-bound cathepsin G 
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Figure 4.3: Quantification of NET production in response to periodontal bacteria 
exposure 
NET production was quantified in response to a panel of periodontal bacteria (1x10
8
 and 
MOI of 1000).  NET release in response to PBS (unstimulated negative control), PMA 
(50nM, positive control) and opsonised S. aureus (5x10
7
 and MOI of 500, positive control) 
was also quantified.  (a) NET-DNA was quantified with Sytox green and NET-bound (b) 
neutrophil elastase, (c) myeloperoxidase and (d) cathepsin G were quantified 
colorimetrically.  Statistical significance was calculated using Kruskal-Wallis and Dunn’s 
multiple comparison post-tests (*p<0.05, ns=not significant).  Data is presented as (a) AFU 
(arbitrary fluorescence units), (c) U/ml or (d, e) mU/ml and expressed as mean ± SEM (n=5 
in triplicate).     
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4.4 NET entrapment of bacteria 
To assess the ability of NETs to immobilise periodontal bacteria, FITC-stained live bacteria 
(1x10
7
 and MOI of 100) were incubated for 1 hour with either unstimulated neutrophils, 
intact NETs (produced by 0.75mM HOCl stimulation) or NET structures following 
degradation with MNase (section 2.2.3.5).  Following multiple wash steps to remove any 
unbound bacteria the amount of bacteria entrapped was fluorometrically quantified and 
normalised to FITC-stained bacteria incubated with PBS (cell-free control).  For clinical 
relevance, data are presented by grouping periodontal bacteria according to the Socransky 
complexes (Socransky et al., 1998).   
 
NET entrapment of bacteria not assigned to a Socransky complex 
Sel. noxia appeared to be entrapped within NET structures relative to bacteria entrapped 
within neutrophils or degraded NETs (negative controls) (1way ANOVA *p=0.0111, n=5).  
However, neither A. actinomycetemcomitans (serotype b) nor P. acnes were significantly 
entrapped within NETs (1way ANOVA p>0.05, n=5) (Figure 4.5a).   
 
NET entrapment of blue complex bacteria 
 
A. viscosus appeared to evade entrapment within NET, compared with bacteria entrapped 
within neutrophils or degraded NETs (negative controls) (1way ANOVA p=0.1169, n=5) 
(Figure 4.5b).  
 
NET entrapment of purple complex bacteria 
V. parvula was found to be significantly entrapped within NETs compared with bacteria 
incubated with unstimulated neutrophils or degraded NET structures (1way ANOVA 
*p=0.0129, n=5) (Figure 4.5c).   
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NET entrapment of yellow complex bacteria 
S. anginosus and S. gordonii were significantly entrapped within NETs, relative to bacteria 
entrapped within neutrophils or degraded NETs (1way ANOVA *p=0.0216 and *p=0.0305, 
respectively, n=5).  However the other yellow complex bacteria assayed, S. sanguinis, S. 
oralis and S. intermedius, appeared to evade entrapment within NET structures in this assay 
system (1way ANOVA p>0.05, n=5) (Figure 4.5d). 
 
NET entrapment of green complex bacteria  
No green complex bacteria assayed appeared significantly entrapped within NETs relative to 
bacteria entrapped within neutrophils or degraded NETs (negative controls) according to the 
assay conditions employed (1way ANOVA p=0.1135, n=5) (Figure 4.5e).   
 
NET entrapment of orange complex bacteria 
 
C. rectus, C. showae and F. nucleatum poly were significantly entrapped within NETs 
relative to bacteria entrapped within neutrophils or degraded NETs (negative controls) (1way 
ANOVA ****p=0.0004, ****p=0.0002, **p=0.0079, respectively, n=5).  However the other 
orange complex bacteria assayed, S. constellatus and F. nucleatum nuc, were not significantly 
entrapped within NET structures (1way ANOVA p>0.05, n=5) (Figure 4.5f).   
 
 
NET entrapment of red complex bacteria 
 
P. gingivalis was significantly entrapped within NET structures compared with bacteria 
incubated with unstimulated neutrophils or degraded NET structures (1way ANOVA 
*p=0.027, n=5) (Figure 4.5g).   
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(e) Green complex bacteria 
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Figure 4.4: NET entrapment of periodontal bacteria 
NET entrapment of (a) bacteria not assigned to a Socransky complex, (b) blue complex 
bacteria, (c) purple complex bacteria, (d) yellow complex bacteria, (e) green complex 
bacteria, (f) orange complex bacteria and (g) red complex bacteria was determined by 
quantifying FITC-stained bacteria immobilised in NET structures. Results are normalised to 
FITC-stained bacteria entrapped in PBS.  Statistical significance (1way ANOVA) of NET-
derived bacterial entrapment is relative to bacteria entrapped within neutrophils and degraded 
NETs (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, ns=not significant).  Data presented as 
AFU (arbitrary fluorescence units) and expressed as mean ± SEM (n=5 in triplicate).     
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4.5 Scanning electron microscopy of NET-bacteria interactions 
To visualise the interactions between NETs and bacteria, NET structures were visualised by 
SEM following incubation with PBS (negative control) and selected live periodontal bacteria 
(1x10
7
 MOI of 100) (2.2.3.8).  As expected, SEM images of unstimulated neutrophils 
demonstrated spherical cells with no NET structures evident (Figure 4.5).  The visualisation 
of neutrophils following incubation with bacteria; A. actinomycetemcomitans serotype a 
(Figure 4.6a), V. parvula (Figure 4.6b) and A. viscosus (Figure 4.6c), revealed the release of 
NET structures from neutrophils.  The strand-like filaments between the neutrophils appeared 
to associate with bacteria, for example A. actinomycetemcomitans (serotype a) appear to 
cluster along the length of the NET structure (Figure 4.6a).  SEM analysis also enabled 
detailed visualisation of bacteria at a high magnification, which consistent with Gram stains 
(Appendix IV), confirmed bacterial morphology.   
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Figure 4.5: Scanning electron microscopy of resting neutrophils 
Resting neutrophils (1x10
5
) were visualised by SEM.  Representative image of 3 
experiments, scale bar represents 10µm. 
 
 
 
a) A. actinomycetemcomitans serotype a 
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b) V. parvula 
 
 
 
c) A. viscosus 
 
 
Figure 4.6: Scanning electron microscopy of neutrophils stimulated with periodontal 
bacteria 
Neutrophils (yellow arrow) (1x10
5
) incubated with live (a) A. actinomycetemcomitans 
serotype a, (b) V. parvula or (c) A. viscosus (1x10
7 
and MOI of 100) were visualised by SEM.  
Blue arrow indicates NET strand structures and bacteria are indicated with green arrows.  
Representative image of 3 experiments, scale bar represents 10µm. 
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4.6 Quantification of NET-mediated killing of periodontal bacteria 
To determine whether NETs are capable of killing entrapped bacteria, periodontal bacteria 
(1x10
7 
and MOI of 100) were incubated with PBS (negative control), unstimulated 
neutrophils, intact NETs (produced by 0.75mM HOCl), degraded NETs (by MNase 
digestion), unseparated NETs (NETs not degraded with MNase prior to bacteria subculture) 
or with cytochalasin B-treated NETs (to block neutrophil phagocytosis) (section 2.2.3.6, 
Appendix II).  Following 1 hour incubation bacteria were released from NETs by MNase 
digestion, diluted and inoculated onto agar plates and cultured for 24 hours prior to 
performing colony counts.  Of the 6 periodontal bacteria assayed, no significant NET-
mediated killing of periodontal bacteria was observed (all analysed by 2way ANOVA, n=5) 
F. nucleatum poly (p=0.5873), S. intermedius (p=0.6007), S. sanguinis (p=0.8977), A. 
viscosus (p=0.9573), V. parvula (p=0.9239) and C. gingivalis (p=0.9787) (Figures 4.7a-f). 
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Figure 4.7: Quantification of NET-mediated killing of periodontal bacteria 
Bacterial colonies were counted following incubation with PBS (negative control), 
neutrophils, intact NETs (0.75mM HOCl), degraded NETs (100U/ml MNase), unseparated 
NETs (NETs not degraded with MNase prior to bacteria subculture) or with cytochalasin B-
treated NETs (to block neutrophil phagocytosis).  No significant NET-mediated killing of 
periodontal bacteria was observed (1way ANOVA p>0.05).  Data presented as total colony 
counts and expressed as mean ± SEM (n=5). 
156 
 
4.7 Effect of NADPH-oxidase pathway modulating agents on ROS and NET production  
To further understand the importance of NADPH-oxidase and downstream products in 
bacteria-induced ROS and NET production, specific components of the NADPH-oxidase 
signalling pathway were targeted (section 2.2.2.3).  Isolated neutrophils were incubated with 
diphenyleneiodonium (DPI) (25µM), an inhibitor of NADPH-oxidase, N-acetyl-cysteine 
(NAC) (10mM), a synthetic glutathione precursor that scavenges H2O2, or taurine (100mM), 
which scavenges HOCl to produce taurine chloramine.  Neutrophil total ROS and NET 
production were measured following pre-incubation with the modulating agent for 30 mins 
prior to stimulation with PMA (50nM), opsonised S. aureus (5x10
7
 and MOI of 500) and a 
panel of 9 selected heat-killed periodontal bacteria (1x10
8
 and MOI of 1000).   
DPI pre-treatment resulted in a reduction in total ROS release in response to all stimuli, 
relative to non-DPI treated cells. This was statistically significant for PMA (*p<0.05), as well 
as following stimulation with opsonised S. aureus (****p<0.0001), S. gordonii 
(****p<0.0001), F. nucleatum poly (*p<0.05) and Sel. noxia (*p<0.05) (2way ANOVA and 
Bonferroni post-tests, n=3) (Figure 4.8a).  NET-DNA was quantified with Sytox green 
following enzymatic degradation of NET structures with MNase.  DPI pre-treatment also 
significantly reduced NET release in response to all stimuli relative to cells that did not 
receive DPI pre-treatment. This was statistically significant in response to PMA 
(****p<0.0001), but not for S. aureus-induced NET production or the periodontal bacteria 
assayed (2way ANOVA and Bonferroni post-tests, n=3) (Figure 4.8b).   
NAC treatment significantly reduced total ROS release in response to all stimuli relative to 
cells that did not receive NAC pre-treatment. This was statistically significant for PMA 
(*p<0.05) and opsonised S. aureus (****p<0.0001), as well as following bacterial stimulation 
with S. gordonii (****p<0.0001) and Sel. noxia (*p<0.05) (2way ANOVA and Bonferroni 
post-tests, n=3) (Figure 4.8c).  NET-DNA was quantified with Sytox green following 
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enzymatic degradation of NET structures with MNase.  NAC treatment reduced NET release 
in response to all stimuli relative to cells that did not receive NAC pre-treatment. This was 
statistically significant for to PMA (****p<0.0001) and Sel. noxia (*p<0.05), but not for 
opsonised S. aureus or the other periodontal bacteria assayed (analysed by 2way ANOVA 
and Bonferroni post-tests, n=3) (Figure 4.8d).   
Taurine treatment significantly reduced total ROS release in response to all stimuli relative to 
cells that did not receive taurine; however this was to a lesser extent than that observed with 
DPI and NAC.  Decreased ROS release following taurine pre-treatment was significant for 
opsonised S. aureus (****p<0.0001), S. gordonii (***p<0.001) and Sel. noxia (*p<0.05) 
(2way ANOVA and Bonferroni post-tests, n=3) (Figure 4.8e).  Taurine pre-treatment had a 
differential effect on neutrophil NET production, relative to untreated cells.  Taurine 
significantly reduced NET production following stimulation with PMA (2way ANOVA and 
Bonferroni post-test ****p<0.0001, n=3), but did not significantly reduce NET production in 
response to opsonised S. aureus or bacterial stimulation (Figure 4.8f).   
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Figure 4.8: Effect of NADPH-oxidase pathway modulating agents on ROS and NET 
production  
Total ROS production and NET production were quantified in response to a panel of 
periodontal bacteria (1x10
8
 and MOI of 1000), as well as PMA (50nM) and opsonised S. 
aureus (5x10
7 
and MOI of 500) following pre-incubation (30 mins) with (a, b) DPI (25µM), 
(c, d) NAC (10mM) or (e, f) taurine (100mM).  Statistical significance was calculated using 
2way ANOVA and Bonferroni post-tests (*p<0.05, **p<0.01, ****p<0.0001, ns=not 
significant).  Data presented as (a, c, e) RLU (relative light units) and (b, d, f) AFU (arbitrary 
fluorescence units).  Data expressed as mean ± SEM (n=3 in duplicate).        
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4.8 Effect of TLR inhibition on ROS and NET production  
To attempt to dissect the signalling involved in ROS NET activation, the effect of TLR 
inhibitors was investigated (section 2.2.2.3).  Isolated neutrophils were incubated with 
chloroquine (100µM), which inhibits TLRs 3, 7 and 9, or OxPAPC (30µg/ml), which inhibits 
TLRs 2 and 4, or both TLR inhibitors.  Neutrophil total ROS and NET production were 
measured following pre-incubation with the inhibitor for 30 mins prior to stimulation with 
PMA (50nM), opsonised S. aureus (5x10
7
 and MOI of 500) and a panel of 9 selected heat-
killed periodontal bacteria (1x10
8
 and MOI of 1000).   
Chloroquine pre-treatment had a differential effect on neutrophil total ROS production.  
Whilst chloroquine significantly reduced ROS production following stimulation with 
opsonised S. aureus (**p<0.01), V. parvula (*p<0.05) and S. gordonii (****p<0.0001), 
chloroquine pre-treatment caused a significant increase in total ROS in PMA-stimulated 
neutrophils (*p<0.05) (2way ANOVA and Bonferroni post-tests, n=3) (Figure 4.9a).  
Chloroquine pre-treatment resulted in a moderate reduction in NET production in response to 
bacterial stimuli, but treatment prior to stimulation with PMA and opsonised S. aureus caused 
a non-significant increase in NET release (2way ANOVA p>0.05) (Figure 4.9b).  
OxPAPC pre-treatment was not found to have an inhibitory effect on ROS production, but 
was found to increase total ROS release relative to cells that did not receive OxPAPC 
treatment.  This was statistically significant for stimulation with opsonised S. aureus, which 
produced significantly higher levels of total ROS following OxPAPC pre-incubation (2way 
ANOVA and Bonferroni post-test ***p<0.001, n=3) (Figure 4.9c).  OxPAPC pre-treatment 
resulted in a non-significant reduction in NET release in response to opsonised S. aureus and 
bacterial stimulation; however OxPAPC treatment prior to PMA stimulation caused a non-
significant increase in NET release (2way ANOVA p>0.05) (Figure 4.9d). 
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Chloroquine and OxPAPC pre-treatment produced a differential effect on neutrophil total 
ROS production relative to cells that did not receive pre-treatment.  Chloroquine and 
OxPAPC pre-treatment caused a significant increase in ROS by PMA-stimulated neutrophils 
(2way ANOVA and Bonferroni post-test **p=0.01, n=3) and a significant decrease in ROS 
by opsonised S. aureus-stimulated neutrophils (2way ANOVA and Bonferroni post-test 
*p=0.05, n=3) (Figure 4.9e).  Chloroquine and OxPAPC pre-treatment resulted in a non-
significant reduction in NET production in response to bacterial stimuli.  However, treatment 
prior to stimulation with PMA and opsonised S. aureus caused a non-significant increase in 
NET release (2way ANOVA p>0.05) (Figure 4.9f). 
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Figure 4.9: Effect of TLR inhibition on ROS and NET production  
Total ROS production and NET production were quantified in response to a panel of 
periodontal bacteria (1x10
8
 and MOI of 1000), as well as PMA (50nM) and opsonised S. 
aureus (5x10
7 
and MOI of 500) following pre-incubation (30 mins) with (a, b) Chloroquine 
(100µM), (c, d) OxPAPC (30µg/ml) or (e, f) Chloroquine and OxPAPC.  Statistical 
significance was calculated using 2way ANOVA and Bonferroni post-tests (*p<0.05, 
**p<0.01, ****p<0.0001, ns=not significant).  Data presented as (a, c, e) RLU (relative light 
units) and (b, d, f) AFU (arbitrary fluorescence units).  Data expressed as mean ± SEM (n=3 
in duplicate).        
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4.9 Discussion 
Neutrophil ROS production is a vital component of the innate immune response which 
enables the killing and clearance of pathogens.  Pathogenic bacteria are known to stimulate 
ROS production via NADPH-oxidase, whereby molecular oxygen is reduced by electrons to 
form O2 ̇-.  The O2̇- is initially converted to H2O2, and finally, H2O2 is converted to HOCl in a 
reaction catalysed by MPO (Chapple 1996, Robinson 2008).  Neutrophils are the 
predominant immune cell in periodontitis, and the results presented here support findings that 
stimulation of peripheral blood neutrophils with periodontal bacteria promotes extracellular, 
intracellular and superoxide ROS release; however data indicates that this may be species 
specific (section 4.2).  Indeed, certain Streptococcal and F. nucleatum species consistently 
elicited higher neutrophil ROS production while, under these experimental conditions, other 
bacteria such as P. gingivalis, were not found to significantly promote ROS release.  
Interestingly, P. gingivalis is reportedly resistant to neutrophil-derived ROS production, 
which is attributed to a non-heme iron protein, rubrerythrin, which shields the bacteria from 
oxidative stress (Mydel et al., 2006).  It is possible that the low levels of P. gingivalis-
induced ROS may function to afford protection to other biofilm organisms that are not 
resistant to ROS.    
 
Whilst it is recognised that ROS facilitate microbial killing, the progression of periodontitis 
appears host-mediated via an exaggerated inflammatory response to microbial plaque 
(Hajishengallis 2014).  ROS release does not discriminate between pathogens and host 
tissues, and therefore tissue injury can arise from plaque-induced extracellular ROS 
production.  ROS is reported to contribute to periodontitis progression by direct mechanisms, 
such as tissue degradation (Sharma & Sharma 2011), lipid peroxidation (Dix & Aikens 1993) 
and DNA strand breaks (Dix et al. 1996).  In addition, ROS are believed to promote disease 
progression indirectly , by for example increasing osteoclast differentiation (Waddington et 
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al., 2000) and initiating a self-perpetuating cycle that activates immune cells to generate 
further ROS (Dahiya et al., 2013).  Notably, Matthews et al., (2007a, 2007b) demonstrated 
increased ROS production in chronic periodontitis, and in light of reports indicating that 
patients also have elevated levels of circulating neutrophils (Al-Rasheed et al., 2012); it is 
possible that periodontitis patients are more susceptible to ROS-induced tissue damage.  A 
mechanism by which patients may be more susceptible to the deleterious effects of ROS is 
due to the discordance between oxidant/antioxidant levels may exist.  This is supported by 
Chapple et al., (2007), who reported that total antioxidant activity is lower in the saliva of 
periodontitis patients.  Neutrophil chemotaxis is also reported to be compromised in chronic 
periodontitis, which is likely to increase neutrophil tissue transit times and thereby potentially 
exacerbating ROS-mediated collateral tissue damage (Roberts et al., 2015).   
 
Quantification of NET-DNA and NET-bound components demonstrated differential NET 
production in response to a panel of periodontal bacteria (section 4.3).  DNA is released in 
other forms of neutrophil cell death processes and the quantification of NET-bound 
components (NE, MPO and CG) provides a DNA-independent measure of NETs.  Other 
published methods to quantify NET production include microscopy (Brinkmann et al., 2004), 
automated microscopy (Hakkim et al., 2011) and immunostaining (Brinkman et al., 2004, 
2010).  It is noteworthy that inter-individual differences between volunteers, such as 
neutrophil responsiveness to stimuli, can also affect NET quantification results regardless of 
the analytical method employed (Barrientos et al., 2013, Halverson et al., 2015).  In the 
current work, assays were not conducted to determine whether bacteria-induced NETs 
contained nuclear or mitochondria DNA (Yousefi et al., 2009).  However, reportedly 
mitochondrial DNA is 100,000 times less abundant in granulocyte NET structures (Pilsczek 
et al., 2010); thus it is likely that nuclear NET-DNA represents a larger proportion of the 
NET structures quantified.  NET production in response to individual periodontal bacteria 
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suggests these events may occur in vivo, and thus differences in NET induction between 
species may be compensated for when these species co-exist within a biofilm structure.  
NETs have previously been shown to exist in purulent exudate from periodontal pockets, 
where they are postulated to entrap invading microbes and prevent their dissemination 
(Vitkov et al., 2009, 2010).  This is corroborated by recent findings by Hirchfeld et al., 
(2015), who demonstrated that following the recruitment of neutrophils to the oral biofilm, 
they can infiltrate the dental plaque and subsequently release NET structures.  Further support 
for the presence of NET production in periodontitis is that periodontal pockets reportedly 
provide an appropriate environment for ROS production, by the provision of sufficient 
oxygen tension and pH (Mettraux et al., 1984, Eggert et al., 1991).  This may suggest that the 
periodontal pocket environment is likely to enable ROS-dependent NET release.  Recent 
findings have also suggested that some periodontal bacteria reduce complement-induced NET 
production, which may also afford protection to other biofilm bacteria by evading NET 
entrapment (Palmer et al., 2015).  Collectively, these findings highlight that whilst 
periodontal bacteria can stimulate for NET release, prospective studies are needed to fully 
elucidate the role of NETs in periodontitis, in particular within the local diseased tissue 
environment. 
 
HOCl-induced NETs were found to entrap all periodontal bacteria to some extent (section 
4.4), which is consistent with previous findings suggesting NETs can ensnare a significant 
majority of microorganisms, including Gram-positive and Gram-negative bacteria 
(Brinkmann et al., 2004).  It is noteworthy that reports by Brinkmann et al., (2012) observed 
that in vivo, and space permitting, NETs may occupy and therefore immobilise bacteria in 
areas 10-15 times larger than the cell they originated from.  Interactions between bacteria and 
NETs are believed to be the result of charge differences between the negatively charged 
chromatin NET backbone and the pathogens’ cell surface (Urban et al 2009).  Furthermore, 
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many periodontal bacteria are reported to release DNases, which in addition to regulating 
biofilm formation (Whitchurch et al., 2002), may have the ability to disassemble NET 
structures and contribute to biofilm pathogenicity and NET evasion (Palmer et al., 2012).  In 
support of this hypothesis, S. aureus nuclease production reportedly confers resistance to 
NET-mediated entrapment and killing. Indeed bacterial DNase expression may explain why 
some periodontal species showed less entrapment, such as S. constellatus, which reportedly 
releases large quantities of DNase (Palmer et al., 2012).  However, further work is required to 
elucidate whether DNase release by specific pathogens allows only these species to 
disseminate, or if DNase release provides a mutually beneficial environment in which non-
DNase producing bacteria present in the biofilm are also afforded protection from NET 
entrapment.   
 
Following bacterial entrapment, the high local concentration of AMPs associated with NETs 
is postulated to kill pathogens (Brinkmann et al., 2012).  In support of this, NET-bound NE is 
believed to cleave bacterial virulence factors (Brinkmann et al., 2004), and in addition MPO 
and CG are reported to be vital for the clearance of invading bacteria (Parker et al., 2012, 
Lappann et al., 2013).  The nuclear DNA backbone is also believed to exhibit direct 
bactericidal properties by disrupting bacterial membrane integrity and lysing bacterial cells 
(Halverson et al., 2015).  The authors postulate that given the low abundance of AMPs on 
NETs (<1-6%), and that a key virulence factor is the release of DNases, it is possible that 
nuclear DNA is the predominant antibacterial component of NETs (Halverson et al., 2015).  
Under the experimental conditions applied here, the incubation of NETs with periodontal 
bacteria did not appear to impede bacterial growth or survival (section 4.6).  However, it is 
difficult to ascertain whether the ongoing growth was a result of NETs not being capable of 
killing these bacteria, or a result of these specific experimental conditions.  Interestingly, 
Menegazzi et al., (2012) also questioned the robustness of NET killing assays and suggested 
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that previous studies where bacteria were not released from NET structures post-incubation 
did not prove that the microbes trapped within NETs were in fact dead.  Indeed, subsequent 
experiments by Menegazzi et al., (2012) addressing this revealed that NETs do not have the 
capacity to kill S. aureus or C. albicans, which is consistent with the protocol applied and the 
results presented here.  Alternatively, an apparent inability of NETs to kill bacteria could be 
due to various stages of the assay that may compromise NET antibacterial capacity, or not 
correctly identifying numbers of viable bacteria; examples of this include MNase digestion of 
NETs prior to co-incubation, incubation conditions, measuring bacterial killing by the 
enumeration of colonies or the bacteria and NET concentrations (MOI).  Future experiments 
to quantify NET-mediated killing may benefit from application of multiple assays performed 
in parallel, such as enumeration of colonies, turbidity measurements (Harris 2012), flow 
cytometry and microscopy of SYTO9/propidium iodide stained bacteria (Halverson et al., 
2015).  Whilst the importance of NETs is evident in individuals with reduced NET release, 
such as neonates (Yost et al., 2009), CGD patients (Bianchi et al., 2009) and PLS patients 
(Sorensen et al., 2014), this could be due to increased bacterial dissemination rather than the 
direct antimicrobial properties of NET structures (Menegazzi et al., 2012).  Conversely, if 
NETs are interacting with, but not killing, periodontal pathogens, it is possible that NET-
bacteria complexes may provide a source of autoantigens and trigger further inflammatory 
responses, as observed in cystic fibrosis (Marcos et al., 2010).  This also raises questions 
regarding NET production within the microbial biofilm (Hirschfeld et al., 2015), as it is not 
known whether NETs prevent bacteria dissemination, or in fact promote biofilm stability and 
growth. 
 
Treatment of neutrophils with DPI (NADPH-oxidase inhibitor) abrogated total ROS release 
in response to PMA and bacterial stimulation, as expected (section 4.7).  ROS inhibition also 
translated to decreased NET release following stimulation with PMA (as previously reported 
171 
 
by Fuchs et al., 2007 & Palmer et al., 2012), as well as following bacterial stimulation.  
These findings confirm that NAPDH-oxidase, at least in part, necessitates NET release; this 
is also evidenced in CGD patients who harbour an NADPH-oxidase mutation and 
consequently do not produce NETs in response to infection (Bianchi et al., 2009).  Notably, 
DPI had a relatively mild effect on NET production in response to S. aureus, which is 
consistent with findings by Pilsczek et al., (2010), who hypothesised that S. aureus may 
trigger the release of NADPH-oxidase independent NET release 1-2 hours after stimulation, 
followed by oxidase dependent NET release at 3-4 hours.  In the current studies, NET 
quantification at 4 hours does not discriminate between oxidase-dependent and -independent 
NET release, which suggests that oxidase-independent NETs are also present, and hence, DPI 
does not significantly reduce the quantification of NETs.  Noteworthy is a report that 
explored the role of autophagy, a homeostatic process facilitating intracellular degradation, 
which has also been suggested to play a role in cell death.  The authors demonstrated that 
both NADPH activity and autophagy are required for NET release, and without autophagy, 
NADPH is insufficient to cause the decondensation of chromatin and mediate NET release 
(Remijsen et al., 2011).   
To establish the contribution of H2O2 to NET release, the effect of increased removal of H2O2 
was determined by the addition of a glutathione peroxidase precursor substrate (NAC), which 
promotes the removal of H2O2 (section 4.7).  NAC pre-treatment of neutrophils demonstrated 
reduced total ROS and NET release, notably the smallest decrease in NET release following 
NAC pre-treatment was again quantified in response to S. aureus.  Reduced NET production 
following NAC treatment is consistent with findings by Palmer et al., (2012) and confirms 
the role of H2O2 in bacterial-induced NET release.   
Subsequently, further work to ascertain whether other H2O2 metabolites are required for NET 
release was undertaken (section 4.7).  One potential pathway involved utilises the conversion 
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of H2O2 to HOCl in a reaction catalysed by MPO, which produces further reactive oxidants to 
facilitate the removal of invading pathogens.  The importance of HOCl in NET production 
was determined by treating cells with taurine, which scavenges HOCl.   The addition of 
taurine resulted in a reduction in total ROS release, however a differential effect on NET 
production was observed.  Whilst PMA-induced NET release decreased, which is consistent 
with findings by Palmer et al., (2012), taurine caused increased NET release in response to 
certain bacterial stimuli.  These findings emphasise the differences between stimuli, as PMA 
may induce NETs dissimilar to those evoked by physiologically relevant bacteria.  
Furthermore, given that taurine has been suggested to reduce NET release by rescuing cells 
from cell death (Palmer et al., 2012); the current results further highlight the need for a 
greater understanding of NETosis and whether bacteria-induced NET release is indeed a form 
of programmed cell death.   
Further experiments aimed to establish the role of TLR activation in NET production (section 
4.8).  Whilst pre-treatment of neutrophils with Chloroquine (intracellular TLR3, 7 and 9 
inhibitor) associated with a moderate decrease in total ROS release in response to opsonised 
S. aureus and bacterial stimuli, PMA-induced ROS production increased.  In addition, 
Chloroquine treatment resulted in moderately reduced bacteria-induced NET production; 
however NET release in response to PMA and opsonised S. aureus increased.  Notably, 
neutrophils are reportedly not responsive to TLR 3 and 7 ligands (Janke et al., 2009), which 
suggests that these observations are attributed to decreased TLR9 signalling.  TLR9 is central 
to the activation of neutrophils by bacterial DNA, which promotes phagocytosis, pro-
inflammatory cytokine release and ROS production (El Kebir et al., 2009).  The importance 
of TLR9 signalling is particularly interesting in light of recent reports suggesting that NET-
DNA can further activate TLR9 on neutrophils and dendritic cells, which may aid the 
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activation of the immune response (e.g. further NET release), or conversely initiate 
autoimmune responses (Itagaki et al., 2015, Lande et al., 2011).   
 
Treatment of cells with OxPAPC (cell surface TLR2 and 4 inhibitor) exhibited increased 
ROS production and a mild decrease in bacteria-induced NET release (section 4.8).  
Similarly, very little differences were observed in NET production in cells pre-treated with 
Chloroquine and OxPAPC.  Previous findings have suggested that ROS release is TLR2 and 
4 dependent (Sabroe et al., 2005); however Gould et al., (2014) demonstrated that TLR2 and 
4 blocking antibodies did not abolish NET release.  Further experiments are required to 
determine whether these discrepancies are a result of differences in experimental procedures 
(such as the stimuli employed), or whether alternative activation pathways are being utilised 
(such as TLR co-receptors or ROS independent NET release) to compensate for the TLR 
inhibition (Perera et al., 2001).   
 
In summary, these data demonstrated variability between periodontal bacteria in their ability 
to stimulate neutrophil ROS production and NET responses.  This variability may contribute 
to the pathogenesis of periodontitis by mechanisms such as bacterial avoidance of NET 
stimulation and thus persistence of infection, or excess NET release with associated 
autoimmunity.  The ability of NETs to entrap bacteria may facilitate pathogen containment 
and prevent their dissemination within tissues and disease progression; however further work 
is needed to elucidate how NETs interact with a bacterial biofilm and whether bacterial 
DNases allow colonising bacteria to subvert NET defences.  Under the experimental 
conditions applied here NETs appeared unable to kill bacteria; if NETs are interacting with, 
but not killing, periodontal pathogens, it is possible that NET-bacteria complexes may 
provide a source of autoantigens.  Furthermore, treatment of neutrophils with activation 
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modulating agents demonstrated that NADPH-oxidase, H2O2, HOCl and intracellular TLRs 
modulate bacteria-induced NET production. 
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 NET PRODUCTION BY PERIPHERAL BLOOD CHAPTER 5:
NEUTROPHILS IN CHRONIC PERIODONTITIS: A 
LONGITUDINAL INTERVENTION STUDY 
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5.1 Introduction 
The results presented in this chapter are based on clinical work in a study coordinated by Dr 
Martin Ling in 2013 and preliminary data from this study concerning NET production have 
previously been reported in Ling (2015); all NET assays and analyses were however 
performed as part of this thesis.  Chronic periodontitis patients, with age and gender-matched 
periodontally healthy controls, were recruited to the study (2.2.6.3).  Neutrophils were 
isolated from the peripheral blood of all volunteers to determine the effect of the periodontal 
inflammatory process on peripheral blood neutrophil NET responses (West Midlands 
Research Ethics Committee 10/H1208/48).   The patients received tailored oral hygiene 
instruction and non-surgical periodontal treatment that involved scaling and root surface 
debridement of periodontal pockets >4mm.  Patients were reviewed 3 months post-therapy, at 
which point blood was also collected to determine the impact of reducing local periodontal 
inflammation via treatment upon peripheral NET production.  At both time points 
periodontitis patients were assayed in parallel with their matched healthy controls.  The 
periodontal status of patients was recorded at both time points, and healthy controls were 
assessed upon recruitment to the study (2.2.6.3.2).  NET-DNA was quantified by quantifying 
NET-DNA with Sytox green (2.2.3.3) and the effect of volunteer age and disease severity 
upon NET production was also analysed.   
 
5.2 Volunteer information 
Patient and control details are illustrated in Table 5.1.  For inclusion and exclusion criteria 
please see section 2.2.6.3.1.  There was no significant difference in age between patients and 
controls (unpaired t-test p=0.501).  One volunteer patient (#13) decided they no longer 
wished to receive periodontal treatment and withdrew from the study; resulting in n=20 pairs 
pre-treatment and n=19 pairs post-treatment.  
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Table 5.1: Age and gender of volunteers in the study   
Age and gender of patients and healthy age- and gender-matched controls (n=20 pairs).  
There was no significant difference in age between patients and controls (12 males and 8 
females, unpaired t-test p=0.501).   
 
 
 
 
 
 
 
 
 
 
 
  
Volunteer number 
Patient 
Gender-matched 
control 
Gender Age Age 
1 Male 42 44 
2 Male 45 42 
3 Male 40 45 
4 Female 56 63 
5 Male 42 41 
6 Male 46 47 
7 Female 47 51 
8 Male 39 33 
9 Male 38 38 
10 Female 38 43 
11 Male 59 55 
12 Male 37 45 
13 Female 48 43 
14 Female 61 59 
15 Male 51 58 
16 Female 42 39 
17 Female 37 35 
18 Female 52 52 
19 Male 57 48 
20 Male 48 48 
Mean 46 46 
SD 8 8 
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 Clinical measures of periodontitis 5.2.1
To determine the severity of periodontitis and the response to treatment, several parameters 
were measured (section 2.2.6.3.2).  Clinical attachment loss (CAL), periodontal probing 
pocket depths (PPD), bleeding on probing (BOP) from the pocket base, gingival index (GI) 
and plaque index (PI) were recorded pre- and post-treatment in periodontitis patients.  
Chronic periodontitis was defined by a minimum of 2 non-adjacent sites per quadrant with 
probing pocket depth >4mm, which bled upon probing and displayed radiographic bone loss 
>30% of the root length, as defined by the European Federation of Periodontology (Tonetti & 
Claffey 2005).  All clinical parameters were measured immediately prior to blood collection 
for neutrophil assays by a single experienced examiner, who also confirmed periodontal 
health in the healthy controls.   
 
 Clinical attachment loss 5.2.2
Clinical attachment loss (CAL) was calculated pre-treatment by summation of periodontal 
pocket depth and gingival recession measurements in accordance with Haffajee & Socransky 
(1986).   Mean CAL and percentage sites with 1-2, 3-4 and >4mm CAL are shown in Table 
5.2 and corresponds to mild, moderate and severe disease, respectively.  From the 20 patients 
recruited to the study, n=12 (60%) presented with generalised moderate and localised severe 
chronic periodontitis, n=3 (15%) presented with generalised mild and localised severe 
chronic periodontitis, and n=5 (25%) presented with generalised severe chronic periodontitis.   
 
 Periodontal Pocket depth 5.2.3
The number of sites measuring over 4mm was significantly higher in patients, compared with 
healthy controls (unpaired t-test ****p<0.0001, n=20 pairs).  This difference between patients 
and controls was reduced although still evident following treatment (unpaired t-test 
***p=0.0017, n=19 pairs).  However, there was a significant difference in the number of sites 
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over 4mm present in periodontitis patients pre- and post-treatment, demonstrating that non-
surgical therapy significantly reduced pocket depths (unpaired t-test ***p=0.0023, n=19 
pairs) in patients, but not to control levels (Table 5.3). 
 
 Bleeding on probing 5.2.4
The percentage of sites that displayed bleeding on probing (BOP) pre-treatment was 
significantly higher in patients compared with healthy controls (unpaired t-test ****p<0.0001, 
n=20 pairs).  This difference between patients and controls reduced but remained significant 
post-treatment (unpaired t-test *p=0.0478, n=19 pairs).  However, there was a significant 
difference in the percentage of sites that bled upon probing in periodontitis patients pre- and 
post-treatment (unpaired t-test ****p<0.0001, n=19 pairs) (Table 5.4).  
 
 Cumulative gingival index 5.2.5
Cumulative gingival index (GI) was significantly higher in patients compared with healthy 
controls pre-treatment (unpaired t-test ****p<0.0001, n=20 pairs).  This difference between 
patients and controls was no longer significant as a result of treatment (unpaired t-test 
p=0.101, n=19 pairs) and GI was significantly different in periodontitis patients pre- and 
post-treatment (unpaired t-test ****p<0.0001, n=19 pairs) (Table 5.5).  
 
 Plaque index 5.2.6
Cumulative plaque index (PI) was significantly higher in patients, compared with the healthy 
controls pre-treatment (unpaired t-test ****p<0.0001, n=20 pairs).  The difference between 
patients and controls was corrected as a result of treatment (unpaired t-test p=0.679, n=19 
pairs) and PI was significantly different in periodontitis patients pre- and post-treatment 
(unpaired t-test ****p<0.0001, n=19 pairs) (Table 5.6). 
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Table 5.2: Clinical attachment loss in periodontitis patients 
Measurements from patients pre-treatment (n=20 pairs).  Data is presented as percentage sites 
with 1-2, 3-4 and >4mm clinical attachment loss (mean ± SD and range).  
 
 
Clinical attachment loss (% sites) 
Volunteer 
Number 
Mean + SD (mm) 
% sites   
1-2mm 
% sites   
3-4mm 
% sites  
 >4mm 
1 4.4+3.2 39.1 21.8 39.1 
2 2.4+1.9 66.7 26.3 7.0 
3 3.7+2.1 36.5 35.3 28.2 
4 3.5+1.8 35.9 41.0 23.1 
5 2.8+1.6 59.0 24.4 16.6 
6 3.7+2.1 37.0 31.2 31.8 
7 3.4+2.4 55.6 21.6 22.8 
8 2.4+0.9 67.9 28.6 3.5 
9 3.4+1.6 36.9 45.8 16.3 
10 2.8+1.3 44.4 48.3 7.2 
11 2.2+1.8 85.7 5.4 8.9 
12 2.9+2.6 66.1 13.3 20.6 
13 6.0+2.7 5.8 33.3 60.8 
14 3.3+2.0 46.4 34.5 19.0 
15 3.9+1.6 20.1 50.3 29.6 
16 3.2+2.2 55.7 25.9 18.4 
17 5.9+3.3 25.6 11.9 62.5 
18 2.2+1.5 78.0 16.7 5.3 
19 4.1+2.5 33.3 33.3 33.3 
20 1.9+1.4 79.0 15.6 5.4 
Mean 3.4 48.7 28.2 23.0 
SD 1.1 21.1 12.4 16.8 
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Table 5.3: Comparison of probing pocket depth in periodontitis patients and healthy 
controls   
Measurements from patients pre-treatment (n=20 pairs) and post-treatment (n=19 pairs), 
compared with healthy matched controls.  Data is presented as probing pocket depths (mean 
± SD and range) and the number of sites >4mm. 
 
  Probing pocket depth 
Volunteer 
Number 
Patient 
Healthy Control 
Pre-treatment Post-treatment 
Mean + 
SD 
(mm) 
Range 
(mm) 
No. 
sites 
>4mm 
Mean + SD 
(mm) 
Range 
(mm) 
No. 
sites 
>4mm 
Mean + 
SD 
(mm) 
Range 
(mm) 
No. 
sites 
>4mm 
1 3.5+2.8 1-12 45 2.7+1.4 1-9 24 2.1+0.9 1-5 1 
2 2.2+1.5 1-12 7 2.2+0.9 1-7 8 2.1+0.9 1-5 1 
3 3.4+2.0 1-9 36 2.7+1.3 1-7 15 1.8+0.7 1-4 0 
4 3.4+1.7 1-9 33 1.6+0.7 0-4 0 2.0+0.8 1-5 3 
5 2.6+1.5 1-7 22 2.0+0.8 0-5 2 1.2+0.4 1-2 0 
6 3.4+2.1 1-8 45 2.5+1.0 1-7 7 1.5+0.6 1-3 0 
7 2.9+1.9 1-12 28 2.2+1.4 1-10 9 1.7+0.6 1-4 0 
8 2.3+0.9 1-7 5 1.4+0.8 0-5 1 2.2+0.9 1-5 4 
9 3.4+1.6 1-8 29 2.4+1.1 1-6 7 1.3+0.5 1-3 0 
10 2.6+1.2 1-7 10 1.8+0.9 1-4 0 1.4+0.6 1-3 0 
11 2.1+1.8 1-9 14 1.5+1.1 0-9 2 1.1+0.4 1-3 0 
12 2.8+2.4 0-12 35 2.5+2.1 1-10 23 1.1+0.4 1-3 0 
13 5.0+2.6 1-13 54 Withdrew 1.1+0.3 1-2 0 
14 2.9+1.7 0-8 25 1.8+1.2 0-6 5 1.8+0.9 1-5 1 
15 2.8+1.4 1-7 23 2.4+1.5 1-8 16 1.3+0.5 1-3 0 
16 3.2+2.2 1-9 32 2.0+1.3 0-9 9 1.1+0.3 1-3 0 
17 4.8+2.7 1-12 91 3.5+2.2 1-10 52 1.4+0.5 1-3 0 
18 2.1+1.5 0-11 8 1.5+0.9 0-7 1 1.7+0.7 1-4 0 
19 2.8+1.6 1-9 13 2.2+1.3 1-9 8 1.6+0.6 1-3 0 
20 1.5+1.0 1-7 5 1.5+0.8 1-7 1 1.3+0.6 1-4 0 
Mean 3.0   2.1   1.5   
SD 0.8   0.5   0.4   
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Table 5.4: The number of sites that bled from the pocket base upon periodontal probing 
in periodontitis patients and healthy controls   
Measurements from patients pre-treatment (n=20 pairs) and post-treatment (n=19 pairs), 
compared with healthy matched controls.   Data is presented as percentage sites with bleeding 
on periodontal probing. 
 
Bleeding on probing (% sites) 
Volunteer Number 
Patient 
Healthy Control 
Pre-treatment Post-treatment 
1 37 23 39 
2 16 14 17 
3 87 33 0 
4 51 8 0 
5 26 5 0 
6 47 12 0 
7 44 11 16 
8 42 18 20 
9 72 15 0 
10 63 13 1 
11 21 10 0 
12 53 22 0 
13 41 Withdrew 0 
14 70 14 20 
15 23 20 2 
16 21 5 0 
17 63 35 9 
18 33 5 16 
19 43 14 17 
20 17 3 8 
Mean 43.5 14.7 8.3 
SD 20.1 8.9 10.8 
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Table 5.5: Gingival indices in periodontitis patients and healthy controls  
Measurements from patients pre-treatment (n=20 pairs) and post-treatment (n=19 pairs), 
compared with healthy matched controls.  Data is presented as individual median gingival 
index (and interquartile range) and full-mouth cumulative values. 
 
 
 
  
Gingival Index 
Volunteer 
Number 
Patient 
Healthy Control 
Pre-treatment Post-treatment 
Individual Cumulative Individual Cumulative Individual Cumulative 
1 1 (1-2) 195 1 (0-1) 111 1 (0-1) 136 
2 1 (1-2) 187 1 (0-1) 137 1 (0-1) 141 
3 3 (2-3) 426 1 (1-2) 216 1 (0-1) 103 
4 3 (2-3) 405 1 (1-1) 169 1 (1-2) 190 
5 2 (2-2) 322 1 (0-1) 94 0 (0-1) 77 
6 2 (2-2) 350 1 (0-1) 149 1 (0-1) 136 
7 2 (1-2) 310 1 (1-2) 216 1 (1-1) 185 
8 2 (1-2) 316 1 (1-2) 235 0 (0-1) 87 
9 2 (1-2) 296 1 (1-1) 126 0 (0-1) 43 
10 1 (1-2) 292 1 (0-1) 112 0 (0-0) 26 
11 1 (1-1) 203 1 (0-1) 122 0 (0-1) 36 
12 2 (1-3) 338 1 (0-1) 125 0 (0-0) 23 
13 2 (2-3) 274 Withdrew 0 (0-1) 43 
14 2 (1-4) 338 1 (0-1) 106 1 (0-1) 140 
15 2 (2-2) 358 0 (0-1) 105 1 (0-1) 108 
16 1 (1-2) 274 0 (0-1) 83 0 (0-1) 49 
17 2 (2-2) 390 1 (0-1) 147 0 (0-1) 81 
18 2 (1-2) 266 0 (0-1) 37 1 (0-1) 108 
19 2 (2-2) 269 1 (1-1) 145 1 (1-1) 178 
20 1 (1-2) 250 0 (0-1) 72 1 (1-1) 177 
Mean  303.0  131.9  103.4 
SD  66.4  50.39  55.62 
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Table 5.6: Plaque indices in periodontitis patients and healthy controls   
Measurements from patients pre-treatment (n=20 pairs) and post-treatment (n=19 pairs), 
compared with healthy matched controls.  Data is presented as median plaque index (and 
interquartile range) and full-mouth cumulative values. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Plaque Index 
Volunteer 
Number 
Patient 
Healthy Control 
Pre-treatment Post-treatment 
Individual Cumulative Individual Cumulative Individual Cumulative 
1 1 (1-2) 210 1 (1-2) 185 1 (1-1) 168 
2 1 (1-1) 137 1 (1-2) 197 1 (0-1) 125 
3 3 (2-3) 429 2 (1-2) 244 1 (1-1) 182 
4 2 (2-3) 382 1 (1-1) 150 2 (1-2) 249 
5 2 (2-3) 367 1 (0-1) 141 1 (1-2) 186 
6 2 (2-2) 311 1 (1-2) 212 1 (1-2) 253 
7 2 (1-3) 351 1 (1-2) 218 1 (1-2) 212 
8 2 (1-2) 314 2 (1-2) 265 1 (0-1) 145 
9 2 (1-2) 256 1 (1-1) 150 0 (0-1) 60 
10 1 (1-2) 228 1 (0-1) 100 1 (1-1) 157 
11 1 (1-2) 250 0 (0-1) 73 1 (1-1) 119 
12 2 (1-2) 267 1 (0-1) 117 0 (0-1) 61 
13 3 (3-4) 345 Withdrew 1 (0-1) 124 
14 2 (2-3) 339 1 (1-2) 135 1 (1-2) 156 
15 2 (2-3) 353 1 (1-1) 116 1 (0-1) 128 
16 2 (1-2) 272 0 (0-1) 51 1 (0-1) 125 
17 2 (1-3) 324 1 (0-1) 106 1 (0-1) 143 
18 2 (1-3) 279 0 (0-1) 57 1 (1-1) 150 
19 2 (2-3) 271 1 (1-2) 147 1 (1-1) 175 
20 2 (2-3) 366 1 (0-1) 122 1 (1-2) 162 
Mean  302.6  146.6  154.0 
SD  68.6  60.5  49.7 
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5.3 Comparison of NET production by periodontitis patients and healthy matched 
controls 
Neutrophils isolated from the peripheral blood of periodontitis patients and healthy matched 
controls were stimulated for NET production with PMA (50nM) and HOCl (0.75mM) 
(section 2.2.3.3).  Baseline NET production in response to PBS (negative unstimulated 
control) was also quantified.  Patient and healthy matched paired samples were assayed in 
parallel and analysed using fluorometric quantification.  There were no significant differences 
between patient and control NET production assessed fluorometrically when neutrophils were 
treated with PBS (unstimulated negative control), PMA or HOCl (Wilcoxon matched pairs 
p=0.78, p=0.30, p=0.69, respectively, n=20 pairs) (Figure 5.1). 
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Figure 5.1: NET production in periodontitis patients (pre-treatment) and healthy 
controls  
Pre-treatment NET production was quantified fluometrically following a 3 hour incubation 
period after neutrophil stimulation.  (a) PBS (unstimulated negative control), (b) PMA 
(50nM) or (c) HOCl (0.75mM).  Statistical significance calculated using Wilcoxon matched 
pairs tests (ns=not significant).  Data are presented as AFU (arbitrary fluorescence units) and 
expressed as mean ± SEM (n=20 pairs in quadruplicate). 
187 
 
 NET production by periodontitis patients and healthy matched controls following 5.3.1
successful treatment 
Three months post-treatment, patients were reviewed and neutrophils from the peripheral 
blood of periodontitis patients and healthy matched controls were isolated and stimulated for 
NET production with PMA (50nM) and HOCl (0.75mM) (section 2.2.3.3).  Baseline NET 
production in response to PBS (negative unstimulated control) was also quantified.  19 
matched pairs were assayed in parallel and analysed by fluorometric quantification.  There 
were significant differences detected between patients and controls in response to PBS 
exposure (unstimulated negative control) (Figure 5.2a) and PMA (Figure 5.2b) (Wilcoxon 
matched pairs *p=0.041, *p=0.021, respectively, n=19 pairs).  However, there were no 
significant differences detected between comparators when neutrophils were stimulated with 
HOCl (Figure 5.2c) (Wilcoxon matched pairs p=0.62, n=19 pairs).  To control for day-to-day 
variations in neutrophil responsiveness, differences in NET production between pre-treatment 
and post-treatment were expressed as a ratio of patient matched healthy controls.  NET 
production by patient neutrophils significantly decreased following treatment in response to 
PBS (unstimulated), PMA (50nM) and HOCl (0.75mM) (Wilcoxon matched pairs 
**p=0.007, **p=0.004, *p=0.012, respectively, n=19 pairs) (Figure 5.3).      
 
188 
 
A
F
U
Patient Control
0
10000
20000
30000 *
A
F
U
Patient Control
0
10000
20000
30000 *
A
F
U
Patient Control
0
10000
20000
30000 ns
a) NET production in response to PBS
b) NET production in response to PMA
c) NET production in response to HOCl
 
Figure 5.2: NET production in post-treatment periodontitis patients and healthy 
controls  
Post-treatment NET production was fluorometrically quantified following successful 
treatment (MNase digestion and Sytox green staining).  (a) PBS (unstimulated negative 
control), (b) PMA (50nM), (c) HOCl (0.75mM).  Statistical significance calculated using 
Wilcoxon matched pairs tests (*p<0.05, ns=not significant). Data are presented as AFU 
(arbitrary fluorescence units) and expressed as mean ± SEM (n=19 pairs in quadruplicate). 
189 
 
A
F
U
Pre Post
0.0
0.5
1.0
1.5
2.0
2.5 **
A
F
U
Pre Post
0.0
0.5
1.0
1.5
2.0
2.5 **
A
F
U
Pre Post
0.0
0.5
1.0
1.5
2.0
2.5 *
a) NET production in response to PBS
b) NET production in response to PMA
c) NET production in response to HOCl
 
Figure 5.3: Pre- and post-treatment NET production by periodontitis patients 
NET production pre- and post-treatment expressed as a ratio of patients to matched controls.  
(a) PBS (unstimulated negative control), (b) PMA (50nM) and (c) HOCl (0.75mM) Statistical 
significance calculated using Wilcoxon matched pairs tests (*p<0.05, **p<0.01).  Data are 
presented as AFU (arbitrary fluorescence units) (n=19 pairs in quadruplicate). 
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 Fluorescence microscopy of NETs from patient and controls pre-treatment  5.3.2
There was no apparent qualitative difference observed between patient and control NET 
production visualised following fluorometric staining with Sytox green (section 2.2.3.7).  
Both PMA (50nM) and HOCl (0.75mM) stimulated NETs, as shown by the extracellular 
web-like structures that stained positive with the DNA-stain, Sytox green (Figure 5.4).  PBS-
treated neutrophils (negative unstimulated control) also stained positive for DNA, which is 
likely to be due to cell death during the incubation period that allowed for Sytox green to 
permeate the compromised cell membrane. 
 
 Fluorescence microscopy of NETs from patient and controls post-treatment  5.3.3
There were no qualitative differences observed between patient and control NETs visualised 
by fluorescence microscopy (Figure 5.5).  Consistent with pre-treatment observations, both 
PMA (50nM) and HOCl (0.75mM) produced extracellular web-like structures. 
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Figure 5.4: Fluorescence microscopy of NETs from patient and controls pre-treatment 
NETs were visualised by fluorescence microscopy (x20 magnification) with Sytox green 
staining in response to PBS (unstimulated negative control), PMA (50nM) and HOCl 
(0.75mM) exposure for 3 hours.  Images are representative of 2 experiments performed in 
triplicate.  Scale bars are 100µm.  
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Figure 5.5: Fluorescence microscopy of NETs from patient and controls post-treatment 
NETs were visualised following successful treatment by fluorescence microscopy (x20 
magnification) with Sytox green staining in response to PBS (unstimulated negative control), 
PMA (50nM) and HOCl (0.75mM) stimulation for 3 hours.  Images are representative of 2 
experiments in triplicate. Scale bar is 100µm.  
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5.4 Effect of age on NET production  
NET production levels were analysed following stratification for age (<50 years vs >50 years 
old) in pre-treatment patients and controls (published in Hazeldine et al., 2014).  Data was 
available for 13 patients and 13 matched controls who were under 50 years (mean age 
42 ± 4.9 years), and 6 patients and controls who were over 50 years of age (mean 
57 ± 3.4 years).  NET production by older periodontally healthy volunteers was significantly 
reduced compared with healthy volunteers under 50 years old (Mann-Whitney PBS 
*p=0.045; PMA; *p=0.045; HOCl *p=0.026, respectively, n=20 pairs).  NET production was 
also reduced in periodontitis patients over 50 years of age in response to HOCl (0.75mM) 
(Mann-Whitney *p=0.026).  There was a similar non-significant reduction in NET 
production in periodontitis patients in response to PBS and PMA (Figure 5.6a).  
 
NET production was also analysed by age (<50 years vs >50 years old) in post-treatment 
patients and controls.  Following the discontinuation of the study by volunteer 13, there were 
data from 12 patients and age matched controls under 50 years and 6 patients and controls 
over 50 years of age which could be used for analysis.  No statistically significant differences 
in NET production between volunteers under 50 years and those over 50 years were observed 
in response to PBS (unstimulated), PMA (50nM) or HOCl (0.75mM) in patients or controls 
(Mann-Whitney p=0.089) (Figure 5.6b). 
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Figure 5.6: The effect of age on pre- and post-treatment NET production in patients and 
healthy controls 
NET production in volunteers <50 (n=13 patients and controls) and >50 (n=6 patients and 
controls) following no stimulation (PBS) and in response to PMA (50nM) and HOCl 
(0.75mM) (a) pre-treatment and (b) post-treatment.  Statistical significance calculated using 
Mann-Whitney tests (*p<0.05, ns=not significant). Data are presented as AFU (arbitrary 
fluorescence units) and expressed as mean ± SEM. 
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5.5 Analysis of the association between severity of periodontitis and NET production 
pre- and post-treatment 
No significant correlation was observed between pocket depth and NET production pre-
treatment (linear regression p=0.92, p=0.94 and p=0.92 for PBS, PMA and HOCl, 
respectively, n=20 pairs) or post-treatment (linear regression p=0.28, p=0.74 and p=0.84 for 
PBS, PMA and HOCl, respectively, n=19 pairs) (Figure 5.7a&b).  No significant correlation 
was observed between bleeding on probing and NET production pre-treatment (linear 
regression p=0.19, p=0.52 and p=062 for PBS, PMA and HOCl, respectively, n=20 pairs) or 
post-treatment (linear regression p=0.72, p=0.53 and p=0.61 for PBS, PMA and HOCl, 
respectively, n=19 pairs) (Figure 5.7c&d).  Furthermore, no significant correlation was 
observed between cumulative gingival index and NET production pre-treatment (linear 
regression p=0.55, p=0.91 and p=0.77 for PBS, PMA and HOCl, respectively, n=20 pairs) or 
post-treatment (linear regression p=0.93, p=0.11 and p=0.41 for PBS, PMA and HOCl, 
respectively, n=19 pairs) (Figure 5.8a&b).  There was also no significant correlation between 
cumulative plaque index and NET production pre-treatment (linear regression p=0.44, 
p=0.17 and p=067 for PBS, PMA and HOCl, respectively, n=20 pairs).  However post-
treatment results revealed a significant negative correlation between plaque index and NET 
production in response to PMA (linear regression *p=0.022, n=19 pairs) (Figure 5.8c&d). 
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Figure 5.7: Analysis of the association between severity of periodontitis and NET production pre- and post-treatment   
Disease severity was plotted against NET production in response to PBS (unstimulated negative control), PMA (50nM) and HOCl (0.75mM).  
Clinical measures included pocket depth and percentage bleeding on probing (BOP %).  There was no significant correlation between pocket depth 
(number of sites over 4mm) or bleeding on probing and NET production either pre- or post-treatment (linear regression p>0.05).  Data are presented 
as AFU (arbitrary fluorescence units) (n=19 in quadruplicate). 
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Figure 5.8: Analysis of the association between periodontitis disease severity and NET production pre- and post-treatment   
Disease severity was plotted against NET production in response to PBS (unstimulated negative control), PMA (50nM) and HOCl (0.75mM).  There 
was no significant correlation between gingival index and NET production pre- or post-treatment (linear regression p>0.05).  No significant 
correlation was observed for plaque index pre-treatment, however a negative correlation was observed between post-treatment PMA-induced NET 
production and plaque index (linear regression *p=0.022).  Data are presented as AFU (arbitrary fluorescence units) (n=19 in quadruplicate). 
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5.6 Discussion 
Neutrophils play a critical role within the periodontal lesion in response to colonisation by 
subgingival bacteria in chronic periodontitis patients (Miyasaki 1991, Schenkein 2000).  
Chronic activation of accumulating neutrophils in the periodontal tissues is thought to induce 
further tissue damage by releasing their cytotoxic arsenal into the extracellular space 
(Kantarci et al., 2003).  There is also evidence to suggest that peripheral neutrophils in 
periodontitis patients exhibit hyperactivity (in the absence of an exogenous stimulus) and 
hyper-reactivity (in response to periodontal bacteria) with regard to ROS production 
(Matthews et al., 2007a, 2007b).  This has been partly attributed to elevated levels of plasma-
derived pro-inflammatory cytokines measured in periodontitis patients, such as IL-8 and GM-
CSF, which may prime circulating neutrophils (Dias et al., 2011).  There is also evidence for 
constitutively defective redox signalling pathways, which may also contribute to neutrophil 
hyper-responsiveness in periodontitis (Dias et al., 2013).  There is however currently no data 
exploring whether these abnormalities extend to aberrant NET production in chronic 
periodontitis patients.  In the present study, to account for interpersonal and intrapersonal 
variability in neutrophilic responses previously described (Harris 2012), neutrophils were 
isolated from chronic periodontitis patients in parallel with age and gender matched healthy 
controls.  To circumvent the potential observer bias that can arise with NET quantification by 
microscopy, NET production was quantified by fluorometric detection of a DNA label.  
Notably qualitative visual characterisation of NET images has also been reported to be 
susceptible to experimental artefacts and misinterpretation. Indeed Krautgartner et al., (2010) 
observed that SEM images of NETs were not able to distinguish NET structures from fibrin. 
This is the first time NET release has been investigated in peripheral blood neutrophils from 
periodontitis patients.  No differences were found between patients and controls (5.3), a 
finding consistent with a parallel study performed by collaborators in a Greek cohort (Dimitra 
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Sakellari, Aristotle University of Thessaloniki - personal communication, unpublished data).  
The data presented here indicate that the elevated ROS release previously reported in 
periodontitis patients (Matthews et al., 2007) may not translate to increased NET production, 
suggesting that NET release may not be solely ROS-dependent and mechanisms that lead to 
ROS-independent NETosis may exist.  This is consistent with reports by Pilsczek et al., 
(2010), who found that NETs were rapidly produced in response to S. aureus in an NADPH-
oxidase independent manner. In this study the authors postulated that NADPH-oxidase 
independent NET production may also arise from vesicular exocytosis, resulting in nuclear 
envelope destruction and the release of nuclear DNA into the cytoplasm prior to release into 
the extracellular space.  However this has, to date, only been demonstrated for S. aureus 
stimulation and other Gram-positive and -negative bacteria previously studied, as well as 
stimulation with PMA, did not elicit such responses.   
 
Increases in intracellular calcium are also required for NET release.  Parker et al., (2012) 
reported that whilst NADPH-oxidase assembly was essential for PMA-activated NET release, 
it was not necessary for the production of NETs by the calcium ionophore, ionomycin.  
Ionomycin stimulation activates NADPH-oxidase; however inhibition of the oxidative burst 
with DPI did not attenuate NET release.  Furthermore, a recently reported self-protective 
mechanism within glutathione deficient periodontitis neutrophils involves re-siting of the 
NADPH-oxidase to membrane-associated lipid rafts. Neutrophils are believed to be endowed 
with the molecular equipment to direct excess ROS extracellularly, and thus ROS cannot act 
intracellularly to facilitate elevated NET production (Dias et al., 2013).  This could also 
explain the discordance in ROS and NET production in periodontitis patients reported here.  
Supporting this premise is that the ROS hyperactivity observed in chronic periodontitis 
patients’ neutrophils is specific to extracellular release, rather than the intracellular ROS that 
would necessitate NET production (Matthews et al., 2007).   
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A further explanation for elevated ROS production with no significant increase in NET 
release may be that if ROS are a prerequisite for NET production, the elevated ROS 
production associated with neutrophil hyperactivity in chronic periodontitis patients may not 
be sufficient to trigger the same increases in NET release, or may be antagonised by the 
intracellular antioxidant repertoire.  Findings by Palmer et al., (2012) lend support to this 
thesis, who reported that concentrations of over 0.5mM of HOCl were needed to trigger NET 
production.  Indeed, Al-Rasheed et al., (2012) reported that levels of peripheral white blood 
cells (including neutrophils) are significantly higher in periodontitis patients (7.22 ± 1.42 x 
10
9
 cells/L) compared with healthy controls (5.64 ± 1.56x10
9
 cells/L).  The current in vitro 
assays utilised neutrophils derived from patients and controls re-suspended at the same 
concentration; however in vivo it is possible that whilst patients may not exhibit hyperactivity 
or reactivity in terms of NET production, NET responses may be greater due to a 
leukocytosis. 
 
Data presented here indicate that NET production following successful non-surgical 
treatment deceased in periodontitis patients (5.3.1).  This was more pronounced when the 
results were expressed as a ratio of patients to control pre- and post-treatment, an analysis 
designed to control for the day-to-day variability of neutrophil assays.  While there are 
currently no published longitudinal studies looking at the effect of periodontal treatment on 
peripheral NET production there have, however, been studies quantifying neutrophil ROS 
production following successful periodontal therapy (Matthews et al., 2007).  These studies 
reported the normalisation of hyper-reactive total ROS production in response to FcγR 
stimulation post-treatment, however the hyperactive extracellular ROS release measured pre-
treatment persisted following treatment.  Ling (2015) also demonstrated that hyperactivity 
and –reactivity with regard to O2
- 
production following bacterial stimulation normalised to 
control levels as a result of successful treatment.  Notably, these findings were reported in the 
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same patients and matched controls employed for the current NET assays, and all assays were 
conducted on the same day.  Whilst there is evidence to suggest NADPH-oxidase 
independent NETosis can occur, significant decreases in O2
-
 production following 
periodontal treatment may associate with reduced NET release.  Interestingly, Remijsen et 
al., (2011) have demonstrated that superoxide production and autophagy are both required for 
PMA-induced NET production, but function independently of each other.  Superoxide is 
believed to be the primary ROS capable of stimulating autophagy and it has been suggested 
that autophagy may provide one of the links to ROS dependence in the decondensation of 
chromatin during NET formation.   
 
Keshari et al., (2012) has previously demonstrated that cytokines, such as IL-1β and TNFα, 
can induce NETs.  Work by Ling (2015) demonstrated that chronic periodontitis neutrophils 
are hyper-reactive to stimulation by F. nucleatum with regard to the release of IL-1β and 
TNFα, as well as IL-6 and IL-8.  No significant difference in TNFα release was measured 
between patients and controls following successful treatment.  This is consistent with the 
premise that periodontitis associates with a perturbed neutrophil phenotype, which successful 
periodontal therapy can partially normalise.  Considering that cytokines can impact upon 
other neutrophilic responses, such as NET release, it is possible that reduced TNFα 
concomitantly attenuates NET release in chronic periodontitis patients.  Notably the other 
cytokines assayed by Ling (2015), IL-1β IL-6 and IL-8, were not restored to the same level as 
the controls, but remained hyper-reactive post-treatment.  This may be explained by systemic 
inflammation in periodontitis patients remaining higher than in unaffected controls, or may 
also relate to a constitutive component to neutrophil hyper-reactivity in periodontitis 
neutrophils. 
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In terms of age, pre-treatment results demonstrated NET production was lower in those over 
50 years of age (published in Hazeldine et al., 2014) (5.4).  This was most pronounced in 
healthy individuals, with NET production being significantly lower in response to stimulation 
by PBS, PMA and HOCl.  By contrast, patients over 50 years of age only produced 
significantly fewer NETs in response to HOCl.  It has previously been reported that ROS 
production by TNFα primed neutrophils in response to IL-8 and LPS stimulation significantly 
decreases with age, which may cause a decline in NADPH-oxidase dependent NET release 
and provide a mechanistic explanation for the results observed (Hazeldine et al., 2014, Fulop 
et al., 2004).  It is possible that these results occur in those over 50 years due to an aberrant 
response to TNFα priming or IL-8 and LPS stimulation.  However, the activation and 
phosphorylation of a signalling molecule downstream of TNFα, p38 mitogen-activated 
protein kinases (MAPK), did not exhibit age-related changes (Hazeldine et al., 2014, 
Tortorella et al., 2004).  The expression of the IL-8 receptors (CXCR1 and CXCR2) and LPS 
receptors (TLR4) has also been reported to be comparable between old and young individuals 
(Fulop et al., 2004).  Thus it is postulated that age-related reductions in NET production may 
be associated with receptor signalling, rather than receptor expression.   
 
Differences in age-associated NET production were not observed in patients or controls post-
treatment (5.4).  It is possible that the declines in NET production in periodontitis patients 
post-treatment affected the data when analysed in terms of age, however this would not 
explain the loss of age-related differences in NET production by healthy controls.  Whilst the 
study aimed to control for as many variables as possible, such as blood being collected 
immediately prior to isolation to minimise the inadvertent activation of neutrophils, it is 
likely that day-to-day variation in neutrophilic responses arise as a result of other variables.  
For example, food consumed prior to donating blood may affect NADPH-oxidase dependent 
NET release as dietary glucose has been suggested to cause exaggerated NADPH oxidase 
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activity (Chapple 2009).  A further limitation of this analysis is that stratification for age 
reduced volunteer numbers and may have resulted in an under powering of the study for sub 
analysis.   
 
NET production by patients was not strongly correlated with the clinical parameters of 
periodontitis, namely pocket depth, bleeding on probing, gingival index and plaque index 
(5.5).  This is not entirely unexpected given that chronic periodontitis was not found to 
associate with aberrant NET release.  However, following successful treatment, a decreased 
plaque index was significantly correlated with reduced NET release in response to PMA; 
however no correlations were observed between the other more physiologically relevant 
stimuli and clinical measures.  Plaque index decreased in patients as a result of treatment and 
it is therefore possible that plaque dysbiosis plays a key role in altering peripheral neutrophil 
function, as colonising bacteria and their virulence factors can disseminate into the systemic 
circulation (Li et al., 2000).  Wahaidi et al., (2009) demonstrated that plaque accumulation is 
associated with neutrophil total ROS hyper-reactivity in response to fMLP.  Significant 
reductions in plaque following treatment may therefore represent a possible mechanism that 
contributes to abrogated NADPH-oxidase dependent NET production in patients; however a 
study with a larger patient cohort and multiple time points would be required to establish this.   
 
In conclusion, this is the first study to quantify peripheral NET release in periodontitis, and 
no differences were observed in NET production between chronic periodontitis patients and 
healthy controls; a finding consistent with a parallel study in a Greek cohort.  However, as a 
result of successful treatment, NET production significantly decreased in patients, which may 
be a result of decreases in O2
-
 production following periodontal treatment.  Age was found to 
associate with decreased NET release; however this was independent of periodontal health 
status suggesting that decreased peripheral NET production does not predispose individuals 
204 
 
to periodontitis.  Furthermore, whilst post-treatment plaque deposits were negatively 
correlated with peripheral NET release; no other clinical measures of periodontitis were 
associated with alterations in NET production.  Overall, the data presented here indicates that 
the neutrophil hyperactivity and hyper-reactivity previously reported in periodontitis patients 
may not translate to peripheral NET production; however it would be interesting to quantify 
peripheral and localised NET release in response to periodontally relevant bacteria in chronic 
periodontitis patients.  
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 NET DEGRADATION AND ITS POTENTIAL EFFECTS CHAPTER 6:
ON NEUTROPHIL RESPONSES AND THE ORAL EPITHELIUM  
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6.1 Introduction 
This chapter outlines preliminary experiments aimed at investigating the production and 
degradation of NET structures in vitro, followed by the quantification of NET degradation in 
chronic periodontitis patients and healthy matched controls (2.2.5.1).  Plasma levels of 
cystatin C, IgG (1-4 subclasses) and FLCs were also determined in patients and orally healthy 
controls as possible contributing factors for altered NET degradation in chronic periodontitis 
(undertaken by The Binding Site Group Ltd, Birmingham, UK, section 2.2.5.2, Appendix V).  
The potential effects of delayed or ineffective NET degradation was investigated by 
evaluating the impact of NET supernatants (2.2.5.3) on neutrophil responses, including ROS 
production (2.2.3.2), further NET production (2.2.3.3) and the ability of NETs to function as 
chemoattractants (2.2.4.2.3).  The effect of NETs on H400 oral epithelial cell growth was 
also determined by incubating NET supernatants with H400 oral epithelial cells and 
quantifying apoptotic activity, metabolic activity and cell membrane integrity.  
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6.2 NET degradation over 24 hours 
To determine the duration of NET stability in vitro, NETs were quantified over a 24-hour 
period with and without MNase degradation.  At each time point there was a significant 
difference between the number of NETs quantified following MNase digestion and the 
addition of PBS (negative control) (2way ANOVA and Bonferroni post-tests ****p<0.0001 at 
1, 2 and 3 hours, n=3).  However this difference between MNase digestion and the negative 
PBS control was reduced at 12 and 24 hours (2way ANOVA and Bonferroni post-tests 
***p<0.001, n=3), due to a noticeable increase in the number of NETs quantified following 
PBS treatment (negative control), suggesting NETs are less stable after 12 hours of 
incubation (Figure 6.1).  
 
 NET degradation with plasma 6.2.1
NETs were incubated with different concentrations of plasma (from a periodontally and 
sytemically healthy individual) for 3 hours.  Percentage NET degradation was calculated 
based on a 1U/ml Mnase digestion for 15 mins which represented 100% degradation 
(Hakkim et al., 2010).  Minimal difference in NET degradation was observed following the 
addition of between 50% and 5% plasma, however below 5% plasma supplementation there 
was a noticeable concentration dependent decrease in NET degradation (Figure 6.2). 
 
 NET degradation with plasma over 24 hours 6.2.2
To assess the incubation period necessary for plasma (from a healthy individual) to degrade 
NETs, NETs were incubated with 10% plasma (Hakkim et al., 2010) or PBS (negative 
control) and quantified at selected time points over 24 hours.  NET degradation increased up 
to 12 hours, and subsequently levels plateaued.  Similarly to MNase experiments (section 
6.2), there was a significant difference between the number of NETs quantified following 
plasma digestion and the addition of PBS (negative control).  This was statistically significant 
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at 2, 3, 12 and 24 hours (2way ANOVA and Bonferroni post-tests (*p<0.05, ***p<0.001, 
****p<0.0001, n=3).  However once again the number of NETs quantified following a PBS 
incubation increased at the 12 and 24-hours time-points (Figure 6.3).   
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Figure 6.1: NET degradation over 24 hours 
Neutrophils were stimulated to produce NETs (0.75mM HOCl) and NET-DNA quantified at 
different time points (Sytox green) following an MNase digestion (1U/ml) or following a no 
digestion control (PBS).  A significantly higher number of NETs were quantified following 
MNase digestion relative to PBS (2way ANOVA ***p<0.001, ****p<0.0001).  Data is 
presented as AFU (arbitrary fluorescence units) and expressed as mean ± SEM (n=3 in 
triplicate).     
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Figure 6.2: NET degradation with plasma 
Neutrophils were stimulated to produce NETs (0.75mM HOCl) and NETs were subsequently 
incubated with different percentage concentrations of plasma for 3 hours and quantified 
(Sytox green).  % NET degradation was calculated based on a 1U/ml MNase digest 
representing 100%.  Plasma samples were derived from periodontally healthy individuals.  
Data expressed as mean ± SEM (n=3 in triplicate).  
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Figure 6.3: NET degradation by plasma over 24 hours 
Neutrophils were stimulated to produce NETs (0.75mM HOCl) and subsequently incubated 
with 10% plasma or PBS (negative control) over 24 hours prior to fluorometric analysis with 
Sytox green.  Statistical significance calculated using 2way ANOVA and Bonferroni post-
tests (*p<0.05, ***p<0.001, ****p<0.0001).  Data expressed as mean ± SEM (n=3 in 
triplicate).   
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6.3 NET degradation by plasma from periodontitis patient’s pre- and post-periodontal 
treatment   
Neutrophils were stimulated for NET production using HOCl (0.75mM) and NETs produced 
were then subjected to a 3 hour 10% plasma incubation.  NETs were incubated with plasma 
derived from periodontitis patients or healthy age/gender matched controls.  Following 
incubation, the numbers of degraded NETs were quantified fluorometrically using Sytox 
green.  The percentage of NETs degraded was calculated in relation to a 15 min MNase 
digestion, which was used to represent the 100% digestion standard (Hakkim et al., 2010, 
section 2.2.5.1).  In the 19 matched pairs analysed there was a significant difference in NET 
degradation by patient and control plasma prior to periodontal treatment (unpaired t-test 
****p=0.0001, n=19), with periodontitis patients degrading significantly fewer NET 
structures.  Patient results also exhibited a larger variance with a range of 77.1 % NET 
degradation, compared with the control range of 52.5 % NET degradation (Figure 6.4a).  
Following successful periodontal treatment NET degradation by patients and healthy matched 
controls was repeated.  NET degradation by post-treatment periodontitis patients’ plasma was 
comparable to that of the controls (unpaired t-test p=0.322, n=19). However a larger % NET 
degradation variance was still observed in patients, with a range of 72.0, compared with the 
control range which was 47.02 (Figure 6.4b). 
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Figure 6.4: NET degradation by plasma from periodontitis patients pre- and post- periodontal treatment  
HOCl-stimulated (0.75mM) neutrophils were incubated with 10% plasma from periodontitis patients and healthy age/gender matched controls 
for 3 hours. NETs were quantified fluorometrically using the Sytox green assay. % NET degradation was calculated based on a 1U/ml MNase 15 
minute digestion which was used to represent the 100% standard. (a) A significant difference between patient and control NET degradation was 
observed pre-treatment (unpaired t-test ****p=0.0001), however this difference was absent when the assay was repeated post-treatment (b) 
(unpaired t-test ns=not significant).  Data expressed as mean ± SEM (n=19 matched pairs).   
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 Variability in NET degradation with patient age 6.3.1
Plasma NET degradation from periodontitis patients was analysed to determine whether an 
age-associated link exists.  Percentage NET degradation was calculated based on a 1U/ml 
MNase degradation representing 100% (Hakkim et al., 2010).  NET degradation results for 
19 patients were plotted against their corresponding age.  No significant correlation was 
found between NET degradation and age (linear regression p=0.52, n=19) (Figure 6.5).  
 
 MNase-treated patient plasma 6.3.2
To determine whether the addition of MNase to plasma samples could restore NET 
degradation in periodontitis patients, 1U/ml MNase-spiked 10% plasma was incubated with 
NETs for 3 hours.  % NET degradation was calculated based on a 1U/ml MNase digest 
representing 100% degradation.  A significant difference was observed between periodontitis 
plasma and MNase-spiked plasma (unpaired t-test ****p=0.0001, n=10).  Of the 10 plasma 
samples treated with 1U/ml MNase, the significant increase in NET degradation was 
observed in 9 patients.  One sample however did not show any considerable increase in NET 
degradation in the presence of MNase supplementation (Figure 6.6). 
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Figure 6.5: NET degradation plotted against patient age 
Percentage NET degradation by periodontitis patient plasma was plotted against patient age.  
% NET degradation was calculated based on a 1U/ml MNase digest which was used to 
represent the 100% standard.  No significant difference was observed between the amount of 
NET degradation and age.  Data expressed ± SEM (n=19 in triplicate). 
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Figure 6.6: MNase-treated patient plasma  
NETs incubated with 1U/ml MNase-spiked periodontitis plasma for 3 hours were quantified 
fluorometrically (Sytox green).  % NET degradation was calculated based on a 1U/ml MNase 
digest, which was used to represent the 100% digestion standard. A significant difference was 
observed between periodontitis plasma and MNase-spiked plasma (unpaired t-test 
****p=0.0001) (n=10 plasma samples in triplicate). 
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Reduced NET degradation in periodontitis patients may be due to elevated circulating 
antibodies or immunoglobulin free light chains (FLCs), which may provide a physical barrier 
and prevent NET digestion by DNase (Hakkim et al., 2010).  To evaluate this hypothesis, 
plasma IgG subclasses 1-4 and FLC concentrations were measured in periodontitis patients 
and age- and gender-matched controls. 
 
 Plasma IgG concentrations in periodontitis and controls 6.3.3
IgG subclass 1-4 concentrations were measured in plasma samples from periodontitis patients 
and healthy matched controls pre- and post- periodontal treatment.  Protein turbidimetric 
analysis demonstrated that patient IgG1 detection was marginally higher than that of the 
controls pre- and post-treatment, however this was not statistically significant (unpaired t-test 
p=0.50, p=0.43 pre- and post-treatment, respectively) (Figure 6.7a).  Plasma IgG subclass 2 
concentrations in patients were significantly higher than controls (unpaired t-test *p=0.038).  
However no significant difference was observed between patient and control plasma IgG2 
levels post-treatment (p=0.11) (Figure 6.7b).  IgG3 plasma levels were significantly higher in 
patients pre- and post-treatment compared with their matched controls (unpaired t-test 
***p=0.0007, **p=0.0042 pre and post-treatment, respectively) (Figure 6.7c).  The detection 
of plasma IgG4 levels in patients and controls demonstrated higher levels in patients, 
however this was only significant post-treatment (unpaired t-test *p=0.042) (Figure 6.7d).  A 
small number of sample readings fell outside of the IgG reference ranges (IgG1: 3.824-
9.286g/litre, IgG2: 2.418-7.003g/litre, IgG3: 0.218-1.761g/litre, IgG4 0.039-0.864) (Schauer 
et al., 2003).  This appeared to be dependent upon disease status, as whilst 8 control readings 
were below the reference ranges (3 pre-treatment and 5 post-treatment), this only occurred in 
3 periodontitis patient samples (1 pre-treatment and 2 post-treatment).  Conversely, no 
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control readings were above the reference ranges, compared with 9 periodontitis patient 
samples (5 pre-treatment and 4 post-treatment).  
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Figure 6.7: Plasma IgG concentrations in periodontitis and controls 
IgG subclasses 1-4 concentrations were measured by protein turbidimetric analysis in plasma 
samples from periodontitis patients and healthy matched controls pre- and post-treatment.  
Statistical significance was calculated using unpaired t-tests (*p<0.05, **p<0.01, ***p<0.001, 
ns=not significant). Data expressed as means ± SEM (n=19 matched pairs).   
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6.3.3.1 Plasma IgG subclasses concentration plotted against NET degradation  
Plasma-derived IgG subclass 1-4 measurements (g/litre) were plotted against pre-treatment % 
NET degradation results for each patient and control (n=19 pairs).  No significant correlation 
by linear regression was observed between IgG subclasses 1-3 and NET degradation (p=0.52, 
p=0.60, p=0.37 for IgG1, IgG2 and IgG3, respectively).  Notably, a significant negative 
correlation was observed between IgG4 and NET degradation (*p=0.023) (Figure 6.8).   
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Figure 6.8: Plasma IgG subclasses concentration plotted against NET degradation  
Plasma IgG subclasses 1-4 measurements (g/litre) were plotted against pre-treatment % NET 
degradation results for each patient and matched control.  A significant negative correlation 
was observed between IgG4 concentration and NET degradation (linear regression *p=0.023) 
(n=19 matched pairs). 
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 Plasma FLC concentrations in periodontitis and controls 6.3.4
Free kappa and lambda light chains were assayed in plasma samples from periodontitis 
patients and healthy matched controls pre- and post-treatment.  Protein turbidimetric analysis 
demonstrated that free kappa light chain concentrations were significantly higher in patients 
than controls, both pre- and post-treatment (unpaired t-test *p=0.049, *p=0.048 pre- and 
post-treatment, respectively) (Figure 6.9a).  Free lambda light chain concentrations in patient 
plasma were higher than controls pre- and post-treatment, however this did not reach 
statistical significance (unpaired t-test p=0.22, p=0.23 pre- and post-treatment, respectively) 
(Figure 6.9b).  The kappa/lambda ratio demonstrated higher levels in patients pre-treatment 
(unpaired t-test *p=0.047), but not post-treatment (p=0.66) (Figure 6.9c).  Similar results 
were observed for summated FLC values, in which patients exhibited significantly higher 
levels pre-treatment (unpaired t-test *p=0.032), however this was not statistically significant 
post-treatment (p=0.085) (Figure 6.9d).  A small number of sample readings fell outside of 
the reference ranges (free kappa light chains: 3.3-19.4mg/litre, free lambda light chains: 5.71-
26.3mg/litre, kappa/lambda ratio: 0.26-1.65, summated FLC: 9.01-45.7) (Katzmann et al., 
2002).  Deviation from the reference range appeared to be dependent on disease state, as 
whilst 4 control readings were below the reference ranges (1 pre-treatment and 3 post-
treatment), this did not occur in any patients.  Conversely, 5 control IgG readings were above 
the reference ranges (2 pre-treatment and 3 post-treatment), compared with 13 patients (6 pre-
treatment and 7 post-treatment). 
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Figure 6.9: Plasma FLC concentrations in periodontitis and controls  
Free kappa light chains, free lambda light chains, the kappa/lambda ratio and summated 
FLCs were measured by protein turbidimetric analysis in plasma samples from periodontitis 
patients and healthy matched controls pre- and post-treatment.  Statistical significance was 
calculated using unpaired t-tests (*p<0.05, ns=not significant). Data expressed as means ± 
SEM (n=19 matched pairs).   
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6.3.4.1 Plasma FLC concentration plotted against NET degradation 
Plasma-derived free kappa light chains (mg/litre), free lambda light chains (mg/litre), 
kappa/lambda ratio and summated FLC measurements were plotted against pre-treatment 
NET degradation data (n=19 pairs).  No significant correlation was observed between FLC 
detection and NET degradation (linear regression p=0.96, p=0.078, p=087, p=0.57 for free 
kappa light chains, free lambda light chains, kappa/lambda ratio and summated FLC, 
respectively) (Figure 6.10).  
 
  
220 
 
% NET degradation
F
L
C
 m
g
/l
it
re
0 40 80 120
0
20
40
60
Kappa
Lambda
Ratio
Summated
R2=0.00077; p=0.87
R2=0.0001; p=0.96
R2=0.0023; p=0.078
R2=0.0091; p=0.57
 
Figure 6.10: Plasma FLC concentration plotted against NET degradation 
Plasma-derived free kappa light chains (mg/litre), free lambda light chains (mg/litre), the 
kappa/lambda ratio and summated FLC measurements were plotted against pre-treatment % 
NET degradation data for each patient and matched control. No significant correlation was 
observed between FLCs and NET degradation (linear regression p>0.05) (n=19 matched 
pairs). 
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Elevated levels of FLC may be the result of excess production by plasma cells, or reduced 
clearance of FLCs by the kidneys (Randers et al., 2000).  To determine whether the increased 
FLC concentrations measured in periodontitis patients were due to impeded FLC clearance, 
cystatin C concentrations were measured in plasma samples from periodontitis patients and 
healthy matched controls as an independent measure of kidney function.  Cystatin C is an 
inhibitor of cysteine proteinases and considered a marker of renal function, where elevated 
levels of cystatin C are positively correlated with decreased renal function (Randers et al., 
2000).   
 
 Plasma-derived cystatin C detection in periodontitis 6.3.5
Protein turbidimetric analysis demonstrated there was no significant difference in cystatin C 
levels (mg/litre) between control and patient plasma samples pre- and post-treatment 
(unpaired t-test p=0.74, p=0.82 pre- and post-treatment, respectively, n=19 matched pairs).  
A small minority of samples were higher than the cystatin C reference range (0.56-
0.99mg/litre); however as this encompassed both patients and controls, this did not appear 
related to periodontal disease status (Figure 6.11).  
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Figure 6.11: Plasma-derived cystatin C detection in periodontitis 
Cystatin C detection by protein turbidimetric analysis revealed no significant difference 
between control and patient plasma samples pre- and post-treatment (unpaired t-test ns=not 
significant).  Data expressed as means ± SEM (n=19 matched pairs).   
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To evaluate the effect of reduced NET degradation on neutrophil responses and the 
epithelium, neutrophils from healthy individuals were stimulated to produce NETs (0.75mM 
HOCl) and the washed NET supernatants collected by MNase digestion (section 2.2.5.3) and 
stored at -80°C by snap freezing (Appendix VI) until required.  NET supernatants were 
subsequently pooled to determine the effect of NET exposure on the neutrophil responses of 
ROS and NET production, chemotaxis and their effect on H400 oral epithelial cells.   
 
6.4 Determination of the DNA-content in NET supernatants 
NET supernatants were used at concentrations of 25%, 50% and 100% (section 2.2.5.4).  To 
ensure outcomes were as a result of exposure to NET structures and not the HOCl stimulus 
initially employed to generate the NETs, a HOCl cell-free supernatant was also collected for 
future assay controls.  To determine the concentration of NET supernatants, NET-DNA was 
quantified in pooled samples (n=10) with Sytox green and compared with a standard curve 
generated using calf thymus DNA (n=5) to provide interpolated values (Palmer 2010).  NET 
supernatants were applied in a volume of 50µl to investigate whether NETs could stimulate 
neutrophils to release ROS, release NETs and the effect of NET supernatants on H400 
epithelial cells growth.  For chemotaxis assays, NET supernatants were used at a volume of 
80µl.  The concentration of DNA present in the HOCl cell-free control and 25%, 50% and 
100% NET supernatant test sample (50µl and 80µl) is presented in table 6.1. 
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Table 6.1: Determination of the DNA-content in NET supernatants 
Pooled NET supernatants DNA content was determined using the Sytox green assay (n=10) 
and compared with a standard curve generated with calf thymus DNA (n=5) to provide 
interpolated values.  Volumes of 50µl of NET supernatants were employed for ROS, NET 
and H400 assays, whilst 80µl were required for chemotaxis assays.  Data presented as AFU 
(arbitrary fluorescence units). 
 
NET 
concentration 
AFU 
reading 
DNA 
(µg/50µl) 
DNA 
(µg/80µl) 
HOCl cell free 126 0.0013 0.0021 
25% 2734 0.14 0.23 
50% 5434 0.30 0.47 
100% 10199 0.57 0.96 
 
  
 
 NET supernatants as a stimulus for ROS production 6.4.1
To determine whether NET supernatants can stimulate peripheral blood neutrophils from a 
different subject to produce ROS, ROS release in response to treatment with HOCl-induced 
NET supernatants was quantified with luminol (2.2.3.2).  ROS release following PBS 
(unstimulated negative control) and PMA (25nM) treatment were employed as negative and 
positive controls, respectively.  PMA induced significantly higher ROS production compared 
with PBS treatment alone (1way ANOVA and Bonferroni post-tests ****p<0.0001, n=5).  
However, NET supernatants at 25%, 50% and 100% did not stimulate neutrophils to release 
ROS when compared with the PBS control (1way ANOVA p>0.05).  HOCl cell free 
supernatants (additional control) did not stimulate neutrophils to release ROS (Figure 6.12a).  
The time-course of ROS production was also analysed following stimulation with NET 
supernatants.  Neutrophils were stimulated at 30 mins and ROS production quantified for 170 
mins after stimulation.  Consistent with the peak ROS signal data, time-course ROS 
production data revealed that PMA induced total ROS production relative to the PBS control.  
ROS production in response to PMA peaked at ~20 mins post-stimulation, followed by a 
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steep decline in ROS release.  NET supernatants (25%, 50% and 100%) and the HOCl-cell 
free supernatant control did not stimulate ROS release (Figure 6.12b). 
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Figure 6.12: NET supernatants as a stimulus for ROS production 
(a) Total ROS production was quantified with luminol in response to PBS (unstimulated), 
PMA (25nM), HOCl cell free supernatant or NET supernatants (25%, 50% and 100%).  
Statistical significance calculated using 1way ANOVA and Bonferroni post-tests 
(****p<0.0001, ns=not significant).  Data is expressed as mean ± SEM. (b) Time course total 
ROS production over 200 mins by cells stimulated with PBS (unstimulated), PMA (50nM), 
HOCl cell free supernatant or NET supernatants (25%, 50% and 100%).  Data is presented as 
RLU (relative light units) (n=5 in triplicate). 
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 NET supernatants as a stimulus for NET production 6.4.2
To determine whether NET supernatants can stimulate neutrophils to produce NETs, NET 
production in response to treatment (4 hours) with HOCl-induced NET supernatants was 
quantified using the Sytox green assay (2.2.3.3).  NET release following PBS (unstimulated) 
and PMA (50nM) treatment were employed as negative and positive controls, respectively.  
PMA induced significantly higher NET release compared with PBS treatment (1way 
ANOVA and Bonferroni post-tests ****p<0.0001, n=5).  However NET supernatants at 25%, 
50% and 100% did not stimulate neutrophils to release NETs, evidenced by no significant 
increase in NETs relative to the PBS control treatment (1way ANOVA p>0.05).  HOCl cell 
free supernatants (additional control) did not stimulate neutrophils to release NETs (Figure 
6.13).  
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Figure 6.13: NET supernatants as a stimulus for NET production 
NET-DNA production was quantified with Sytox green in response to PBS (unstimulated), 
PMA (50nM), HOCl cell free supernatant or NET supernatants (25%, 50% and 100%).  
Statistical significance calculated using 1way ANOVA and Bonferroni post-tests 
(****p<0.0001, ns=not significant).  Data presented as AFU (arbitrary fluorescence units) and 
expressed as mean ± SEM (n=5 in triplicate).      
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 The ability of NETs to induce neutrophil chemotaxis 6.4.3
To determine whether NETs serve as chemoattractants and induce the directional migration 
of neutrophils towards them, NET supernatants were employed as chemoattractants and 
neutrophil chemotaxis was analysed using the Insall Chamber (2.2.4.2.3).  The movement of 
15 randomly chosen cells was tracked by video microscopy and the quantitative data 
generated used to produce spider plots and to calculate neutrophil speed, velocity and 
resultant vector length (Roberts et al., 2015).   
 
Spider plots enable visualisation of individual cell movement (µm) from a central point, 
where the top of the Y-axis represents the source of the chemoattractant.  Cells displayed 
directional movement towards the known chemoattractant, fMLP.  Neutrophil migration was 
observed in response to 25% NET supernatants, and to greater extent with 50% and 100% 
NET supernatants; however this movement did not appear to be towards the chemoattractant 
source, and lacked directionality (Figure 6.14). 
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Figure 6.14: Spider plots representing neutrophil migration in response to NET 
supernatants 
Spider plots show the tracking (µm) of individual neutrophils (n=15 cells from n=5 
experiments) from a central reference point (0, 0) towards the chemoattractant.  The top of 
the Y-axis represents the source of the chemoattractant.  Neutrophil chemotaxis in response 
to a known chemoattractant, fMLP (100nM), was employed as a positive control.  Cell 
migration was tracked in response to 25%, 50% and 100% NET supernatants.   
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Whilst spider diagrams represent a relatively novel way to visualise cell migration in 
response to a chemoattractant, they cannot be used objectively or quantitatively to measure 
neutrophil movement.  Thus, the data generated from tracking 15 individual cells was used to 
quantify the speed, velocity and directional accuracy of neutrophil migration.  
 
6.4.3.1 Neutrophil speed in response to NET supernatants 
Neutrophil speed (µm/min) in response to fMLP (100nM, positive control) was significantly 
greater than for RPMI (negative control) (1way ANOVA and Bonferroni post-test 
****p<0.0001, n=5).  The speed of neutrophil migration in response to NET supernatants 
(25%, 50% and 100%) was also significantly higher than RPMI (1way ANOVA and 
Bonferroni post-test ****p<0.0001 for 25%, 50% and 100%, n=5).  However, increased 
neutrophil speed in response to NET supernatants was significantly lower than for fMLP-
induced migration (positive control) (1way ANOVA and Bonferroni post-test ****p<0.0001 
for 25%, 50% and 100%, n=5, statistics not shown on graph).  Notably, HOCl cell free 
supernatants (additional control) did not induce an increase in neutrophil speed (1way 
ANOVA p>0.05) (Figure 6.15).  
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Figure 6.15: Neutrophil speed in response to NET supernatants 
Neutrophil chemotactic speed (µm/min) in response to fMLP (100nM, positive control), 
RPMI (negative control) and different concentrations of NET supernatants was measured.  
Statistical significance calculated using 1way ANOVA and Bonferroni post-test 
(****p<0.0001, ns=not significant).  Data calculated from the tracking of 15 cells and is 
expressed as mean ± SEM (n=5). 
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6.4.3.2 Neutrophil velocity in response to NET supernatants 
Velocity is the speed of movement in a specific direction towards a chemoattractant.  
Neutrophil velocity in response to fMLP (100nM, positive control) was significantly higher 
than for RPMI (negative control) (1way ANOVA and Bonferroni post-test ****p<0.0001, 
n=5).  However NET supernatant-induced velocity was not significantly different to (1way 
ANOVA p>0.05) (Figure 6.16). 
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Figure 6.16: Neutrophil velocity in response to NET supernatants 
Neutrophil velocity (µm/min) in response to fMLP (100nM, positive control), RPMI 
(negative control) and different concentrations of NET supernatants was measured.  
Statistical significance calculated using 1way ANOVA and Bonferroni post-test 
(****p<0.0001, ns=not significant).  Data calculated from the tracking of 15 cells and is 
expressed as mean ± SEM (n=5). 
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6.4.3.3 Directional accuracy of neutrophil movement (resultant vector length) 
Representative angular histograms and resultant vector plots of neutrophil directional 
chemotaxis in response to fMLP (100nM) or 100% NET supernatants were plotted.  The 
angular histograms measure cell directionality and strength of this movement, which is 
determined by the histogram bar angle and width, respectively.  Angular histograms and 
resultant vector plots of neutrophil migration in response to fMLP (100nM, positive control) 
show strong directional accuracy of movement towards the chemoattractant.  However 
neutrophil chemotaxis in response to 100% NET supernatants exhibited movement that was 
not directionally targeted towards the source of the chemoattractant (90°), evidenced by the 
cell movement endpoint (blue circles on circle circumference) being in every direction and 
the shortness of the red line (Figure 6.17). 
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Figure 6.17: Directional accuracy of neutrophil movement (resultant vector length) 
Representative angular histograms and resultant vector plots of neutrophils treated with 
fMLP (100nM) or 100% NET supernatants.  The angle and width of the histogram bars 
indicates the direction and the proportion of cells migrating in that direction, respectively.  
The resultant vector plots indicate the strength and directionality of the cells in response to 
the chemoattractant.  The red line denotes the mean resultant vector and the dashed line 
shows the variation (95% confidence intervals) within the entire cohort of cells.  The length 
of the red line is indicative of the strength of cell directionality.  The blue circles along the 
circumference of the plot represent individual neutrophil migration end-points.  For both 
plots, 90° at the top of both plots represents the source of the chemoattractant.   
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6.4.3.4 Neutrophil resultant vector length 
The resultant vector length measures the directional accuracy of neutrophil chemotaxis 
towards the chemoattractant.  Resultant vector length was calculated from the resultant vector 
plots, in which the red line denotes the mean resultant vector and the dashed line shows the 
variation (95% confidence intervals) within the entire cohort of cells.  The length of the red 
line is indicative of the strength of cell directionality.  Resultant vector length in response to 
fMLP (100nM, positive control) was found to be significantly higher than neutrophil 
migration when RPMI (negative control) was employed as a chemoattractant (1way ANOVA 
and Bonferroni post-test ***p<0.001, n=5).  However NET supernatant-induced chemotaxis 
did not cause a significant increase in neutrophil directional movement, compared with the 
RPMI control (1way ANOVA p>0.05) (Figure 6.18). 
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Figure 6.18: Neutrophil resultant vector length 
Resultant vector length of neutrophil chemotaxis in response to fMLP (100nM, positive 
control), RPMI (negative control) and different concentrations of NET supernatants was 
measured.  Statistical significance calculated using 1way ANOVA and Bonferroni post-test 
(***p<0.001, ns=not significant).  Data calculated from the tracking of 15 cells and is 
expressed as mean ± SEM (n=5).  
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6.5 The effect of NETs on H400 oral epithelial cell responses 
To evaluate the effect of reduced NET degradation on the activity and viability of oral 
epithelial cells, H400s were cultured in a 96-well plate (until 90% confluent) and incubated 
with NET supernatants (25%, 50% and 100%).  At 4 and 24 hours, the impact of NET 
supernatants on H400 oral epithelial cell growth was determined by quantifying caspase 
activity (apoptosis), ATP activity (metabolic activity) and LDH release (cytotoxicity).  HOCl 
cell free supernatants were employed as a control, RPMI and 0.1% triton were used as 
negative and positive treatment controls, respectively. 
 
 The effect of NETs on H400 oral epithelial cell apoptosis 6.5.1
To investigate whether NET supernatants induce apoptosis in H400 oral epithelial cells, 
caspase-3 and 7 production by H400s (90% confluent) was measured at 4 and 24 hours 
(2.2.1.2.4).  Treatment with triton (0.1%, positive control) caused a decrease in caspase 
activity at 4 and 24 hours, relative to the RPMI negative control, however this was not 
statistically significant (1way ANOVA p>0.05, n=5).  Caspase activity in response to RPMI 
(negative control), HOCl cell free supernatants and NET supernatants (25%, 50% and 100%) 
was higher at 24 hours than 4 hours.  A concentration dependent decrease in caspase-3 and 7 
production was observed at 24 hours following treatment with 25%, 50% and 100% NET 
supernatants, however this was not statistically significant (1way ANOVA p>0.05, n=5) 
(Figure 6.19).   
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Figure 6.19: The effect of NETs on H400 oral epithelial cell caspase activity 
Apoptotic activity in H400 oral epithelial cells was determined by measuring caspase-3 and -
7 activity at 4 and 24 hours in response to RPMI (negative control), 0.1% triton (positive 
control), HOCl cell free supernatants (additional control) and NET supernatants (25%, 50% 
and 100%).  Statistical significance calculated using 1way ANOVA (ns=not significant).  
Data expressed as RLU (relative light units) and mean ± SEM (n=5 in triplicate). 
 
 
 The effect of NETs on H400 oral epithelial cell metabolic activity 6.5.2
To investigate the metabolic activity of H400 oral epithelial cells in response to NET 
supernatants, ATP production by H400s (90% confluent) was measured at 4 and 24 hours 
(2.2.1.2.5).  Treatment with triton (0.1%, positive control) caused a significant decrease in 
metabolic activity at 4 and 24 hours, relative to the RPMI negative control (1way ANOVA 
and Bonferroni post-tests **p<0.01, ***p<0.001 at 4 and 24 hours, respectively,  n=5).  
Metabolic activity in response to RPMI (negative control), HOCl cell free supernatants and 
NET supernatants (25%, 50% and 100%) was higher at 24 hours, relative to 4 hours.  A 
concentration dependent decrease in ATP production was observed at 24 hours following 
treatment with 25%, 50% and 100% NET supernatants, however this was not statistically 
significant (1way ANOVA p>0.05, n=5) (Figure 6.20).   
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Figure 6.20: The effect of NETs on H400 oral epithelial cell metabolic activity 
Metabolic activity of H400 oral epithelial cells was determined by measuring ATP release at 
4 and 24 hours in response to RPMI (negative control), 0.1% triton (positive control), HOCl 
cell free supernatants (additional control) and NET supernatants (25%, 50% and 100%).  
Statistical significance calculated using 1way ANOVA and Bonferroni post-test (**p<0.01, 
***p<0.001).  Data expressed as RLU (relative light units) and mean ± SEM (n=5 in 
triplicate). 
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 The effect of NETs on H400 oral epithelial cell lactate dehydrogenase release 6.5.3
To investigate whether NETs induce cytotoxicity in H400 oral epithelial cells, lactate 
dehydrogenase (LDH) was measured at 4 and 24 hours (2.2.5.7).  LDH is released by 
damaged membranes, therefore an increase in LDH, and thus an increase in AFU, is 
associated with reduced membrane integrity.  Treatment with triton (0.1%, positive control) 
caused a significant increase in LDH release at 4 and 24 hours, relative to the RPMI negative 
control (1way ANOVA and Bonferroni post-tests ****p<0.0001 at 4 and 24 hours, n=5).  
LDH release in response to RPMI (negative control), HOCl cell free supernatants and NET 
supernatants (25%, 50% and 100%) was higher at 24 hours, relative to 4 hours.  Despite a 
noticeable increase in LDH release at 24 hours following treatment with 100% NET 
supernatants, this was not statistically significant.  There was no significant increase in LDH 
release as a result of treatment with HOCl free supernatants or NET supernatants (25% and 
50%) (1way ANOVA p>0.05, n=5) (Figure 6.21).   
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Figure 6.21: The effect of NETs on H400 oral epithelial cell lactate dehydrogenase 
release 
LDH released into the media was quantified at 4 and 24 hours in response to RPMI (negative 
control), 0.1% triton (positive control), HOCl cell free supernatants (additional control) and 
NET supernatants (25%, 50% and 100%).  Statistical significance calculated using 1way 
ANOVA and Bonferroni post-test (****p<0.0001).  Data expressed as AFU (arbitrary 
fluorescence units) and mean ± SEM (n=5 in triplicate). 
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6.6 Discussion 
 
Plasma-derived NET degradation was significantly lower in chronic periodontitis patients 
pre-treatment relative to periodontally healthy matched controls (section 6.3).  This is the first 
report evaluating NET degradation in periodontitis, however the removal of NETs has been 
well characterised in other diseases such as systemic lupus erythematosus (SLE) patients, in 
which NET clearance by sera was reportedly impeded in a subset of patients (Hakkim et al., 
2010, Leffler et al., 2012).  The mechanisms involved in the removal of NETs remain to be 
thoroughly elucidated; however reports indicate that degradation of the DNA backbone by 
DNase 1 initiates their removal, followed by the engulfment of degraded structures by 
macrophages and further degradation in the lysosome.  Key to this process is NET clearance 
resembles a mechanism similar to that of apoptosis, whereby macrophages behave non-
phlogistic, do not release pro-inflammatory cytokines and thus NET disassembly is regarded 
as an “immunologically silent” process (Farrera & Fadeel 2013).  Possible reported 
explanations for attenuated NET degradation in SLE patients include the presence of DNase1 
inhibitors preventing the enzymatic removal of the NETs (Yeh et al., 2003), or alternatively 
higher antibody titers in patients’ plasma, which may provide a physical barrier to NET 
removal by binding to NETs and blocking the DNase cleavage sites (Hakkim et al., 2010, 
Leffler et al., 2012).  Notably contradictory findings are reported regarding the effect of 
supplementing patient sera with DNase to restore NET degradation in all “low-degrading” 
patients (Hakkim et al., 2010, Leffler et al., 2012).  In the periodontitis cohort studied here, 9 
out of 10 patients displayed restored NET degradation following the addition of MNase 
(section 6.3.2), suggesting that if enzymatic inhibitors are present, they may be DNase 
specific.  Following non-surgical treatment, NET degradation in periodontitis patients was 
restored and no significant difference was detected between patients and controls.  This is 
consistent with reports by Leffler et al., (2012), who demonstrated that NET degradation was 
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improved when SLE patients were in remission, relative to during a disease flare.  Notably, as 
with the SLE cohort, reduced NET degradation was a variable phenomenon and only 
observed in a subset of periodontitis patients; this could be linked to disease susceptibility, 
disease severity, disease activity status or bacterial load and virulence factors (such as 
bacteria-derived DNases).  
 
To establish whether a physical barrier, such as circulating antibodies or immunoglobulin 
free light chains (FLC), may be preventing the enzymatic removal of NETs, IgG subclasses 
were quantified in patient and matched control plasma samples.  In addition to analysing 
immunoglobulins, levels of FLCs were measured.  Immunoglobulins comprise 2 identical 
heavy and 2 identical light chains (either kappa or lambda), however during their normal 
synthesis by B cells, there is an excess of light chain production which is released into 
circulation and known as FLCs (Solomon 1985).  However, FLC overproduction has been 
reported in several chronic diseases, such as SLE (Aggarwal et al., 2011) and rheumatoid 
arthritis (RA) (Gottenberg et al., 2007), which may be the result of chronic immune 
stimulation (Brebner & Stockley 2013).  Periodontitis has been linked to these pathologies 
(Fabbri et al., 2014, Smit et al., 2012), and furthermore, periodontitis is a disease exacerbated 
by a chronic inflammatory-immune host response and notably overactive B cells are deemed 
partly responsible (Reinhardt et al., 1988).  Accordingly, the results reported here 
demonstrate increased plasma-derived FLCs and IgG 1-4 subclasses in periodontitis patients 
(sections 6.3.3, 6.3.4).  Increased IgG levels are consistent with the findings of Graswinckel 
et al., (2004), who reported higher levels of IgG1 and IgG2 in periodontitis patients relative 
to controls.  In the present study, cystatin C levels were also measured to establish whether 
excessive plasma FLCs in periodontitis patients resulted from insufficient renal FLC 
clearance; notably no differences in renal clearance were observed between patients and 
controls.  There is a paucity of data pertaining to FLCs and periodontitis; however the results 
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here suggest that in this patient cohort, periodontitis is associated with elevated FLC 
production.  Further experiments are therefore warranted to determine whether increasing 
circulating levels of antibodies and FLCs prevents the enzymatic degradation of NETs in 
periodontitis. 
 
Attenuated NET removal may constitute an antimicrobial host response during periods of 
infection, as NETs can prevent microbial dissemination by entrapping various periodontal 
bacteria (section 4.4).  In support of the contribution of NETs to the host response in SLE, 
impeded NET production in NADPH-oxidase KO mice exhibited exacerbated lupus-like 
symptoms, which led the authors to conclude that NET release does not contribute to SLE in 
vivo (Campbell et al., 2012).  The host’s ability to adjust the extracellular “life-span” of 
NETs in response to the microbial biofilm may also explain why no differences in peripheral 
NET release were observed between periodontitis patients and controls (see Chapter 4).  
Notably, it has been reported that mice immunised with NETs produced in vitro with H2O2 
did not demonstrate a break in immune tolerance as a result of NET-derived immunogens.  In 
support of the premise that NETs are non-immunogenic, the work in this chapter 
demonstrated that under the reported experimental conditions, treatment of peripheral 
neutrophils with HOCl-stimulated NET supernatants did not prompt ROS or NET production.  
In addition, no NET-mediated cytotoxicity was identified in H400 cells following their 
incubation with NET supernatants.  This is contradictory to findings by Saffarazadeh et al., 
(2012), who demonstrated that NETs induced cell death in epithelial cells.  These differences 
may be a result of different cell lines (Saffarazadeh employed alveolar epithelial cells), or due 
to differences in the NET supernatants, for example Saffarazadeh employed PMA-induced 
NETs whereas HOCl was the NET stimulus of choice in the work outlined here.   
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NET supernatants employed as chemoattractants did however increase neutrophil 
chemotaxis; albeit non-directional movement, suggesting that whilst increased motility was 
observed, neutrophils were not being recruited to NET structures (section 6.4.3).  Increased 
neutrophil speed in the absence of directionality may be detrimental to the host, as the 
random movement of cells may cause ROS-mediated collateral tissue damage during 
neutrophil tissue transit (Roberts et al., 2015).  It is difficult to ascertain whether these 
observations reflect in vivo chemotaxis, where bacteria and host derived chemoattractants 
will also be present and may provide a chemical hierarchy (Kim & Haynes 2012) that 
overrides the chemotactic signals produced by NETs.  Interestingly, NETs have been 
suggested to provide danger signals that activate DNA receptors (such as TLR9), which 
subsequently alert the immune system (Brinkmann et al., 2012).  Activation of DNA 
receptors was not investigated here; however the work outlined in this chapter suggests that 
under the experimental conditions reported, NETs do not activate neutrophil effector 
functions.    
Evaluating pro-inflammatory responses to NETs produced in vitro is subject to various 
limitations and may not be representative of the localised NET production in periodontitis.  
For example, in vivo NETs are produced in response to a diverse microbial biofilm, the host 
response is chronic, and inflammatory mediators may prime neutrophils prior to NET 
production (Matthews et al., 2007a, 2007b).  Notably, NET-evoked pro-inflammatory 
responses have been suggested to act synergistically with the presence of microbes, whereby 
immune response proteins in the extracellular milieu are required in addition to NET 
structures (Farrera & Fadeel 2013).  In accordance with this, several studies have suggested 
that NETs complexed with bacteria and anti-NET antibodies may be resistant to degradation 
and may exacerbate diseases such as cystic fibrosis (Dwyer et al., 2014) and small vessel 
vasculitis (SVV) (Kessenbrock et al., 2009).  Several of the peptides associated with the 
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NET-DNA backbone are reportedly autoantigens, such as MPO and PR3, which in SVV, 
trigger the release of anti-neutrophil cytoplasmic antibodies (ANCAs), and notably the 
production of ANCAs subsequently induce the production of NETs (Kessenbrock et al., 
2009).  Findings by Gomes et al., (2009) suggest this may also be of relevance in 
periodontitis, as the induction of experimental periodontitis in rats resulted in significantly 
elevated levels of MPO in the gingival tissues, however whether this was NET-bound MPO 
was not determined.  Furthermore, in the light of our findings that circulating IgG levels are 
higher in periodontitis patients (6.3.3), it’s noteworthy that IgG reportedly interacts with 
chromatin, and these IgG-chromatin complexes potentiate autoantibody production 
(Leadbetter et al., 2002).  Thus in chronic periodontitis, increased IgG levels, a bacterial 
biofilm and delayed NET removal may break immune tolerance, resulting in autoantibody 
production and further impeded NET removal which generates a self-perpetuating disease 
cycle.    
Histones represent 70% of NET-associated proteins (Urban et al., 2009) and are proposed to 
be key autoantigens in autoimmune diseases (Van Bavel et al., 2011).  Histones undergo 
post-translational modifications during the formation of NETs, whereby arginine residues are 
converted to citrulline by the enzymatic activity of PAD4.  Notably, autoantibodies produced 
in Felty’s syndrome, a form of rheumatoid arthritis, preferentially react with citrullinated 
histones; this suggests that NET release and the protein modifications required for this 
mechanism to occur are implicated in autoimmunity (Dwivedi et al., 2012, 2014).  Notably 
recent findings investigating the association between RA and periodontitis demonstrated 
higher levels of anti-citrullinated protein antibody (ACPAs) against citrullinated and 
uncitrullinated peptides in periodontitis patients.  It is possible that NET production in 
periodontal tissues may serve as a plausible mechanism for ACPA production following a 
break in immune tolerance to NET-derived citrullinated peptides released by neutrophils (de 
248 
 
Pablo et al., 2009), and this process may be exacerbated if NETs are not removed in a timely 
manner. 
The recent discovery that P. gingivalis possesses a unique PAD enzyme (PPAD) capable of 
citrullinating bacterial and host proteins might also contribute to the generation of ACPAs 
(Wegner et al., 2010).  It has been suggested that PPADs can likely disseminate from the 
bacterial biofilm, thus it is possible that NETs and PPADs interact during colonisation by P. 
gingivalis.  This raises questions as to whether PPADs have the ability to citrullinate proteins 
associated with NETs that would ordinarily be citrullinated by host PADs.  For example, the 
NET-bound peptide, LL-37, is citrullinated by host-derived PAD2 and PAD4, and certain 
citrullinated LL-37 peptides are reportedly pro-inflammatory relative to the uncitrullinated 
peptide (Kilsgard et al., 2012).  It is interesting to speculate that if P. gingivalis is also able to 
citrullinate NET-derived peptides that promote pro-inflammatory responses, it may utilise 
this mechanism to bring about non-resolving inflammation that is characteristic of 
periodontitis.  Furthermore, in SLE, LL-37 reportedly promotes the production of 
autoantibodies and the production of immune complexes that are capable of stimulating 
plasmacytoid dendritic cells to release type 1 IFN (Lande et al., 2011).  This may be of 
relevance in periodontitis, where the reduced NET degradation reported here may provide a 
possible explanation for the increased levels of type 1 IFN observed in chronic periodontitis 
patients (Wright et al., 2008).   
In summary, a subset of periodontitis patients displayed impeded NET degradation; however 
NET degradation was restored following successful non-surgical treatment.  This may be the 
result of increased circulating IgGs and FLCs in patients, which may provide a physical 
barrier preventing enzymatic removal of NETs; further experiments are however warranted to 
confirm this.  Subsequent assays to determine the effect of delayed NET removal 
demonstrated that NETs did not stimulate for neutrophil ROS production, further NET 
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release, or induce NET-mediated cytotoxicity in H400 cells.  Notably, NETs employed as 
neutrophil chemoattractants caused increased neutrophil migration speed, however this 
movement did not exhibit directionality.  Whilst no NET-induced pro-inflammatory 
responses were observed here, NETs are implicated in disease progression in several 
pathologies (Cooper et al., 2013), thus it is possible that in vitro assays do not fully mimic the 
in vivo environment in periodontitis, comprising a microbial biofilm, complex pro-
inflammatory mediators and chronic immune activation. 
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 EFFECT OF CIGARETTE SMOKE EXTRACT ON CHAPTER 7:
NEUTROPHIL RESPONSES 
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7.1 Introduction 
Smoking is a significant risk factor for periodontitis, and cigarette smoke extract (CSE) has 
previously been shown to impact upon neutrophil ROS production (section 1.7.3, Matthews 
et al., 2011, 2012).  However, there is no published data on the effects of CSE upon NET 
formation; therefore to further understand the impact of smoking on neutrophilic responses, 
healthy neutrophils were treated with CSE previously prepared (section 2.2.4.1, Matthews et 
al., 2011).  In addition to CSE, the effect of specific cigarette constituents on neutrophil 
responses was also assayed, including pre-incubation with nicotine, cotinine and thiocyanate 
(SCN-) (University of Birmingham Ethics Reference ERN_13-0325) (section 2.2.4.2.1). 
Neutrophil directional chemotaxis in response to the known chemoattractants, fMLP and IL-
8, was also measured in cells primed with increasing concentrations of CSE.  The speed, 
velocity and directional chemotactic accuracy were measured using the Insall chamber and 
real-time video microscopy (sections 2.2.4.2.3 & 2.2.4.2.4, Roberts et al., 2015).  Finally, the 
impact of CSE and SCN- treatment on neutrophil inflammatory and redox related gene 
expression was determined by real time PCR (2.2.4.3). 
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7.2 Effect of cigarette smoke extract on NET release 
NET production was determined as previously described by quantifying NET-DNA in the 
Sytox green assay (2.2.4.2.1, Appendix VIII) Matthews et al., 2011, 2012).  The effect of 
CSE (at concentrations of 1%, 5% or 10%) on NET release did not differ significantly from 
PBS-treated cells (unstimulated negative control) (1way ANOVA p=0.99, n=10) (Figure 
7.1a).  By contrast, CSE priming and subsequent stimulation with PMA (50nM) was 
associated with significantly decreased NET production at concentrations of 5% and 10% 
CSE (1way ANOVA and Dunnett’s post-tests *p<0.05, ****p<0.0001 for 5% and 10% CSE, 
respectively, n=10) (Figure 7.1b).  However, when cells were primed with CSE and 
stimulated with HOCl (0.75mM), no differences in NET production due to CSE priming were 
observed (1way ANOVA p=0.90, n=10) (Figure 7.1c). 
 
 Fluorescence visualisation of NETs following treatment with CSE 7.2.1
NET production in response to PMA (50nM) stimulation (Figure 7.2a) was qualitatively 
compared visually between neutrophils primed for 30 mins with increasing concentrations of 
CSE prior to stimulation (2.2.4.2.2).  NETs were visualised by fluorescence microscopy after 
staining with Sytox green, which targets DNA.  NET-like structures appeared aggregated 
when primed with 1% CSE prior to PMA stimulation (Figure 7.2b).  In contrast, cells that 
were primed with 5% or 10% CSE and subsequently stimulated with PMA did not form 
visible web-like structures, however aggregates of DNA were observed (Figures 7.2c&d).   
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Figure 7.1: Effect of cigarette smoke extract on NET production   
NET-DNA was quantified fluorometrically in response to stimulation with 1, 5 or 10% CSE 
and compared with PBS-treated cells (unstimulated negative control).  (a) 4 hour stimulation 
of neutrophils with CSE, (b) 30 min CSE priming prior to stimulation with PMA (50nM), (c) 
30 min CSE priming prior to stimulation with HOCl (0.75mM).  Statistical significance was 
calculated using 1way ANOVA and Dunnett’s post-tests (*p<0.05, ****p<0.0001, ns=not 
significant).  Data are presented as AFU (arbitrary fluorescence units) and are expressed as 
mean ± SEM (n=10 in triplicate).  
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Figure 7.2: Fluorescence visualisation of NETs in response to cigarette smoke extract 
NETs were visualised with Sytox green using fluorescence microscopy (x20 magnification), 
following stimulation with (a) PMA (50nM), or primed for 30 mins with (b) 1% CSE, (c) 5% 
CSE or (d) 10% CSE, prior to PMA stimulation.  Images are representative of 2 experiments 
in duplicate.  Scale bar represents 100µm.  
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7.3 Effect of CSE components on NET release 
To attempt to determine whether specific CSE components of CSE were contributing to the 
attenuated NET release observed, the effect of specific cigarette constituents on NET release 
were investigated, including nicotine, cotinine and SCN-. 
 
Effect of nicotine on NET production 
Nicotine stimulation (applied at concentrations of 1µg/ml, 5µg/ml or 10µg/ml) (2.1.4.1, 
2.2.4.2.1) did not alter NET production compared with unstimulated control cells (1way 
ANOVA p=0.23, n=10).  Nicotine priming for 30 mins and subsequent stimulation with 
PMA (50nM) and HOCl (0.75mM) was also found to have no apparent effect on NET 
release, compared with cells primed with PBS (1way ANOVA p=0.98, p=0.75 for PMA and 
HOCl respectively, n=10) (Figure 7.3a).   
 
Effect of cotinine on NET production 
Cotinine stimulation (applied at concentrations of 1µg/ml, 5µg/ml or 10µg/ml) (2.1.4.2, 
2.2.4.2.1) did not alter NET production compared with PBS (negative control cells) (1way 
ANOVA p=0.85, n=10).  Cotinine priming for 30 mins and subsequent stimulation with 
PMA (50nM) and HOCl (0.75mM) was also found to have no effect on NET release (1way 
ANOVA p=0.96, p=0.99 for PMA and HOCl respectively, n=10) (Figure 7.3b).   
 
Effect of thiocyanate on NET production 
SCN- stimulation at lower concentrations (applied at concentrations of 50µM, 100µM) 
(2.1.4.3, 2.2.4.2.1) did not alter NET production relative to unstimulated control cells.  
However stimulation with 150µM SCN
- 
resulted in a significant increase in NET release 
(1way ANOVA and Dunnett’s post-tests *p<0.05).  SCN- priming for 30 mins prior to PMA 
(50nM) stimulation inhibited NET release compared with un-primed neutrophils; this was 
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observed at all concentrations of SCN
- (1way ANOVA and Dunnett’s post-tests ***p<0.001 
for each concentration).  SCN- priming for 30 mins prior to HOCl (0.75mM) stimulation also 
inhibited NET release compared with un-primed neutrophils; this was observed in all 
concentrations of SCN
- (1way ANOVA and Dunnett’s post-tests ***p<0.001 for each 
concentration) (Figure 7.3c). 
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Figure 7.3a: Effect of nicotine on NET production   
NET-DNA production was quantified fluorometrically in response to stimulation with 
1µg/ml, 5µg/ml or 10µg/ml nicotine and PBS-treated cells (unstimulated negative control).  
(i) 4 hour stimulation of neutrophils with nicotine, (ii) 30 min nicotine priming prior to 
stimulation with PMA (50nM), (iii) 30 min nicotine priming prior to stimulation with HOCl 
(0.75mM).  Statistical significance was calculated using 1way ANOVA and Dunnett’s post-
tests (ns=not significant). Data are presented as AFU (arbitrary fluorescence units) and are 
expressed as mean ± SEM (n=5 in triplicate). 
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Figure 7.3b: Effect of cotinine on NET production   
NET-DNA production was quantified fluorometrically in response to stimulation with 
1µg/ml, 5µg/ml or 10µg/ml cotinine with PBS-treated cells (unstimulated negative control). 
(i) 4 hour stimulation of neutrophils with cotinine, (ii) 30 min cotinine priming prior to 
stimulation with PMA (50nM), (iii) 30 min cotinine priming prior to stimulation with HOCl 
(0.75mM).  Statistical significance was calculated using 1way ANOVA and Dunnett’s post-
tests (ns=not significant). Data are presented as AFU (arbitrary fluorescence units) and are 
expressed as mean ± SEM (n=5 in triplicate). 
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Figure 7.3c: Effect of thiocyanate (SCN-) on NET production 
NET-DNA production was quantified fluorometrically in response to stimulation with 50µM, 
100µM or 150µM SCN- and PBS-treated cells (unstimulated negative control). (i) 4 hour 
stimulation of neutrophils with SCN-, (ii) 30 min SCN- priming prior to stimulation with 
PMA (50nM), (iii) 30 min SCN- priming prior to stimulation with HOCl (0.75mM).  
Statistical significance was calculated using 1way ANOVA and Dunnett’s post-tests 
(*p=0.05, ***p<0.001, ns=not significant).   Data are presented as AFU (arbitrary 
fluorescence units) and are expressed as mean ± SEM (n=5 in triplicate).   
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 Fluorescence visualisation of NETs following nicotine, cotinine and thiocyanate 7.3.1
treatment 
 
NET production was visualised following 30 mins priming with increasing concentrations of 
nicotine, cotinine and SCN, and followed by stimulation with PMA (50nM) (2.2.4.2.2).  
Fluorescence microscopy of Sytox green stained DNA was employed.  Nicotine (1µg/ml, 
5µg/ml or 10µg/ml) and cotinine (1µg/ml, 5µg/ml or 10µg/ml) priming prior to PMA 
stimulation resulted in NET production, as shown by the extracellular web-like structures that 
stained positive with Sytox green.  In contrast, cells that were primed with SCN- (50µM, 
100µM or 150µM) prior to PMA stimulation formed no apparent NET-like structures, 
however aggregates of DNA were observed (Figure 7.4).  Sytox green can also stain non-
viable cells, as it is able to permeate the compromised cell membrane; however Sytox green 
staining does not differentiate between DNA derived from NETs and DNA released by other 
cell processes, such as necrosis.  It is therefore possible that SCN- treatment led to cell 
necrosis rather than NETosis (investigated in section 7.3.2).  
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Figure 7.4: Fluorescence visualisation of NETs in response to CSE and its key 
components 
NETs were visualised following Sytox green staining using fluorescence microscopy (x20 
magnification). NETs visualised in response to nicotine (a) 1µg/ml, (b) 5µg/ml or (c) 
10µg/ml; cotinine (a) 1µg/ml, (b) 5µg/ml or (c) 10µg/ml; or SCN- (a) 50µM, (b) 100µM or 
(c) 150µM.  Images are representative of 2 experiments in duplicate.  Scale bar represents 
100µm.  
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 Cell viability following treatment with CSE and CSE components  7.3.2
To determine whether reduced NET production may be due to CSE- or CSE components- 
induced neutrophil cell death, the effect of CSE and CSE components (nicotine, cotinine and 
SCN
-
) on neutrophil viability was compared with unstimulated cells (PBS).  Following 4 
hours of incubation, trypan blue exclusion revealed that CSE and CSE components did not 
significantly affect neutrophil viability (1way ANOVA p=0.23).  Data are presented as the 
percentage number of viable cells (Figure 7.5). 
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Figure 7.5: Cell viability following treatment with CSE and CSE components  
Percentage cell viability was determined by differential counts of cells stained with trypan 
blue (1:1 dilution).  Viability of neutrophils treated with CSE, nicotine, cotinine and SCN- 
was not significantly different from PBS-treated cells (unstimulated negative control). 
Statistical significance calculated using a 1way ANOVA (ns=not significant). Data are 
presented as the percentage of viable cells and are expressed as mean ± SEM (n=3 in 
duplicate).   
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7.4 Neutrophil chemotactic accuracy 
Neutrophil directional chemotaxis following 30 mins incubation with PBS (negative control) 
or CSE (1%, 5% or 10%) was determined by real-time video microscopy.  Neutrophil 
migration was measured in response to known chemoattractants, fMLP (100nM) and IL-8 
(10nM), as well as RPMI (negative control).  The movement of 15 randomly chosen cells 
(validated by H. Roberts) was tracked and the quantitative data generated used to generate 
spider plots and calculate neutrophil speed, velocity and resultant vector length.   
 
 Analysis of migration of CSE-treated neutrophils in response to fMLP using 7.4.1
spider plots 
 
Spider plots enable visualisation of individual cell movement (µm) from a central point, 
where the top of the Y-axis represents the source of the chemoattractant (100nM fMLP).  
Cells incubated with PBS displayed directional movement towards the source of the 
chemotactic signals.  However this directionality appeared reduced in cells incubated with 
increasing concentrations of CSE, demonstrated by the non-directional cell movement 
following 1% and, to a greater extent, 5% CSE treatment.  Cells incubated with 10% CSE 
showed minimal migrational movement in any direction (Figure 7.6). 
 
The movement of individual cells from a central point in response to IL-8 (10nM) was also 
visualised using spider plots.  Movement of cells incubated with PBS displayed directionality 
of movement towards the source of the chemotactic signals; however it was noted that IL-8 
did not behave as strongly as fMLP as a chemoattractant, evidenced by the reduced 
directionality in cell movement.  There was greater variation in cell movement following 
treatment with 1% and 5% CSE, with less directional movement towards the chemoattractant.  
Consistent with the observations for fMLP, neutrophils treated with 10% CSE exhibited very 
little movement in any direction (Figure 7.7). 
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fMLP: PBS control    fMLP: 1% CSE 
 
 
fMLP: 5% CSE    fMLP: 10% CSE 
 
 
Figure 7.6: Analysis of migration of CSE-treated neutrophils in response to fMLP using 
spider plots 
Spider plots of individual neutrophils (n=15 cells from n=5 experiments) from a central 
reference point (0, 0) in response to fMLP (100nM).  Cells were incubated with PBS 
(control) or CSE (1%, 5% or 10%) prior to the addition of fMLP.  The top of the Y-axis 
represents the source of the chemoattractant (fMLP).  Whilst PBS-treated neutrophils 
generally moved towards the source of the chemoattractant signal, CSE-treated neutrophils 
exhibited less directional movement.  
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Figure 7.7: Analysis of migration of CSE-treated neutrophils in response to IL-8 using 
spider plots 
Spider plots show the tracking (µm) of individual neutrophils (n=15 cells from n=5 
experiments) from a centre reference point (0, 0) in response to IL-8 (10nM).  Cells were 
incubated with PBS (control) or CSE (1%, 5% or 10%) prior to the addition of IL-8.  The top 
of the Y-axis represents the source of the chemoattractant (fMLP).   
Whilst PBS-treated neutrophils generally moved towards the source of the chemoattractant 
signal, CSE-treated neutrophils exhibited less directional movement.  
 
-150
-100
-50
0
50
100
150
-150 -100 -50 0 50 100 150
µm 
-150
-100
-50
0
50
100
150
-150 -100 -50 0 50 100 150
µm 
-150
-100
-50
0
50
100
150
-150 -100 -50 0 50 100 150
µm 
-150
-100
-50
0
50
100
150
-150 -100 -50 0 50 100 150
µm 
266 
 
Whilst spider diagrams represent a novel way to visualise cell migration in response to a 
chemoattractant, they cannot be used to quantify neutrophil movement.  Thus, the data 
generated from tracking 15 individual cells was used to quantify the speed, velocity and 
directional accuracy of neutrophil migration. 
 
7.4.1.1 Speed of CSE treated neutrophils 
The speed (µm/minute) of neutrophil chemotaxis in response to fMLP (100nM) significantly 
increased following incubation with 5% CSE, compared with cells incubated with PBS (1way 
ANOVA and Bonferroni post-test ***p<0.001, n=5).  However, treatment with 10% CSE 
resulted in significantly decreased speed of neutrophil migration in response to fMLP (1way 
ANOVA and Bonferroni post-test ***p<0.001, n=5).  Notably the speed of 10% CSE-treated 
neutrophils in response to fMLP was not significantly different from cells moving in response 
to the negative control chemoattractant, RPMI.  Neutrophil speed in response to IL-8 (10nM) 
following 10% CSE treatment was significantly lower than that for PBS controls (1way 
ANOVA and Bonferroni post-test ***p<0.001, n=5) (Figure 7.8).   
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Figure 7.8: Speed of CSE treated neutrophils 
Neutrophil speed (µm/min) following incubation with CSE (0 [PBS], 1%, 5% or 10%) in 
response to (a) fMLP (100nM), (b) IL-8 (10nM) and RPMI (negative control, shown on each 
graph).  Statistical significance was calculated using 1way ANOVA and Bonferroni post-tests 
(*p<0.05, ***p<0.001, ns=not significant).  Data calculated from the tracking of 15 cells and 
data is expressed as mean ± SEM (n=5). 
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7.4.1.2 Velocity of CSE treated neutrophils 
Velocity is the speed of movement in a specific direction towards a chemoattractant. 
Neutrophil velocity was significantly decreased in response to fMLP (100nM) following 
treatment with 1%, 5% and 10% CSE, compared with those treated with PBS (1way ANOVA 
and Bonferroni post-test *p<0.05, **p<0.01 and ****p<0.0001 for 1%, 5% and 10% for CSE 
treatment, respectively, n=5).  The velocity of 10% CSE-treated neutrophils in response to 
fMLP was not significantly different from cells moving in response to the negative control 
chemoattractant, RPMI (p>0.05).  Neutrophil velocity in response to IL-8 (10nM) was also 
significantly lower in CSE treated cells compared to cells incubated with PBS (1way 
ANOVA Bonferroni post-test ****p<0.0001 for 1%, 5% and 10% CSE treatment, n=5).  The 
velocity of 5% and 10% CSE-treated neutrophils in response to IL-8 was not significantly 
different from cells moving in response to the negative control chemoattractant, RPMI 
(p>0.05, n=5) (Figure 7.9). 
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Figure 7.9: Velocity of CSE treated neutrophils  
Neutrophil velocity (µm/minute) following incubation with CSE (0 [PBS], 1%, 5% or 10%) 
in response to (a) fMLP (100nM), (b) IL-8 (10nM) and RPMI (negative control, shown on 
each graph).  Statistical significance was calculated using 1way ANOVA and Bonferroni 
post-tests (*p<0.05, **p<0.01, ****p<0.0001, ns=not significant). Data calculated from the 
tracking of 15 cells and data is expressed as mean ± SEM (n=5). 
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7.4.1.3 Directional accuracy of neutrophil movement (resultant vector length) 
Representative angular histograms and resultant vector plots of neutrophils treated with PBS 
(control) or 10% CSE in response to fMLP (100nM) were produced.  The angular histograms 
measure cell directionality and strength of this directional movement, which is determined by 
the histogram bar angle and width, respectively.   
 
Angular histograms and resultant vector plots in response to fMLP 
Whilst there was a relatively strong movement towards the chemoattractant in cells treated 
with PBS (negative control), 10% CSE-treated neutrophils demonstrated very little 
directionality towards fMLP (100nM).  These plots are consistent with the histograms, where 
10% CSE-treated cells exhibited a lack of directional movement (Figure 7.10).   
 
Angular histograms and resultant vector plots in response to IL-8 
Representative angular histograms and resultant vector plots of neutrophils treated with PBS 
(control) in response to IL-8 (10nM) also demonstrated migration towards the source of the 
chemotactic signals.  However, whilst 10% CSE-treated cells were found to have reduced 
directional movement to IL-8, this was to a lesser extent than for fMLP (Figure 7.11). 
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Figure 7.10: Directional accuracy of neutrophil movement (resultant vector length) 
Representative angular histograms and resultant vector plots of neutrophils treated with PBS 
(control) or 10% CSE in response to fMLP (100nM).  The angle and width of the histogram 
bars indicates the direction and the proportion of cells migrating in that direction, 
respectively.  The resultant vector plots indicate the strength and directionality of the cells in 
response to the chemoattractant.  The red line denotes the mean resultant vector and the 
dashed line shows the variation (95% confidence intervals) within the entire cohort of cells.  
The length of the red line is indicative of the strength of cell directionality.  The blue circles 
along the circumference of the plot represent individual neutrophil migration end-points.  For 
both plots, 90° at the top of both plots represents the source of the chemoattractant (fMLP).  
The above plots show neutrophil directional chemotaxis is reduced in 10% CSE-treated 
neutrophils compared with PBS-treated control cells, evidenced by the distribution and 
strength of cell directionality. 
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Figure 7.11: Directional accuracy of neutrophil movement (resultant vector length) 
Representative angular histograms and resultant vector plots of neutrophils treated with PBS 
(control) or 10% CSE in response to IL-8 (10nM).  The angle and width of the histogram bars 
indicates the migrational direction and the proportion of cells migrating in that direction, 
respectively.  The resultant vector plots indicate the strength and directionality of the cells in 
response to the chemoattractant.  The red line denotes the mean resultant vector and the 
dashed line shows the variation (95% confidence intervals) within the entire cohort of cells.  
The length of the red line is indicative of the strength of cell directionality.  The blue circles 
along the circumference of the plot represent individual neutrophil migration end-points.  For 
both plots, 90° at the top of both plots represents the source of the chemoattractant (IL-8).  
The above plots show neutrophil directional chemotaxis is reduced in 10% CSE-treated 
neutrophils compared with PBS-treated control cells, evidenced by the distribution and 
strength of cell directionality. 
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7.4.1.4 Resultant vector length of CSE-treated neutrophil migration  
The resultant vector length measures the directional accuracy of neutrophil chemotaxis 
towards the chemoattractant.  The resultant vector lengths were calculated from the resultant 
vector plots, in which the red line denotes the mean resultant vector and the dashed line 
shows the variation (95% confidence intervals) within the entire cohort of cells.  The length 
of the red line is indicative of the strength of cell directionality.  Incubation of neutrophils 
with 5% and 10% CSE caused significant decreases in resultant vector length in response to 
fMLP (100nM), compared with cells incubated with PBS (negative control) (1way ANOVA 
and Bonferroni post-test *p<0.05, **p<0.001 for 5% and 10% CSE, respectively, n=5).  The 
resultant vector lengths of 5% and 10% CSE-treated neutrophils in response to fMLP was not 
significantly different from cells moving in response to the negative control chemoattractant, 
RPMI (p>0.05) (Figure 7.12a).  Neutrophil resultant vector lengths in response to IL-8 
(10nM) were also significantly lower in 5% and 10% CSE-treated cells compared with cells 
incubated with PBS (1way ANOVA and Bonferroni post-test **p<0.01, *p<0.05 for 5% and 
10% CSE treatment, respectively, n=5).  The resultant vector length of 5% and 10% CSE-
treated neutrophils in response to IL-8 was not significantly different from cells moving in 
response to the negative control chemoattractant, RPMI (p>0.05) (Figure 7.12b). 
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Figure 7.12: Resultant vector length of CSE-treated neutrophil migration 
Resultant vector length following incubation with CSE (0 [PBS], 1%, 5% or 10%) was 
determined in response to (a) fMLP (100nM), (b) IL-8 (10nM) and RPMI (negative control 
shown on each graph).  Statistical significance was calculated using 1way ANOVA and 
Bonferroni post-tests (*p<0.05, **p<0.01, ***p<0.001, ns=not significant). Data calculated 
from the tracking of 15 cells and data is expressed as mean ± SEM (n=5). 
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7.5 Gene expression following CSE and SCN- treatment 
Quantitative real-time PCR analysis was employed to compare neutrophil inflammatory and 
redox related gene expression profiles in response to CSE and SCN- treatment (Please also 
see Appendices IX, X, XI, XII).   
 
 Impact of CSE on neutrophil gene expression  7.5.1
Neutrophil gene expression of NF-ĸB, HSP40, IL-8, P-47phox, P-67phox and GP-91phox was 
quantified by real-time PCR following CSE treatment (1%, 5% or 10%).  Data are expressed 
as a ratio of the reference gene, YWHAZ, and RNA expression of cells treated with PBS 
(negative control) was normalised to 1.  In response to CSE treatment, HSP40 expression 
increased, and was statistically significant at concentrations of 5% and 10% CSE (2way 
ANOVA and Bonferroni post-tests ****p=0.0001 for 5% and 10%, n=3 technical repeats).  
Other trends included a CSE-concentration dependent decrease in NF-ĸB and GP-91phox 
expression.  Reduced expression of P-47
phox
 and P-67
phox 
was also observed, however these 
differences were not statistically significant (Figure 7.13a). 
 
 Impact of thiocyanate on neutrophil gene expression 7.5.2
Neutrophil gene expression of NF-ĸB, HSP40, IL-8, P-47phox, P-67phox, GP-91phox were 
quantified by real-time PCR following SCN- treatment (50µM, 100µM or 150µM).  Data are 
expressed as a ratio of the reference gene, YWHAZ, and RNA expression of cells treated 
with PBS (negative control) was normalised to 1. In response to all concentrations of SCN- 
treatment, HSP40 expression significantly increased (2way ANOVA and Bonferroni multiple 
comparisons tests ****p=0.0001 for 50µM, 100µM or 150µM, n=3 technical repeats).  The 
expression of P-47
phox
 increased, and was statistically significant following 150µM SCN- 
treatment (2way ANOVA and Bonferroni multiple comparisons tests ****p=0.0001, n=3 
technical repeats).  P-67
phox
 expression was also elevated following treatment with 100µM 
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and 150µM SCN- (2way ANOVA and Bonferroni multiple comparisons tests ****p<0.0001 
for both concentrations, n=3 technical repeats).  SCN- treatment at all concentrations was 
found to have an inhibitory effect on the expression of GP-91
phox;
 however this was not 
statistically significant (Figure 7.13b).  
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Figure 7.13: Gene expression following cigarette smoke extract or thiocyanate 
treatment 
Neutrophil gene expression following treatment with (a) CSE or (b) SCN- is expressed as a 
ratio to the reference gene, YWHAZ, and RNA expression in cells treated with PBS 
(unstimulated negative control) is normalised to 1.  Statistical significance was calculated 
using 1way ANOVA and Bonferroni post-tests (****p<0.0001).  Data is expressed as mean ± 
SEM (n=10 pooled biological repeats and n=3 technical repeats in triplicate). 
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7.6 Discussion 
The data reported in this chapter demonstrated that CSE has a differential effect upon ex vivo 
NET release, with CSE priming having an inhibitory effect upon PMA-induced NET 
production, but no effect on HOCl-induced NET formation.  However, direct stimulation of 
neutrophils with CSE did not trigger NET release (section 7.2).  This is in line with findings 
by Buls et al., (2015), who also demonstrated attenuated PMA-induced NET release 
following CSE treatment.  Notably the authors highlight commonalities between the effects 
of the anti-inflammatory drug Mesalazine and CSE, suggesting that smoking has a beneficial 
role in ulcerative colitis (UC) due to its ability to reduce NET release, and therefore reduce 
the aberrant inflammatory response.  Whilst this may be true in UC, an inflammatory 
condition characterised by an exaggerated neutrophil response in the absence of a microbial 
infection, disease severity in pathologies such as periodontitis is positively correlated with 
smoking (Grossi et al., 1994, 1995).  This may be due to the presence of a pathogenic biofilm 
in periodontitis, whereby reduced NET production as a result of smoking may indirectly 
associate with reduced bacterial clearance and thus disease chronicity.   
 
There is a paucity of literature investigating smoking and NET release, however there are 
several reports demonstrating the inhibitory effect of CSE on PMA-induced neutrophil ROS 
production (Ryder et al., 1998, Nguyen et al., 2001).  PMA is a potent agonist for PKC, 
which triggers neutrophil NADPH-oxidase activation, and subsequent ROS production and 
ROS-dependent NET release.  Whilst it is recognised that smoke exposure can alter PKC 
signalling and therefore influence cell inflammatory responses (Wyatt et al., 1999, Whang et 
al., 2013), the exact mechanisms involved in the cigarette-associated inhibition of neutrophil 
responses are not fully understood.  Reduced neutrophil total and extracellular ROS and 
superoxide following CSE pre-treatment (Matthews et al., 2011, 2012) have been observed in 
response to the periodontal pathogen, F. nucleatum.  This suggests that smoking may subvert 
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the elimination of periodontal bacteria, as neutrophils are unable to effectively kill the 
colonising pathogens.  No observable differences in HOCl-induced NET production 
following CSE priming supports a mechanism involving perturbed PKC signalling, as unlike 
PMA, HOCl activates neutrophils downstream of PKC (Palmer et al., 2012).  Notably the 
current data demonstrates that the inhibitory effects of CSE on NET release are not due to 
cytotoxic effects, as neutrophil viability was shown by trypan blue dye exclusion. 
 
No differences were observed in NET release following pre-treatment with nicotine or 
cotinine, which is consistent with previous reports showing no differences in ROS production 
as a result of nicotine or cotinine exposure (Matthews et al., 2011, 2012).  On the other hand, 
SCN- stimulation caused a concentration dependent increase in NET release, whilst SCN- 
priming reduced PMA- and HOCl-induced NET production (section 7.3).  SCN- is a product 
of hydrogen cyanide and the preferred substrate of MPO, which results in an increase in the 
production of hypothiocyanous acid (HOSCN) and a decrease in HOCl.  HOSCN levels are 
therefore of particular interest in smokers, as SCN- is markedly increased in the plasma of 
these individuals (Morgan et al., 2011).  HOSCN selectively reacts with thiols (such as 
glutathione) (Nagy et al., 2009), and due to elevations in HOSCN in smokers, causes 
increased depletion of thiols in these individuals.  Interestingly increases in HOSCN, 
following a switch from HOCl production as a result of increased SCN-, is believed to afford 
protection against non-thiol targets and HOCl-mediated tissue damage (Talib et al., 2012), 
yet HOSCN is still toxic towards pathogenic bacteria (Chandler et al., 2013).  Notably in 
order to benefit from increased levels of HOSCN, it is believed that adequate thiol repair 
systems are required, which if compromised, for example in smokers who reportedly have 
decreased antioxidant capacity (Reilly et al., 1996), increased levels of HOSCN may actually 
exacerbate tissue damage.  Thus Talib et al., (2012) concluded that equilibrium between 
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HOSCN and HOCl production is required, and whether this is deleterious or beneficial may 
depend upon each individual’s antioxidant defences.    
 
With that in mind, salivary SCN- is reportedly implicated in the delayed wound healing 
observed in smokers (Mosely et al., 1977).  Conversely, a study investigating the effects of 
SCN- on gingival health demonstrated that toothpaste containing SCN- and H2O2 can inhibit 
plaque accumulation and gingivitis in periodontally healthy non-smokers (Rosin et al., 2001).  
The authors hypothesise that this is the result of a synergistic process comprising the 
antimicrobial effects of SCN- and the ability of SCN- to enhance tissue regeneration (Kramer 
& Böhland 1996).  A further consideration, which may be of particular relevance in 
periodontitis, where neutrophils are the predominant immune cell, is that HOSCN has been 
shown to up-regulate adhesion molecules such as E-selectin and intracellular adhesion 
molecule-1 (ICAM-1) in in-vitro experiments with human umbilical vein endothelial cells 
(HUVEC).  Notably HOSCN-treated HUVEC monolayers bound 8-fold more neutrophils 
compared with untreated monolayers, which suggests HOSCN may promote neutrophil 
extravasation (Jian-Guo et al., 2006).  These findings may extend to periodontitis, whereby 
increased neutrophil accumulation in the gingival tissues of smokers, as a result of increased 
SCN-, may contribute to the self-perpetuating inflammation characteristic of the disease. 
Chemotaxis is the movement of cells along a chemical signal gradient towards an infectious 
stimulus, which is orchestrated by various chemoattactants.  During this process, neutrophils 
form pseudopods in the direction of the gradient following the ligation of GPCRs in response 
to chemoattactants (Andrew & Insall 2007).  Neutrophils pre-treated with CSE exhibited 
reduced speed, velocity and directionality (resultant vector length) relative to untreated 
neutrophils, in response to fMLP and IL-8 (7.4).  Notably, neutrophils were washed 
following pre-treatment with CSE, suggesting that the continued presence of CSE is not 
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required to exert its inhibitory effects on chemotaxis and thus transient cigarette exposure 
may have long-standing effects.  Neutrophil chemotaxis is believed to be modulated by ROS, 
as chemotaxis in CGD patients and healthy DPI-treated (DPI is an NADPH-oxidase inhibitor) 
neutrophils exhibit reduced directionality (Hattori et al., 2010).  The authors postulate that 
neutrophils produce multiple pseudopods and NADPH-derived ROS are involved in 
modulating neutrophil directionality by destroying pseudopods that are not in the direction of 
the chemoattractant.  This may be of interest in CSE-treated neutrophils, as CSE treatment 
has been found to have a significant inhibitory effect on neutrophil ROS release (Matthews et 
al., 2011, 2012); therefore reduced ROS as a result of CSE treatment may contribute to the 
reduced chemotactic directionality observed in these studies.  As previously discussed (1.7.3) 
smoking is a major risk factor for the development of periodontitis (Grossi et al., 1994, 
1995), and indeed recent findings by Roberts et al., (2015) have demonstrated that neutrophil 
chemotaxis is dysfunctional in chronic periodontitis patients.  
Conversely, whilst smoking may associate with reduced chemotaxis, the severity of 
periodontitis (determined by pocket depth) is positively correlated with neutrophil counts in 
dental plaque, saliva and GCF (Bhadbhade et al., 2012).  This suggests that whilst 
chemotactic accuracy may be compromised in periodontitis, neutrophils still reach the 
infected tissues, albeit with longer tissue transit times that may associate with increased 
neutrophil-mediated tissue damage.  Worthy of note is the role of the matrikine, proline-
glycine-proline (PGP), an extracellular matrix-derived peptide implicated in many cellular 
processes, including neutrophil chemotaxis, which is regulated by various MMPs, and 
increased levels have been reported to cause  dose dependent neutrophil chemotaxis (van 
Houweligen et al., 2008). Cigarette smoking is reported to increase MMP and PGP 
production, as well as inactivating leukotriene A4 hydrolase, which normally functions to 
reduce PGP-mediated neutrophil chemotaxis (Wells et al., 2014).  Collectively, these results 
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suggest that smoking promotes elevations in PGP-mediated neutrophil chemotaxis and 
recruitment; however whilst the contribution of smoking and PGP-mediated chemotaxis is 
described in inflammatory diseases such as COPD (Snelgrove et al., 2010), their role in 
periodontitis remains to be elucidated. 
 
Relative to the reference gene, YWHAZ, CSE and SCN- treatment caused a concentration 
dependent increase in neutrophil HSP40 expression (section 7.5.1).  HSPs are highly 
conserved molecular chaperones that are involved in the protection of other proteins by 
orchestrating processes such as protein translation and folding (Benjamin & McMillan 1998).  
HSP expression is elevated in response to cell stressors, such as heat shock (Edwards & 
Hansen 1996) and wound healing (Laplante et al., 1998), which affords protection and 
facilitates cell recovery.  HSP40 is also believed to interact with and regulate many processes 
performed by HSP70 (Fan et al., 2003). Guzik et al., (2011) demonstrated that HSP70 
significantly increases immediately following 100% CSE treatment, and notably HSP70 
reportedly confers cell protection by inhibiting caspase dependent and independent apoptosis.  
This is consistent with findings by Matthews et al., (2011), who also reported reduced 
neutrophil caspase-3 and -7 activity following CSE treatment.  Elevations in HSP40 in 
response to CSE and SCN- treatment shown in the current work may therefore suppress 
apoptosis by interactions with HSP70.  In the periodontal tissues of smokers, this may 
associate with neutrophil longevity and necrosis, which may contribute to exacerbated 
inflammation tissue damage and adverse treatment responses (Delima et al., 2010).      
 
Following treatment with SCN-, P-47
phox
 and P-67
phox 
gene expression levels were 
significantly increased.  Both P-47
phox
 and P-67
phox 
are cytosolic subunits that play a critical 
role in the activation of NADPH-oxidase (section 7.5.2).  The current findings investigating 
the ability of SCN- to stimulate neutrophils suggests that SCN- results in a concentration 
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dependent increase in NET release, which was supported by the gene expression data 
whereby SCN- activates NADPH-oxidase. It would be interesting to characterise this 
mechanism further by analysing gene expression in response to priming with SCN- prior to 
stimulation with periodontal bacteria, however due to time constraints this was not 
investigated in the present work.  Differences in P-47
phox
 and P-67
phox 
expression were not 
observed following CSE treatment, highlighting that despite SCN- being a major component 
of cigarette smoke, these substances alter neutrophil function by distinct mechanisms.  
Notably the expression of P-47
phox
 and P-67
phox 
does not differ between non-smoker chronic 
periodontitis patients and healthy controls (Matthews et al., 2007), suggesting that other 
mechanisms are involved in the exaggerated neutrophil responses observed in periodontitis.  
Furthermore, despite not reaching statistical significance, GP-91
phox
 expression was 
considerably lower in response to all concentrations of CSE and SCN- treatment.  Findings 
by Matthews et al., (2007) demonstrated that GP-91
phox
 expression was down-regulated in 
both healthy and periodontitis patient-derived neutrophils following stimulation with 
periodontal bacteria.  In SCN- treated cells, this may well be a protective mechanism to 
compensate for the increased expression of P-47
phox
 and P-67
phox 
observed following SCN- 
treatment. Notably, abolished GP-91
phox
 expression is characteristic of X-linked CGD, which 
is associated with reduced ROS production and consequently recurrent bacterial infections 
(Williams et al., 1995).  As previously discussed, decreased ROS production is reported in 
CSE-treated neutrophils (Matthews et al., 2011, 2012), thus it is possible that reduced GP-
91
phox
 gene expression also contributes to attenuated ROS release and the subsequent 
reductions in NADPH-oxidase dependent NET production observed in CSE and SCN- 
primed neutrophils.  
 
In conclusion, the presented data demonstrates that CSE and SCN- priming have an 
inhibitory effect on NET release, albeit these responses appear stimulus specific, and CSE 
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treated neutrophils exhibit reduced chemotaxis in response to known chemoattractants.  CSE 
and SCN- both promoted HSP40 expression; however differential Phox gene expression was 
observed in response to CSE and SCN- treatment.  Collectively these data suggest that 
cigarette smoking alters neutrophil activation and SCN- is one component of cigarettes that 
may contribute to the perturbed innate immune responses observed in vivo. 
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 NET PRODUCTION IN OTHER INFLAMMATORY CHAPTER 8:
PERIODONTAL DISORDERS: GINGIVITIS & PAPILLON 
LEFÈVRE SYNDROME 
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8.1 Introduction 
To enhance our understanding of the temporality of NET production following plaque 
accumulation and their contribution to periodontal tissue damage, studies of neutrophil 
function during the transition from health to gingivitis were performed (section 8.2).  In 
addition, NET production in patients with Papillon Lefèvre syndrome (PLS) was 
systematically evaluated in order to shed light upon key stages in the process, which may be 
dependent upon the cathepsin C and neutrophil serine proteases (NSPs) reported to be 
deficient in PLS patients (section 8.3). 
 
8.2 Experimental gingivitis 
To quantify peripheral neutrophil responses in experimental gingivitis, a split mouth 21-day 
experimental gingivitis model was investigated in 10 healthy volunteers (Loe et al., 1965).  
(2.2.6.2). Volunteers wore a mouth guard that covered the maxillary left 4-6 teeth (test) 
during brushing for 21 days (3 weeks) (South Birmingham Research Ethics Committee 
2004/074).  At day 21 of plaque accumulation all plaque was removed by prophylaxis and 
volunteers recommenced normal brushing prior to final assessment at day 35 (designated as 
return to health).  The maxillary right 4-6 teeth (control) were used as a control, as these teeth 
were subjected to normal oral hygiene procedures throughout the 21-day period of non-
brushing at test sites.  Neutrophils were isolated from the peripheral blood of volunteers to 
study NET production in response to known stimuli during transition from gingival health to 
gingivitis (2.2.3.3, 2.2.3.4).  Plasma-derived NET degradation and plasma levels of IgG (1-4 
subclasses) and FLCs were also determined (undertaken by The Binding Site Group Ltd, 
Birmingham, UK, sections 2.2.5.1, 2.2.5.2).  In addition, the effect of plaque on neutrophil 
ROS and NET responses were also investigated.  
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 Clinical measures of gingivitis 8.2.1
To confirm the development of gingival inflammation and subsequent resolution of gingivitis 
at 35 days, several clinical parameters were measured (section 2.2.6.3.2).  Plaque index (PI) 
and gingival index (GI) were recorded at days 0, 7, 14, 21 and 35 from test and control sites.  
The volume of gingival crevicular fluid (GCF) was also measured using a calibrated 
Periotron 8000
TM 
(Chapple et al., 1999).  GCF was collected over a 30 sec period by inserting 
Periopaper strips (OraFlow) into the mesio-buccal gingival crevices of test and control sites.  
All clinical parameters were measured immediately prior to blood collection for neutrophil 
assays by a single experienced examiner. 
 
8.2.1.1 Plaque index 
Mean plaque indices measured across 3 sites from volunteers at days 0, 7, 14, 21 and 35 were 
significantly higher at the test site compared with the control site at days 7, 14 and 21 (2way 
ANOVA and Bonferonni post-test **p<0.01, ****p<0.0001, ****p<0.0001 for days 7, 14 and 
21, respectively, n=10) (Table 8.1).   
 
8.2.1.2 Gingival index 
Mean gingival indices measured across 3 sites from volunteers at days 0, 7, 14, 21 and 35 
were significantly higher at the test site compared with the control site at days 14 and 21 
(2way ANOVA and Bonferonni post-test **p<0.01, *p<0.05 for days 14 and 21, respectively, 
n=10) (Table 8.2).   
 
8.2.1.3 Gingival crevicular fluid 
Mean gingival crevicular fluid (GCF) calibrated volumes recorded from 3 test and control 
sites at days 0, 7, 14, 21 and 35 were higher at test sites at days 7, 14 and 21; however this did 
not reach statistical significance (n=10) (Table 8.3).   
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Table 8.1: 21-day gingivitis model: plaque index 
Plaque indices were recorded from volunteers’ test and control sites at days 0, 7, 14, 21 and 35. Data are presented as mean plaque index across 
3 sites (mean ± SD and range) (n=10). 
 
 
 
Plaque Index 
Volunteer Number 
Control Test 
Day: 0 Day: 7 Day: 14 Day: 21 Day: 35 Day: 0 Day: 7 Day: 14 Day: 21 Day: 35 
1 1.33 0.67 0.33 0.33 0.33 1.00 1.67 1.33 4.67 0.00 
2 1.00 1.00 1.33 1.00 1.00 0.67 1.33 3.67 2.33 1.00 
3 1.67 1.33 1.33 1.33 0.67 1.00 1.00 1.67 3.67 0.33 
4 2.00 0.33 1.00 2.00 1.33 1.67 2.33 3.33 4.33 1.33 
5 1.33 0.67 0.00 0.33 0.33 1.67 3.67 5.00 5.00 1.00 
6 0.33 0.00 0.33 0.00 0.33 0.67 1.00 3.33 5.00 0.33 
7 2.00 1.00 1.00 1.00 2.33 1.67 3.67 5.00 5.00 2.00 
8 0.67 0.00 0.00 0.00 0.00 0.67 1.33 3.67 3.00 0.33 
9 0.33 0.00 0.33 0.00 0.33 0.33 1.67 3.00 2.00 0.33 
10 1.33 0.33 0.33 0.00 1.00 1.67 4.00 5.00 5.00 0.67 
Mean 1.2 0.5 0.6 0.6 0.8 1.1 2.2 3.5 4.0 0.7 
SD 0.6 0.5 0.5 0.7 0.7 0.5 1.2 1.3 1.2 0.6 
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Table 8.2: 21-day gingivitis model: gingival index 
Gingival index measurements were recorded from volunteers’ test and control sites at days 0, 7, 14, 21 and 35. Data presented as mean gingival 
index across 3 sites (mean ± SD and range) (n=10). 
 
 
Gingival Index 
Volunteer Number 
Control Test 
Day: 0 Day: 7 Day: 14 Day: 21 Day: 35 Day: 0 Day: 7 Day: 14 Day: 21 Day: 35 
1 0.00 0.00 0.33 0.33 0.33 1.67 0.33 1.00 0.33 0.33 
2 0.00 0.33 0.33 0.00 0.67 2.00 1.67 1.33 1.33 0.00 
3 0.00 0.00 0.00 0.67 0.00 0.67 0.33 0.33 0.33 0.00 
4 0.00 0.00 0.33 0.00 0.00 0.67 1.00 1.33 1.33 0.67 
5 0.33 0.67 1.33 0.67 0.00 0.33 1.00 1.67 1.67 0.00 
6 0.67 0.00 0.00 1.00 0.33 0.67 2.33 2.00 1.67 0.33 
7 0.67 0.00 0.33 0.00 0.00 1.00 1.00 2.33 2.00 1.33 
8 0.33 0.33 0.00 0.67 0.33 1.00 0.67 1.00 1.00 0.00 
9 0.33 0.00 0.00 0.00 0.00 0.00 0.67 0.33 0.33 0.00 
10 0.33 0.00 0.00 0.00 0.00 0.67 1.00 1.00 1.33 0.67 
Mean 0.3 0.1 0.3 0.3 0.2 0.9 1.0 1.2 1.1 0.3 
SD 0.3 0.2 0.4 0.4 0.2 0.6 0.6 0.6 0.6 0.4 
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Table 8.3: 21-day gingivitis model: gingival crevicular fluid volume 
Gingival crevicular fluid (GCF) volumes were recorded from volunteers’ test and control sites at days 0, 7, 14, 21 and 35. Data presented as 
mean volumes (µl) across 3 sites (mean ± SD and range) (n=10). 
 
Gingival crevicular fluid calibrated volumes (µl) 
Volunteer Number 
Control Test 
Day: 0 Day: 7 Day: 14 Day: 21 Day: 35 Day: 0 Day: 7 Day: 14 Day: 21 Day: 35 
1 0.06 0.17 0.11 0.08 0.08 0.12 0.21 0.18 0.36 0.14 
2 0.28 0.11 0.14 0.22 0.11 0.51 0.63 0.34 0.53 0.59 
3 0.05 0.03 0.06 0.39 0.06 0.06 0.23 0.23 0.79 0.52 
4 0.13 0.40 0.50 0.11 0.20 0.08 0.59 1.11 2.50 1.16 
5 0.07 0.32 0.25 0.49 1.38 0.15 1.08 0.56 0.39 2.64 
6 0.04 0.17 0.08 0.05 0.14 0.09 0.13 0.27 0.14 0.20 
7 0.54 1.12 0.33 1.29 0.24 0.68 3.75 5.12 4.92 0.33 
8 0.15 0.05 0.05 0.05 0.12 0.16 0.25 0.17 0.32 0.30 
9 0.06 0.15 0.07 0.07 0.10 0.07 0.14 0.08 0.09 0.06 
10 0.09 0.06 0.08 0.05 0.09 0.17 0.47 0.79 0.44 0.18 
Mean 0.1 0.3 0.2 0.3 0.3 0.2 0.7 0.9 1.0 0.6 
SD 0.2 0.3 0.1 0.4 0.4 0.2 1.1 1.5 1.5 0.8 
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 NET production during the 21-day experimental gingivitis model  8.2.2
Blood was collected from study volunteers at days 0, 21 and 35 to assay NET-DNA 
production in response to PMA (50nM) and HOCl (0.75mM) (2.2.3.3).  Baseline NET 
production in response to PBS (negative unstimulated control) was also quantified.  There 
was no significant difference in NET production between each time-point in any treatment 
condition (1way ANOVA p=0.1621, p=0.1092, p=0.0546 in response to PBS (unstimulated), 
PMA or HOCl, respectively, n=10) (Figure 8.1). 
 
 Visualisation of NET production during the 21-day experimental gingivitis model 8.2.3
There was no qualitative difference observed in NET production at days 0, 21 and 35 
(2.2.3.7).  Both PMA (50nM) and HOCl (0.75mM) produced NETs, and some PBS-treated 
neutrophils also stained positive for DNA, which is likely due to necrosis during the 
incubation period, which enables Sytox green to permeate the compromised cell membrane 
(Figure 8.2). 
 
  
292 
 
A
F
U
0 21 35 
0
2000
4000
6000
8000
ns
a) NET production in response to PBS
Time/days
A
F
U
0 21 35 
0
5000
10000
15000
20000
ns
b) NET production in response to PMA
Time/days
A
F
U
0 21 35 
0
5000
10000
15000
20000
25000
ns
c) NET production in response to HOCl
Time/days
 
Figure 8.1: NET production during the 21-day experimental gingivitis model  
NETs were quantified fluorometrically following a 3 hour incubation period at days 0, 21 and 
35.  (a) PBS (unstimulated negative control), (b) PMA-stimulated neutrophils (50nM) and (c) 
HOCl-stimulated neutrophils (0.75mM).  Statistical significance calculated using 1way 
ANOVA (ns=not significant). Data presented as arbitrary fluorescence units (AFU) and 
expressed as mean ± SEM (n=10 in triplicate). 
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Figure 8.2: Visualisation of NET production during the 21-day experimental gingivitis model              
NETs were visualised by fluorescence microscopy (x20 magnification) with Sytox green staining in response to PBS (negative unstimulated 
control), PMA (50nM) and HOCl (0.75mM) at days 0, 21 and 35.  Images are representative of 10 volunteers in duplicate.  Scale bar is 100µm. 
           PBS       PMA    HOCl 
0 days 
21 days 
35 days 
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 NET degradation by volunteer plasma during the 21-day experimental gingivitis 8.2.4
model  
To investigate the effect of gingivitis upon NET degradation by plasma, neutrophils were 
stimulated for NET production with HOCl (0.75mM) and NETs were subsequently subjected 
to 3 hours incubation with 10% plasma (2.2.5.1).  NETs from periodontally and systemically 
healthy volunteers were incubated with plasma derived from experimental gingivitis 
volunteers at 0, 21 and 35 days.  Following incubation, the number of degraded NETs was 
quantified fluorometrically using the Sytox green assay.  The percentage of NETs degraded 
was calculated in relation to a 15 min MNase digestion, which was used to represent the 
100% digestion standard (Hakkim et al., 2010).  In the 10 volunteers analysed there was no 
significant difference in NET degradation between the different time-points (1way ANOVA 
p=0.3828, n=10).  It was also noted that the lowest NET-degrading plasma (27%, 47% and 
26% at time-points 0, 21 and 35 days respectively) were from the same individual (Figure 
8.3).  
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Figure 8.3: NET degradation by volunteer plasma during the 21-day experimental 
gingivitis model 
HOCl-stimulated (0.75mM) neutrophils were incubated with 10% plasma from volunteers at 
days 0, 21 and 35.  NETs were quantified fluorometrically using the Sytox green assay. % 
NET degradation was calculated based on a 1Unit/ml MNase digest, which was used to 
represent the 100% standard.  Statistical significance calculated using 1way ANOVA (ns=not 
significant).  Data presented as % NET degradation and expressed as mean ± SEM (n=10 in 
triplicate). 
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Whilst NET degradation appeared unimpeded in experimental gingivitis relative to health, 
chronic periodontitis patients exhibited reduced NET degradation by plasma, which may be 
the result of increased levels of IgGs and free light chains (FLCs) (Chapter 6).  To determine 
whether volunteers with experimental gingivitis also had elevated levels of circulating IgGs 
and FLCs, IgG subclass 1-4 and FLC concentrations were measured in plasma collected at 
days 0, 21 and 35 (2.2.5.2, Appendix V). 
 
 
8.2.4.1 Plasma IgG concentrations during the 21-day experimental gingivitis model 
 
IgG subclasses 1-4 concentrations were measured in plasma samples from study volunteers at 
days 0, 21 and 35.  Protein turbidimetric analysis demonstrated no significant differences 
between the detection of IgG1, IgG2, IgG3 or IgG4 at the different time-points analysed (1 
way ANOVA p=0.903, p=0.996, p=0.924, p=0.952 for IgG1, IgG2, IgG3 and IgG4, 
respectively, n=10).  A small number of samples were outside of the IgG reference ranges 
(IgG1: 3.824-9.286g/L, IgG2: 2.418-7.003g/L, IgG3: 0.218-1.761g/L, IgG4 0.039-0.864) 
(Schauer et al., 2003), however, this was not associated with specific time-points in the 
gingivitis model (Figure 8.4). 
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Figure 8.4: Plasma IgG concentrations during the 21-day experimental gingivitis model 
IgG subclasses 1-4 concentrations were measured in plasma samples from study volunteers at 
days 0, 21 and 35.  Protein turbidimetric analysis demonstrated no significant difference 
between the detection of IgG1, IgG2, IgG3 or IgG4 at the different time points (1 way 
ANOVA, ns=not significant).  Data expressed as means ± SEM (n=10).   
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8.2.4.2 Plasma FLC concentration during the 21-day experimental gingivitis model 
 
Free kappa and lambda light chains were measured in plasma samples from study volunteers 
at days 0, 21 and 35.  Protein turbidimetric analysis demonstrated no significant differences 
between the detection of free kappa light chain, free lambda light chains, the kappa/lambda 
ratio or summated FLC values (1 way ANOVA p=0.972, p=0.741, p=0.969, p=0.833 for 
free kappa light chain, free lambda light chains, kappa/lambda ratio or summated FLC values, 
respectively, n=10).  A small number of samples were outside of the reference ranges (free 
kappa light chains: 3.3-19.4mg/litre, free lambda light chains: 5.71-26.3mg/litre, 
kappa/lambda ratio: 0.26-1.65, summated FLC: 9.01-45.7) (Katzmann et al., 2002), however, 
this was not associated with specific time-points in the gingivitis model (Figure 8.5). 
  
299 
 
Time/days
m
g
/l
it
re
0 21 35
0
5
10
15 ns
a) Kappa
Time/days
m
g
/l
it
re
0 21 35
0
5
10
15
20 ns
b) Lambda
Time/days
0 21 35
0.0
0.5
1.0
1.5
K
a
p
p
a
/L
a
m
b
d
a
 r
a
ti
o
ns
c) Kappa/Lambda ratio
Time/days
S
u
m
m
a
te
d
0 21 35
0
10
20
30
40 ns
d) Summated FLC
 
 
Figure 8.5: Plasma FLC concentration during the 21-day experimental gingivitis model 
Free kappa and free lambda light chains, the kappa/lambda ratio and summated FLCs were 
measured in plasma samples from study volunteers at days 0, 21 and 35.  Protein 
turbidimetric analysis demonstrated no significant difference between the detection of free 
kappa light chain, free lambda light chains, the kappa/lambda ratio or summated FLC values 
(1 way ANOVA, ns=not significant).  Data expressed as means ± SEM (n-10).   
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The ability of a plaque biofilm to stimulate neutrophil responses 
Increasing concentrations of plaque were employed as a stimulus for ROS and NETs in 
neutrophils derived from a healthy volunteer to investigate whether plaque activates 
neutrophil effector functions (2.2.6.2.4).  Neutrophil NET and ROS production were 
quantified in response to stimulation with plaque at increasing percentage concentrations (0, 
12.5, 25, 50 75 and 100%), compared with PMA (50nM) stimulation (Figure 8.6).  There was 
a gradual increase in NET and ROS production in response to neutrophil stimulation by 
plaque (n=2).  Based on these results, subsequent experiments assaying NET and ROS 
production in response to plaque derived from the experimental gingivitis model were diluted 
in PBS and used at 25%. 
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Figure 8.6: The ability of a plaque biofilm to stimulate neutrophil responses 
The effect of increasing concentrations of plaque (0, 12.5, 25, 50, 75 and 100%) and PMA 
(50nM) on neutrophils (a) ROS and (b) NET production.  Data expressed as mean ± SEM.  
Data is presented as (a) RLU (relative light units) and (b) AFU (arbitrary fluorescence units) 
(n=2 in triplicate). 
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 Neutrophil ROS and NET production in response to plaque stimulation 8.2.5
Plaque was collected from test and control sites from 10 volunteers at days 0, 7, 14, 21 and 
35.  Plaque samples (n=10) were homogenised, pooled and diluted (to 25% of the original 
concentration) for subsequent assays in which plaque was employed as a stimulus for NET 
and ROS production in healthy volunteers (n=5) (2.2.6.2.4).  To characterise the plaque 
samples collected, the amount of protein (2.2.6.2.5.3), LPS (2.2.6.2.5.1) and DNA 
(2.2.6.2.5.2) in the pooled plaque samples were measured to enable the ROS and NET 
quantification results to be normalised for the plaque content.   
 
ROS production normalised for protein content 
Plaque collected from test sites at 7, 14 and 21 days induced significantly higher ROS 
production after normalising for plaque protein content (2way ANOVA and Bonferroni post-
tests **p<0.01, ****p<0.0001 and **p=0.01 at days 7, 14 and 21, respectively, n=10 samples 
and n=5 technical repeats) (Figure 8.7a) 
 
ROS production normalised for LPS content 
Plaque collected from test sites at 7, 14 and 21 days induced significantly higher ROS 
production after normalising for plaque LPS content (2way ANOVA and Bonferroni post-
tests *p<0.05, ****p<0.0001, **p<0.01 at days 7, 14 and 21, respectively, n=10 samples and 
n=5 technical repeats) (Figure 8.7b) 
 
ROS production normalised for DNA content 
Plaque collected from test sites at 7, 14 and 21 days induced significantly higher ROS 
production after normalising for plaque DNA content (2way ANOVA and Bonferroni post-
tests ****p<0.0001, ****p<0.0001, *p<0.05 at days 7, 14 and 21, respectively, n=10 samples 
and n=5 technical repeats) (Figure 8.7c). 
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Figure 8.7: ROS production in response to plaque stimulation 
ROS production was quantified in response to plaque stimulation (25%) collected at 0, 7, 14, 
21 and 35 days from test and control sites and employed as a stimulus on healthy volunteer 
neutrophils.  ROS production was normalised for (a) plaque protein content, (b) plaque LPS 
content, (c) plaque DNA content.  Statistical significance was calculated using 2way 
ANOVA and Bonferroni post-tests (*p<0.05, ****p<0.0001). Data presented as RLU 
(relative light units) and expressed as mean ± SEM (n=10 samples and n=5 technical repeats).   
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NET production normalised for protein content 
Plaque collected from test sites at 7, 14 and 21 days induced significantly higher NET 
production after normalising for plaque protein content (2way ANOVA and Bonferroni post-
tests p<0.01, p<0.0001, p=0.01 for days 7, 14 and 21, respectively, n=10 samples and n=5 
technical repeats) (Figure 8.8a). 
 
NET production normalised for LPS content 
Plaque collected from test sites at 7, 14 and 21 days induced significantly higher NET 
production after normalising for plaque LPS content (2way ANOVA and Bonferroni post-
tests p<0.01, p<0.0001, p<0.01 at days 7, 14 and 21, respectively, n=10 samples and n=5 
technical repeats) (Figure 8.8b). 
 
NET production normalised for DNA content 
Plaque collected from test sites at 7 and 14 days induced significantly higher NET production 
after normalising for plaque DNA content (2way ANOVA and Bonferroni post-tests 
p<0.0001for days 7 and 14, n=10 samples and n=5 technical repeats) (Figure 8.8c). 
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Figure 8.8: NET production in response to plaque stimulation 
NETs were quantified in response to plaque stimulation (25%) collected at 0, 7, 14, 21 and 35 
days from test and control sites and employed as a stimulus on healthy volunteer neutrophils. 
NET production was normalised for (a) plaque protein content, (b) plaque LPS content, (c) 
plaque DNA content.  Statistical significance was calculated using 2way ANOVA and 
Bonferroni post-tests (*p<0.05, **p<0.01, ****p<0.0001). Data presented as AFU (arbitrary 
fluorescence units) and expressed as mean ± SEM (n=10 samples and n=5 technical repeats).   
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8.3 Papillon Lefèvre syndrome 
The release of NETs represents a multi-stage process that is reliant on the neutrophil serine 
protease (NSP), neutrophil elastase (NE) (Papayannopoulos et al., 2010).  NE is activated by 
cathepsin C, which is the deficient cysteine protease in PLS patients.  Therefore, PLS patients 
provide an interesting clinical model for the study of NET biology in relation to periodontitis. 
NET responses in PLS patients with severe pre-pubertal periodontitis were investigated 
alongside healthy gender-matched controls (2.2.6.4).  All PLS patients were genotyped, 
assessed for co-morbidities and their dermatological and periodontal health determined 
(2.2.6.4.1).  Neutrophils were isolated from patients and controls to investigate what effect 
cathepsin C deficiency in PLS had upon peripheral NET production.  NETs were quantified 
by the release of NET-DNA (Sytox green) and also NET-bound proteases (neutrophil elastase 
[NE], myeloperoxidase [MPO] and cathepsin G [CG]) (2.2.3.3, 2.2.3.4).  Plasma samples 
were also collected from patients and controls and subsequent experiments analysed plasma 
samples for the expression of NE and LL-37 (2.2.6.4.2).  Whilst the production of NET-DNA 
was quantified in all patients, due to low patient blood neutrophil counts, subsequent NET 
assays did not include patient 1 or 2. 
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Table 8.4: Clinical measures of PLS  
PLS patient volunteer information, including age, sex, ethnicity, PLS type, mutation, oral health, dermatological health, co-morbidities and 
current medication.  Abbreviations: BMI, (body mass index), PPK (palmar plantar hyperkeratosis) 
 
 
Volunteer 
no. 
Age Sex Ethnicity BMI PLS type Mutation Oral health 
Dermatological 
health 
Co-morbidities Medication 
1 12 Male Caucasian 18.93 Heterozygous 
1/2 G139R; 1/2 
N427T 
No significant 
pocketing 
No skin problems None recorded None recorded 
2 14 Female Indian 19.90 Heterozygous Unidentified 
Tooth pain & 
discomfort, teeth 
very mobile, 
bleeding on 
brushing. 
Moderate PPK 
β-thalassemia 
carrier (from 
mother) 
None recorded 
3 14 Female Pakistani 20.04 Homozygous 2/2 R272P Dentures 
PPK - quite bad 
on feet, deep 
fissures; hands ok 
None recorded 
Acitretin once 
daily. Vitamin 
D replacement 
therapy 
4 9 Male Pakistani 22.83 Not done 2/2 R272P 
Teeth OK and good 
oral hygiene. 
Lips prone to 
cracking 
Vitamin D 
deficiency.  
Previous cerebral 
intracranial 
abscesses. 
Acitretin once 
daily 
5 14 Male Pakistani 18.15 Homozygous 2/2 R272P 
Dentures with pain 
on replacing and 
denture stomatitis. 
Mild PPK - hands 
very good 
History of recurrent 
infections since 
birth. 
Acitretin once 
daily 
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 Comparison of NET production by PLS patients and healthy controls 8.3.1
Venous blood was collected from PLS patients and controls to quantify their NET-DNA 
production in response to a 4 hour stimulation with PMA (50nM), HOCl (0.75mM), 
opsonised S. aureus (5x10
7 
and MOI of 500), S. gordonii (1x10
8 
and MOI of 1000) or F. 
nucleatum poly (1x10
8 
and MOI of 1000) (2.2.3.3).  Baseline NET production in response to 
PBS (unstimulated negative control) was also quantified.  There was no significant difference 
in NET-DNA production between patients and controls in response to PBS (2way ANOVA 
and Bonferroni post-tests p>0.05).  Systemically and periodontally healthy controls exhibited 
higher NET release in response to stimulation, which was statistically significant for PMA, 
HOCl and F. nucleatum poly (2way ANOVA and Bonferroni post-tests p<0.0001, p<0.0001, 
p<0.001, respectively) (Figure 8.9a).  
 
8.3.1.1 Quantification of NET-bound components in PLS patients and healthy controls 
In addition to quantifying NET-DNA, NET release from PLS patients and controls was 
determined by quantifying NET-bound proteins (2.2.3.4).  NE, MPO and CG were 
colorimetrically quantified in response to 4 hours stimulation with PMA (50nM), HOCl 
(0.75mM), A. actinomycetemcomitans (serotype b) or V. parvula (all bacteria at 1x10
8 
and 
MOI of 1000) and PBS (unstimulated negative control).    
 
Quantification of NET-bound neutrophil elastase 
Healthy controls produced significantly more NETs, as determined by NET-bound neutrophil 
elastase (NE), compared with PLS patients in response to PMA (50nM), HOCl (0.75mM), A. 
actinomycetemcomitans (serotype b) and V. parvula (all bacteria at 1x10
8 
and MOI of 1000) 
(2way ANOVA and Bonferroni post-tests ****p<0.0001, ****p<0.0001, ***p<0.001, 
****p<0.0001, respectively). There was no difference between control and patient NET 
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production in response to PBS (unstimulated negative control) (2way ANOVA and 
Bonferroni post-tests p>0.05) (Figure 8.9b).   
Quantification of NET-bound myeloperoxidase 
Healthy controls produced significantly more NETs, as determined by NET-bound 
myeloperoxidase (MPO), compared with PLS patients in response to PMA (50nM), HOCl 
(0.75mM), A. actinomycetemcomitans (serotype b) and V. parvula (all bacteria at 1x10
8 
and 
MOI of 1000) (2way ANOVA and Bonferroni post-tests *p<0.05, ***p<0.001, *p<0.05, 
*p<0.05, respectively). There was no difference between control and patient NET production 
in response to PBS (unstimulated negative control) (2way ANOVA and Bonferroni post-tests 
p>0.05) (Figure 8.9c).   
 
Quantification of NET-bound cathepsin G 
Healthy controls produced significantly more NETs, as determined by NET-bound cathepsin 
G (CG), compared with PLS patients following stimulation with HOCl, A. 
actinomycetemcomitans (serotype b) or V. parvula (2way ANOVA and Bonferroni post-tests 
****p<0.0001, ***p<0.001, ****p<0.0001, respectively). There was no difference between 
control and patients NET production in response to PMA or PBS (unstimulated negative 
control) (Figure 8.9d). 
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c) NET-bound myeloperoxidase 
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Figure 8.9: Comparison of NET production by PLS patients and healthy controls 
NET bound (a) NET-DNA (n=5 patients, n=4 controls) (b) NET-bound NE, (c) NET-bound 
MPO and (d) NET-bound CG were quantified in PLS patients and healthy controls 
fluorometrically in response to 4 hours of stimulation with PMA (50nM), HOCl (0.75mM), 
opsonised S. aureus (5x10
7 
and MOI of 500), or heat-killed bacteria (1x10
8 
and MOI of 
1000).  Statistical significance was calculated using 2way ANOVA and Bonferroni post-tests 
(*p<0.05, ***p<0.001, ****p<0.0001).  Data is presented as (a) AFU (arbitrary fluorescence 
units), (c) U/ml or (d, e) mU/ml and expressed as mean ± SEM (quantification of NET-bound 
components n=3 pairs). 
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 Fluorescence visualisation of NET production in PLS patients 8.3.2
A qualitative difference was observed in NET production between PLS patients and healthy 
controls, with patients producing fewer PMA-induced (50nM) extracellular web-like 
structures that stained positive with the DNA-stain, Sytox green (2.2.3.7).  No difference in 
NET production was observed between patients and controls in PBS-treated neutrophils, 
however some cells stained positive for DNA, which is likely to be cells that have necrosed 
during the incubation period and enabled Sytox green to permeate the compromised cell 
membrane (Figure 8.10). 
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Figure 8.10: Fluorescence visualisation of NET production in PLS patients 
NETs were visualised (x10 magnification) with Sytox green in response to treatment with 
PBS (negative control) or PMA (50nM) for 3 hours.  Images are representative of 5 
experiments performed in duplicate.  Scale bar represents 100µm. 
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 Quantification of plasma NE in PLS 8.3.3
 
Plasma was isolated from the peripheral blood of PLS patients and controls (2.2.6.2.3).  
Plasma-derived NE was quantified by ELISA and demonstrated significantly less NE in PLS 
patients (Mann-Whitney *p=0.0294) (2.2.6.4.2.1).  A NE standard curve enabled absorbance 
readings to be converted into ng/ml of NE (Figure 8.11a). 
 
 Quantification of plasma LL-37 in PLS  8.3.4
 
Plasma was isolated from the peripheral blood of PLS patients and controls (2.2.6.2.3).  
Plasma-derived LL-37 was quantified by ELISA and demonstrated significantly less LL-37 
in PLS patients (Mann-Whitney *p=0.0297) (2.2.6.4.2.2).  An LL-37 standard curve enabled 
absorbance readings to be converted into ng/ml of LL-37 (Figure 8.11b). 
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Figure 8.11: Quantification of plasma derived neutrophil elastase and LL-37 in PLS 
Plasma derived (a) NE and (b) LL-37 were quantified in plasma from PLS patients and 
healthy controls by ELISA.  Statistical significance was calculated using Mann-Whitney tests 
*p=0.0294, *p=0.0297 for NE and LL-37, respectively). Data presented as ng/ml and 
expressed as mean ± SEM (n=4 pairs). 
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8.4 Discussion 
Gingivitis is an inflammatory response to bacterial plaque that precedes periodontitis in 
susceptible individuals (Hajishengallis 2014).  Gingivitis, whilst normally chronic in nature, 
can be rapidly induced and reversed, and therefore the 21-day gingivitis model developed by 
Loe et al., (1965) constitutes a useful model to investigate the role of a supragingival plaque 
biofilm in the pathogenesis of periodontal disease and systemic diseases with periodontal 
manifestations.  In the current study, no significant differences were observed in peripheral 
blood NET production during the 21-day gingivitis model (section 8.2.2).  This is not 
unexpected, as peripheral NET release by chronic periodontitis patients was no different to 
healthy controls (Chapter 5).  Furthermore, there was no significant difference in plasma-
derived NET degradation or plasma levels of IgG and FLCs throughout the gingivitis study 
period.  Clinical measures of inflammation increased up to 21 days (plaque accumulation) on 
the test side, followed by a decrease at 35 days (return to health), which confirms volunteer 
compliance and the validity of the study for both the induction and resolution of 
inflammation (section 8.2.1).  Consistent with our findings, Wahaidi et al., (2009) 
demonstrated no systemic oxidative response to the accumulation of plaque in a 21-day 
gingivitis model.  Conversely, it has been reported that plaque accumulation during the 21-
day experimental gingivitis model results in significant increases in peripheral blood 
neutrophil counts (Kowolik et al., 2001). 
 
Plaque was collected from test and control sites at 0, 7, 14, 21 and 35 days and pooled.  
Plaque was used as a stimulus for neutrophil ROS and NET production, and results 
normalised to plaque DNA, LPS and protein content.  Neutrophil ROS and NET production 
increased in response to homogenised plaque collected from test sites at 7, 14 and 21 days 
(plaque accumulation), and there was no difference at 0 (baseline) or 35 days (return to 
health) (section 8.2.5).  Given that all results were normalised to the plaque content (DNA, 
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LPS, protein content), this data suggests that increased neutrophil responses may be due to 
changes in plaque composition, rather than the quantify.  However, microbial characterisation 
of the biofilm was not performed as part of this study, however this would be interesting to 
explore.  Indeed, a study by Eberhard et al., (2013) which identified bacterial species in 
plaque produced from a 21-day experimental gingivitis model included species such as P. 
gingivalis, F. nucleatum and V. parvula, and notably, experiments in Chapter 4 revealed that 
these bacterial species were capable of stimulating healthy neutrophils to produce ROS and 
NETs.  Consistent with this, Hirschfeld et al., (2015) demonstrated that the 21-day plaque 
biofilm comprises neutrophils and NET structures.  The authors hypothesised that neutrophils 
are recruited to supragingival plaque, where they exert bactericidal activity, such as 
phagocytosis, degranulation and NET release.  However, as discussed previously (Chapter 4), 
further work is needed to elucidate whether NETs prevent bacterial dissemination, or whether 
the infiltration of neutrophils and the release of NETs in supragingival plaque actually 
promotes biofilm stability and growth (Hirschfeld et al., 2015). 
 
The study population may be a limitation of the current study, as whilst there were both male 
and female volunteers, all volunteers were aged between 19 and 21.  Furthermore it has been 
suggested that the 21-day model of experimental gingivitis may not fully reflect persistent 
chronic gingivitis, as a study by Loesche & Grossman (2001) comparing experimental and 
chronic gingivitis revealed that volunteers enrolled in the 21-day model demonstrated higher 
levels of plaque accumulation.  This discordance is believed to be a limitation of the 
experimental model, for example, individuals with persistent gingivitis do not neglect all 
forms of oral hygiene (as is the case with the vinyl mouth guard), and gingivitis is a chronic 
state that persists for longer than 21 days. 
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PLS is an autosomal recessive disease causes by a mutation in the CTSC gene that encodes 
the lysosomal cysteine protease, cathepsin C.  Cathepsin C plays a vital role in the post-
translational processing of neutrophil serine proteases (NSPs), where it removes N-terminal 
amino acids that block the active site of NSPs.  Thus, a lack of cathepsin C results in the 
production of NSPs that do not exhibit enzymatic activity.  NSPs, such as NE, CG and PR3, 
are synthesised as inactive pro-enzymes in the bone marrow and prior to storage in neutrophil 
azurophilic granules as zymogens, they undergo cathepsin-C mediated processing.  In 
response to neutrophil activation, these lysosomal proteins are released into the 
phagolysosome or undergo limited exocytosis to facilitate bacterial clearance.  The loss of 
cathepsin C activity in PLS patients results in the cessation of NSP function and stability, 
which is associated with severe periodontal destruction (Sorensen et al., 2014).   
 
This study demonstrated impeded NET release in PLS patients (NET-DNA and NET-bound 
components) (sections 8.3.1, 8.3.1.1), which is consistent with recent findings by Sorensen et 
al., (2014), who demonstrated abrogated NET release in a single adult female PLS patient.    
It is postulated that the reduced NET production is a result of dysfunctional NE in PLS 
patients (Sorensen et al., 2014), as Papayannopoulos et al., (2010) demonstrated that NE is 
necessary for NET release.  Following neutrophil activation, NE is reportedly released from 
azurophilic granules and translocates to the nucleus where it promotes chromatin 
decondensation prior to NET expulsion (Papayannopoulos et al., 2010).  The importance of 
NE in NET production is also exemplified in ELA2-neutropenia, in which deficient NE 
associates with diminished NET production; however this is not observed when NE is fully 
functional in HAX1-neutropenia (Happle et al., 2011).  In the absence of post-translational 
processing in PLS patients, NSP proforms have been suggested to either be constitutively 
released following their synthesis in the bone marrow (Garwicz et al., 2005), or degraded 
(Pham & Lay 1999).  Indeed Sorensen et al., (2014) demonstrated that NSP production and 
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allocation to granules appeared normal in PLS immature neutrophils, however the proteins 
were absent from mature neutrophils; suggesting NSPs are degraded prior to their release 
from the bone marrow.  Accordingly, in the current study NE levels were significantly lower 
in patient-derived plasma samples, relative to the controls (section 8.3.3). 
 
In healthy individuals PR3 cleaves cathelicidin (hCAP-18) extracellularly to produce the 
bactericidal peptide LL-37.  In PLS patients, deficient LL-37 results from a failure to encode 
fully functioning cathepsin C, and consequently compromised PR3 activity.  Confirming this, 
LL-37 was significantly lower in PLS plasma samples relative to healthy controls (section 
8.3.4).  This is consistent with the findings of de Haar et al., (2006), who reported that in 
addition to LL-37 deficiency, neutrophils derived from PLS patients demonstrate a reduced 
capacity to kill A. actinomycetemcomitans compared with healthy controls.  This may, 
however, be a direct result of inhibited LL-37 antimicrobial activity, as LL-37 is reportedly 
involved in the clearance of A. actinomycetemcomitans (Ji et al., 2007).  Notably patients 
with Morbus Kostmann syndrome, a severe congenital neutropenia that is associated with 
LL-37 deficiency, are also susceptible to a high prevalence of A. actinomycetemcomitans 
infection and severe periodontitis in adulthood (Putsep et al., 2002, Gonzales & Frydman 
2014); supporting the hypothesis that LL-37 plays a vital role in bacterial clearance.  It has 
also been suggested that the overgrowth of A. actinomycetemcomitans in PLS patients may 
provide favourable conditions for the proliferation of other periodontal bacteria, such as P. 
gingivalis (Eick et al., 2014). 
It is noteworthy that despite the loss of function of NSPs, the associated immunodeficiency is 
modest, with 15-20% of patients reporting recurrent infections, such as tonsillitis and liver 
abscesses (Sorensen et al., 2014, Almuneef et al., 2002).  Accordingly, the physical 
examination of one patient revealed that IgGs, complement, as well as T- and B-cell 
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responses were within the normal reference ranges (Sorensen et al., 2014).  The fact that 
patients do not succumb to major illnesses, and also reports from in vitro studies 
demonstrating that PLS neutrophils elicit normal bactericidal activity against infection (Pham 
et al., 2004), suggests that NSPs do not constitute the only antimicrobial defence mechanism.  
This also indicates that NE-dependent NETs may not play a critical role in host defence, or 
that alternative compensatory defence mechanisms have evolved in PLS.  It is also unlikely 
that deficient NET release accounts for the severe periodontitis observed in PLS, as CGD 
patients, who also lack the ability to produce NETs, do not present with severe periodontal 
destruction (Bianchi et al., 2009).  Thus, severe periodontitis may be the result of other 
neutrophil abnormalities, such as perturbed chemotaxis, which is reportedly defective in PLS 
patients.  However, normal neutrophil levels are reported in the GCF of PLS patients, 
suggesting that whilst the neutrophils are recruited normally, they may exhibit longer tissue 
transit times and contribute to collateral periodontal tissue destruction (Firatli et al., 1996).  A 
possible explanation for the mild systemic immunodeficiency observed in PLS are recent 
findings by Glenthoj et al., (2015), who demonstrated that NSPs are not required for the 
processing and activity of neutrophil α-defensins, which are a family of peptides that possess 
antimicrobial activity.  Notably, PLS patients are able to synthesise α-defensins, which 
constitute 50% of azurophil granules (Rice et al., 1987), and it has been proposed that the 
presence of these microbicidal peptides may afford protection and compensate for absent 
NSPs.     
 
In conclusion, peripheral NET production did not change throughout the 21-day gingivitis 
model study; however neutrophil ROS and NET production significantly increased in 
response to stimulation with homogenised plaque samples collected from test sites.  These 
findings suggest that whilst the plaque biofilm evokes ROS and NET release in situ, biofilm 
accumulation and the subsequent localised inflammation in gingivitis do not impact upon 
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systemic neutrophil responses.  NET production was impeded in PLS patients, which is 
hypothesised to be the result of absent NE.  Furthermore, LL-37, which reportedly plays an 
important role in the clearance of A. actinomycetemcomitans, was lower in PLS patient 
plasma samples compared with controls.  However, despite the severe periodontal 
destruction, the majority of PLS patients are not susceptible to recurrent infections, which 
suggests that NSPs and NET release is not the only process involved in host defence.   
Further work is thus required to elucidate the mechanisms that result in dysfunctional NSPs 
associated with severe periodontitis in PLS. 
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 CONCLUDING REMARKS CHAPTER 9:
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9.1 Summary of main findings 
 
The aim of this thesis was to further explore the role of NETs in periodontal diseases, 
including experimental gingivitis, chronic periodontitis and Papillon Lefèvre syndrome (PLS) 
patients.  Specific aims were to investigate: 
1. The interactions between NETs and a range of periodontal bacteria.   
2. NET production by peripheral blood neutrophils from healthy volunteers developing 
experimental gingivitis, chronic periodontitis patients and PLS patients. 
 
3. NET degradation by periodontitis patients’ plasma and the potential effects of NETs 
on neutrophil responses. 
 
4. The impact of CSE upon NET production, neutrophil chemotaxis and the expression 
of key genes involved in neutrophil activation. 
 
 
In order to study NET release, neutrophils were isolated from the peripheral blood of 
volunteers using discontinuous Percoll gradients.   Preliminary experiments (Chapter 3) 
investigated neutrophil preparation techniques and Percoll appeared to be the most 
appropriate isolation method, evidenced by the metabolic activation and higher NET release 
by Percoll-isolated cells.  Percoll was subsequently selected as the isolation technique for all 
ex vivo neutrophil assays in this thesis. 
 
Neutrophil stimulation with a panel of periodontal bacteria demonstrated differential ROS 
and NET release between organisms (Chapter 4).  This variability may contribute to the 
pathogenesis of periodontal diseases by mechanisms such as bacterial avoidance of host 
responses, which may promote bacteria colonisation and persistence of infection.  Whilst 
neutrophil responses may limit dysbiosis and the emergence of pathogenic bacteria, excessive 
NET and ROS release may conversely cause periodontal tissue damage and indirectly support 
the proliferation of pathogenic bacteria by providing a source of nutrients.   
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NETs were found to entrap all periodontal bacteria tested to some extent, consistent with 
previous findings suggesting NETs can entrap a significant majority of microorganisms 
(Brinkmann et al., 2004).  Notably, many periodontal bacteria are reported to release DNases, 
which may have the ability to disassemble NET structures and contribute to biofilm 
pathogenicity (Palmer et al., 2011).  However, further work is required to elucidate whether 
DNase release by certain bacterial pathogens specifically allows these species to disseminate, 
or whether DNase release provides a mutually beneficial environment in which all biofilm 
bacteria are also afforded protection.  Recent findings by Hirschfeld et al., (2015) 
demonstrated that following the recruitment of neutrophils to the oral biofilm, they can 
infiltrate the dental plaque and subsequently release NET structures.  Whilst the ex vivo NET 
assays presented in this thesis further our understanding of the interactions that occur 
between NETs and specific periodontal bacteria, these data are not representative of an in 
vivo bacterial biofilm.  It is interesting to speculate that differences in NET induction between 
periodontal species may be compensated for when these species co-exist within a biofilm 
structure.  Under the experimental conditions employed, the incubation of NETs with 
periodontal bacteria did not appear to impede bacterial growth or survival.  It is difficult to 
ascertain whether this uninhibited growth was the result of NETs being unable to kill these 
bacteria, or a result of the experimental conditions, as the robustness of NET killing assays 
previously published has been questioned (Menegazzi et al., 2011).   
 
To investigate NET release by peripheral blood neutrophils in chronic periodontitis, a 
longitudinal intervention study was undertaken (Chapter 5).  This is the first study to quantify 
peripheral NET release in periodontitis, and no differences were observed in NET production 
between chronic periodontitis patients and healthy controls; a finding consistent with a 
collaborative parallel study in a Greek cohort.  Given that NET production is ROS-
dependent, and it is well established that chronic periodontitis patient neutrophils are 
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hyperactive and hyper-reactive with respect to ROS release (Matthews  et al., 2007a, 2007b), 
no differences in NET release between patients and controls suggests that the hyper-
responsive phenotype does not extend to NET release.  Notably, NET production following 
successful non-surgical periodontal treatment decreased in periodontitis patients.  In terms of 
age, pre-treatment results demonstrated NET production was lower in healthy controls, and to 
lesser extent, patients, over 50 years of age (published in Hazeldine et al., 2014).  It is 
postulated that age-related reductions in NET production may be associated with reduced 
receptor signalling in response to stimulation (Hazeldine et al., 2014); however, further work 
is required to understand the age-associated changes in NET production, which appear to be 
independent of periodontal inflammatory status. 
 
NET degradation by chronic periodontitis patients’ plasma was measured, for the first time, 
and demonstrated that NET degradation was significantly lower in a subset of chronic 
periodontitis patients pre-treatment, relative to periodontally healthy matched controls 
(Chapter 6).  Following non-surgical treatment, NET degradation in periodontitis patients 
was comparable to controls.  Attenuated NET degradation has been reported in SLE, and has 
been suggested to be the result of DNase 1 inhibitors or the presence of a physical barrier that 
prevents DNase 1 access to cleavage sites on the NET backbone (Hakkim et al., 2010, Leffler 
et al., 2012).  Consistent with findings in SLE, plasma IgG subclass concentrations were 
significantly higher in periodontitis patients, relative to controls.  In addition, plasma 
immunoglobulin FLC concentrations were higher in patients, and notably plasma cystatin C 
levels (an independent measure of renal clearance) demonstrated that elevated FLC in 
patients is not a result of insufficient renal FLC clearance, and thus likely to be due to FLC 
overproduction by B cells.  Increased circulating IgG and FLCs in periodontitis patients may 
provide a physical barrier and prevent the enzymatic degradation of NETs by DNase 1, 
however further experiments are required to confirm this hypothesis in periodontitis.   
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Attenuated NET removal may constitute an antimicrobial host response during periods of 
infection, as NETs can prevent microbial dissemination by entrapping various periodontal 
bacteria (Chapter 4).  Indeed, under the reported experimental conditions, treatment of 
peripheral neutrophils with NET supernatants did not prompt ROS or further NET 
production, or induce NET-mediated cytotoxicity in H400 cells; suggesting NETs are non-
immunogenic (Chapter 6).  Conversely, it is possible that NET production in periodontal 
tissues may serve as a plausible mechanism for anti-citrullinated protein antibodies (ACPAs) 
production following a break in immune tolerance, and this process may be exacerbated if 
NETs are not removed efficiently (dePablo et al., 2009).  Whilst no NET-induced pro-
inflammatory responses were observed in this thesis, it is possible that ex vivo assays do not 
fully mimic the in vivo environment in periodontitis, comprising a microbial biofilm, other 
pro-inflammatory mediators and chronic activation of immune defence systems. 
Pre-treatment of peripheral neutrophils with cigarette smoke extract (CSE) had an inhibitory 
effect on NET release, which may be due to alterations in PKC signalling and subsequently 
attenuated neutrophil ROS production (Matthews et al., 2011, 2012) (Chapter 7).  Cigarette 
smoking may therefore subvert the elimination of periodontal bacteria in vivo, as neutrophils 
are unable to effectively kill the colonising pathogens, which may be one mechanism to 
explain why smoking is a major risk factor for the development of periodontitis (Grossi et al., 
1994, 1995).  Notably, no differences were observed in NET release following pre-treatment 
with nicotine or cotinine.  However, neutrophil priming with thiocyanate (SCN-), the 
preferred substrate for MPO causing the production of hypothiocyanous acid (HOSCN), 
caused a reduction in NET release.  Increased HOSCN production concomitantly decreases 
HOCl production, a process that may afford protection of non-thiol targets against HOCl-
mediated tissue damage (Talib et al., 2012).   
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Neutrophils pre-treated with CSE exhibited reduced chemotactic speed, velocity and 
directionality (resultant vector length), which may be the result of attenuated ROS production 
(Hattori et al., 2010) (Chapter 7).  However, given that the severity of periodontitis is 
positively correlated with neutrophil counts in dental plaque, saliva and GCF (Bhadbhade et 
al., 2012), whilst chemotactic accuracy may be compromised in smokers, neutrophils still 
reach the infected tissues, albeit with longer tissue transit times, which may be associated 
with increased neutrophil-mediated tissue damage (Roberts et al., 2015).  Furthermore, 
relative to the reference gene YWHAZ, CSE and SCN- treatment caused a concentration 
dependent increase in neutrophil HSP40 expression.  SCN- treatment was also associated 
with a significant increase in P-47
phox
 and P-67
phox 
expression; however this was not observed 
following CSE treatment of neutrophils, highlighting that despite SCN- being a major 
component of cigarette smoke, these substances alter neutrophil activation and function by 
distinct mechanisms. 
NET production by peripheral blood neutrophils did not alter during the 21-day experimental 
gingivitis study period (Chapter 8), consistent with chronic periodontitis patients (Chapter 5). 
Neutrophil ROS and NET production significantly increased in response to stimulation with 
homogenised plaque samples collected from volunteer test sites.  These findings suggest that 
whilst the local periodontal inflammation does not impact upon systemic neutrophil 
responses, the plaque biofilm evokes ROS and NET release in situ.  Indeed, findings by 
Hirschfeld et al., (2015) demonstrated that the plaque biofilm that results from the 21-day 
gingivitis model comprises neutrophils and NET structures.   However, whether ex vivo 
assays (Chapter 4) are reflective of the in vivo interactions between the biofilm bacteria and 
NETs remains to be determined. 
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Peripheral NET release was impeded in PLS patients (Chapter 8) relative to healthy controls, 
which is consistent with recent findings by Sorensen et al., (2014), who  hypothesised that 
decreased NET production results from absent NSPs from mature neutrophils, and 
subsequently absent NE.  Accordingly, in the current study NE concentrations were 
significantly lower in patient-derived plasma samples, relative to the non-PLS controls.  
Additionally, LL-37, which is reportedly involved in the clearance of A. 
actinomycetemcomitans (Tanaka et al., 2000), was significantly lower in PLS plasma samples 
compared with control samples.  However, despite the severe prepubertal periodontal 
destruction seen in PLS patients, the majority of PLS patients are not susceptible to recurrent 
infections, which suggests that NSPs and NET release do not play a predominant role in host 
periodontal defence or that compensatory mechanisms exist which are less effective in the 
periodontium.  It is therefore likely that the periodontal destruction seen in PLS arises due to 
a constant stimulation of neutrophil recruitment and activation by the plaque biofilm and 
absent NSPs impacts upon multiple pathways that result in periodontal tissue destruction. 
 
9.2 Overall conclusion and recommendations for future research 
 
This thesis contributes to our understanding of NET release and function in the pathogenesis 
of periodontal diseases.   The data presented in this thesis indicate that NETs contribute to 
innate immunity, as they are released in response to a homogenised plaque biofilm and to 
specific bacteria that are associated with periodontitis.  However, given that periodontitis 
pathogenesis is characterised by exaggerated neutrophil responses, NETs may also facilitate 
the progression of the disease, as if NET degradation and removal is inefficient they may 
provide a source of autoantigens.  It is hoped that a greater understanding of NET responses 
in periodontal diseases in the future may contribute to improvements in prevention, 
diagnostic and treatment strategies.   
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Additional questions and further areas of research identified from the results presented in this 
thesis remain.  Therefore recommendations for future research include:  
 
 Quantification of peripheral NET production in response to a bacterial biofilm.  Whilst 
NETs were quantified in response to individual bacterial species associated with 
periodontitis (Chapter 4), it is possible that peripheral NET responses by neutrophils 
exposed to biofilm of varying complexity.  In addition to studying peripheral NET 
hyperactivity/hyper-reactivity, it would be interesting to quantify in situ NET release in 
the gingival tissues of chronic periodontitis patients.    
 
 NET degradation was significantly impeded in periodontitis patients relative to healthy 
controls.  It is hypothesised that this is the result of increased circulating antibodies and 
FLCs that provide a physical barrier and prevent enzymatic degradation of NET 
structures (Chapter 6).  Indeed antibody and FLC concentrations were higher in the 
plasma of periodontitis patients, however subsequent experiments are required to confirm 
that this is resulting in attenuated NET removal.  Experiments involving the removal of 
IgGs and FLCs from “low-degrading” plasma samples prior to quantifying NET 
degradation would address the current hypothesis.  
 
 The effect of CSE and SCN pre-treatment on NET production in response to stimulation 
with periodontally-relevant bacteria.  CSE and SCN- were found to have an inhibitory 
effect on PMA-induced NET production (Chapter 7).  Whilst PMA is a known NET 
stimulus, it is possible that cigarette components will have a different effect on bacteria-
induced NET production, which would be of relevance in chronic periodontitis patients.  
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I. ROS and NET production in response to live and dead bacteria 
To determine whether neutrophil activation differs between live and heat-killed bacterial 
stimuli, ROS and NET production were quantified in response to stimulation with 4 bacterial 
species.  Live and heat-killed bacteria were assayed in parallel at the same concentration 
(1x10
8
 and MOI of 1000).  Total ROS production quantified by enhanced luminol 
chemiluminescence was significantly higher in cells stimulated with heat-killed bacteria.  
This was statistically significant following stimulation with C. rectus, F. nucleatum poly and 
S. aureus compared with live bacteria (2way ANOVA and Bonferroni post-tests *p<0.05, 
****p<0.0001, *p<0.05, respectively, n=3) (Figure Ia).  Quantification of NET-DNA with 
Sytox green demonstrated that live bacteria induced elevated NET release compared with 
dead bacteria after 4 hours, however this was not statistically significant (2way ANOVA 
p>0.05, n=3) (Figure Ib).  
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Figure I: ROS and NET production in response to live and dead bacteria 
Live and heat-killed bacteria (both at 1x10
8
 and MOI of 1000) were employed as neutrophil 
stimuli.  (a) Total ROS production measured by luminol enhanced chemiluminescence.  Data 
is presented as RLU (relative light units). (b) Quantification of NET-DNA with Sytox green.  
Data is presented as AFU (arbitrary fluorescence units).  Statistical significance calculated 
using 2way ANOVA and Bonferroni post-tests (*p<0.05, ****p<0.0001 ns=not significant).  
Data expressed as mean ± SEM (n=3 in triplicate). 
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II. NET killing preliminary assays 
 
NET localisation to plastic-ware  
To determine the location of NETs post stimulation, NETs were fluorometrically quantified 
by digestion assay Sytox green staining under three different conditions:   
1. The supernatant was carefully aspirated off and the NETs in the supernatant were 
quantified with MNase digestion and Sytox green staining in a fresh plate.   
2. The addition of fresh RPMI to selected wells, which was mixed by pipetting and 
quantified in the same plate.   
3. NETs were quantified in the same well without the addition of fresh media but 
subjected to mixing by pipetting.   
These preliminary experiments indicated that NETs adhere to the culture well surface, as 
there was no significant difference between the number of NETs quantified in the well with 
or without the addition of fresh media (1way ANOVA p>0.05, n=2).  However there were 
significantly fewer NETs present in the well supernatant if removed from the well prior to the 
addition of MNase (1way ANOVA, ****p<0.0001, n=2).  These findings would allow for the 
media to be aspirated off prior to the addition of live bacteria to the well in future killing 
assays (Figure IIa).  This data was also corroborated by neutrophil and NET visualisation 
analysis, whereby 50nM PMA-stimulated neutrophils present in a 24-well plate were 
incubated for 3 hours, after which the supernatant was removed and the well contents 
visualised under bright field microscopy or by fluorometric analysis following Sytox green 
straining (Figure IIb). 
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Bacteria incubated with penicillin-streptomycin  
Treatment of bacteria with increasing concentrations of penicillin-streptomycin (pen-strep) 
was employed as a positive control for bacterial growth inhibition.  S. sanguinis 
(representative graph) was incubated with PBS (negative control) or pen-strep 
(concentrations ranging from 0.125-8.0µg/ml) for 1 hour prior to diluting the bacterial 
suspension and inoculating agar plates for the enumeration of colonies 24 hours later.  A 
concentration dependent decrease in bacterial growth was observed as a result of pen-strep 
treatment, relative to the PBS control.  This was statistically significant at 8.0µg/ml (Kruskal-
Wallis and Dunn’s post-tests *p<0.05, n=3) (Figure IIc).  
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Figure II: NET killing preliminary experiments   
(a) Neutrophils were stimulated for NET production (0.75mM HOCl for 3 hours) in a 24-well 
plate and the NETs fluorometrically quantified (Sytox green) under different experimental 
conditions.  NETs were quantified in: 1) the supernatant carefully removed from the well; 2) 
in the well following the careful removal of the supernatant and the addition of fresh media 
which was mixed by pipetting; and 3) in the well where the supernatant had been mixed by 
pipetting.  Statistical significance was calculated using 1way ANOVA (***p<0.001).  Data 
presented as AFU (arbitrary fluorescence units) and expressed as mean ± SEM (n=2 in 
triplicate).  (b) Microscopic analysis by stimulating neutrophils to produce NETs (50nM 
PMA for 3 hours) and removing the supernatant.  Adherent neutrophils were visualised under 
(i) brightfield and (ii) following the addition of Sytox green stain.  Representative images of 2 
experiments. (c)  Bacteria (representative graph showing S. sanguinis) incubated with PBS 
(negative control) or pen-strep (concentrations ranging from 0.125-8.0µg/ml) for 1 hour prior 
to inoculating agar plates to determine the effect on colony counts 24 hours later.  Statistical 
significance calculated using Kruskal-Wallis and Dunn’s post-tests (*p<0.05). Data presented 
as colony counts and expressed as mean ± SEM (n=3). 
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III.  Validation of the quantification of NET-bound components 
NET-bound components (NE, MPO and CG) were quantified following stimulation with 
PMA (50nM) to serve as a DNA-independent measure of NET release and to distinguish 
DNA release by necrosis from NETosis.  NETs were washed in a 24-well plate (2x in PBS) 
to ensure the quantification of neutrophil granule components associated with NET 
structures, and not components concurrently released during neutrophil activation.  To 
validate the assumption that wash steps enable only the quantification of NET bound 
components, preliminary experiments compared the quantification of commercially available 
MPO (0.5U/ml) in the supernatants of unwashed and washed wells.  MPO was significantly 
higher (OD540nm) in unwashed wells, compared with washed (Mann-Whitney *p=0.028, n=3).  
Similar observations were observed for the quantification of NE and CG (data not shown).  
These preliminary results confirm that 2 wash steps are sufficient to remove components in 
the supernatants and quantify only components associated with NETs (Figure III). 
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Figure III: Validation of the quantification of NET-bound components  
Commercially available MPO (0.5U/ml) was quantified in the supernatants of unwashed and 
washed wells (2x PBS).  MPO was significantly higher (OD540nm) in unwashed wells (2x PBS 
wash steps), compared with washed (Mann-Whitney *p=0.028).  Data presented as OD540nm 
and expressed as mean ± SEM (n=3 in duplicate).  
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IV.   Gram stains of bacteria 
               
 
 
                 
 
 
               
 
 
               
 
 
366 
 
C. sput (33612[4]) 
Gram negative 
Ovoid/rods 
 
S. constellatus (27823[M32b]) 
Gram positive 
Cocci/ovoid 
 
C. rectus (33238[371]) 
Gram negative 
Ovoid/rods 
 
 
C. showae (51146) 
Gram negative 
Ovoid/rods 
 
F. nucleatum nuc (25586) 
Gram negative 
Rods 
 
F. nucleatum poly (10953) 
Gram negative 
Rods 
 
P. gingivalis (W83) 
Gram negative 
Rods 
 
S. aureus (9144) 
Gram positive 
Cocci 
 
               
 
 
 
                
 
 
       
 
 
Figure IV: Gram stains of bacterial cultures 
Bacterial species were confirmed by Gram staining and analysis of bacteria morphology.  
Gram-negative bacteria stained-pink and Gram-positive bacteria stained blue.  Cell 
morphologies included cocci (spherical), ovoid or rods (bacilli).  Bacteria ATCC numbers are 
provided. 
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V. Comparisons between free light chain detection in plasma and serum samples 
The assay employed for the detection of FLCs carried out by The Binding Site is validated in 
serum samples (Katzmann et al., 2002).  To validate this technique in plasma samples for 
subsequent analysis of chronic periodontitis plasma samples, kappa and lambda FLCs were 
quantified in plasma and serum samples from the same individuals in parallel (n=30).  No 
significant difference was observed in the quantification of kappa (unpaired t-test p=0.58) or 
lambda (unpaired t-test p=0.28) FLCs in plasma and serum samples.  Based on these results, 
FLCs were quantified in plasma samples using the same technique currently used by The 
Binding Site for the quantification of FLC in serum samples (Figure V). 
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Figure V: Comparison between free light detection in plasma and serum samples 
(a) Kappa and (b) lambda FLCs were quantified in plasma and serum from the same 
individuals (n=30).  No significant difference was observed in the quantification of kappa 
(p=0.58) or lambda (p=0.28) FLCs in plasma and serum samples (analysed by unpaired t-
test).  Data presented as mg/l and expressed as mean ± SEM (n=30). 
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VI.   Collection and storage of NET supernatants 
To store NET supernatants for subsequent assays investigating the effect of NETs on 
neutrophil responses and H400 epithelial cell growth, NETs were collected and stored at 
different temperatures.  Storage conditions included 20°C, 37°C, 4°C, -20°C and -80°C (slow 
freezing by 1°C/minute or snap freezing with liquid nitrogen).  The effectiveness of the 
storage method was determined by comparing the number of NETs (NET-DNA) quantified in 
the supernatant with Sytox green before and after storage for 24 hours.  Results are presented 
as raw AFU data, as well as a ratio of the number of NETs quantified prior to storage.  No 
significant differences were observed in the number of NETs quantified between the storage 
conditions compared with NET quantification results prior to storage (2way ANOVA 
p>0.05, n=5) (Figure VIa).  Data expressed as a ratio of NET quantification results prior to 
storage demonstrated that the number of NETs quantified in the supernatant decreased as a 
result of storage at some temperatures, however this did not reach statistical significance 
(2way ANOVA p>0.05, n=5).  Quantification of NET-DNA in supernatants stored at -80°C 
by snap freezing in liquid nitrogen was the most representative of the NETs prior to storage, 
evidenced by the smallest ratio change.  Based on these findings, all NET supernatants were 
stored at -80°C by snap freezing prior to subsequent assays (Figure VIb). 
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Figure VI: NET supernatant storage 
NETs were stored at different temperatures (20°C, 37°C, 4°C, -20°C and -80°C [slow 
freezing by 1°C/minute or snap freezing with liquid nitrogen]).  The effectiveness of the 
storage method was determined by comparing the number of NETs before and after storage 
for 24 hours.  (a) NETs quantified by comparing AFU (arbitrary fluorescence units) values. 
(b) NET quantification expressed as a ratio of the number of NETs quantified prior to.  
Statistical significance calculated using 2way ANOVA (ns=not significant).  Data expressed 
as mean ± SEM (n=5 in triplicate). 
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VII. H400 cell counting 
Preliminary experiments compared in situ and trypsinised cell counts of H400 epithelial cells.  
In situ cell counts involved counting the cells comprising the monolayer adhered to the 
bottom of the flask.  Trypsinised counts were performed by discarding the supernatants from 
the flask and washing in PBS, followed by the addition of T-EDTA for 10 mins at room 
temperature.  The cell suspension was transferred to a fresh universal tube, centrifuged and 
re-suspended in cell culture media for subsequent cell counts.  Cell counts were compared at 
2, 3, 4 and 5 days after seeding flasks at 2x10
5
.  Results demonstrated that higher cell counts 
were achieved when cells were counted in situ compared with trypsinised cells.  However, 
both methods demonstrated comparable shaped growth curves, with similar standard 
deviations.  In situ cell counts may be less accurate, as the monolayer confluency may not be 
consistent across the entire flask.  Furthermore, to seed cells in a 96-well plate for subsequent 
NET supernatant assays, the cells will require trypsinising as they will not remain in the 
flask.  Therefore, all future counts for assays involving H400s and NET supernatants relied 
on trypsinised counts (Figure VII). 
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Figure VII: H400 cell counting 
Preliminary experiments compared (a) in situ and (b) trypsinised cell counts of H400 
epithelial cells.  Cell counts were compared at 2, 3, 4 and 5 days after seeding flasks at 2x10
5
.  
Results are representative of a single experiment, data expressed as the mean ± Std Dev.  
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VIII. Effect of cigarette smoke extract and cigarette smoke extract components on the 
fluorometric quantification of calf thymus DNA 
As it has previously been found that CSE inhibits luminol and isoluminol enhanced-
chemiluminescence (Matthews et al., 2011), preliminary studies were undertaken to establish 
whether CSE interferes with the NET quantification assay with Sytox green.  CSE (1%, 5%, 
10%) incubated with calf thymus DNA for 4 hours did not significantly affect the 
fluorometric quantification of calf thymus DNA (1way ANOVA p=0.98, n=5).  The same 
preliminary experiments were employed to determine whether CSE components affect the 
quantification of NET-DNA.  Nicotine (1µg/ml, 5µg/ml, 10µg/ml), cotinine (1µg/ml, 5µg/ml, 
10µg/ml) and SCN- (50µM, 100µM, 150µM) also had no inhibitory effect on NET 
quantification (1way ANOVA p=0.99, p=0.98, p=0.99 for nicotine, cotinine and SCN-, 
respectively, n=5).  Based on these results, neutrophils were not washed following a 30 min 
pre-treatment with CSE or CSE components in subsequent assays (Figure VIII). 
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Figure VIII: Effect of cigarette smoke extract and cigarette smoke extract components on the fluorometric quantification of calf thymus 
DNA 
Calf thymus DNA at increasing concentrations (µg) was incubated with PBS (negative control), CSE, nicotine, cotinine or SCN- for 4 hours.  
Post-incubation DNA was quantified fluorometrically with Sytox green.  Statistical significance was calculated using 1way ANOVA (ns=not 
significant).   Data are presented as Log10 AFU (arbitrary fluorescence units) and are expressed as mean ± SEM (n=5 in triplicate). 
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IX.   Isolation of neutrophil RNA 
The amount and purity of RNA isolated from treated neutrophils was determined by 
measuring the absorbance and the ratio of absorbance at 260/280nm.  Pure RNA has a 
260/280nm absorbance of 2.1, thus a value between 1.8-2.0nm is considered to be pure 
(Sambrook et al., 1989; Manchester 1996).  Adequate amounts (µg/ml) of RNA were 
measured for each sample, and based on the amount of RNA in each sample, samples were 
equally pooled across the treatment conditions (n=10 biological repeats per treatment 
condition) (Table IX a&b).  
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Table IX: Quantity and purity of RNA 
The amount and purity of isolated neutrophil RNA was determined by measuring the 
absorbance and the ratio of absorbance at 260/280nm. 
 
 
 
 
  
Sample 
No.  
PBS CSE 1% CSE 5% CSE 10% 
RNA 
µg/ml 
260nm/2
80nm 
ratio 
RNA 
µg/ml 
260nm/2
80nm 
ratio 
RNA 
µg/ml 
260nm/2
80nm 
ratio 
RNA 
µg/ml 
260nm/2
80nm 
ratio 
1 28.6 1.43 42.30 1.33 31.6 1.57 29.3 1.69 
2 31.9 1.99 54.90 1.40 32.5 1.61 28.2 1.7 
3 36.6 1.55 32.00 1.75 45.7 1.50 59.3 1.80 
4 55.0 1.60 31.08 1.90 29.6 1.15 31.3 1.70 
5 31.1 1.55 29.30 1.46 50.4 1.33 51.6 120 
6 33.1 1.29 33.50 1.30 54.5 1.19 43.1 1.25 
7 31.9 1.84 34.70 1.51 46.2 1.41 38.1 1.65 
8 33.5 1.62 49.80 1.12 33.9 1.18 54.5 1.23 
9 31.9 1.84 47.30 1.62 25.6 1.67 34.6 1.51 
10 45.1 1.21 33.70 1.89 57.0 1.24 32.4 1.58 
Sample 
No. 
PBS SCN
- 
50µM SCN
- 
100µM SCN
- 
150µM 
RNA 
µg/ml 
260nm/2
80nm 
ratio 
RNA 
µg/ml 
260nm/2
80nm 
ratio 
RNA 
µg/ml 
260nm/2
80nm 
ratio 
RNA 
µg/ml 
260nm/2
80nm 
ratio 
1 38.1 1.66 54.1 1.50 57.5 1.33 47.2 1.69 
2 32.8 1.73 56.9 1.65 59.0 1.62 49.5 1.72 
3 42.9 1.71 54.6 1.66 56.5 1.59 41.9 1.69 
4 66.3 1.56 55.7 1.48 36.8 1.41 20.8 1.87 
5 42.6 1.85 55.6 1.51 43.8 1.59 51.1 1.76 
6 52.0 1.82 42.4 1.94 36.9 1.55 48.0 1.80 
7 32.0 1.49 49.0 1.65 28.0 1.76 31.0 1.71 
8 29.5 1.71 45.8 1.39 38.4 1.70 24.6 1.70 
9 41.7 1.45 39.6 1.30 59.7 1.80 35.8 1.81 
10 47.6 1.47 29.3 1.58 26.2 1.74 36.5 1.69 
a) 
b) 
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X. Determination of stable housekeeping genes 
Preliminary assays determined the melt curves, amplification and efficiency of reference 
genes and the genes of interest.  Target gene expression was determined by calculating fold 
changes in gene expression as a ratio of a reference housekeeping gene.  The most 
appropriate housekeeper gene was determined by analysis of crossing point (CP) data with 
statistical algorithm BestKeeper (Pfaffl et al., 2004).  CP data indicates the number at which 
the fluorescence generation crosses the threshold and thus a sufficient number of amplicons 
have been produced (Rasmussen 2001).  BestKeeper expression indicates that all candidate 
housekeeping genes had standard deviations lower than 1, suggesting they were all viable 
housekeeping genes for the study of these cells.  However, YWHAZ had the lowest standard 
deviation (0.45) and was therefore considered the most stable of the reference genes tests.  
Based on these results, the YWHAZ housekeeping gene was considered the most consistent 
and therefore used as the reference against which to quantify the expression of genes of 
interest (Table X).   
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Table X: Comparison of housekeeping genes. 
Analysis of 4 candidate housekeeping genes (HKG) used crossing point (CP) data.  
Abbreviations: SD (standard deviation), coefficient of variance % of CP (the coefficient of 
variance expressed as a percentage on the CP level), minimum/maximum [x-fold] (the 
extreme values of expression levels expressed as an absolute x-fold over- or under-regulation 
coefficient).  Pfaffl et al., 2004, Rasmussen 2001. 
 
 
CP data of housekeeping Genes  
 
GAPDH YWHAZ HPRT1 RPL13 
 
HKG 1 HKG 2 HKG 3 HKG 4 
Number of samples 4 4 4 4 
Geometric mean of CP 29.50 27.36 32.40 25.58 
Arithmetic mean of CP 29.52 27.36 32.41 25.59 
Minimum CP 27.99 26.96 31.73 24.94 
Maximum CP 30.87 28.27 33.72 26.46 
SD of CP 0.79 0.45 0.65 0.56 
coefficient of variance (% 
of CP) 
2.66 1.66 2.02 2.20 
minimum [x-fold] -2.48 -1.31 -1.58 -1.49 
maximum [x-fold] 2.28 1.85 2.45 1.73 
Std Dev of absolute 
regulation coefficients 
1.60 1.31 1.48 1.40 
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XI.   RNA expression of cigarette smoke extract treated neutrophils relative to other 
reference genes 
Neutrophil RNA expression of NF-ĸB, HSP40, IL-8, P-47phox, P-67phox and GP-91phox was 
quantified by RT-PCR following CSE treatment (1%, 5%, 10%).  Data are expressed as a 
ratio of the reference genes, GADPH, HPTY1 and RPL13, and RNA expression of cells 
treated with PBS (negative control) were normalised to 1.   
 
GADPH 
In response to CSE treatment, HSP40 expression increased and this was statistically 
significant at concentrations of 5% and 10% CSE (2way ANOVA and Bonferroni post-tests 
****p<0.0001 for 5% and 10%, n=10 biological repeats, n=3 technical repeats) (Figure XIa).   
 
HPTY1 
In response to CSE treatment, HSP40 expression increased and this was statistically 
significant at concentrations of 5% and 10% CSE (2way ANOVA and Bonferroni post-tests 
****p<0.0001 for 5% and 10%, n=10 biological repeats, n=3 technical repeats).  Other non-
significant trends included decreases in P-67
phox 
and GP-91
phox 
expression (Figure XIb). 
 
RPL13 
In response to CSE treatment, HSP40 expression increased and this was statistically 
significant at concentrations of 5% and 10% CSE (2way ANOVA and Bonferroni post-tests 
**p<0.01, ****p<0.0001 for 5% and 10%, respectively, n=10 biological repeats, n=3 
technical repeats).  Other non-significant trends included a CSE-concentration dependent 
decrease in NF-ĸB and decreased GP-91phox expression (Figure XIc). 
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Figure XI: RNA expression of CSE treated neutrophils relative to other reference genes 
Data are expressed as a ratio of the reference gene and RNA expression of cells treated with 
PBS (negative control) was normalised to 1.  RNA expression as a ratio of reference gene (a) 
GAPDH, (b) HPTY1, (c) RPL13.  Statistical significance calculated using 2way ANOVA 
and Bonferroni post-tests (**p<0.01, ****p<0.0001).  Data is expressed as mean ± SEM 
(n=10 pooled biological repeats and n=3 technical repeats). 
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XII. RNA expression of thiocyanate treated neutrophils relative to other reference 
genes 
Neutrophil RNA expression of NF-ĸB, HSP40, IL-8, P-47phox, P-67phox and GP-91phox was 
quantified by real time PCR following SCN- treatment (1%, 5% or 10%).  Data are expressed 
as a ratio of the reference genes, GADPH, HPTY1 and RPL13, and RNA expression of cells 
treated with PBS (negative control) were normalised to 1.   
 
GADPH 
In response to all concentrations of SCN- treatment, HSP40 expression significantly 
increased (2way ANOVA and Bonferroni multiple comparisons tests ****p<0.0001 for 50µM 
and 100µM, p<0.05 for 150µM, n=3 technical repeats).  The expression of P-67
phox
 increased 
following 50µM SCN- treatment (2way ANOVA and Bonferroni multiple comparisons tests 
*p<0.05, n=10 biological repeats, n=3 technical repeats).  SCN- treatment at all 
concentrations was found to have an inhibitory effect on the expression of GP-91
phox
; 
however this was not statistically significant (Figure XIIa). 
 
HPTY1 
In response to all concentrations of SCN- treatment, HSP40 expression increased and this 
was statistically significant at concentrations of 50µM and 150µM SCN- (2way ANOVA and 
Bonferroni post-tests ****p<0.0001 for 50µM and 150µM, n=3 technical repeats).  The 
expression of P-47
phox
 increased following treatment with 150µM SCN- (2way ANOVA and 
Bonferroni multiple comparisons tests ****p<0.0001, n=10 biological repeats, n=3 technical 
repeats).  SCN- treatment at all concentrations was found to increase P-67
phox 
expression and 
was statistically significant at 100µM and 150µM SCN- (2way ANOVA and Bonferroni 
multiple comparisons tests **p<0.01, ****p<0.0001 for 100µM and 150µM SCN-, 
respectively, n=10 biological repeats, n=3 technical repeats) (Figure XIIb). 
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RPL13 
In response to SCN- treatment, HSP40 expression significantly increased and this was 
statistically significant at concentrations of 50µM and 100µM SCN- (2way ANOVA and 
Bonferroni post-tests **p<0.01, ***p<0.001 for 50µM and 100µM SCN-, respectively, n=10 
biological repeats, n=3 technical repeats).  P-67
phox 
expression increased following treatment 
with 100µM SCN- (2way ANOVA and Bonferroni post-tests ****p<0.0001, n=10 biological 
repeats, n=3 technical repeats).  Decreased GP-91
phox 
expression was also observed in 
response to all concentrations of SCN-, however this was not statistically significant (Figure 
XIIc). 
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Figure XII: RNA expression of thiocyanate treated neutrophils relative to other 
reference genes 
Data are expressed as a ratio of the reference gene and RNA expression of cells treated with 
PBS (negative control) was normalised to 1.  RNA expression as a ratio of reference gene (a) 
GAPDH, (b) HPTY1, (c) RPL13.  Statistical significance calculated using 2way ANOVA 
and Bonferroni post-tests (*p<0.05, **p<0.01, ****p<0.0001).  Data is expressed as mean ± 
SEM (n=10 pooled biological repeats and n=3 technical repeats). 
